Health News Briefing健康新闻简报

Singapore haze, 9pm Tuesday: West 24-h PSI edges up to 142, a new high for the day, with Central 122, East 106 and South 102 Unhealthy; NEA forecasts an Unhealthy 110–180 for Wednesday as smoke from Kalimantan drifts in新加坡烟霾（周二晚9时）：西部24小时PSI升至142，再创当日新高；中部122、东部106、南部102为“不健康”。环境局预测周三PSI为110–180（不健康），加里曼丹烟雾正飘向新加坡

Official NEA real-time readings (data.gov.sg) at 9pm on 20 Oct 2026: 24-h PSI West 142, Central 122, East 106, South 102 (Unhealthy, 101–200) and North 86 (Moderate). 1-h PM2.5 was 94 µg/m³ in the West and 74 in Central (Band II Elevated, 56–150), 50 in the East and 39 in both the North and South (Normal). At 8pm the West had read PSI 141 with PM2.5 93 and Central PM2.5 80. In its 7:25pm haze update NEA said that despite afternoon showers, residual smoke haze from Kalimantan was observed drifting towards Singapore and smoke haze was also seen over Sumatra; its 24-h PSI forecast for 21 Oct is 110–180, in the Unhealthy range.2026年10月20日晚9时国家环境局官方实时数据（data.gov.sg）：24小时PSI西部142、中部122、东部106、南部102（不健康，101–200），北部86（中等）。1小时PM2.5西部94微克/立方米、中部74（二级“偏高”，56–150），东部50，北部和南部均为39（正常）。晚8时西部PSI为141，PM2.5为93，中部PM2.5为80。环境局在晚7时25分的烟霾通报中表示，尽管午后有阵雨，仍观察到来自加里曼丹的残余烟霾飘向新加坡，苏门答腊上空也出现烟霾；其对10月21日的24小时PSI预测为110–180，处于“不健康”范围。

Why it matters: 为何重要：Wednesday's forecast is higher than Tuesday's (90–160): people with heart or lung disease, older people, children and pregnant women should plan to cut outdoor exertion and check hourly PM2.5 before going out.周三的预测高于周二（90–160）：心肺疾病患者、老人、儿童和孕妇应计划减少户外剧烈活动，并在外出前查看每小时PM2.5。

NEA real-time PSI/PM2.5 (data.gov.sg); NEA haze situation update ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-9pm-psi-west-142-new-day-high-central-122-pm25-west-94-nea-forecast-oct21-110-180-unhealthy

Malaysia's parliamentary health select committee will hand a memorandum on transboundary haze to Indonesia's embassy on Wednesday; in the same budget debate an MP said 382 of 1,055 doctors offered permanent posts in Sabah and Sarawak this year did not report for duty马来西亚国会卫生特别委员会将于周三向印尼大使馆递交跨境烟霾问题备忘录；同场预算辩论中有议员指出，今年获派沙巴和砂拉越常任职位的1,055名医生中有382人未报到

Health Special Select Committee chairman Suhaizan Kaiat (PH-Pulai) told the Dewan Rakyat on 20 Oct 2026, during debate on the 2027 Supply Bill, that the committee would deliver a memorandum on transboundary haze to the Indonesian embassy the next morning, citing its effects on public health, safety, the economy and relations between neighbours (Sinar Harian). Khoo Poay Tiong (PH-Kota Melaka) urged action against Malaysian companies allegedly linked to forest burning in Indonesia, citing a Greenpeace report naming 20 companies, and suggested following Singapore's warning notices to 10 firms. Andi Muhammad Suryady Bandy (BN-Kalabakan) said 36% — 382 of 1,055 — medical officers offered permanent placements in Sabah and Sarawak this year did not report for duty, and asked for the RM360 regional allowance to be reviewed. Separately, Harian Metro reported that decisions to close schools because of haze are made jointly by the education, health and natural resources ministries.据《Sinar Harian》报道，国会卫生特别委员会主席Suhaizan Kaiat（希盟-埔莱）2026年10月20日在下议院辩论《2027年财政预算案》时表示，委员会将于次日上午向印尼大使馆递交跨境烟霾问题备忘录，指出烟霾影响公共卫生、民众安全、国家经济及邻国关系。Khoo Poay Tiong（希盟-马六甲市区）援引绿色和平组织点名20家公司的报告，促请政府对涉嫌参与印尼森林焚烧的本地公司采取行动，并建议效仿新加坡向10家公司发出警告通知。Andi Muhammad Suryady Bandy（国阵-卡拉巴干）指出，今年获派沙巴和砂拉越常任职位的医务官中有36%（1,055人中的382人）未报到，并要求检讨每月360令吉的地区津贴。另据《Harian Metro》报道，因烟霾关闭学校的决定由教育部、卫生部和自然资源部三部共同作出。

Why it matters: 为何重要：The haze has now become a diplomatic and parliamentary issue in Malaysia, while the Borneo doctor shortfall shows how hard it is to staff hospitals in the regions closest to the fires.烟霾已成为马来西亚的外交和国会议题；而婆罗洲医生缺额则显示，离火场最近的地区医院人手有多难补齐。

Sinar Harian; Harian Metro ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-parliament-health-select-committee-haze-memorandum-indonesian-embassy-382-of-1055-mos-no-show-sabah-sarawak

Dengue on Vietnam's resort island of Phu Quoc passes 1,000 cases this year, 6.9 times the same period of 2025; two-thirds are in An Thoi, and more than 400 people have been mobilised for a mosquito-larvae clean-up越南度假岛富国岛今年登革热病例超过1,000例，是2025年同期的6.9倍；三分之二集中在安泰，当局动员400多人开展清除蚊子幼虫行动

The People's Committee of the Phu Quoc special zone (An Giang province) has launched a campaign against mosquito larvae and dengue across eight neighbourhoods of An Thoi, Dan Tri reported on 20 Oct 2026. The zone has recorded more than 1,000 dengue cases so far this year, 6.9 times the same period of 2025; An Thoi alone accounts for 672 cases (65.11%). Officials blamed alternating rain and heat that leave water standing in containers, high population density and tourism, more than 10,000 construction workers whose movements make outreach harder, and patchy weekly larvae removal by households. Over 417 health workers, soldiers, businesses and residents' representatives were split into 67 teams to inspect water containers, destroy larvae, clear bushes and unblock drains.据《民智报》2026年10月20日报道，富国特区（安江省）人民委员会已在安泰8个街区启动灭蚊幼虫、防控登革热行动。今年以来该特区登革热病例超过1,000例，是2025年同期的6.9倍；仅安泰就有672例，占65.11%。官员将原因归于晴雨交替使容器积水、人口密集和旅游业繁忙、逾1万名流动的建筑工人增加宣传难度，以及部分居民未坚持每周清除蚊子幼虫。逾417名医务人员、军人、企业和街区代表分成67个工作组，检查盛水容器、清除幼虫、清理灌木并疏通排水沟。

Why it matters: 为何重要：Phu Quoc draws many Chinese and other Asian tourists; travellers should use repellent and seek care for fever within two weeks of returning.富国岛吸引大量中国及其他亚洲游客；旅客应使用驱蚊剂，回国两周内如发热应及时就医。

Dan Tri (Phu Quoc special zone People's Committee) ↗ · r-2026-10-vietnam-phu-quoc-dengue-over-1000-cases-6-9x-2025-an-thoi-672-65pct-417-people-larvae-campaign

Hong Kong's Department of Health refers a registered Chinese medicine practitioner suspected of issuing sick-leave certificates without seeing patients to the Chinese Medicine Council and the police for criminal investigation香港卫生署将一名涉嫌未经诊症即签发病假证明书的注册中医师个案转介香港中医药管理委员会及警方作刑事调查

Following media reports, the Department of Health said on 20 Oct 2026 that it had referred the case of a registered Chinese medicine practitioner suspected of issuing sick-leave certificates without consultation to the Chinese Medicine Council of Hong Kong and the Hong Kong Police Force for criminal investigation and follow-up. Registered and listed Chinese medicine practitioners must follow the Council's code of practice and its reference guidelines on sick-leave and attendance certificates, issuing them on professional judgement of each patient's condition. Complaints are handled under the Chinese Medicine (Disciplinary) Regulation (Cap 549D); practitioners have previously been struck off the register for issuing misleading or false sick-leave certificates.香港卫生署2026年10月20日表示，就传媒报道怀疑有一名注册中医师在未有诊症的情况下发出病假证明书，已把个案转介香港中医药管理委员会及香港警务处作刑事调查及跟进。注册及表列中医须遵守管委会订定的《中医守则》及《注册中医签发病假证明书及到诊证明书参考指引》，根据个人专业判断，因应病人个别情况签发病假证明。投诉按《中医（纪律）规例》（第549D章）处理；过去曾有中医师因发出具误导成分或虚假的病假证明书而被除名。

Why it matters: 为何重要：Trust in sick-leave certificates matters for employers and for Hong Kong's growing integration of Chinese medicine into the public health system.病假证明的可信度关系到雇主，也关系到香港正在推进的中医药融入公营医疗体系。

HKSAR Government press release (Department of Health) ↗ · r-2026-10-hk-dh-refers-registered-chinese-medicine-practitioner-suspected-sick-leave-certificates-without-consultation-police

A chemotherapy-protection drug first used in China through Hainan's Boao Lecheng pilot zone is now made in Haikou and will supply the US and European markets from 2027, Simcere says; its China price after insurance listing is under 5% of the original US price先声药业：借助海南博鳌乐城先行区率先在国内使用的化疗骨髓保护药科赛拉，已实现海口本地化生产，预计2027年“海口造”产品将供应欧美市场；进入医保后国内价格不到海外价格的5%

China News Service reported on 20 Oct 2026 from Simcere's plant in the Haikou National High-tech Zone that trilaciclib (Cosela), licensed from a US partner, protects patients' bone-marrow stem cells from chemotherapy damage. Approved in the US in February 2021 at about US$1,400 a vial, it was used by Chinese patients in the Boao Lecheng international medical tourism pilot zone within four months under special-access rules; more than 30 patients there joined a real-world study, and NMPA granted conditional import approval in July 2022, 17 months after the US. Local production began in Haikou in April 2024 with annual capacity of 2 million vials, and after inclusion in the national reimbursement list its retail price fell to 466 yuan a vial. In the first half of 2026 Simcere signed a supply agreement with its US partner; production for the US and Europe will gradually move to Haikou, with supply expected from 2027. Simcere president Zhou Yunshu credited Hainan Free Trade Port tariff and tax policies.中新社2026年10月20日在海口国家高新区先声药业生产基地报道：由先声药业与美国企业合作引进的注射用盐酸曲拉西利（科赛拉）可为患者骨髓造血干细胞穿上“防弹衣”，减少化疗对正常造血的损伤。该药2021年2月在美国获批，每支售价1400美元；不到4个月后，中国患者借助特许政策在博鳌乐城先行区用上该药，30多位患者参与真实世界研究；2022年7月获国家药监局附条件批准进口注册，中美获批时间差仅一年零五个月。2024年4月在海口实现本土化生产，年产能200万支；进入国家医保目录后零售价降至466元一支，不到海外价格的5%。2026年上半年先声药业与美国合作公司达成生产供货协议，美欧生产端将逐步转移至海口，预计2027年供应欧美市场。先声药业集团总裁周云曙表示，这得益于海南自贸港的零关税和税收政策。

Why it matters: 为何重要：An example of China's 'use first in Lecheng, then register, then manufacture' route cutting both the delay and the cost of new medicines for Chinese patients — and now reversing the flow toward export.这是中国“乐城先行先用—注册—本地生产”路径的一个例子，既缩短了中国患者用上新药的时间，也降低了费用——如今还开始反向出口。

China News Service ↗ · r-2026-10-simcere-trilaciclib-cosela-haikou-made-to-supply-us-europe-2027-boao-lecheng-real-world-466-yuan-nrdl

Guangxi and five Vietnamese border provinces and cities agree to deepen cross-border health cooperation, including joint thalassaemia and cataract treatment projects, and their CDCs sign a disease-control memorandum广西与越南五省市同意深化跨境卫生合作，合作开展地中海贫血和白内障治疗项目，双方疾控中心签署疾病预防控制合作谅解备忘录

The Guangxi Zhuang Autonomous Region Health Commission said on 19 Oct 2026 (China News Service, 20 Oct) that a 2026 health exchange meeting between Guangxi and Vietnam's Quang Ninh, Lang Son, Cao Bang, Tuyen Quang and Hai Phong was held in Wuzhou. The commission and the five Vietnamese health departments signed meeting minutes agreeing to keep rotating the exchange, to sign a new health cooperation implementation plan when appropriate, and to expand training and cooperation in cross-border medical care, AI in health care, infectious-disease control and traditional medicine, including joint thalassaemia and cataract treatment projects. The CDCs of Guangxi and the five provinces and cities signed a memorandum of understanding on disease prevention and control, and the Vietnamese delegation visited the China–ASEAN Medical and Health Cooperation Centre (Guangxi).据中新网10月20日报道，广西壮族自治区卫生健康委员会19日介绍，2026年中国广西与越南广宁、谅山、高平、宣光、海防五省市卫生专场交流会近日在梧州举行。自治区卫健委与越南五省市卫生厅签署会议纪要，同意继续机制化轮流举办卫生专场交流活动，择机签署新一轮卫生合作执行计划，深化人才培训交流，加强跨境医疗、人工智能+医疗卫生保健、传染病防控、传统医药等领域合作，合作开展地中海贫血和白内障治疗项目。广西与越南五省市疾控中心签署《关于疾病预防控制领域合作的谅解备忘录》；越南代表团还参观了中国—东盟医疗保健合作中心（广西）等机构。

Why it matters: 为何重要：Thalassaemia is one of the most common inherited blood disorders in Guangxi and northern Vietnam; cross-border screening and treatment cooperation can reach families on both sides.地中海贫血是广西和越南北部最常见的遗传性血液病之一；跨境筛查和治疗合作可惠及边境两侧的家庭。

China News Service (Guangxi Health Commission) ↗ · r-2026-10-guangxi-vietnam-five-provinces-health-exchange-thalassaemia-cataract-projects-cdc-mou-cross-border-medical

Korean surgeons from Seoul National University Bundang Hospital perform free reconstructive surgery on 36 Vietnamese children with facial deformities in Ho Chi Minh City, the 28th mission of a programme running since 1996韩国首尔大学盆唐医院外科团队在胡志明市为36名面部畸形越南儿童免费实施重建手术，这是该项目自1996年启动以来的第28次义诊

Seoul National University Bundang Hospital said on 20 Oct 2026 (Korea Biomedical Review) that its volunteers operated on 36 Vietnamese children with facial deformities at Military Hospital 175 in Ho Chi Minh City from 4 to 10 Oct, working alongside Vietnamese surgeons, anaesthetists and nurses who observed and learned reconstructive techniques. The programme, organised with Smile for Children and SK ecoplant and described as Korea's largest overseas medical volunteer initiative, was led by SNUBH plastic surgery chief Kim Baek-kyu and Smile for Children chairman Baek Rong-min. Surgery can help children breathe, swallow and speak more easily as well as reduce stigma; the team also donated instruments, equipment and medicines, and sponsors covered surgical costs.据《Korea Biomedical Review》报道，首尔大学盆唐医院2026年10月20日表示，其义诊团队于10月4日至10日在胡志明市第175军医院为36名面部畸形的越南儿童实施手术，越南外科、麻醉和护理人员一同参与并观摩学习重建技术。该项目由盆唐医院与“微笑儿童”（Smile for Children）基金会和SK ecoplant联合举办，被视为韩国规模最大的海外医疗志愿项目，由盆唐医院整形外科主任金白圭和“微笑儿童”理事长白龙敏带队。手术可帮助患儿更顺畅地呼吸、吞咽和说话，并减少歧视；团队还捐赠了手术器械、医疗设备和药品，手术费用由赞助方承担。

Why it matters: 为何重要：Cleft lip/palate and other craniofacial differences are common birth conditions in Asia; surgery plus local training is what changes long-term access.唇腭裂等颅面畸形是亚洲常见的先天性疾病；手术加上本地培训才能真正改善长期可及性。

Korea Biomedical Review (SNUBH) ↗ · r-2026-10-snubh-28th-vietnam-mission-36-children-facial-deformities-free-reconstructive-surgery-military-hospital-175

A drug with a new mechanism for bipolar mania meets its goals in a phase 2 trial: RAP-219, which targets a brain-region-specific AMPA receptor partner, improved mania scores by 3.1 points more than placebo over three weeks, without the drowsiness of current drugs (company topline data)一种全新机制的双相躁狂药物在2期试验中达到主要终点：靶向脑区特异性AMPA受体辅助蛋白的RAP-219在三周内使躁狂评分比安慰剂多改善3.1分，且无现有药物常见的嗜睡（公司公布的顶线数据）

Rapport Therapeutics announced on 20 Oct 2026 topline results from a US randomised, double-blind phase 2 trial in 253 inpatient adults with acute bipolar I mania (YMRS ≥25). RAP-219 0.75 mg once daily, a TARPγ8-selective AMPA receptor negative allosteric modulator, reduced the Young Mania Rating Scale by 15.4 points from a baseline of 36.9 at week 3, versus 12.3 points with placebo — a 3.1-point difference (p=0.045); the CGI-BP mania severity score improved by 0.4 points more (p=0.024). Adverse-event rates were similar (51.6% vs 52.8%), all mild or moderate with no serious events; agitation was more frequent (16.7% vs 9.4%) and 3.2% vs 0.8% stopped because of side effects. Akathisia and extrapyramidal symptoms were not reported. Phase 3 trials are planned for the second half of 2027.Rapport Therapeutics于2026年10月20日公布一项美国随机双盲2期试验的顶线结果，入组253名急性双相I型躁狂住院成人（YMRS≥25）。每日一次0.75毫克RAP-219（TARPγ8选择性AMPA受体负性变构调节剂）在第3周使杨氏躁狂评定量表从基线36.9分下降15.4分，安慰剂组下降12.3分，差值3.1分（p=0.045）；CGI-BP躁狂严重度评分多改善0.4分（p=0.024）。不良事件发生率相近（51.6%对52.8%），均为轻中度，无严重不良事件；激越更常见（16.7%对9.4%），因不良反应停药者为3.2%对0.8%。未报告静坐不能和锥体外系症状。计划于2027年下半年启动3期试验。

Why it matters: 为何重要：Medium confidence: these are company-reported topline data from a short inpatient trial with a modest effect size and a p-value just under 0.05; full peer-reviewed results are still to come.中等可信度：这是公司公布的短期住院试验顶线数据，效应量不大，p值仅略低于0.05；完整的同行评议结果尚待发表。

Rapport Therapeutics (GlobeNewswire) ↗ · r-2026-10-rapport-rap-219-tarp-gamma8-ampa-nam-bipolar-mania-ph2-253-pts-ymrs-3-1-placebo-adjusted-p-0-045

UK Covid inquiry finds care homes were 'something of an afterthought' and there was no 'protective ring': more than 43,000 deaths involving Covid in care homes, hospital discharges without testing, PPE shortages and blanket do-not-resuscitate orders英国新冠调查认定，养老院在疫情中“几乎是事后才被想到”，所谓“保护圈”并不存在：养老院逾4.3万人死亡与新冠有关，存在未经检测即出院转入、防护装备短缺及一刀切“不予心肺复苏”等问题

The UK Covid-19 Inquiry published its Module 6 report on the care sector on 20 Oct 2026. The 287-page report finds that, contrary to then health secretary Matt Hancock's claim of a 'protective ring', care was 'something of an afterthought'. More than 43,000 deaths involving Covid were recorded in care homes between March 2020 and July 2022. It criticises PPE shortages (staff improvised with bin bags and ponchos), March 2020 guidance in England, Wales and Northern Ireland that did not ask for discharged hospital patients to be isolated without testing, a fragile workforce, visiting restrictions that stayed too tight after evidence showed visitors were a marginal risk, and evidence of blanket DNACPR orders, which rose from 16,800 to 26,500 in the first nine months. It makes eight recommendations for future pandemics (BBC).英国新冠调查委员会于2026年10月20日发布关于照护行业的第6模块报告。这份287页的报告认定，与时任卫生大臣马特·汉考克所称的“保护圈”相反，照护行业“几乎是事后才被想到”。2020年3月至2022年7月，养老院共记录逾4.3万例与新冠有关的死亡。报告批评了防护装备短缺（员工只能用垃圾袋和雨披代替）、2020年3月英格兰、威尔士和北爱尔兰的指引未要求对未经检测即出院转入的患者进行隔离、照护人员队伍脆弱、在证据显示探访者风险很低后探视限制仍过严，以及存在一刀切“不予心肺复苏”（DNACPR）医嘱的证据——此类医嘱在疫情头九个月从16,800份增至26,500份。报告为未来疫情提出8项建议（BBC）。

Why it matters: 为何重要：Ageing societies in China, Japan and Korea have large and growing care-home populations; the lessons on discharge testing, staff support and humane visiting apply directly.中国、日本、韩国等老龄化社会的养老机构入住人数庞大且不断增长；关于出院检测、员工支持和人性化探视的教训可直接借鉴。

UK Covid-19 Inquiry / GOV.UK; BBC News ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-uk-covid-inquiry-module-6-care-sector-report-no-protective-ring-afterthought-43000-deaths-dnacpr-16800-26500

Singapore haze, 7pm Tuesday: West 24-h PSI holds at 140, the day's high, with Central 122, East 106 and South 103 Unhealthy and North 85 Moderate. Hourly PM2.5 dipped to the day's lowest at 5–6pm, then edged back up in the West (79) and Central (76)新加坡烟霾（周二晚7时）：西部24小时PSI维持在当日最高的140；中部122、东部106、南部103为“不健康”，北部85为“中等”。每小时PM2.5在傍晚5–6时降至当日最低后，西部（79）和中部（76）略有回升

Official NEA real-time readings at 7pm on 20 Oct 2026 (data.gov.sg): 24-h PSI West 140, Central 122, East 106, South 103 (Unhealthy, 101–200) and North 85 (Moderate). 1-h PM2.5 was 79 µg/m³ in the West, 76 in Central and 56 in the East (Band II Elevated, 56–150), 54 in the South and 30 in the North (Normal). Hourly PM2.5 had fallen to the day's lowest at 5pm (24–77 µg/m³) and 6pm (West 73, Central 67) after afternoon showers, before rising slightly at 7pm. The 24-h PSI first reached 140 in the West at 5pm. NEA's forecast for 20 Oct was PSI 90–160, and it has warned that east-southeasterly winds from Tuesday night to Thursday may bring more smoke from fires in Kalimantan.2026年10月20日晚7时国家环境局官方实时数据（data.gov.sg）：24小时PSI西部140、中部122、东部106、南部103（不健康，101–200），北部85（中等）。1小时PM2.5西部79微克/立方米、中部76、东部56（二级“偏高”，56–150），南部54、北部30（正常）。午后阵雨后，每小时PM2.5在下午5时（24–77微克/立方米）和6时（西部73、中部67）降至当日最低，晚7时又略有回升。西部24小时PSI于下午5时首次达到140。环境局对10月20日的预测为PSI 90–160，并警告周二晚至周四的东南偏东风可能从加里曼丹火场带来更多烟雾。

Why it matters: 为何重要：The evening uptick comes just as NEA expects winds to turn and carry Kalimantan smoke overnight, so vulnerable people should check hourly PM2.5 before going out tonight and tomorrow morning.傍晚读数回升之际，正是环境局预计风向转变、夜间可能带来加里曼丹烟雾之时；易感人群今晚和明早外出前应查看每小时PM2.5。

NEA real-time PSI/PM2.5 (data.gov.sg); Lianhe Zaobao; CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-7pm-psi-west-140-central-122-east-106-south-103-pm25-west-79-central-76-rebound

Taiwan sees a jump in mpox clade Ib: 18 cases so far in October, the most in a month since October 2024, and 16 of them are clade Ib. Only 2 of the 16 had been vaccinated; about 32,000 people still need their second dose台湾M痘Ib型病例明显增加：10月迄今已确诊18例，创2024年10月以来单月新高，其中16例为Ib型；16人中仅2人曾接种疫苗，约3.2万人仍待接种第2剂

Taiwan CDC said on 20 Oct 2026 that 52 mpox cases (41 local, 11 imported) have been confirmed this year to 19 Oct, and 568 since mpox became a notifiable disease in June 2022. Since the first clade Ib case in May, 30 clade Ib infections have been found (22 local, 8 imported; Thailand was the most common place of infection, with 6). October's 18 cases to the 19th are the highest monthly count since October 2024, and the month may end near three times the monthly average; 16 of the 18 were clade Ib. The 16 patients were in their 20s to 40s, all reported unprotected sex and only two had ever been vaccinated. Of 112,774 people with at least one dose by end-September, 31,927 (28%) have not had the second. Two doses give about 90% protection, one dose about 40–80%; the vaccine and tecovirimat also work against clade Ib. 327 clinics offer free vaccination.台湾疾管署2026年10月20日表示，今年截至10月19日共确诊52例M痘（41例本土、11例境外移入），自2022年6月列为法定传染病以来累计568例。自今年5月出现首例Ib型病例以来，已检出30例Ib型（22例本土、8例境外移入；感染地以泰国6例居首）。10月截至19日已确诊18例，创2024年10月以来单月新高，推估本月确诊数可能接近月平均的3倍；18例中16例为Ib型。这16名确诊者年龄20多岁至40多岁，均有不安全性行为，仅2人曾接种疫苗。截至9月底，112,774人至少接种1剂，其中31,927人（28%）尚未接种第2剂。接种2剂保护力约9成，仅1剂约4至8成；疫苗及抗病毒药Tecovirimat对Ib型同样有效。全台327家合作医疗院所提供公费接种。

Why it matters: 为何重要：Clade Ib spreads more easily within households and can be more severe in people with weak immunity, such as young children and pregnant women — so a rise in local Ib cases matters beyond the groups first affected.Ib型更易在家户内传播，对幼童、孕妇等免疫力较弱者可能更严重——因此本土Ib型病例上升的影响不限于最初受波及的人群。

Taiwan CDC via Ministry of Health and Welfare ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-taiwan-cdc-mpox-clade-ib-30-cases-18-in-october-highest-since-oct-2024-16-of-18-ib-31927-need-2nd-dose

Malaysia haze, 5pm Tuesday: 25 areas still Unhealthy and the situation 'stable' — Batu Muda (Kuala Lumpur) 173, Johan Setia 171, Petaling Jaya and Shah Alam 169; Pegoh in Ipoh improves by 16 points to 135马来西亚烟霾（周二下午5时）：25个地区空气仍“不健康”，整体“稳定”——吉隆坡峇都慕达173、柔佛士迪亚171、八打灵再也和莎阿南169；怡保Pegoh下降16点至135

According to the Air Pollutant Index Management System (APIMS) at 5pm on 20 Oct 2026 (Astro Awani), 25 areas recorded Unhealthy API readings with no marked change. Batu Muda in Kuala Lumpur was highest at 173, followed by Johan Setia (171), Petaling Jaya and Shah Alam (169 each), Cheras (168), Bukit Rambai (166), Nilai (165), Klang (164), Putrajaya (163) and Banting (162). Seremban read 160 and Port Dickson 154; Alor Gajah and Melaka city 157; Larkin 159, Pasir Gudang and Kota Tinggi 156. Pegoh in Ipoh fell from 151 at 4pm to 135; Tanjung Malim improved to 112. All Pahang stations were Moderate (highest 97) and all Sabah and Sarawak stations Moderate or Good; eight areas were Good, with Kimanis (Sabah) lowest at 28.据马来西亚空气污染指数管理系统（APIMS）2026年10月20日下午5时数据（Astro Awani报道），25个地区空气污染指数处于“不健康”水平，整体无明显变化。吉隆坡峇都慕达最高，为173；其后为柔佛士迪亚（171）、八打灵再也和莎阿南（各169）、蕉赖（168）、武吉兰美（166）、汝来（165）、巴生（164）、布城（163）和万津（162）。芙蓉160、波德申154；亚罗牙也和马六甲市157；拉庆159，巴西古当和哥打丁宜156。怡保Pegoh从下午4时的151降至135；丹绒马林改善至112。彭亨所有监测站为“中等”（最高97），沙巴和砂拉越所有监测站为“中等”或“良好”；8个地区为“良好”，沙巴金马利最低，为28。

Why it matters: 为何重要：The Klang Valley has now sat in the Unhealthy band all day; outdoor activity curbs for schools and vulnerable groups remain relevant.巴生谷全天处于“不健康”水平；学校及易感人群减少户外活动的措施仍有必要。

Astro Awani (APIMS data) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-apims-oct20-5pm-25-areas-unhealthy-batu-muda-173-johan-setia-171-pj-shah-alam-169-pegoh-falls-16

Palangka Raya's acute respiratory infection count rises to 11,276 since June as thick haze blankets the Central Kalimantan capital; August was the worst month (3,104) and October has already logged 1,743印尼中加里曼丹首府帕朗卡拉亚被浓重烟霾笼罩，6月以来急性呼吸道感染病例升至11,276例；8月最多（3,104例），10月已录得1,743例

The Palangka Raya city health office said on 20 Oct 2026 (iNews) that acute respiratory infection (ISPA) cases since June 2026 have risen from 10,233 to 11,276 amid smoke from forest and land fires. Health office head Riduan said the highest monthly number was in August (3,104 cases), while October had recorded 1,743 cases up to the previous day. Thick haze covered the city on Tuesday, disrupting daily activities; children, older people and people with breathing problems are most at risk.帕朗卡拉亚市卫生局2026年10月20日表示（iNews报道），在森林和土地火灾烟雾影响下，2026年6月以来的急性呼吸道感染（ISPA）病例从10,233例升至11,276例。卫生局局长Riduan称，单月病例最多的是8月（3,104例），10月截至前一天已录得1,743例。周二浓重烟霾笼罩全市，影响居民日常活动；儿童、老人及有呼吸系统问题的人群风险最高。

Why it matters: 为何重要：Palangka Raya has recorded some of the highest air-pollution readings of this fire season; local case counts show the health toll building week by week.帕朗卡拉亚在本火灾季录得多个最高空气污染读数；当地病例数据显示健康损害正逐周累积。

iNews.id (Palangka Raya City Health Office) ↗ · r-2026-10-palangka-raya-ispa-11276-since-june-up-from-10233-august-peak-3104-october-1743-dinkes

Bangladesh dengue deaths reach 357 this year, with 1,366 more people hospitalised in a day; a government death review found more than a third of patients died within a day of admission, many after diagnosis delays of three days or more孟加拉国今年登革热死亡人数升至357人，单日新增住院1,366人；政府死亡病例审查发现，超过三分之一的患者在入院一天内死亡，许多人诊断延误三天以上

In the 24 hours to 8am on 20 Oct 2026, five dengue patients died and 1,366 were hospitalised, according to the Directorate General of Health Services, taking 2026 totals to 357 deaths and 115,617 cases; 5,944 patients were in hospital. A review of 119 deaths by the Institute of Epidemiology, Disease Control and Research (IEDCR) found that more than one-third died within a day of admission; 62.5% died of dengue shock syndrome and 31.2% of expanded dengue syndrome, and many had diagnostic delays of at least three days. Clinicians cited late referrals, long journeys from districts and transfers without stabilisation, and urged early admission for high-risk groups (pregnant women, infants, older adults and people with chronic diseases or obesity).据孟加拉国卫生服务总局数据，截至2026年10月20日上午8时的24小时内，5名登革热患者死亡、1,366人住院，使2026年累计死亡357人、病例115,617例；目前有5,944名患者住院治疗。流行病学、疾病控制与研究所（IEDCR）对119例死亡病例的审查发现，超过三分之一在入院一天内死亡；62.5%死于登革休克综合征，31.2%死于扩展型登革综合征，许多人诊断延误至少三天。临床医生指出转诊过晚、从地区长途转运以及未经稳定处理即转院等问题，并敦促孕妇、婴儿、老年人及慢性病或肥胖患者等高危人群及早住院。

Why it matters: 为何重要：Most dengue deaths are preventable with early recognition and careful fluid management; the review points to delays in the system rather than the virus alone.多数登革热死亡可通过早识别和规范补液避免；审查结果指向医疗体系的延误，而不仅是病毒本身。

The Daily Star (DGHS, IEDCR) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-bangladesh-dengue-357-deaths-115617-cases-1366-new-iedcr-review-third-die-within-day-of-admission

China issues 2026 service-capability standards for township hospitals and community health centres: fewer, simpler criteria, more focus on quality, TCM, rehabilitation, digital services and care for older people and children, and support for home beds and long prescriptions国家卫健委等发布2026版乡镇卫生院和社区卫生服务中心服务能力标准：精简条款、为基层减负，更加强调医疗质量、中医药、康复护理、数智化服务及“一老一小”服务，鼓励家庭病床和长期处方

The National Health Commission, the National Administration of Traditional Chinese Medicine and the National Disease Control and Prevention Administration have revised the 2022 standards into the Township Hospital Service Capability Standard (2026) and Community Health Service Centre Service Capability Standard (2026) (reported 20 Oct 2026). The NHC's primary health department said the new versions remove duplicated clauses, merge similar content and simplify scoring tiers to reduce the burden on primary-care facilities, and adjust criteria so they fit most institutions despite regional differences. They cover service functions and resources, basic medical and public-health services, operational and general management, with emphasis on medical quality, better services and TCM; they highlight specialty departments, integrating treatment and prevention, rehabilitation and nursing, and digital services; strengthen services for older people, children and emergencies; and encourage family sickbeds, long-term and extended prescriptions, home visits and mobile clinics.国家卫生健康委、国家中医药局、国家疾控局近日对2022版标准进行修订，形成《乡镇卫生院服务能力标准（2026版）》和《社区卫生服务中心服务能力标准（2026版）》（2026年10月20日报道）。国家卫生健康委基层卫生健康司有关负责人表示，新版标准删除重复交叉条款、合并相近内容、精简评价条款档次，为基层医疗卫生机构减负；并考虑区域差异和机构发展不平衡，优化评价条款，确保适用于绝大多数基层机构。新版标准分为服务功能与资源配置、基本医疗和公共卫生服务、业务管理、综合管理等章节，重点强调医疗质量、优化服务、中医药服务；突出特色科室建设、医防融合、康复护理、数智化服务；围绕“一老一小”提升老年人、儿科、急诊急救服务能力；鼓励提供家庭病床、长期处方、延伸处方以及上门服务、巡回诊疗等。

Why it matters: 为何重要：Township hospitals and community centres are where most rural and older Chinese get care; these standards decide what services they are expected to offer.乡镇卫生院和社区卫生服务中心是多数农村居民和老年人就医的地方；这些标准决定了它们应提供哪些服务。

National Daily Economic News via Sina Finance (NHC) ↗ · r-2026-10-nhc-2026-service-capability-standards-township-hospitals-community-health-centres-family-beds-yilao-yixiao

Chinese-made drugs made up 80% of the innovative medicines approved in China in the first three quarters of 2026, the industry ministry says, with breakthroughs in cancer, psychiatry, anti-infectives, gout and rare diseases工信部：2026年前三季度我国获批创新药中国产占比达80%，肿瘤、精神、抗感染、痛风、罕见病等多领域药物研究取得突破

Wang Weiming, chief engineer of the Ministry of Industry and Information Technology, told a State Council Information Office press conference on 20 Oct 2026 that domestically developed products accounted for 80% of the innovative drugs approved in China in the first three quarters of the year, and that drug research had made breakthroughs in several areas including oncology, psychiatry, anti-infectives, gout and rare diseases. The brief Xinhua report did not give the total number of approvals.工业和信息化部总工程师王卫明2026年10月20日在国新办新闻发布会上表示，前三季度我国获批创新药中，国产占比达80%，肿瘤、精神、抗感染、痛风、罕见病等多领域药物研究取得突破。新华社简讯未公布获批创新药总数。

Why it matters: 为何重要：Shows how quickly China's own pipeline now dominates new approvals at home — relevant to drug prices and access for patients in China and, increasingly, abroad.表明国产研发管线已迅速主导国内新药审批——这关系到中国乃至越来越多海外患者的用药价格与可及性。

Xinhua ↗ · r-2026-10-miit-q1-q3-2026-domestic-share-80pct-of-approved-innovative-drugs-scio-wang-weiming

Hong Kong suspends poultry meat and egg imports from H5N1 bird-flu outbreak areas in Manitoba (Canada) and Minnesota and Indiana (US); Hong Kong imported about 24,190 tonnes of US poultry meat and 20.2 million US eggs in the first half of the year香港暂停从加拿大曼尼托巴省及美国明尼苏达州、印第安纳州H5N1禽流感疫区进口禽肉及禽类产品（包括禽蛋）；上半年香港从美国进口约24,190吨禽肉及约2,020万只禽蛋

The Centre for Food Safety said on 20 Oct 2026 that, following World Organisation for Animal Health notifications of highly pathogenic H5N1 avian influenza outbreaks in the Municipality of Pembina, Manitoba (Canada), and in Stearns County and Benton County, Minnesota, and Jay County, Indiana (US), it had told the trade to suspend imports of poultry meat and products, including eggs, from these areas with immediate effect. In the first six months of 2026 Hong Kong imported no poultry meat or eggs from Canada, but about 24,190 tonnes of chilled and frozen poultry meat and about 20.2 million eggs from the US.香港食物安全中心2026年10月20日表示，鉴于世界动物卫生组织通报加拿大曼尼托巴省Pembina市，以及美国明尼苏达州Stearns县、Benton县和印第安纳州Jay县爆发高致病性H5N1禽流感，已指示业界即时暂停从上述地区进口禽肉及禽类产品（包括禽蛋）。2026年上半年，香港没有从加拿大进口禽肉或禽蛋，但从美国进口约24,190吨冷藏及冷冻禽肉和约2,020万只禽蛋。

Why it matters: 为何重要：H5N1 is spreading through North American poultry and dairy herds again this autumn; import controls are one of the ways Asian cities limit exposure.今年秋季H5N1再次在北美禽类和奶牛中扩散；进口管控是亚洲城市降低暴露风险的手段之一。

HKSAR Government press release (Centre for Food Safety) ↗ · r-2026-10-hk-cfs-suspends-poultry-imports-h5n1-pembina-manitoba-stearns-benton-minnesota-jay-indiana

One in four Korean adults has metabolic fatty liver disease, but 42% of people told about it at a health check do nothing next — most because they don't think it is serious, even though heart disease is a leading cause of death in these patients韩国四分之一成年人患代谢相关脂肪性肝病，但在体检中被告知的人有42%没有任何后续行动——多数认为不严重，而心血管疾病正是这类患者的主要死因之一

Health Chosun (20 Oct 2026) reported analyses by the National Institute of Health of the Korea Disease Control and Prevention Agency: Korea National Health and Nutrition Examination Survey data put the prevalence of metabolic dysfunction-associated fatty liver disease in adults at 24.1%. In a survey of 1,000 patients, 79.9% found out incidentally at a health screening, but only 57.7% then visited a medical institution; 42.3% took no action, most often (41.6%) because they did not think it was serious. KDCA data indicate losing 3–5% of body weight can reduce liver fat, and 7–10% may improve steatohepatitis and fibrosis. Kyung Hee University Hospital at Gangdong hepatologist Lee Moon-hyung advised liver fibrosis testing and regular follow-up for people with obesity or diabetes.《健康朝鲜》（2026年10月20日）报道了韩国疾病管理厅国立保健研究院的分析：韩国国民健康营养调查数据显示，成人代谢相关脂肪性肝病患病率为24.1%。在对1,000名患者的调查中，79.9%是在体检中偶然发现，但随后仅57.7%前往医疗机构就诊；42.3%未采取任何行动，最常见原因（41.6%）是认为病情不严重。疾病管理厅资料显示，体重减轻3%–5%可减少肝脏脂肪，减轻7%–10%可能改善脂肪性肝炎和肝纤维化。庆熙大学江东医院消化内科教授李文亨建议，肥胖或糖尿病人群应进行肝纤维化检测并定期随访。

Why it matters: 为何重要：Fatty liver is just as common in China and across East Asia, often in people who are not obese; the gap between a screening result and follow-up is a familiar problem.脂肪肝在中国和整个东亚同样常见，且常见于非肥胖人群；体检发现后不随访是普遍问题。

Health Chosun (KDCA National Institute of Health data) ↗ · r-2026-10-korea-mafld-24-1pct-adults-42-3pct-no-follow-up-after-screening-kdca-nih-1000-patients-cvd-risk

Japan's three-yearly national Patient Survey runs this week: about 6,600 hospitals, 5,900 clinics and 1,600 dental clinics record every patient seen on one assigned day between 20 and 23 October, data used for medical planning and fee revisions日本每三年一次的全国“患者调查”本周进行：约6,600家医院、5,900家诊所和1,600家牙科诊所在10月20日至23日间指定的一天记录所有就诊患者，数据用于医疗规划和诊疗报酬修订

The Ministry of Health, Labour and Welfare's 2026 Patient Survey, a core national statistical survey held every three years, collects data on patients using medical facilities. Facilities are selected by stratified random sampling nationwide: about 6,600 hospitals, 5,900 general clinics and 1,600 dental clinics. Hospital inpatients and outpatients are recorded on one ministry-assigned day between Tue 20 and Thu 22 Oct; clinic and dental patients on one assigned day among 20, 21 and 23 Oct; discharges are covered for 1–30 September. Facilities answer online or by post, and the Statistics Act requires both reporting and confidentiality. Results feed medical-care plans, medical fee revisions and other policy.厚生劳动省2026年患者调查是每三年一次的国家核心统计调查，收集利用医疗机构的患者情况。调查对象按分层随机抽样从全国选取：约6,600家医院、5,900家一般诊所和1,600家牙科诊所。医院住院和门诊患者以10月20日（周二）至22日（周四）中厚劳省指定的一天为对象；诊所及牙科患者以10月20、21、23日中指定的一天为对象；出院患者覆盖9月1日至30日。医疗机构可在线或邮寄填报，《统计法》规定了报告义务和保密义务。结果用于医疗计划制定、诊疗报酬修订等政策。

Why it matters: 为何重要：This snapshot is how Japan measures how many people are being treated for each disease — figures later cited across Asia for comparisons of ageing and chronic disease.这次“快照”是日本掌握各类疾病就诊人数的方式——其数据常被亚洲各地用于老龄化和慢性病的比较。

Ministry of Health, Labour and Welfare (Japan) ↗ · r-2026-10-japan-mhlw-2026-patient-survey-oct20-22-6600-hospitals-5900-clinics-1600-dental-every-3-years

The first 90 days on antipsychotic drugs are when blood sugar and weight climb fastest: in nearly 97,000 people in England, HbA1c rose about 14 times faster and weight 9 times faster than before treatment, most of all with olanzapine服用抗精神病药物的头90天血糖和体重上升最快：英格兰近9.7万人中，糖化血红蛋白上升速度约为治疗前的14倍、体重约9倍，奥氮平最为明显

A UCL-led observational study in The Lancet Psychiatry (reported 20 Oct 2026; NIHR-funded) analysed NHS GP records of nearly 97,000 adults aged 18–59 with severe mental illness who started olanzapine, quetiapine, risperidone or aripiprazole between 2000 and 2023, comparing two years before and after initiation. In the first 90 days, HbA1c rose about 14 times faster and weight about 9 times faster than before treatment; with olanzapine, HbA1c rose about 50 times faster and weight about 10 times faster. Among people with prediabetes at the start, 19% developed type 2 diabetes within two years versus 3% with normal glucose. Women had larger early HbA1c increases. Glucose and weight did not always change together, so weight checks alone may miss problems. The authors advise checking both before treatment and during the first months; the design cannot prove causation.伦敦大学学院牵头、英国国家卫生与护理研究院资助的一项观察性研究发表于《柳叶刀·精神病学》（2026年10月20日报道），分析了近9.7万名18–59岁重性精神疾病成人的英国国民医疗服务体系全科记录，他们在2000–2023年间开始服用奥氮平、喹硫平、利培酮或阿立哌唑，研究比较了用药前后各两年的数据。用药头90天内，糖化血红蛋白上升速度约为治疗前的14倍，体重约为9倍；奥氮平组糖化血红蛋白上升约50倍、体重约10倍。起始时为糖尿病前期者，两年内19%发展为2型糖尿病，血糖正常者为3%。女性早期糖化血红蛋白升幅更大。血糖与体重变化并不总是同步，仅监测体重可能漏诊。作者建议用药前及用药头几个月同时检查体重和血糖；该研究设计无法证明因果关系。

Why it matters: 为何重要：People with severe mental illness die years earlier, largely from heart disease and diabetes; a clear monitoring window is simple to act on in any health system.重性精神疾病患者寿命明显缩短，主要源于心脏病和糖尿病；明确的监测窗口在任何医疗体系中都易于落实。

The Lancet Psychiatry via Pharmafile (UCL) ↗ · r-2026-10-ucl-lancet-psychiatry-antipsychotics-first-90-days-hba1c-14x-weight-9x-faster-97000-olanzapine-50x

Daily vitamin C for people at risk of leukaemia: in a small blinded trial of 109 patients with pre-leukaemic blood disorders, 1,000 mg a day did not slow abnormal cell growth but was linked to fewer adverse events and, in an exploratory analysis, better survival at about three years每天服用维生素C的白血病高危人群：一项纳入109名白血病前期血液病患者的小型盲法试验中，每日1,000毫克未能减缓异常细胞扩增，但不良事件更少，且探索性分析显示约三年时生存更好

The phase 2 EVITA trial (Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team, led by Kirsten Grønbæk, University of Copenhagen; published in Cancer; ScienceDaily 20 Oct 2026) randomised 109 untreated patients with clonal cytopenia of undetermined significance (CCUS) or lower-risk myelodysplastic syndrome to 1,000 mg oral vitamin C or placebo daily for 12 months at four hospitals in Denmark and the US. More than half had low vitamin C at baseline, which normalised with supplementation. Vitamin C did not significantly change the rate of clonal expansion, but the supplement group had fewer adverse events and cytokine changes associated with better outcomes, and an exploratory analysis found they were significantly more likely to be alive after about three years. Vitamin C supports TET2, an enzyme often mutated in these disorders. Researchers say a phase 3 trial is needed before any recommendation.II期EVITA试验（范安德尔研究所–“站起来对抗癌症”表观遗传学梦之队，由哥本哈根大学Kirsten Grønbæk领衔；发表于《Cancer》；ScienceDaily 2026年10月20日报道）在丹麦和美国4家医院将109名未接受治疗的意义未明克隆性血细胞减少症（CCUS）或低危骨髓增生异常综合征患者随机分为每日口服1,000毫克维生素C组或安慰剂组，持续12个月。超过一半患者基线维生素C水平偏低，补充后恢复正常。维生素C未显著改变克隆扩增速度，但补充组不良事件更少，细胞因子变化与较好预后相关；探索性分析发现补充组约三年后存活的可能性显著更高。维生素C可支持TET2酶的活性，而TET2在这类疾病中常发生突变。研究者表示，在作出任何推荐前需开展III期试验。

Why it matters: 为何重要：Pre-leukaemic clones are common with age and usually just watched; a cheap supplement is worth testing properly, but the survival signal is exploratory and the trial small.白血病前期克隆随年龄增长很常见，通常只能观察等待；廉价补充剂值得规范检验，但生存信号属探索性结果，且试验规模小。

Van Andel Institute via ScienceDaily; Cancer (ACS) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-evita-oral-vitamin-c-ccus-lower-risk-mds-ph2-109-pts-fewer-adverse-events-exploratory-survival-tet2

Singapore haze, 4pm Tuesday: West 24-h PSI edges up to 139, the day's high, with Central 123, East 106 and South 104 still Unhealthy and North 89 Moderate. Hourly PM2.5 in the West eases from 106 to 92 µg/m³新加坡烟霾（周二下午4时）：西部24小时PSI微升至139，为当日最高；中部123、东部106、南部104仍属“不健康”，北部89为“中等”。西部每小时PM2.5从106回落至92微克/立方米

Official NEA real-time readings at 4pm on 20 Oct 2026 (data.gov.sg): 24-h PSI West 139, Central 123, East 106, South 104 (Unhealthy, 101–200) and North 89 (Moderate). 1-h PM2.5 was 92 µg/m³ in the West, 75 in Central, 58 in the East (Band II Elevated, 56–150), 52 in the South and 42 in the North (Normal). 24-h mean PM2.5 was 92 µg/m³ in the West and 77 in Central. Compared with 3pm (West 138, hourly PM2.5 106), the 24-h index barely moved while hourly fine-particle levels fell in every region. NEA's forecast for 20 Oct is PSI 90–160 and it has warned that east-southeasterly winds from Tuesday night to Thursday may bring more smoke from Kalimantan.2026年10月20日下午4时国家环境局官方实时数据（data.gov.sg）：24小时PSI西部139、中部123、东部106、南部104（不健康，101–200），北部89（中等）。1小时PM2.5西部92微克/立方米、中部75、东部58（二级“偏高”，56–150），南部52、北部42（正常）。24小时平均PM2.5西部92微克/立方米、中部77。与下午3时（西部138，每小时PM2.5 106）相比，24小时指数几乎持平，而各区域每小时细颗粒物水平均有下降。环境局对10月20日的预测为PSI 90–160，并警告周二晚至周四的东南偏东风可能从加里曼丹带来更多烟雾。

Why it matters: 为何重要：The hourly dip is welcome, but the 24-h index is still at the day's peak and more smoke is forecast overnight, so outdoor-exertion advice stands.每小时读数回落值得欢迎，但24小时指数仍处当日高位，且预计夜间烟雾增多，减少户外剧烈活动的建议仍然有效。

NEA real-time PSI/PM2.5 (data.gov.sg) via Haze.SG ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-4pm-psi-west-139-central-123-east-106-south-104-pm25-west-eases-92

China's drug regulator drafts rules on market exclusivity for new rare-disease and children's medicines, the follow-through to the revised Drug Administration Law regulations; public comments are open until 18 November国家药监局起草《药品市场独占期实施办法》，为罕见病治疗用药品和儿童用药品设立市场独占期，配套新修订《药品管理法实施条例》；意见征集至11月18日

The NMPA General Office published the draft Measures for the Implementation of Drug Market Exclusivity for public comment on 20 Oct 2026. The NMPA says the measures are meant to further encourage research and development of medicines for rare diseases and for children, and to implement the newly revised Regulations for the Implementation of the Drug Administration Law. Comments can be sent by email until 18 November 2026. The published notice does not itself state the length of the exclusivity periods; those details are in the attached draft.国家药监局综合司于2026年10月20日就《药品市场独占期实施办法（征求意见稿）》公开征求意见。国家药监局表示，此举旨在进一步鼓励罕见病治疗用药品和儿童用药品研发，做好新修订《中华人民共和国药品管理法实施条例》的配套实施工作。意见可于2026年11月18日前通过电子邮件反馈。公告正文未写明独占期具体时长，相关细节见所附征求意见稿。

Why it matters: 为何重要：Most rare diseases are genetic and many have no treatment; a guaranteed period without generic competition is one of the main tools other regulators use to make these drugs worth developing.大多数罕见病属遗传病且缺乏治疗手段；保证一段无仿制药竞争的时期，是其他监管机构促进此类药物研发的主要手段之一。

NMPA via China Quality News Network (Sina Finance) ↗ · r-2026-10-nmpa-draft-drug-market-exclusivity-measures-rare-disease-paediatric-comments-to-nov18

Off-the-shelf stem-cell therapy for Parkinson's: all nine patients in China's phase 1 trial of XS411 improved, with motor scores better by more than 30 points on average at six months, more good 'on' time and PET signs that the grafts make dopamine; a blinded phase 2 is under way通用型干细胞治疗帕金森病：XS411中国I期试验9例受试者全部改善，6个月时运动评分平均改善超过30分，优质“开期”时间增加，PET显示移植细胞已能合成多巴胺；盲法II期正在推进

Beijing Tiantan Hospital investigators reported results of XellSmart's allogeneic (universal) iPSC-derived XS411 dopaminergic cell injection at the International Congress of Parkinson's Disease and Movement Disorders in Korea (China News Service, 20 Oct 2026). Nine patients with mid-to-late Parkinson's (average disease duration about 10 years) received grafts into both posterior putamens with standard anti-rejection therapy. All met the primary safety and tolerability endpoints, with no dose-limiting toxicity, serious adverse events or XS411-attributed adverse events. At six months the off-state MDS-UPDRS Part III score improved by more than 30 points on average, and good 'on' time without troublesome dyskinesia rose by more than 5 hours a day, with further gains at 12 months. 18F-DOPA PET showed increased uptake along the graft tracts. A multicentre, randomised, blinded phase 2 led by Tiantan with PUMCH, Soochow University's Second Affiliated Hospital and Jiangsu Province Hospital is in progress; the company says enrolment of 30 patients is complete.首都医科大学附属北京天坛医院研究团队在韩国举行的国际帕金森病与运动障碍大会上报告了士泽生物通用型（异体）iPSC来源XS411多巴胺能细胞注射液的I期结果（中新社，2026年10月20日）。9例中晚期帕金森病患者（平均病程约10年）在规范抗免疫排斥治疗下接受双侧后部壳核移植，全部达到主要安全性和耐受性终点，未观察到剂量限制性毒性、严重不良事件或归因于XS411的不良事件。移植后6个月，关期MDS-UPDRS第III部分评分较基线平均改善超过30分，不伴严重异动症的优质开期时间平均每天增加超过5小时，12个月时疗效继续改善。18F-DOPA PET显示移植针道区域摄取增加。由天坛医院牵头、北京协和医院、苏州大学附属第二医院和江苏省人民医院等参与的多中心随机盲法II期试验正在进行；企业称30例受试者已全部入组。

Why it matters: 为何重要：A ready-made cell product that does not need donor matching could make dopamine-cell replacement scalable — but nine open-label patients are a small start, and the blinded trial will be the real test.无需配型的“现成”细胞产品可让多巴胺细胞替代疗法具备规模化可能——但9例开放标签患者只是起点，盲法试验才是真正的检验。

Institutions: 机构：PUMCH协和

China News Service (Sina); MDS abstracts; DrugTimes ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-xellsmart-xs411-allogeneic-ipsc-dopaminergic-parkinsons-ph1-9-patients-updrs-30pt-tiantan-ph2

Taiwan CDC case report: a woman in her 40s who bought unlabelled 'botox' online and had it injected at home by the seller ended up in intensive care on a ventilator with suspected botulism — CDC warns to use only licensed clinics and approved products台湾疾管署个案报告：一名40余岁女性网购来源不明的肉毒杆菌针剂，由卖方到家中施打，之后疑似肉毒杆菌中毒入住加护病房并使用呼吸器——疾管署提醒应选择合格医疗机构和核准产品

Taiwan's Epidemiology Bulletin (vol. 42, no. 20, published 20 Oct 2026) describes a case reported in March 2025: a non-Taiwanese woman in her 40s bought botulinum toxin injections of unknown origin through an online platform and had them injected at home by the seller's staff. Days later she developed difficulty swallowing, dry mouth, drooping eyelids and muscle weakness, was admitted to a medical-centre ICU and needed a ventilator. After self-paid botulinum antitoxin she stabilised and was discharged after three weeks. The CDC urges people to choose licensed facilities with qualified medical staff, check that products are approved, and seek care promptly — telling doctors about the injection — if symptoms appear. The same issue previews World One Health Day (3 Nov) and Taiwan's 2026–2030 national One Health joint action plan.台湾《疫情报导》第42卷第20期（2026年10月20日出刊）报告一例2025年3月通报的个案：一名40余岁非本国籍女性经网络平台购买来源不明的肉毒杆菌针剂，由卖方人员到其住家施打。数日后出现吞咽困难、口干、眼睑下垂、肌肉无力等症状，入住医学中心加护病房并使用呼吸器，自费使用肉毒杆菌抗毒素后病情稳定，住院3周出院。疾管署建议民众选择合格医疗机构、具合法医事资格的执行人员，并确认制剂为核准产品；施打后如出现可疑症状应尽快就医并主动告知注射史。同期还介绍了世界防疫一体日（11月3日）及台湾2026–2030年国家防疫一体联合行动方案。

Why it matters: 为何重要：Cut-price cosmetic injections sold online are spreading across Asia; this case shows how a beauty treatment can become a life-threatening poisoning.网购低价医美针剂在亚洲各地蔓延；本例显示一次美容注射可能演变为危及生命的中毒。

Taiwan CDC Epidemiology Bulletin ↗ · r-2026-10-taiwan-cdc-epidemiology-bulletin-illegal-cosmetic-botox-suspected-botulism-icu-ventilator-antitoxin

South Korea approves seladelpar (Livdelzi) for primary biliary cholangitis, the autoimmune bile-duct disease that mostly strikes women, for adults who do not respond to or cannot tolerate first-line ursodeoxycholic acid韩国批准塞拉德帕（Livdelzi）治疗原发性胆汁性胆管炎——这种主要见于女性的自身免疫性胆管疾病——用于对一线熊去氧胆酸应答不足或不耐受的成人

Korea's Ministry of Food and Drug Safety said on 20 Oct 2026 it approved Gilead's Livdelzi capsules (seladelpar) for primary biliary cholangitis (PBC), an autoimmune disease in which the immune system attacks small bile ducts in the liver. It is for adults with an inadequate response to ursodeoxycholic acid (UDCA), in combination, or as monotherapy for those who cannot tolerate UDCA. The drug activates PPARδ to reduce bile-acid synthesis. The MFDS says about 4,000 people in Korea are diagnosed each year, about 90% of them women, and untreated disease can progress to cirrhosis. The drug was reviewed as No. 52 under Korea's GIFT fast-track programme.韩国食品药品安全部2026年10月20日宣布批准吉利德Livdelzi胶囊（塞拉德帕）用于原发性胆汁性胆管炎（PBC）。PBC是一种免疫系统攻击肝内小胆管的自身免疫病。该药用于对熊去氧胆酸（UDCA）应答不足的成人（联合用药），或不耐受UDCA者（单药治疗），通过激活PPARδ减少肝内胆汁酸合成。食药部称韩国每年约有4,000人发病，约90%为女性，延误治疗可能进展为肝硬化。该药作为韩国GIFT快速通道第52号产品获得加快审评。

Why it matters: 为何重要：PBC is common among middle-aged women in East Asia, and roughly a third do not respond fully to UDCA — they now have a second-line option in Korea.PBC在东亚中年女性中并不少见，约三分之一患者对UDCA应答不充分——他们在韩国有了二线选择。

Chosun Biz (MFDS announcement) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-mfds-approves-livdelzi-seladelpar-pbc-ursodiol-inadequate-gift-52

Korean study: six in 10 people with geographic atrophy, a late form of age-related macular degeneration, struggle to climb stairs — a quality-of-life burden as heavy as wet macular degeneration韩国研究：每10名地图状萎缩（晚期年龄相关性黄斑变性的一种）患者中有6人爬楼梯困难——生活质量负担与湿性黄斑变性相当

Kim Jae-hwi and Kim Ye-ji of Kim's Eye Hospital with Prof. Gong Min-gwi of Sungkyunkwan University analysed 15,030 adults aged 40+ in the Korea National Health and Nutrition Examination Survey (2017–2021), the first Korean analysis of geographic atrophy using these data (Journal of Korean Medical Science; reported 20 Oct 2026). 61.5% of people with geographic atrophy reported difficulty climbing stairs, versus 40.1% without macular degeneration and 64.9% with wet macular degeneration; 27.3% had trouble getting around and 15.2% felt limited in everyday activities. EQ-5D scores were 0.93 in both geographic atrophy and wet AMD.金眼科医院Kim Jae-hwi、Kim Ye-ji与成均馆大学Gong Min-gwi教授分析了2017–2021年韩国国民健康营养调查中15,030名40岁以上成人，这是韩国首次利用该数据分析地图状萎缩（《韩国医学科学杂志》；2026年10月20日报道）。地图状萎缩患者中61.5%报告爬楼梯困难，而无黄斑变性者为40.1%、湿性黄斑变性患者为64.9%；27.3%行动困难，15.2%日常活动受限。地图状萎缩与湿性AMD患者的EQ-5D评分均为0.93。

Why it matters: 为何重要：Geographic atrophy has had far less attention and treatment than wet AMD; the data argue for mobility and daily-living support as Asian populations age.地图状萎缩获得的关注和治疗远少于湿性AMD；随着亚洲人口老龄化，数据提示需要提供行动和日常生活支持。

Financial News (Korea); Journal of Korean Medical Science ↗ · r-2026-10-kims-eye-geographic-atrophy-quality-of-life-knhanes-15030-stairs-61-5pct-jkms

Korea's government-funded aftercare programme for foreign medical tourists has never tracked how many patients drop out of follow-up after flying home, data released by a lawmaker show议员公布的数据显示：韩国政府资助的外国患者回国后随访项目，从未追踪有多少患者回国后中断随访

Data from the Korea Health Industry Development Institute (KHIDI), released on 20 Oct 2026 by Rep. So Byung-hoon (Democratic Party), show the ICT-based programme offering pre-visit consultations and post-return follow-up to foreign patients received 1.1 billion won in 2023–2025 and 380 million won in 2026. Institutions are assessed on a combined count of consultations and aftercare cases (minimum 80 a year), so a target could be met with no aftercare at all; KHIDI recorded completed aftercare but not discontinuations or reasons, and verification relied mainly on documents. KHIDI said it would consider spot checks.共同民主党议员So Byung-hoon于2026年10月20日公布韩国保健产业振兴院（KHIDI）数据：该项目利用信息通信技术为外国患者提供来韩前咨询和回国后随访，2023–2025年获拨11亿韩元，2026年另拨3.8亿韩元。机构考核按咨询与随访合计数量（每年至少80例），理论上可在零随访情况下达标；振兴院只记录完成的随访，未记录中断人数及原因，核查主要依赖提交文件。振兴院表示将考虑实地抽查。

Why it matters: 为何重要：Many Chinese and other Asian patients travel to Korea for surgery and cosmetic procedures; complications after returning home are a real gap in care.许多中国及其他亚洲患者赴韩手术和医美；回国后的并发症处理是实实在在的照护缺口。

The Korea Herald ↗ · r-2026-10-korea-khidi-foreign-patient-aftercare-program-untracked-dropouts-so-byung-hoon

Malaysia and WHO aim to finalise the remaining WHO Pandemic Agreement work by May 2027, Health Minister Dzulkefly says after meeting Tedros at the Western Pacific Regional Committee in Manila, stressing a balance between patents and fair access马来西亚卫生部长祖基菲里在马尼拉世卫组织西太区域委员会会议期间会见谭德塞后表示，马来西亚与世卫组织力争在2027年5月前完成《世卫组织大流行协定》相关工作，强调在知识产权保护与公平获取之间取得平衡

Malaysian Health Minister Dzulkefly Ahmad said on 20 Oct 2026 (Facebook post, via Bernama) that he and WHO Director-General Tedros Adhanom Ghebreyesus reaffirmed a joint commitment to finalise the WHO Pandemic Agreement by May 2027, during a courtesy call on the sidelines of the 77th WHO Regional Committee for the Western Pacific in Manila (19–22 Oct). Malaysia stressed balancing intellectual-property protection with equitable access to medical countermeasures in emergencies, was invited to take a strategic leadership role in the region on emergency preparedness, and reiterated support for sustainable WHO financing; Tedros praised Malaysia's primary-care transformation.马来西亚卫生部长祖基菲里2026年10月20日（脸书帖文，经马新社报道）表示，他在马尼拉第77届世卫组织西太平洋区域委员会会议（10月19–22日）期间礼节性拜会世卫组织总干事谭德塞，双方重申力争于2027年5月前完成《世卫组织大流行协定》。马方强调在突发卫生事件中平衡知识产权保护与医疗应对物资的公平获取，并获邀在区域应急准备方面发挥战略领导作用，同时重申支持世卫组织可持续筹资；谭德塞赞赏马来西亚的初级卫生保健改革。

Why it matters: 为何重要：How patents and vaccine sharing are handled in the next pandemic will decide whether Asian countries get supplies early or late.下一次大流行中如何处理专利和疫苗分享，将决定亚洲国家能早还是晚获得物资。

Malay Mail (Bernama) ↗ · r-2026-10-malaysia-who-pandemic-agreement-annex-may-2027-dzulkefly-tedros-wpro-rc77

Hokkaido University finds that digesting dulse, an edible red seaweed, releases a four-amino-acid peptide, EVYR, that blocks the blood-sugar enzyme DPP-IV — the same target as a class of diabetes pills — and measures how much is released北海道大学发现，食用红藻掌状红皮藻（dulse）在消化过程中释放一种由4个氨基酸组成的肽EVYR，可抑制调节血糖的DPP-IV酶（与一类糖尿病口服药靶点相同），并首次定量其释放量

Yuya Kumagai, Tadashi Hatanaka and colleagues simulated human digestion of dulse (Devaleraea inkyuleei) from Hokkaido's cold coasts and identified a novel peptide, EVYR, that inhibits dipeptidyl peptidase-IV (DPP-IV). Using liquid chromatography–tandem mass spectrometry they quantified how much EVYR is released during digestion — described as the first quantitative study of a bioactive peptide generated from algae digestion. The paper appeared in Food Bioscience (3 June 2026); Hokkaido University publicised it on 20 Oct 2026. The work is lab-based, so effects on human blood sugar have not been tested.熊谷祐也、畑中唯史等人模拟人体消化北海道寒冷海岸出产的掌状红皮藻（Devaleraea inkyuleei），鉴定出一种可抑制二肽基肽酶-IV（DPP-IV）的新肽EVYR，并用液相色谱–串联质谱定量其在消化中的释放量——被称为首个定量分析藻类消化产生生物活性肽的研究。论文发表于《食品生物科学》（2026年6月3日），北海道大学于2026年10月20日发布。研究仅限实验室，尚未检验对人体血糖的作用。

Why it matters: 为何重要：Seaweed is a staple across East Asia; this points to a possible food-based way to support blood-sugar control, but human trials are needed.海藻是东亚常见食物；研究提示可能存在一种通过饮食辅助控糖的途径，但仍需人体试验。

Hokkaido University; Food Bioscience ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hokkaido-u-dulse-red-alga-evyr-peptide-dpp-iv-inhibitor-digestion-quantified-food-biosci

Singapore haze, 3pm Tuesday: West 24-h PSI keeps climbing to 138, Central 123, East 105 and South 104 — four regions Unhealthy, North 89. Hourly PM2.5 in the West reaches 106 µg/m³ as NEA warns Kalimantan smoke may drift in from Tuesday night新加坡烟霾（周二下午3时）：西部24小时PSI继续攀升至138，中部123、东部105、南部104——四个区域“不健康”，北部89。西部每小时PM2.5达106微克/立方米；环境局警告周二晚起加里曼丹烟雾可能飘入

Official NEA real-time readings at 3pm on 20 Oct 2026 (data.gov.sg): 24-h PSI West 138, Central 123, East 105, South 104 (Unhealthy, 101–200) and North 89 (Moderate). 1-h PM2.5 was 106 µg/m³ in the West, 83 in Central, 72 in the East and 60 in the South (Band II Elevated, 56–150) and 37 in the North (Normal). 24-h mean PM2.5 rose to 91 µg/m³ in the West and 76 in Central. At 1pm CNA had reported West 133, Central 121, South and East 103 and North 90. The readings rose steadily through the day from noon's West 130 / Central 119. Singapore is in its 16th day of unhealthy air this episode, already longer than the 14 days of 2015. NEA's forecast for 20 Oct is PSI 90–160; from Tuesday night to Thursday, east-southeasterly winds and dry weather over parts of Kalimantan may bring more smoke.2026年10月20日下午3时国家环境局官方实时数据（data.gov.sg）：24小时PSI西部138、中部123、东部105、南部104（不健康，101–200），北部89（中等）。1小时PM2.5西部106微克/立方米、中部83、东部72、南部60（二级“偏高”，56–150），北部37（正常）。24小时平均PM2.5西部升至91微克/立方米，中部76。亚洲新闻台此前报道下午1时西部133、中部121、南部和东部103、北部90。读数自中午（西部130、中部119）起全天持续上升。本轮烟霾中新加坡已是第16个空气不健康日，长于2015年的14天。环境局对10月20日的预测为PSI 90–160；周二晚至周四，东南偏东风加上加里曼丹部分地区干燥天气，可能带来更多烟雾。

Why it matters: 为何重要：Readings are rising, not falling, through Tuesday afternoon — people in the West and Central areas should keep reducing prolonged outdoor exertion.周二下午读数仍在上升而非回落——西部和中部居民应继续减少长时间户外剧烈活动。

NEA real-time PSI/PM2.5 (data.gov.sg) via Haze.SG; CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-3pm-psi-west-138-central-123-east-105-south-104-pm25-west-106

Indonesia's fire and haze crisis spreads: Ketapang in West Kalimantan records an air-quality index of 697 (Hazardous), satellites count 8,973 hotspots in 24 hours, and the security minister says police have identified 97 companies in burning cases印尼林火与烟霾危机扩散：西加里曼丹吉打邦空气质量指数达697（危险），卫星24小时内探测到8,973个热点，政治安全统筹部长称警方已在焚烧案件中锁定97家公司

Surabaya Inside reported that Ketapang, West Kalimantan, recorded ISPU 697 (Hazardous; main pollutant PM10) at 09:00 WIB on 19 Oct 2026, with PM2.5 at 502; Padang, West Sumatra, had reached 480 on 16 Oct, forcing cancellation of Car Free Day and the distribution of 11,000 masks, while Karimun extended learning from home on 19–20 Oct. IQAir readings on Tuesday morning put Palembang at AQI 287, Pekanbaru 185 and Jakarta 153. Katadata, citing the Forestry Ministry's SiPongi system, said 8,973 hotspots (520 high-confidence) were detected in the 24 hours to 11:51 WIB on 20 Oct, led by Central Kalimantan (1,221), South Sumatra (1,053) and South Kalimantan (837). Coordinating Minister for Political and Security Affairs Dudung Abdurachman said police had identified 97 companies in land-burning cases; weather-modification (cloud-seeding) operations are planned for 16–25 Oct.Surabaya Inside报道，2026年10月19日09:00（西印尼时间），西加里曼丹吉打邦空气污染标准指数（ISPU）达697（危险，主要污染物PM10），PM2.5为502；西苏门答腊巴东10月16日曾达480，当地取消无车日并发放1.1万只口罩，卡里汶则把居家学习延长至10月19–20日。周二上午IQAir读数显示巨港AQI 287、北干巴鲁185、雅加达153。Katadata援引林业部SiPongi系统称，截至10月20日11:51的24小时内共探测到8,973个热点（520个高可信度），以中加里曼丹（1,221个）、南苏门答腊（1,053个）和南加里曼丹（837个）最多。政治安全统筹部长Dudung Abdurachman表示，警方已在土地焚烧案件中锁定97家公司；人工增雨（云催化）作业计划在10月16日至25日进行。

Why it matters: 为何重要：Thousands of active hotspots across Kalimantan and Sumatra mean the source of the region's haze is far from under control, so neighbouring countries face more smoky days.加里曼丹和苏门答腊仍有数以千计的活跃热点，意味着区域烟霾源头远未得到控制，邻国还将面对更多烟霾日。

Surabaya Inside; Katadata Databoks (Kemenhut SiPongi); tvOne News ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-indonesia-ketapang-ispu-697-hotspots-8973-central-kalimantan-1221-97-companies-padang-480

Taiwan extends free flu antivirals for seven high-transmission groups — including medical staff, care-home residents, schoolchildren and poultry workers — to 15 November, after 159 severe flu cases and 44 deaths in one week, nearly all H1N1. COVID-19 has dropped out of its epidemic period台湾将七类高传播风险族群公费流感抗病毒药物扩大用药延长至11月15日——包括医护人员、长照机构住民、学生和禽畜从业人员等——此前一周新增159例流感重症、44人死亡，几乎均为H1N1。新冠疫情已脱离流行期

Taiwan CDC's weekly briefing (20 Oct 2026, deputy director-general Lin Ming-cheng and epidemic intelligence centre head Kuo Hung-wei): influenza-like-illness outpatient and ER visits in week 41 (11–17 Oct) were 123,820, down 5.4%, but last week (13–19 Oct) brought 159 new severe flu cases (151 H1N1, 7 A-unsubtyped, 1 B) and 44 deaths (42 H1N1). H1N1 makes up 92.7% of circulating flu. Expanded publicly funded antiviral eligibility (Tamiflu and Rapiacta, at about 4,000 contract clinics) is extended to 15 Nov for medical staff; long-term-care residents and staff; preschool and childcare staff and nannies; students from kindergarten to junior-college year 3; people living with or caring for high-risk people; poultry, livestock and zoo workers; and crowded institutions such as barracks. COVID-19 has stayed below the epidemic threshold for two weeks (W41 visits 3,873, −27.7%; 25 severe cases and 5 deaths in 7 days; main variant PQ.16.1.1). By 19 Oct about 3.4 million flu shots (1.1× last year) and over 1.07 million COVID shots (1.4×) had been given; Novavax became available on 19 Oct.台湾疾管署周二例行记者会（2026年10月20日，副署长林明誠、疫情中心主任郭宏偉）：第41周（10/11–10/17）类流感门急诊123,820人次，下降5.4%，但上周（10/13–10/19）新增流感重症159例（151例H1N1、7例A型未分型、1例B型），死亡44例（42例H1N1）。H1N1占社区流行流感病毒92.7%。公费流感抗病毒药剂（克流感、易剋冒，约4,000家合约院所）扩大用药对象延长至11月15日，包括：医事人员；长照机构住民及工作人员；幼儿园、托育机构人员及保母；幼儿园至五专1–3年级学生；与高风险者同住或照顾者；禽畜及动物园工作人员；军营等人口密集机构。新冠已连续两周低于流行阈值、脱离流行期（第41周就诊3,873人次，降27.7%；近7天新增25例本土重症、5例死亡；主流变异株PQ.16.1.1）。截至10月19日，流感疫苗已接种约340万剂（为去年同期1.1倍），新冠疫苗逾107万剂（1.4倍）；Novavax疫苗10月19日起开打。

Why it matters: 为何重要：Early antivirals cut the risk of severe flu; keeping wider access open through mid-November targets the settings where H1N1 spreads fastest.及早用抗病毒药可降低流感重症风险；把扩大用药延续到11月中旬，正是针对H1N1传播最快的场所。

ETtoday Health; SETN; Taiwan CDC ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-taiwan-cdc-flu-antiviral-expanded-eligibility-extended-nov15-159-severe-44-deaths-h1n1-92pct-covid-out-of-epidemic

Japan will stop calling births that need medical procedures 'abnormal deliveries': after the obstetrics society dropped the term, the government says official notices will switch to wording such as 'delivery with insurance-covered care', to spare mothers distress日本将不再把需医疗处置的分娩称为“异常分娩”：继日本妇产科学会弃用该词后，政府表示官方通知将改用“伴随保险诊疗的分娩”等表述，以减轻产妇心理负担

Nikkei (20 Oct 2026): Health Minister Kenichiro Ueno and Minister for Children's Policy Hiroshi Nakatsuka met representatives of the Japan Society of Obstetrics and Gynecology, and Ueno said the ministry would act 'in step with the society'. The term 'ijō bunben' (abnormal delivery) has customarily been used for births involving caesarean section, vacuum extraction or other procedures, to distinguish deliveries covered by health insurance. Notices such as those on the childbirth lump-sum allowance will gradually use phrases like 'delivery with insurance-covered care' or 'delivery with obstetric surgery', and private insurers and local governments will be asked to revise health-check and vaccination questionnaires. The society will ask clinicians to name the actual procedure — 'vaginal delivery', 'emergency caesarean' — rather than labelling births normal or abnormal.日本经济新闻（2026年10月20日）：厚生劳动大臣Kenichiro Ueno与儿童政策担当大臣Hiroshi Nakatsuka会见日本妇产科学会代表，Ueno表示厚劳省将“与学会步调一致”。为区分是否产生医保诊疗，剖宫产、吸引分娩等伴随医疗处置的分娩历来被称为“异常分娩”。今后有关生育一次性补助等的通知将逐步改为“伴随保险诊疗的分娩”“伴随产科手术的分娩”等表述，并呼吁民间保险及地方政府修改体检和预防接种问诊单。学会将要求临床改用“经阴道分娩”“紧急剖宫产”等实际处置名称，而不再以正常、异常区分。

Why it matters: 为何重要：Words on official forms shape how women feel about their births; dropping 'abnormal' acknowledges that caesareans and assisted births are routine care.官方表格上的用词影响女性如何看待自己的分娩；弃用“异常”一词，是承认剖宫产和助产属于常规医疗。

Nikkei; NTV News; Sankei ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-mhlw-jsog-drop-abnormal-delivery-term-ijo-bunben-insurance-covered-delivery-ueno

Japanese researchers repurpose the ALS drug riluzole against Alzheimer's-type damage: a week of treatment restored learning in rats exposed to toxic amyloid-beta by spurring brain immune cells to clear it日本研究者把渐冻症药物利鲁唑“老药新用”于阿尔茨海默病样损伤：给药一周即恢复了暴露于毒性β淀粉样蛋白动物的学习能力，机制是促使脑内免疫细胞将其清除

Ube Nippo (20 Oct 2026): a team led by Prof Dai Mitsushima (Yamaguchi University) and Assoc Prof Ryoichi Kimura (Sanyo-Onoda City University) reported in the Journal of Neuroinflammation that riluzole, an approved ALS drug, given for 7 days restored learning in a model in which amyloid-beta 1-42 oligomers are injected into the hippocampus. The drug mobilised astrocytes and microglia to clear the toxic protein and prevented the loss of dendritic spines, the tiny structures where neurons connect. The researchers propose riluzole as a drug-repositioning candidate for Alzheimer's disease.宇部日报（2026年10月20日）：山口大学Dai Mitsushima教授与山阳小野田市立山口东京理科大学Ryoichi Kimura副教授团队在《神经炎症杂志》报道，已获批用于肌萎缩侧索硬化（ALS）的利鲁唑连续给药7天，可使海马注射β淀粉样蛋白1-42寡聚体的模型恢复学习能力。药物调动星形胶质细胞和小胶质细胞清除毒性蛋白，并防止神经元连接所在的树突棘丢失。研究者提出利鲁唑可作为阿尔茨海默病的老药新用候选。

Why it matters: 为何重要：A cheap, already-approved drug that recruits the brain's own clean-up cells would be a fast route to clinical trials — though animal results often fail to translate.一种便宜且已获批的药物若能调动大脑自身的“清洁工”，将是进入临床试验的快捷路径——不过动物结果常常难以在人体复现。

Ube Nippo (Journal of Neuroinflammation) ↗ · r-2026-10-yamaguchi-sanyo-onoda-riluzole-als-drug-alzheimers-abeta-oligomer-glia-clearance-spines-j-neuroinflamm

University of Tokyo (PNAS): watching single mitochondrial DNA molecules, researchers show the two strands of mtDNA can copy themselves at different times as cells wake from rest and start dividing — a shift that helps keep cell energy and function stable东京大学（PNAS）：研究者观察单个线粒体DNA分子，发现细胞从休止期进入增殖期时，线粒体DNA的两条链可在不同时间各自复制——这种转变有助于维持细胞能量与功能稳定

A group led by Assoc Prof Noriko Hosoya (University of Tokyo Graduate School of Medicine) reported in PNAS (online 16 Oct 2026, US Eastern time; university release 20 Oct) that when cells move from a resting to a proliferating state, mitochondrial DNA changes how it replicates, which maintains cellular homeostasis. Using a technique that visualises individual DNA molecules, they observed that the two strands of double-stranded mtDNA sometimes behave differently, each with its own replication dynamics. The authors say the finding will help research on how energy metabolism relates to cell function.东京大学医学系研究科细谷纪子（Noriko Hosoya）副教授团队在PNAS（美国东部时间2026年10月16日在线；校方10月20日发布）报道：细胞由休止期转入增殖期时，线粒体自身的DNA会改变复制方式，从而维持细胞功能稳态。研究者利用单分子DNA可视化技术，观察到双链线粒体DNA的两条链有时表现出各自不同的复制动态。作者表示，这一发现将有助于研究能量代谢与细胞功能的关系。

Why it matters: 为何重要：Mitochondrial DNA defects cause inherited energy disorders and feature in ageing and cancer; understanding how it copies itself is basic groundwork for those fields.线粒体DNA缺陷可导致遗传性能量代谢病，也与衰老和癌症相关；弄清它如何复制是这些领域的基础工作。

Institutions: 机构：UTokyo东大

University of Tokyo Graduate School of Medicine; PNAS ↗ · r-2026-10-u-tokyo-hosoya-mitochondrial-dna-asynchronous-strand-replication-quiescence-to-proliferation-pnas

South Korea's healthy life expectancy is falling — from 70.93 years in 2020 to 68.56 in 2023, far below the 73.3 target — and the poorest fifth of people can expect 8 fewer healthy years than the richest韩国健康预期寿命持续下降——由2020年的70.93岁降至2023年的68.56岁，远低于73.3岁的目标——收入最低的五分之一人群比最高的五分之一少约8年健康寿命

Yonhap (20 Oct 2026), citing Korea Health Promotion Institute data submitted to a member of the National Assembly health committee: healthy life expectancy — years lived without illness or disability — was 70.93 in 2020, 70.51 in 2021, 69.89 in 2022 and 68.56 in 2023. The national health plan's target is 73.3 years, but on current trends the 2030 figure is projected at only 71.01. In 2023, people in the bottom 20% income group had a healthy life expectancy of 62.94 years versus 71.07 for the top 20%, a gap of 8.13 years.韩联社（2026年10月20日）援引韩国健康增进开发院提交给国会保健福祉委员会议员的数据：健康预期寿命（无疾病或残障生存年数）2020年为70.93岁，2021年70.51岁，2022年69.89岁，2023年68.56岁。国家健康计划目标为73.3岁，但按目前趋势，2030年预计仅为71.01岁。2023年收入最低20%人群的健康预期寿命为62.94岁，最高20%为71.07岁，相差8.13年。

Why it matters: 为何重要：Koreans are living longer but spending more of those years in poor health, with a widening rich–poor gap that national targets are missing.韩国人寿命在延长，但带病生存的年数更多，贫富差距也在拉大，国家目标难以达成。

Yonhap News Agency ↗ · r-2026-10-korea-healthy-life-expectancy-68-56-2023-falling-income-gap-8-13y-khepi

South Korea's blood supply fell below the safe five-day level on 191 of 273 days this year, and type O — used in emergencies — on 208 days. With shortages, family-arranged 'designated donations' have jumped 4.4-fold韩国今年273天中有191天血液库存低于5天的安全水平，急救用O型血有208天不足。因供血紧张，由亲友为特定患者献血的“指定献血”激增4.4倍

Yonhap (20 Oct 2026), citing Korean Red Cross data obtained by Rep. Han Ji-a (People Power Party): from January to September, red-cell stocks were below the adequate level of five days' supply on 191 of 273 days (70%), already more than the 116 days for all of last year; on 15 Apr stock fell to 2.9 days. Type O red cells, used when a patient's blood type cannot be checked in time, were below five days on 208 days, including 48 days under three days. Designated donations, where family or friends give blood for a specific patient, reached 35,197 versus 8,013 a year earlier (+339.3%), raising their share of transfusion donations from 0.8% last year to 2.1%. Rep. Han called for separate forecasting and emergency supply of type O blood so that getting blood does not depend on a patient's social network.韩联社（2026年10月20日）援引国民力量党议员Han Ji-a从大韩红十字会获得的数据：1–9月的273天中，红细胞制剂库存低于5天适当水平的有191天（70%），已超过去年全年的116天；4月15日一度降至2.9天。在无法及时确认患者血型时用于紧急输血的O型红细胞有208天低于5天，其中48天不足3天。亲友为特定患者献血的“指定献血”达35,197例，去年同期为8,013例（增339.3%），在输血用献血中的占比由去年的0.8%升至2.1%。Han议员呼吁单独预测和建立O型血紧急供应体系，避免能否获得血液取决于患者的人脉。

Why it matters: 为何重要：Chronic blood shortages put emergency and surgical patients at risk and push the burden onto families to find donors.长期供血不足危及急诊和手术患者，并把寻找献血者的负担转嫁给家属。

Yonhap News Agency; Chosun Biz ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-red-cross-blood-stock-below-5-day-level-191-of-273-days-type-o-208-designated-donations-4-4x

Singapore haze, noon Tuesday: West 24-h PSI climbs to 130 and Central to 119, with East and South at 102 — four of five regions Unhealthy. Hourly PM2.5 hits 101 in the West. The Straits Times says this is Singapore's 16th day of unhealthy air, longer than the 14-day stretch of the 2015 haze crisis新加坡烟霾（周二中午12时）：西部24小时PSI升至130、中部119，东部和南部均为102——五个区域中四个处于“不健康”。西部每小时PM2.5达101。《海峡时报》指出，这是新加坡第16个空气不健康的日子，已超过2015年烟霾危机时持续14天的纪录

NEA readings at 12pm on 20 Oct 2026 (via Haze.SG): 24-h PSI West 130 (its highest in the past 24 hours, which ranged 114–130), Central 119, East 102 and South 102 (Unhealthy), North 89 (Moderate). 1-h PM2.5 was 101 µg/m³ in the West, 79 in Central, 59 in the South and 57 in the East (Band II Elevated, 56–150) and 44 in the North (Normal); the West's 24-h mean PM2.5 rose to 83 µg/m³. At 11am, CNA and The Straits Times reported PSI West 128, Central 117 and East 101, with the North (89) and South (100) still Moderate. The Straits Times notes air quality began dipping just before midday after a brief Moderate window on 19 Oct, and that Singapore is in its 16th day of unhealthy air, surpassing the 14-day run of the 2015 crisis (23 Sep–7 Oct). NEA's forecast for 20 Oct is PSI 90–160; it warns that from Tuesday night to Thursday east-southeasterly winds and dry weather over parts of Kalimantan may bring more smoke, and that the risk of severe transboundary haze remains.2026年10月20日中午12时国家环境局读数（经Haze.SG）：24小时PSI西部130（为过去24小时最高，区间114–130）、中部119、东部102、南部102（不健康），北部89（中等）。1小时PM2.5西部101微克/立方米、中部79、南部59、东部57（二级“偏高”，56–150），北部44（正常）；西部24小时平均PM2.5升至83微克/立方米。上午11时，亚洲新闻台和《海峡时报》报道西部PSI 128、中部117、东部101，北部（89）和南部（100）仍为中等。《海峡时报》指出，10月19日短暂回到“中等”后，空气质量在中午前再度转差；新加坡已连续第16天空气不健康，超过2015年危机期间（9月23日至10月7日）的14天。环境局对10月20日的预测为PSI 90–160，并警告周二晚至周四东南偏东风加上加里曼丹部分地区天气干燥，可能带来更多烟霾，严重跨境烟霾风险仍在。

Why it matters: 为何重要：The short break on Monday is over: four regions are back in the Unhealthy band and this episode is now officially longer than 2015's.周一的短暂喘息已经结束：四个区域重回“不健康”，这一轮烟霾持续时间已正式超过2015年。

NEA real-time PSI/PM2.5 via Haze.SG; The Straits Times; CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-noon-psi-west-130-central-119-east-south-102-16th-unhealthy-day-beats-2015

Malaysia haze, noon Tuesday: 28 areas still Unhealthy (down from 31 at 11am) — Batu Muda in Kuala Lumpur hits 173, the day's highest so far, with Johan Setia 171, Petaling Jaya 169 and Shah Alam 168; Tanjung Malim in Perak newly enters the Unhealthy band马来西亚烟霾（周二中午12时）：仍有28个地区空气“不健康”（上午11时为31个）——吉隆坡峇都慕达达173，为当日迄今最高，佐汉斯迪亚171、八打灵再也169、莎阿南168；霹雳州丹绒马林新进入“不健康”级别

Astro Awani, citing the Department of Environment's APIMS (12pm, 20 Oct 2026): Batu Muda 173, Johan Setia 171, Petaling Jaya 169, Shah Alam 168, Cheras 167; Nilai and Bukit Rambai 165, Seremban 162, Larkin 158, Tasek Ipoh 155, Pegoh Ipoh 152, Tangkak 152 and Paka (Terengganu's only Unhealthy station) 157. Rompin fell from 152 to 130 but stays Unhealthy; Tanjung Malim rose to 121; Indera Mahkota (99), Temerloh (97) and Kemaman (100) slipped back to Moderate. Sabah and Sarawak had no Unhealthy readings (Kimanis lowest nationally at 26). Earlier, Bernama reported 30 Unhealthy areas at 9am, with Batu Muda and Johan Setia both at 172, 31 Moderate and 7 Good. API 101–200 is Unhealthy; 201–300 Very Unhealthy.Astro Awani援引环境局APIMS数据（2026年10月20日中午12时）：峇都慕达173、佐汉斯迪亚171、八打灵再也169、莎阿南168、蕉赖167；汝来和武吉南眉165、芙蓉162、拉庆158、怡保打昔155、怡保柏高152、东甲152，帕卡157（登嘉楼唯一“不健康”站点）。云冰由152降至130，但仍属“不健康”；丹绒马林升至121；英迪拉马哥打（99）、淡马鲁（97）和甘马挽（100）回落至“中等”。沙巴和砂拉越没有“不健康”读数（基马尼斯26，全国最低）。此前马新社报道，上午9时全国有30个地区“不健康”，峇都慕达和佐汉斯迪亚均为172，31个“中等”、7个“良好”。API 101–200为不健康，201–300为非常不健康。

Why it matters: 为何重要：The Klang Valley stayed stuck in the 160s–170s all morning; the slight drop in the number of bad stations came mostly from Pahang and Terengganu.巴生谷整个上午都停留在160至170多点；“不健康”站点数量略减，主要来自彭亨和登嘉楼。

Astro Awani (DOE APIMS); Bernama via Malay Mail ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-apims-oct20-noon-28-areas-unhealthy-batu-muda-173-johan-setia-171-tanjung-malim-121

Indonesia, Tuesday morning: Palangka Raya's air-quality index hits 4,196 — more than 13 times the 'Hazardous' threshold — and Hazardous readings now reach Sulawesi (Tomohon 1,463). In Palembang, hourly PM2.5 peaked at 476.9 µg/m³ overnight as smoke from Ogan Komering Ilir fires returned印尼周二上午：帕朗卡拉亚空气质量指数达4,196——超过“危险”门槛13倍以上——“危险”读数已蔓延至苏拉威西（托莫洪1,463）。巨港因奥甘科默林伊利尔火灾烟雾回流，每小时PM2.5夜间最高达476.9微克/立方米

Katadata (20 Oct 2026), citing Ministry of Environment (KLH) monitoring: the worst ISPU readings on Tuesday morning were Palangka Raya, Central Kalimantan, 4,196 (main pollutant PM10); Kapuas regency 1,500; Tomohon, North Sulawesi, 1,463; Murung Raya 1,358; and East Kotawaringin 1,296. ISPU above 300 is Hazardous; KLH advises everyone to avoid all outdoor activity and sensitive groups to stay indoors. Detik reported that Palembang, South Sumatra, returned to the black (Hazardous) category: the Musi 2 PM2.5 station recorded 436.1 µg/m³ at 01:00 WIB, 476.9 at 02:00, easing to 314.8 by 08:00. Wandayantolis, head of the South Sumatra climatology station, said the smoke still comes from land fires in Ogan Komering Ilir, pushed by northwesterly winds, and urged residents to wear masks outdoors.Katadata（2026年10月20日）援引环境部（KLH）监测：周二上午空气污染标准指数（ISPU）最差的是中加里曼丹帕朗卡拉亚4,196（主要污染物PM10），卡普阿斯县1,500，北苏拉威西托莫洪1,463，穆隆拉亚1,358，东哥打瓦林因1,296。ISPU超过300即为“危险”；环境部建议所有人避免一切户外活动，敏感人群留在室内。Detik报道，南苏门答腊巨港重回“黑色”（危险）级别：Musi 2 PM2.5监测站01:00（西印尼时间）为436.1微克/立方米，02:00为476.9，至08:00降至314.8。南苏门答腊气候站站长Wandayantolis表示，烟雾仍来自奥甘科默林伊利尔的土地火灾，受西北风推动，呼吁居民外出佩戴口罩。

Why it matters: 为何重要：These are some of the worst readings of the season and show the smoke footprint spreading beyond Kalimantan and Sumatra.这是本季最严重的读数之一，显示烟雾影响范围正从加里曼丹和苏门答腊向外扩散。

Katadata (KLH ISPU); detikSumbagsel (BMKG South Sumatra) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-indonesia-klh-ispu-oct20-palangka-raya-4196-kapuas-1500-tomohon-1463-palembang-pm25-476

China's National Health Commission asks the public to propose next year's 'practical projects for the people' — a list of concrete health-service improvements it plans to roll out nationwide in 2027. Suggestions are open from 19 to 25 October via the NHC website国家卫生健康委向社会公开征集2027年卫生健康系统“为民服务实事项目”意见建议——即计划于2027年在全国推行的一批具体卫生健康服务改进举措。征集时间为10月19日至25日，可通过国家卫生健康委官网提交

In a notice dated 19 October 2026 (republished on 20 Oct), the NHC said that, to implement the spirit of the recent National Health Conference, it will continue to carry out a batch of practical projects for the people across the health system in 2027, aiming to strengthen inclusive, basic and safety-net services. Members of the public can log in to a dedicated 'Solicit 2027 practical projects' section on the NHC website between 19 and 25 October to submit ideas. The commission said it will study the suggestions carefully so that the benefits of high-quality health development reach everyone more fairly.国家卫生健康委在2026年10月19日发布（10月20日被转载）的公告中表示，为贯彻落实全国卫生与健康大会精神，拟于2027年继续在全国卫生健康系统实施一批为民服务实事项目，进一步提升普惠性、基础性、兜底性服务水平。公众可于10月19日至25日登录国家卫生健康委官网“征集2027年卫生健康系统为民服务实事项目”专栏提交建议。国家卫生健康委表示将认真研究，让卫生健康事业高质量发展成果更多、更公平地惠及全体人民。

Why it matters: 为何重要：These annual lists set concrete targets (such as clinic hours, screening or pediatric services) that local health systems must deliver, so public input can shape what changes next year.这类年度清单会为各地卫生系统设定必须完成的具体目标（如门诊时间、筛查或儿科服务），公众意见可以影响明年的改变。

National Health Commission (via 新黄河 / ifeng) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nhc-solicits-2027-practical-health-projects-for-the-people-oct19-25

Japan: RIKEN chemists build a cancer-killing 'switch' that turns on only where carbon monoxide is abundant — inside cancer cells. A palladium complex tucked into the pocket of the blood protein albumin killed human breast and liver cancer cells in the lab while barely affecting normal cells日本：理化学研究所化学家研制出一种只在一氧化碳丰富处——即癌细胞内——才“开启”的抗癌材料。把钯配合物嵌入血液蛋白白蛋白的口袋中，可在实验室杀死人乳腺癌和肝癌细胞，而对正常细胞几乎无影响

Nikkei (20 Oct 2026): a RIKEN-led group used a palladium complex that becomes anticancer when it reacts with carbon monoxide (CO), which is present at higher levels in cancer cells than in normal cells. Because such complexes lose function by reacting with other substances in blood, the team fixed the complex inside a binding pocket of albumin so that it reacts only with gaseous CO. In cultured cells, the material acted as an anticancer agent against human breast and liver cancer cells but had almost no effect on normal human cells, which the researchers say could reduce side effects. Chief scientist Katsunori Tanaka said he hopes to help create drugs that work inside the body without side effects; the team plans safety and efficacy tests in animals before aiming for clinical trials. The work was published in Nature Communications.《日本经济新闻》（2026年10月20日）：理化学研究所等团队利用一种与一氧化碳（CO）反应后才产生抗癌作用的钯配合物；癌细胞中的CO含量高于正常细胞。由于这类配合物在血液中会与其他物质反应而失活，团队把配合物固定在白蛋白的结合口袋中，使其只与气体CO反应。在培养细胞中，该材料对人乳腺癌和肝癌细胞发挥抗癌作用，而对正常人细胞几乎无影响，研究者认为有望减少副作用。主任研究员田中克典表示，希望助力开发在体内发挥作用而无副作用的药物；团队计划先在实验动物中验证安全性和有效性，再争取开展临床试验。成果发表于《自然-通讯》。

Why it matters: 为何重要：Using a tumour's own chemistry as the trigger is one route to more selective chemotherapy, though this is still cell-culture work.利用肿瘤自身化学特征作为触发器，是实现更精准化疗的一条路径，但目前仍处于细胞实验阶段。

Institutions: 机构：RIKEN理研

Nikkei (日本経済新聞) ↗ · r-2026-10-riken-tanaka-albumin-anchored-palladium-complex-reacts-with-cellular-co-kills-cancer-cells-natcommun

Korea: a single blood protein, moesin, distinguished asthma flare-ups from stable asthma with an AUC of 0.986 in a Soonchunhyang University Bucheon Hospital study — and unlike eosinophil counts, it seems to capture non-allergic airway inflammation韩国：顺天乡大学富川医院研究发现，血液蛋白moesin区分哮喘急性加重与稳定期的AUC达0.986——与嗜酸性粒细胞计数不同，它似乎还能反映非过敏性气道炎症

Sportschosun (20 Oct 2026): a team led by Professor Jang An-su (Pulmonary and Allergy Medicine) compared 10 candidate proteins linked to airway-barrier damage, vascular remodelling, inflammation and cytoskeletal change — including moesin, claudin-4, claudin-5, angiopoietin and annexins A1 and A5 — in plasma from 100 asthma patients and 25 controls, measured in stable and exacerbation phases. Moesin performed best (AUC 0.986; sensitivity 97.3%, specificity 91.7%), ahead of annexin A5 (0.956) and claudin-5 (0.902). Moesin was markedly higher during exacerbations but did not differ between healthy people and stable patients, and it was not clearly associated with blood eosinophils; higher levels tracked with higher white-cell counts and total IgE and lower lung function. Moesin links the cell membrane to the cytoskeleton. The study appeared in the journal Allergy; the team plans larger studies before clinical use.《体育朝鲜》（2026年10月20日）：呼吸与过敏内科Jang An-su教授团队比较了10种与气道屏障损伤、血管重塑、炎症和细胞骨架变化相关的候选蛋白——包括moesin、claudin-4、claudin-5、血管生成素以及膜联蛋白A1和A5——检测100名哮喘患者和25名对照者在稳定期和急性加重期的血浆。moesin表现最佳（AUC 0.986；灵敏度97.3%，特异度91.7%），优于膜联蛋白A5（0.956）和claudin-5（0.902）。急性加重期moesin明显升高，但健康人与稳定期患者之间无显著差异，且与血嗜酸性粒细胞无明确关联；其水平越高，白细胞计数和总IgE越高、肺功能越差。moesin是连接细胞膜与细胞骨架的蛋白。研究发表于《Allergy》杂志；团队计划开展更大规模研究后再推进临床应用。

Why it matters: 为何重要：An objective blood test for 'is this a flare?' could help emergency and clinic doctors decide quickly on steroids or admission.一项能客观判断“是否急性加重”的血液检测，可帮助急诊和门诊医生迅速决定是否使用激素或住院。

Sportschosun; Allergy (journal) ↗ · r-2026-10-soonchunhyang-bucheon-moesin-blood-marker-asthma-exacerbation-auc-0-986-allergy

Korea: among 26,161 people with chronic kidney disease but no heart disease, those taking beta blockers for at least six months had about twice the risk of death (2.09×) and a third more major cardiovascular events than non-users, a national insurance-data study from Inje University Ilsan Paik Hospital finds韩国：仁济大学一山白病院利用全国医保数据研究发现，在26,161名患有慢性肾病但无心血管病的人中，服用β受体阻滞剂至少六个月者的死亡风险约为不服用者的2倍（2.09倍），主要心血管事件风险高出三分之一

Sportschosun (20 Oct 2026): nephrologists Han Sang-yeop and Han Seung-hyeon analysed Korean health-insurance data on patients with eGFR below 60 mL/min/1.73 m² and no prior cardiovascular disease, followed from 2012–2015, comparing 9,067 beta-blocker users with 17,094 non-users. Users had 2.09 times the risk of all-cause death and 1.33 times the risk of major cardiovascular events; for components, cardiovascular death was 2.07×, heart attack 1.29×, stroke 1.21× and heart-failure hospitalisation 1.58×. The excess death risk tended to be larger in patients with poorer kidney function. The authors stress that this is an observational study and cannot show that beta blockers caused the harm; further clinical studies are needed. Published in Clinical Kidney Journal (European Renal Association).《体育朝鲜》（2026年10月20日）：肾内科Han Sang-yeop和Han Seung-hyeon教授分析韩国医保数据中eGFR低于60 mL/min/1.73 m²、且既往无心血管病的患者（2012–2015年随访），比较9,067名β受体阻滞剂使用者和17,094名未使用者。使用者全因死亡风险为2.09倍，主要心血管事件风险为1.33倍；分项来看，心血管死亡2.07倍、心肌梗死1.29倍、卒中1.21倍、心衰住院1.58倍。肾功能越差，死亡风险增幅越大。作者强调这是观察性研究，不能证明β受体阻滞剂直接导致风险增加，仍需进一步临床研究。论文发表于欧洲肾脏协会官方期刊《Clinical Kidney Journal》。

Why it matters: 为何重要：Beta blockers are often prescribed 'just in case' to kidney patients; this signal argues for checking whether they are really needed in those without heart disease.肾病患者常被“预防性”开具β受体阻滞剂；这一信号提示，对没有心脏病的患者应审视是否确有必要。

Sportschosun; Clinical Kidney Journal ↗ · r-2026-10-inje-ilsan-paik-beta-blockers-ckd-without-cvd-all-cause-death-2-09x-26161-nhis-ckj

Korea: longer and more varied antibiotic use was linked to a higher risk of Graves' disease — up to 50% higher with four or more antibiotic classes — in a study of 311,911 adults aged 40+ by Seoul National University and Italian collaborators. The authors stress it shows association, not causation韩国：首尔大学与意大利合作者对311,911名40岁以上成人的研究发现，抗生素使用时间越长、种类越多，格雷夫斯病风险越高——使用四类及以上抗生素者风险最高升高50%。作者强调这只表明关联而非因果

Seoul Shinmun (20 Oct 2026): researchers from Seoul National University College of Medicine, the SNU Medical Research Center and a Catholic university medical school in Italy used National Health Insurance data on adults who had national health screening in 2005–2006, checked antibiotic prescriptions over 2002–2006 and followed them for up to 13 years. After adjusting for age, sex, lifestyle and comorbidities, Graves' disease risk was 23% higher with 1–14 cumulative prescription days and 43% higher with 15–60 days and with 61+ days, versus no antibiotics; people prescribed four or more different classes had 50% higher risk. Graves' disease is an autoimmune thyroid disorder in which antibodies over-stimulate the thyroid; antibiotics may act by disrupting the gut microbiome. Korea's antibiotic use was 31.8 DDD per 1,000 people per day in 2023, second highest in the OECD. Lead author Professor Park Sang-min said the absolute risk difference is small, the results do not prove causation, and patients should not stop prescribed antibiotics. Published in the European Journal of Endocrinology.《首尔新闻》（2026年10月20日）：首尔大学医学院、首尔大学医学研究院与意大利一所天主教大学医学院的研究团队，利用国民健康保险数据，选取2005–2006年接受国家健康体检的成年人，核查其2002–2006年的抗生素处方，并随访最长13年。校正年龄、性别、生活方式和合并症后，与未用抗生素者相比，累计处方1–14天者格雷夫斯病风险高23%，15–60天和61天以上者均高43%；使用四类及以上不同抗生素者风险高50%。格雷夫斯病是一种自身抗体过度刺激甲状腺的自身免疫病；抗生素可能通过扰乱肠道菌群起作用。2023年韩国抗生素用量为每千人每日31.8 DDD，居经合组织第二。领衔的Park Sang-min教授表示，绝对风险差异不大，结果不能证明因果，患者不应擅自停用医生开具的抗生素。论文发表于《欧洲内分泌学杂志》。

Why it matters: 为何重要：It adds to evidence that antibiotics may tilt the immune system via the gut — another reason for careful prescribing in a high-use country.它为“抗生素可能经由肠道影响免疫系统”增添了证据，也是抗生素高用量国家审慎处方的又一理由。

Seoul Shinmun; European Journal of Endocrinology ↗ · r-2026-10-snu-antibiotics-graves-disease-risk-up-50pct-four-classes-311911-adults-eje

Korea may back away from labelling GLP-1 obesity drugs as 'medicines of concern for misuse': the presidential Regulatory Rationalization Committee has sent the drug regulator's proposal to a full review, tentatively on 30 October, amid doubts inside government about whether the label would work韩国可能放弃把GLP-1类减肥药列为“滥用担忧药品”：总统直属的规制合理化委员会已把食药处的提案提交全体审查，暂定10月30日举行，政府内部也对该标签是否有效存疑

Korea Health Log (20 Oct 2026): after a five-day online preliminary review, the committee said on 7 Oct that of 15 amendments submitted, only the Ministry of Food and Drug Safety's plan to designate GLP-1 obesity treatments as drugs of concern for misuse and abuse was classed as 'important' and sent to a full review, a step taken when stakeholder views sharply conflict. An official said the full review is tentatively set for 30 Oct and that the ministry must answer objections to get the rule passed. A ministry official was quoted as saying designation 'will not be easy' given fairness and effectiveness concerns, especially as obesity patients get no insurance coverage. Committee vice-chair Park Yong-jin wrote on 12 Oct that the plan should be reconsidered, noting personal imports are already restricted at customs. Park Jung-hwan of the Korean Society for the Study of Obesity urged more effective anti-misuse measures and priority insurance coverage for vulnerable groups.韩国健康日志（2026年10月20日）：委员会在为期5天的线上预审后于10月7日表示，提交的15项修订案中，只有食品药品安全处把GLP-1类肥胖治疗药指定为“滥用担忧药品”的方案被列为“重要”并提交全体审查——该程序在利益相关方意见严重对立时启动。一名官员表示全体审查暂定10月30日，食药处须回应反对意见方能通过。报道援引食药处一名官员称，鉴于公平性和实效性问题，尤其是肥胖患者目前没有医保报销，指定“不会容易”。委员会副委员长Park Yong-jin在10月12日发文称应重新考虑该方案，并指出个人海外代购已在海关受限。大韩肥胖学会的Park Jung-hwan呼吁采取更有效的防滥用措施，并优先为弱势群体提供医保报销。

Why it matters: 为何重要：How Korea regulates semaglutide- and tirzepatide-type drugs will shape access and off-label use in one of Asia's fastest-growing obesity-drug markets.韩国如何监管司美格鲁肽、替尔泊肽类药物，将影响这一亚洲增长最快的减肥药市场之一的可及性和超适应证使用。

Korea Health Log (Young Doctors); Seoul Economic Daily ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-glp1-obesity-drugs-misuse-designation-full-regulatory-review-oct30-may-be-withdrawn

Korea: 91% of teenagers in a Save the Children survey had confided feelings or personal worries to AI chatbots in the past three months, and 9.1% of them had discussed self-harm or suicide with AI. A lawmaker says suicide-prevention research and policy are not keeping up韩国：救助儿童会调查显示，91%的青少年在过去三个月里曾向AI聊天机器人倾诉情绪或个人烦恼，其中9.1%与AI谈及自伤或自杀。一名国会议员称自杀预防研究和政策未能跟上

Newspim (20 Oct 2026): data provided to Seo Young-seok, Democratic Party secretary on the National Assembly's Health and Welfare Committee, show that of 229 valid respondents aged 14–18, 209 (91.3%) had emotional or personal conversations with generative AI in the previous three months. Topics included grades, study and career (71.3%), relationships with family, friends or partners (35.9%) and seeking comfort or empathy (30.1%); 52 (24.9%) talked about loneliness, anxiety or depression, 41 (19.6%) treated the AI like a friend or partner, and 19 (9.1%) discussed thoughts or worries about self-harm or suicide. The survey report says crisis moments in such chats call for checking whether preventive responses work rather than assuming causation. The government plans adolescent psychological autopsies from 2027 that will include digital records, but the Korea Foundation for Suicide Prevention said it has no research linking AI chats, searches or social media to suicide prevention and no plans for it.Newspim（2026年10月20日）：国会保健福祉委员会共同民主党干事Seo Young-seok议员获得的数据显示，在229名14至18岁有效受访者中，209人（91.3%）在过去三个月与生成式AI进行过情感或私人对话。话题包括成绩、学业和升学就业（71.3%），与家人、朋友或恋人的关系（35.9%），以及寻求安慰或共情（30.1%）；52人（24.9%）谈及孤独、焦虑或抑郁，41人（19.6%）把AI当作朋友或恋人，19人（9.1%）与AI讨论过自伤或自杀的想法或烦恼。调查报告指出，此类对话中出现危机时，应检视预防性应对是否有效，而非断定因果。政府计划自2027年起开展包含数字记录分析的青少年心理解剖，但韩国生命尊重希望财团表示目前没有利用AI对话、搜索和社交媒体开展自杀预防的研究，也无相关计划。

Why it matters: 为何重要：Korea has one of the highest youth suicide rates in the OECD; chatbots are becoming a first confidant, which raises the stakes for safety design and monitoring.韩国青少年自杀率居经合组织前列；聊天机器人正成为青少年的“第一倾诉对象”，这让安全设计和监测更加关键。

Newspim; Save the Children Korea survey ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-save-the-children-teens-ai-emotional-chats-91pct-9-1pct-self-harm-suicide-seo-young-seok

Nature Medicine: genome, transcriptome and DNA-methylation profiling of 423 newly diagnosed multiple-myeloma patients in the MIDAS trial shows which tumours are most likely to reach MRD-negativity after four-drug Isa-KRd induction; a multi-omics model predicts it with an AUC of 0.77《自然-医学》：对MIDAS试验中423名新诊断多发性骨髓瘤患者进行基因组、转录组和DNA甲基化分析，揭示哪些肿瘤在四药Isa-KRd诱导后最可能达到微小残留病（MRD）阴性；多组学模型预测的AUC为0.77

Per a 生物通 summary of the Nature Medicine paper (20 Oct 2026; ClinicalTrials.gov NCT04934475): researchers profiled tumour samples from the phase 3 MIDAS trial, in which all patients received isatuximab, carfilzomib, lenalidomide and dexamethasone (Isa-KRd). Of 368 evaluable patients, 44.8% were MRD-negative at 10⁻⁶ (59.8% at 10⁻⁵), with rates differing by expression subgroup — highest in HP1, HP3 and MS, lowest in CD2 and MF. B-cell-differentiation programs went with MRD positivity, and proliferation/MYC programs with MRD negativity; these signatures were validated in CASSIOPEIA. Whole-genome sequencing found a median of 9,360 somatic mutations per tumour, chromothripsis in 16%, and BRCA2 mono-allelic inactivation in 47.5%; new driver alterations were validated across 1,451 patients in MMRF, MANHATTAN and CASSIOPEIA. Nine methylation subgroups were linked to MRD. A random-forest model combining all three layers predicted post-induction MRD status (AUC 0.77), better than clinical or genomic models alone.据生物通对《自然-医学》论文的介绍（2026年10月20日；ClinicalTrials.gov NCT04934475）：研究者分析了III期MIDAS试验的肿瘤样本，该试验所有患者均接受伊沙妥昔单抗、卡非佐米、来那度胺和地塞米松（Isa-KRd）诱导。在368名可评估患者中，44.8%在10⁻⁶阈值达到MRD阴性（10⁻⁵阈值为59.8%），不同表达亚组差异显著——HP1、HP3和MS组最高，CD2和MF组最低。B细胞分化程序与MRD阳性相关，增殖/MYC程序与MRD阴性相关，并在CASSIOPEIA队列中得到验证。全基因组测序显示每例肿瘤中位9,360个体细胞突变，16%存在染色体碎裂，47.5%存在BRCA2单等位失活；新驱动改变在MMRF、MANHATTAN和CASSIOPEIA共1,451例患者中得到验证。九个DNA甲基化亚组与MRD相关。整合三层数据的随机森林模型预测诱导后MRD状态的AUC为0.77，优于单独的临床或基因组模型。

Why it matters: 为何重要：With four-drug induction now standard, knowing early who will not reach deep remission could guide intensification or alternative strategies.四药诱导已成标准方案，提前识别难以达到深度缓解的患者，可为强化治疗或替代策略提供依据。

Nature Medicine (via 生物通 summary) ↗ · r-2026-10-natmed-midas-isa-krd-multiomics-mrd-predictors-423-ndmm-random-forest-auc-0-77

Singapore haze, 10am Tuesday: West 24-h PSI edges up to 126 and Central to 115 (Unhealthy); hourly PM2.5 climbs to 96 in the West and is Elevated in four of five regions. NEA says showers may thin the haze today, but east-southeasterly winds from Tuesday night to Thursday could bring Kalimantan smoke back新加坡烟霾（周二上午10时）：西部24小时PSI升至126、中部115（不健康）；西部每小时PM2.5升至96，五个区域中有四个处于“偏高”。国家环境局表示今天阵雨或可减轻烟霾，但周二晚至周四的东南偏东风可能把加里曼丹烟霾再次带来

NEA readings at 10am on 20 Oct 2026 (via Haze.SG): 24-h PSI West 126 and Central 115 (Unhealthy), East 99, South 98 and North 89 (Moderate); over the past 24 hours the West ranged 114–126. 1-h PM2.5 was 96 µg/m³ in the West (24-h peak 105), 72 in Central, 61 in the South and 58 in the East (Band II Elevated, 56–150) and 49 in the North (Normal); the West's 24-h mean PM2.5 was 80 µg/m³. At 9am, CNA reported PSI 125 West and 114 Central, with PM2.5 Elevated everywhere except the North. NEA's forecast for 20 Oct remains PSI 90–160 (Moderate to Unhealthy): showers may reduce haze on Tuesday, though Sumatra smoke may still drift in, and from Tuesday night to Thursday east-southeasterly winds with dry conditions over parts of Kalimantan may bring smoke towards Singapore; NEA says the risk of severe transboundary haze remains. MOH advice: when 1-h PM2.5 is in the High band (151–250), the elderly, pregnant women and people with chronic heart or lung conditions should avoid outdoor activity; N95s are generally not needed for commuting or indoors.2026年10月20日上午10时国家环境局读数（经Haze.SG）：24小时PSI西部126、中部115（不健康），东部99、南部98、北部89（中等）；过去24小时西部在114–126之间。1小时PM2.5西部96微克/立方米（24小时内最高105），中部72、南部61、东部58（二级“偏高”，56–150），北部49（正常）；西部24小时平均PM2.5为80微克/立方米。亚洲新闻台报道，上午9时西部PSI 125、中部114，除北部外各区PM2.5均“偏高”。环境局对10月20日的预测仍为PSI 90–160（中等至不健康）：周二阵雨可能减轻烟霾，但苏门答腊烟霾仍可能飘来；周二晚至周四，加里曼丹部分地区天气干燥并吹东南偏东风，可能把烟霾带向新加坡，环境局称严重跨境烟霾风险仍在。卫生部建议：1小时PM2.5处于“高”级（151–250）时，长者、孕妇和慢性心肺病患者应避免户外活动；通勤或室内一般无需N95口罩。

Why it matters: 为何重要：The morning dip did not last — readings are creeping up again in the West, and NEA expects Kalimantan smoke to return midweek.早晨的好转没有持续——西部读数再度上升，环境局预计周中加里曼丹烟霾将卷土重来。

NEA real-time PSI/PM2.5 via Haze.SG; CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-10am-psi-west-126-central-115-pm25-west-96-elevated-four-regions

Malaysia haze, 8am Tuesday: 29 areas Unhealthy on APIMS — Johan Setia 171, Petaling Jaya 166, Nilai and Shah Alam 165, Cheras 164, Bukit Rambai 163, Putrajaya 162 — with seven Johor stations above 100; only seven areas recorded Good air马来西亚烟霾（周二早8时）：APIMS显示29个地区“不健康”——佐汉斯迪亚171、八打灵再也166、汝来和莎阿南165、蕉赖164、武吉南眉163、布城162，柔佛有7个站点超过100；全国仅7个地区空气“良好”

The Star (20 Oct 2026, 9am MYT), citing the Department of Environment's APIMS portal at 8am: Selangor — Johan Setia 171, Petaling Jaya 166, Shah Alam 165, Klang 162, Banting 158; Kuala Lumpur — Cheras 164 (Batu Muda was the national high, 172 at 7am per Sin Chew); Putrajaya 162; Negeri Sembilan — Nilai 165, Seremban 159, Port Dickson 145; Melaka — Bukit Rambai 163, Alor Gajah 155, Bandaraya Melaka 152; Johor — Larkin 157, Pasir Gudang 156, Kota Tinggi 154, Kluang 151, Pengerang 151, Tangkak 131, Batu Pahat 130; Pahang — Rompin 153, Balok Baru 152, Jerantut 137, Indera Mahkota 125, Temerloh 103; Perak — Tasek Ipoh 155, Pegoh 152; Terengganu — Paka 155. 32 areas were Moderate and seven Good. At 7am, Sin Chew reported 29 stations Unhealthy, 23 of them above 150, with Batu Muda at 172. API 101–200 is Unhealthy and 201–300 Very Unhealthy.《星报》（2026年10月20日大马时间上午9时）援引环境局APIMS早8时数据：雪兰莪——佐汉斯迪亚171、八打灵再也166、莎阿南165、巴生162、万津158；吉隆坡——蕉赖164（据《星洲日报》，峇都慕达早7时以172点全国最高）；布城162；森美兰——汝来165、芙蓉159、波德申145；马六甲——武吉南眉163、亚罗牙也155、马六甲市152；柔佛——拉庆157、巴西古当156、哥打丁宜154、居銮151、边加兰151、东甲131、峇株巴辖130；彭亨——云冰153、关丹巴洛峇鲁152、而连突137、关丹英迪拉马哥打125、淡马鲁103；霹雳——怡保打昔155、怡保北阁152；登嘉楼——甲抛155。另有32个地区“中等”、7个“良好”。《星洲日报》报道，早7时全国29个监测站“不健康”，其中23个超过150点，峇都慕达172点居首。空污指数101–200为“不健康”，201–300为“非常不健康”。

Why it matters: 为何重要：Much of the west-coast belt from KL to Johor is sitting just below the 200 mark at which school closures are recommended.从吉隆坡到柔佛的西海岸带大片地区指数逼近建议停课的200点门槛。

The Star (APIMS); Sin Chew Daily ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-apims-oct20-8am-29-areas-unhealthy-johan-setia-171-nilai-165-putrajaya-162-32-moderate

Indonesia: Palangka Raya's air-quality index (ISPU) hit 1,291 — far into the Hazardous range — on 19 Oct, and BMKG estimated 24-hour PM10 at 756.3 µg/m³, about ten times the national standard; Jambi was Very Unhealthy at 264 and morning visibility in Palangka Raya fell to 600 m–1 km印尼：中加里曼丹首府帕朗卡拉亚10月19日空气质量指数（ISPU）高达1,291，远超“危险”级；气象局估算24小时PM10为756.3微克/立方米，约为国家标准的10倍；占碑ISPU 264（非常不健康），帕朗卡拉亚早晨能见度降至600米至1公里

Kabar18 (20 Oct 2026), citing data reported by Detik: BMKG estimated PM10 in Palangka Raya at 756.3 µg/m³ for 07:00 WIB 19 Oct to 07:00 WIB 20 Oct, more than ten times the 75 µg/m³ 24-hour standard under Government Regulation 22/2021, while Pontianak was in the Unhealthy category. On the same day the Ministry of Environment's monitoring put Palangka Raya's ISPU at 1,291 (Hazardous, main pollutant PM2.5) and Jambi city at 264 (Very Unhealthy). Prokalteng reported morning visibility of about 600 m to 1 km, with BMKG forecasters saying air quality remained Hazardous; BMKG urged residents — especially vulnerable groups — to limit outdoor activity and wear masks. Earlier, Health Minister Budi Gunadi Sadikin advised infants, toddlers, the elderly and pregnant women to stay indoors during the smoke and to seek care at a puskesmas if cough, eye or skin irritation develops.Kabar18（2026年10月20日）援引Detik报道的数据：气象局（BMKG）估算10月19日7时至20日7时（西印尼时间）帕朗卡拉亚PM10为756.3微克/立方米，超过2021年第22号政府条例规定的24小时标准（75微克/立方米）10倍以上；坤甸处于“不健康”。同日环境部监测显示，帕朗卡拉亚ISPU为1,291（危险，首要污染物PM2.5），占碑市为264（非常不健康）。Prokalteng报道早晨能见度约600米至1公里，气象局预报员称空气质量仍为“危险”；气象局呼吁居民尤其是易感人群减少户外活动并佩戴口罩。此前卫生部长布迪·古纳迪·萨迪金建议婴幼儿、长者和孕妇在烟霾期间留在室内，如出现咳嗽、眼睛或皮肤刺激应尽快到社区卫生中心（puskesmas）就诊。

Why it matters: 为何重要：Readings this extreme in Central Kalimantan are the source of the smoke now drifting towards Singapore and Malaysia.中加里曼丹如此极端的读数，正是如今飘向新加坡和马来西亚烟霾的源头。

Kabar18 (BMKG / KLH ISPU data via Detik); Prokalteng ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-palangka-raya-ispu-1291-hazardous-bmkg-pm10-756-jambi-264-visibility-600m

Korea: patients who travelled outside their home region for emergency retinal-detachment surgery — three in four of them to the Seoul area — had a 40% higher risk of later registering as visually disabled, in a nationwide study of 54,269 operations; surgical delay was more common among those who travelled (42.0% vs 33.6%)韩国：一项涵盖54,269例手术的全国研究显示，离开居住地区接受急诊视网膜脱离手术的患者（其中四分之三去了首都圈）日后登记为视力残疾的风险高40%；跨区就医者手术延误更常见（42.0%对33.6%）

EunAh Kim (Samsung Changwon Hospital, Sungkyunkwan University) and Seonghee Nam, Epidemiology and Health (published online 2 Oct 2026; reported in Yonhap's health column): HIRA claims for 54,269 patients aged 11 or older who had rhegmatogenous retinal detachment surgery within 30 days of diagnosis in 2014–2023. 5,224 (9.6%) had surgery outside their region of residence; 76.4% of them went to the Seoul metropolitan area, the only net recipient region (+12.2%), while Jeju (−38.6%) and Gangwon (−28.8%) had the largest outflow. After adjustment for demographics, comorbidities and socioeconomic factors, transfer was associated with visual-disability registration (adjusted HR 1.4, 95% CI 1.2–1.7) but not with reoperation. The authors note claims data cannot separate referral of complex cases, patient preference and transfer-related delay. Jeju's net outflow shrank from −69.8% in 2018 to −2.6% in 2023, which they cite as evidence that targeted regional investment works.Kim EunAh（成均馆大学三星昌原医院）和Nam Seonghee，《流行病学与健康》（2026年10月2日在线发表；韩联社健康专栏报道）：利用健康保险审查评价院数据，纳入2014–2023年确诊后30天内接受孔源性视网膜脱离手术、年龄11岁及以上的54,269名患者。其中5,224人（9.6%）在居住地区以外接受手术，他们中76.4%去了首都圈——唯一的净流入地区（+12.2%）；济州（−38.6%）和江原（−28.8%）流出最多。校正人口学、合并症和社会经济因素后，跨区就医与视力残疾登记相关（校正HR 1.4，95%CI 1.2–1.7），但与再次手术无关。作者指出，理赔数据无法区分复杂病例转诊、患者偏好和转运延误各自的作用。济州净流出从2018年的−69.8%降至2023年的−2.6%，作者认为这说明有针对性的地区投入有效。

Why it matters: 为何重要：Retinal detachment is a race against time; where you live can still shape whether you keep your sight, even under universal insurance.视网膜脱离治疗分秒必争；即使在全民医保下，居住地仍可能影响能否保住视力。

Yonhap News Agency; Epidemiology and Health ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-retinal-detachment-surgery-interregional-transfer-visual-disability-ahr-1-4-54269-epih

Korea: in a Samsung Medical Center study of 2,024 cancer survivors, 14.3% had gained weight after treatment — and 63.5% of them said weight control was going badly, versus about 30% of those who lost or kept weight; adjusted unmet need was 3.4 times higher韩国：三星医疗院对2,024名癌症幸存者的研究发现，14.3%的人治疗后体重增加——其中63.5%表示体重管理不顺利，而体重减轻或不变者约为30%；校正后未满足需求高出3.4倍

Professors Shin Dong-wook and Choi Hye-rim (Cancer Survivors' Quality of Life Research Institute, Samsung Medical Center), Cancer Medicine, reported by The Herald Business (20 Oct 2026): survivors two months to two years after surgery were compared with pre-diagnosis weight — 36.8% (744) had lost weight, 48.9% (990) were stable and 14.3% (290) had gained, especially employed women under 50 and patients with breast or gynaecological cancers. 29.6% of the weight-loss group and 30.1% of the stable group said weight management was not going well, against 63.5% of the weight-gain group; after adjusting for age and comorbidities, unmet need was 3.4 times that of the stable group. The top barrier for those who lost weight was a lack of reliable diet and exercise information (40.5%); for those who gained it was giving up the pleasure of eating (40.2%), followed by disliking exercise and not knowing how to adjust routines (26.6% each) and treatment side-effects (23.9%). 54.8% of the weight-gain group would use digital health tools. Shin suggested GLP-1 drugs may help some patients, advising specialist consultation.三星医疗院癌症幸存者生活质量研究所Shin Dong-wook和Choi Hye-rim教授团队，发表于《癌症医学》，《Herald Business》2026年10月20日报道：研究对象为术后2个月至2年的幸存者，与确诊前体重相比，36.8%（744人）体重下降、48.9%（990人）基本不变、14.3%（290人）增加，增重在50岁以下在职女性及乳腺癌、妇科癌症患者中尤为明显。减重组和稳定组分别有29.6%和30.1%表示体重管理不顺利，增重组则高达63.5%；校正年龄和合并症后，增重组的未满足需求是稳定组的3.4倍。减重者最大的障碍是缺乏可靠的饮食和运动信息（40.5%）；增重者最难的是放弃“吃的乐趣”（40.2%），其次是不喜欢运动、不知如何调整饮食运动（各26.6%）和治疗副作用（23.9%）。增重组54.8%愿意使用数字健康工具。Shin教授认为GLP-1类药物或可帮助部分患者，建议咨询专科医生。

Why it matters: 为何重要：Weight gain after cancer can raise recurrence and cardiovascular risk, yet these survivors look 'well' and get the least attention.癌症治疗后增重可能增加复发和心脑血管风险，但这些幸存者看起来“恢复良好”，反而最少受到关注。

The Herald Business (Cancer Medicine) ↗ · r-2026-10-smc-cancer-survivors-weight-gain-14-3pct-unmet-need-3-4x-2024-survivors-cancer-medicine

Philippines DOH, 20 Oct: dengue 205,347 cases as of 14 Oct, 22% below 2025 (CFR 0.38%) and still under epidemic thresholds; leptospirosis 13,530 cases — 47% more than last year — but new cases fell 55% in late September and flagged areas dropped from 46 to 6菲律宾卫生部（10月20日）：截至10月14日登革热205,347例，比2025年同期少22%（病死率0.38%），仍低于流行阈值；钩端螺旋体病13,530例，比去年多47%，但9月下旬新增病例下降55%，被标记地区从46个减至6个

Daily Tribune (20 Oct 2026), citing the latest DOH reports: dengue cases nationwide reached 205,347 as of 14 October, 22% lower than the 261,749 recorded in the same period of 2025, with a case-fatality rate of 0.38%; 22,095 cases were reported from 17–30 September, 2% fewer than in 3–16 September, and provinces/highly urbanised cities flagged for increases fell from 11 to 9. Leptospirosis cases from 17–30 September totalled 1,159, a 55% decline from 2,570 in 3–16 September, and flagged areas fell from 46 to 6. The 2026 total of 13,530 leptospirosis cases is still 47% above the 9,188 of the same period last year, although the CFR (5.41%) is lower than 2025's 10.37%. DOH said it will keep monitoring to confirm the downward trend.《每日论坛报》（2026年10月20日）援引卫生部最新报告：截至10月14日全国登革热205,347例，比2025年同期的261,749例低22%，病死率0.38%；9月17日至30日报告22,095例，比9月3日至16日少2%，被标记病例上升的省份/高度城市化城市由11个减至9个。钩端螺旋体病9月17日至30日共1,159例，比9月3日至16日的2,570例下降55%，被标记地区由46个降至6个。2026年累计13,530例钩体病仍比去年同期9,188例高47%，但病死率（5.41%）低于2025年的10.37%。卫生部表示将继续监测以确认下降趋势。

Why it matters: 为何重要：After a flood-heavy season, leptospirosis is easing — but the year's toll is still far above 2025.在洪水频发的季节过后，钩端螺旋体病正在缓解，但全年累计仍远高于2025年。

Daily Tribune (DOH data) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-philippines-doh-dengue-205347-down-22pct-leptospirosis-13530-up-47pct-cfr-5-41

Australia (WEHI, Blood): prime editing makes therapeutic T cells resistant to the transplant drug tacrolimus while leaving them sensitive to cyclosporin — a 'control dial' that could let patients on immunosuppression keep corrected or CAR T cells alive, and switch them off if needed澳大利亚（WEHI，《血液》）：利用先导编辑让治疗性T细胞对移植常用药他克莫司产生耐药、同时仍对环孢素敏感——形成一个“控制旋钮”，可让需持续免疫抑制的患者保住经修正的T细胞或CAR-T细胞，必要时再将其抑制

WEHI (20 Oct 2026), study published in Blood (first author Esther Bandala-Sanchez; co-senior authors Miles Horton and Tom Lew): using cells from people with subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic lymphohistiocytosis (SPTCL-HLH), a rare immune-related blood cancer of children and young adults, the team used prime editing to correct a disease-causing mutation and add a second edit making the corrected cells resistant to tacrolimus. The same platform was then applied to virus-specific T cells, which could help transplant recipients fight infection without stopping anti-rejection drugs, and to CAR T cells. Edited cells stayed functional under immunosuppression and remained sensitive to other drugs, so one drug could support corrected cells while suppressing others, with cyclosporin kept in reserve to wind them back. The work used existing hospital medicines and was tested preclinically; the team, with Peter Mac, Royal Melbourne Hospital, Westmead, University of Sydney and Austin Health, is working toward a first-in-human trial.WEHI（2026年10月20日），研究发表于《血液》（第一作者Esther Bandala-Sanchez，共同通讯作者Miles Horton和Tom Lew）：团队用皮下脂膜炎样T细胞淋巴瘤合并噬血细胞性淋巴组织细胞增生症（SPTCL-HLH，一种多见于儿童和年轻人的罕见免疫相关血液肿瘤）患者的细胞，借助先导编辑纠正致病突变，并再加一处编辑使修正后的细胞耐受他克莫司。该平台随后又用于病毒特异性T细胞（有望帮助移植受者在不停用抗排斥药的情况下对抗感染）和CAR-T细胞。经编辑的细胞在免疫抑制下仍保持功能，并对其他药物保持敏感：可用一种药支持修正细胞、同时抑制其他免疫细胞，必要时再用环孢素“调低”它们。该方法使用医院现有药物，目前处于临床前阶段；团队与Peter Mac、皇家墨尔本医院、Westmead医院、悉尼大学和Austin Health合作，正推进首次人体试验。

Why it matters: 为何重要：Many patients who most need cell therapy cannot stop immunosuppressants; this design works with the drugs they already take.许多最需要细胞疗法的患者无法停用免疫抑制剂；这一设计正好与他们已在使用的药物兼容。

WEHI (Blood) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-wehi-blood-prime-editing-tacrolimus-resistant-cyclosporin-sensitive-t-cells-sptcl-hlh-control-dial

Israel nationwide study (Cancer): ischaemic stroke was about 80% more common than expected in the year after a cancer diagnosis, peaking at 2.5 times expected in the first three months; after pancreatic cancer the risk was 5.9 times expected以色列全国研究（《癌症》）：癌症确诊后一年内缺血性卒中发生率比预期高约80%，前三个月最高达预期的2.5倍；胰腺癌确诊后风险为预期的5.9倍

Libruder et al., Cancer (2026), University of Haifa with Israel's Ministry of Health, as summarised by Health Chosun (20 Oct 2026): the Israel National Cancer Registry and Stroke Registry were linked to follow 182,221 people aged 40+ with a first invasive cancer diagnosed in 2014–2021 for one year; 1,125 first ischaemic strokes occurred. The standardised incidence ratio was 1.8 for the first year, 2.5 in months 0–3, 1.6 in months 3–6 and 1.5 in months 6–12. By site, pancreatic cancer had the highest SIR (5.9), stomach and bladder cancers about two to three times, and risk rose with more advanced stage. Severance Hospital neurologist Heo Jun-nyeong explained that cancer cells release pro-coagulant substances and trigger inflammation and platelet activation (Trousseau syndrome); Lee Sang-hyung (Ilsan CHA Hospital) urged calling 119 for sudden one-sided weakness, slurred speech or vision loss, which can be mistaken for treatment side-effects.Libruder等，《癌症》（2026年），以色列海法大学与卫生部合作，据Health Chosun 2026年10月20日综述：研究将以色列国家癌症登记和卒中登记数据关联，对2014–2021年首次确诊浸润性癌症的182,221名40岁及以上人群随访一年，共发生1,125例首次缺血性卒中。第一年标准化发病比为1.8，0–3个月为2.5，3–6个月为1.6，6–12个月为1.5。按部位，胰腺癌最高（5.9），胃癌和膀胱癌约为2–3倍，确诊时分期越晚风险越高。延世大学Severance医院神经科Heo Jun-nyeong教授解释，癌细胞会分泌促凝物质并引发炎症和血小板活化（Trousseau综合征）；一山CHA医院Lee Sang-hyung教授提醒，突发单侧无力、言语含糊或视力丧失应立即呼叫119，这些症状容易被误认为治疗副作用。

Why it matters: 为何重要：The first weeks after a cancer diagnosis are a high-risk window for stroke — blood pressure, glucose and hydration matter alongside cancer care.癌症确诊后的最初几周是卒中高危期——在抗癌治疗的同时也要管好血压、血糖和水分。

Cancer (Wiley); Health Chosun ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-cancer-journal-israel-registry-ischemic-stroke-after-cancer-sir-1-8-first-3-months-2-5-pancreatic-5-9

Singapore haze, 8am Tuesday: 24-h PSI Unhealthy in the West (125) and Central (114); hourly PM2.5 Elevated in the West (88), Central (78), South (59) and East (56). NEA warns winds turning east-southeasterly from Tuesday night to Thursday may bring Kalimantan smoke back新加坡烟霾（周二早8时）：24小时PSI西部（125）和中部（114）为“不健康”；每小时PM2.5西部88、中部78、南部59、东部56，均处“偏高”。国家环境局提醒，周二晚至周四风向转为东南偏东，可能再把加里曼丹的烟霾吹来

Readings at 8am on 20 Oct 2026 (NEA data via Haze.SG): 24-h PSI West 125 and Central 114 (Unhealthy), East 99, South 96 and North 89 (Moderate); West's 24-h PSI had peaked at 132 in the past day. 1-h PM2.5 was 88 µg/m³ in the West, 78 in Central, 59 in the South and 56 in the East (Band II Elevated, 56–150) and 40 in the North (Normal). In its 19 Oct 6pm update, NEA said showers and a wind shift to south-southeasterly had improved air quality on Monday afternoon and kept its 20 Oct forecast at PSI 90–160 (Moderate to Unhealthy). Showers are forecast on Tuesday and south-southeasterly winds may reduce smoke from Kalimantan, though some haze from Sumatra may drift in; from Tuesday night to Thursday, winds are likely to turn east-southeasterly with dry conditions over the region, which may carry Kalimantan smoke towards Singapore.2026年10月20日早8时读数（国家环境局数据，经Haze.SG）：24小时PSI西部125、中部114（不健康），东部99、南部96、北部89（中等）；西部24小时PSI过去一天最高曾达132。1小时PM2.5西部88、中部78、南部59、东部56微克/立方米（二级“偏高”，56–150），北部40（正常）。国家环境局10月19日晚6时通报称，周一下午的阵雨和风向转为南-东南风使空气改善，10月20日预测维持PSI 90–160（中等至不健康）。周二预报有阵雨，南-东南风可能减少来自加里曼丹的烟霾，但苏门答腊的部分烟霾仍可能飘来；周二晚至周四，区域风向可能转为东南偏东且天气干燥，或把加里曼丹的烟霾带向新加坡。

Why it matters: 为何重要：Tuesday may be a little better, but NEA expects smoke to return midweek — plan outdoor activities around the hourly PM2.5 reading.周二或许稍好，但环境局预计周中烟霾会卷土重来——户外活动请以每小时PM2.5为准。

NEA haze update 19 Oct (weather.gov.sg); NEA real-time PSI/PM2.5 via Haze.SG ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct20-8am-psi-west-125-central-114-pm25-west-88-central-78-nea-kalimantan-smoke-tue-night-thu

Malaysia haze worsens, 7am Tuesday: 28 areas Unhealthy, led by Batu Muda, Kuala Lumpur (172), Johan Setia (168), Petaling Jaya and Nilai (164); only six stations record Good air马来西亚烟霾加剧（周二早7时）：28个地区“不健康”，吉隆坡峇都慕达（172）、Johan Setia（168）、八打灵再也和汝来（164）居前；全国仅6个监测站空气“良好”

Astro Awani (20 Oct 2026, 7:50am), citing DOE's APIMS: 28 areas were Unhealthy (API 101–200) at 7am, up from 25 at 7pm on Monday. After Batu Muda, Johan Setia, Petaling Jaya and Nilai came Cheras and Shah Alam (162), Bukit Rambai, Melaka (161), Klang (160), Putrajaya and Seremban (159). In Johor, Larkin and Pasir Gudang read 156, Kota Tinggi 153, Kluang 147, Pengerang 143, Tangkak 136 and Batu Pahat 117; areas in Melaka, Perak, Pahang and Terengganu recorded 152–155. 34 stations were Moderate, all Sarawak stations were Moderate (32–92), and only Kota Kinabalu, Labuan, Langkawi, Limbang, Kimanis and ILP Miri were Good. Children, older people and those with breathing problems are advised to limit outdoor activity and wear masks. Selangor schools open as usual on 20 Oct with outdoor activities suspended and masks encouraged; parents may keep worried children home after informing the school (JPN Selangor).Astro Awani（2026-10-20早7:50）引述环境局APIMS：早7时有28个地区“不健康”（API 101–200），比周一晚7时的25个增加。紧随峇都慕达、Johan Setia、八打灵再也和汝来之后的是蕉赖和莎阿南（162）、马六甲武吉南眉（161）、巴生（160）、布城和芙蓉（159）。柔佛方面，拉庆和巴西古当156、哥打丁宜153、居銮147、边佳兰143、东甲136、峇株巴辖117；马六甲、霹雳、彭亨和登嘉楼部分地区为152–155。34个监测站为“中等”，砂拉越所有站点均为“中等”（32–92），仅亚庇、纳闽、浮罗交怡、林梦、金马利和美里ILP“良好”。儿童、老人和有呼吸问题者应减少户外活动并戴口罩。雪兰莪州教育局称，10月20日学校照常上课，但暂停户外活动、鼓励戴口罩；家长担心的可在通知学校后让孩子留在家中。

Why it matters: 为何重要：The Klang Valley woke up to some of the worst air of this haze episode — keep children and older relatives indoors where possible.巴生谷今早的空气属这轮烟霾中最差之列——尽量让孩子和长辈留在室内。

Astro Awani (DOE APIMS); Media Selangor (JPN Selangor) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-apims-oct20-7am-28-areas-unhealthy-batu-muda-172-johan-setia-168-pj-nilai-164

Osaka University: within 30 minutes of a stroke, the beating cilia lining the brain's ventricles disappear, letting cerebrospinal fluid flood into brain tissue and worsen swelling; regrowing them with an HDAC6 inhibitor reduced oedema and improved movement in mice (Cell Press Blue)大阪大学：脑梗塞发生30分钟内，覆盖脑室壁的上衣细胞运动性纤毛迅速消失，使脑脊液涌入脑组织、加重脑水肿；用HDAC6抑制剂促进纤毛再生可减轻小鼠脑水肿并改善运动功能（《Cell Press Blue》）

Osaka University Graduate School of Medicine press release (20 Oct 2026): Furumiya, Yamashita and colleagues used a mouse middle-cerebral-artery occlusion model and fluorescent CSF tracers. Early after stroke, inflow through the glymphatic system and outflow to the dura decreased, while transependymal influx — CSF passing from the ventricles between ependymal cells into brain tissue — increased. The motile cilia of ependymal cells were lost within 30 minutes, driven by calcium entry via NMDAR2A and the enzyme HDAC6 (shown with drugs and AAV ependymal-specific knockdown). Giving an HDAC6 inhibitor after stroke promoted cilia regrowth from the next day, reducing transependymal influx, oedema and infarct size and improving motor function, without changing glymphatic flow. Human ependymal cells express NMDAR2A, and cilia loss was seen in post-mortem brain tissue from stroke patients. Published online 20 Oct 2026 (Japan time), DOI 10.1016/j.cpblue.2026.100147.大阪大学医学系研究科新闻稿（2026-10-20）：古宫健至、山下俊英等利用小鼠大脑中动脉闭塞模型和荧光示踪脑脊液发现，脑梗塞后早期经类淋巴系统的流入和向硬膜的排出减少，而经上衣细胞间隙从脑室流入脑组织的“跨室管膜流入”增强。上衣细胞运动性纤毛在30分钟内消失，由NMDAR2A介导的钙内流和HDAC6酶驱动（通过药物和AAV上衣细胞特异性敲低证实）。脑梗塞后给予HDAC6抑制剂可从次日起促进纤毛再生，减轻跨室管膜流入、脑水肿和梗塞范围并改善运动功能，而不改变类淋巴流动。人类上衣细胞也表达NMDAR2A，脑梗塞患者死后脑组织中亦观察到纤毛消失。论文于日本时间10月20日在线发表，DOI 10.1016/j.cpblue.2026.100147。

Why it matters: 为何重要：Brain swelling is a major cause of death after large strokes; protecting these tiny 'gatekeeper' hairs is a new treatment idea.脑水肿是大面积脑梗塞后的主要死因之一；保护这些微小的“门卫”纤毛是一种新的治疗思路。

Institutions: 机构：Osaka U阪大

Osaka University Graduate School of Medicine ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-osaka-u-ependymal-cilia-loss-transependymal-csf-influx-stroke-brain-edema-hdac6-cell-press-blue

Korea's Ministry of Food and Drug Safety designates eight more 'national essential medicines' needing supply support — including paediatric amino-acid infusions, a pig-lung surfactant for newborn breathing distress and daunorubicin for acute myeloid leukaemia韩国食品药品安全部新指定8种需保障供应的“国家必需药品”——包括儿童复方氨基酸输液、用于新生儿呼吸窘迫综合征的猪肺提取物注射剂和用于急性髓系白血病的柔红霉素注射剂

Yonhap (20 Oct 2026): MFDS designated the eight items (by ingredient and dosage form) on 19 Oct. National essential medicines are drugs vital to healthcare whose stable supply cannot be ensured by the market alone; they are designated through inter-ministerial consultation. The new items, used to treat newborns and cancer patients, include 6% and 10% compound amino-acid infusions for infants and children, porcine lung extract injection for neonatal respiratory distress syndrome and daunorubicin injection for acute myeloid leukaemia. Vice Minister Kim Yong-jae, chair of the supply council set up in 2016, pledged active support; from next month the council will be expanded into a public–private body including groups from production, import, distribution, prescribing, dispensing and use.韩联社（2026-10-20）：食品药品安全部于10月19日按成分和剂型新指定8个品种。国家必需药品是医疗上必不可少、但仅靠市场难以稳定供应的药品，通过跨部门协商指定。新增品种用于新生儿和癌症患者治疗，包括婴幼儿用6%和10%复方氨基酸输液、用于新生儿呼吸窘迫综合征的猪肺提取物注射剂及用于急性髓系白血病的柔红霉素注射剂。2016年成立的稳定供应协议会主席、食药部次长Kim Yong-jae表示将积极支持；该协议会将从下月起扩大为涵盖生产、进口、流通、处方、调剂和使用各环节团体的官民联合协议会。

Why it matters: 为何重要：Old, low-profit drugs for newborns and leukaemia patients are prone to shortages; official designation helps keep them on shelves.用于新生儿和白血病患者的老药利润低、易断供；官方指定有助于保障供应。

Yonhap News Agency ↗ · r-2026-10-mfds-8-new-national-essential-medicines-amino-acid-infusion-poractant-daunorubicin

Korea: 42 of the 100 most-viewed YouTube videos on senior health in April were made with generative AI and 24 impersonated doctors or other experts; after a lawmaker raised it, Google closed 10 channels and removed 31 videos韩国：今年4月YouTube上“老年健康”类播放量前100的视频中，42个由生成式AI制作，24个冒充医生等专家；经国会议员指出后，谷歌关闭10个频道并删除31个视频

Yonhap (20 Oct 2026): analysis of data from the Korea Health Promotion Institute by Rep. Park Yong-gap (Health and Welfare Committee) found fake-expert accounts staged as if treating patients, and some videos missing AI labels. In the institute's health-information survey, 45.4% of people in their 60s look up health information at least weekly, mainly via portals (49.7%) and YouTube (14.4%). The institute can only recommend voluntary action and had never requested removals. Google Korea reviewed 100 videos on 51 channels, closed 10 channels that broke YouTube guidelines and deleted 31 videos, added AI labels to 13 and demonetised 10 videos on five channels. Park called for a standing monitoring body of public agencies, platforms and doctors.韩联社（2026-10-20）：国会保健福祉委员会议员Park Yong-gap分析韩国健康促进开发院资料发现，有账号以虚假专家名义伪装成在医疗现场诊治患者，部分视频未标注AI标签。该院健康信息认知调查显示，60多岁人群中45.4%每周至少查一次健康信息，主要渠道为门户网站（49.7%）和YouTube（14.4%）。该院只能建议自律整改，从未提出删除请求。谷歌韩国审查了51个频道的100个视频，关闭10个违反YouTube准则的频道并删除31个视频，为13个视频补加AI标签，并对5个频道的10个视频停止广告收益。Park Yong-gap呼吁由公共机构、平台和医生组成常设监测机制。

Why it matters: 为何重要：AI-made 'doctors' giving health advice can mislead older viewers — check who is really behind a health video.AI生成的“医生”提供健康建议可能误导老年观众——看健康视频要核实发布者身份。

Yonhap News Agency ↗ · r-2026-10-korea-top100-senior-health-youtube-42-ai-generated-24-fake-doctors-google-closes-10-channels

Tianjin Medical University Cancer Hospital launches a multilateral regional cancer-control alliance with cancer centres from Sri Lanka, Kazakhstan, Belarus, Uzbekistan, Nepal, Azerbaijan, Indonesia and Kyrgyzstan under the SCO framework天津医科大学肿瘤医院在上合组织框架下发起肿瘤防治多边区域联盟，斯里兰卡、哈萨克斯坦、白俄罗斯、乌兹别克斯坦、尼泊尔、阿塞拜疆、印尼和吉尔吉斯斯坦的肿瘤机构共同参与

At a symposium on cancer prevention and multilateral cooperation for an SCO health community, held in Tianjin on 17–18 Oct 2026 by the Tianjin Anti-Cancer Association and Tianjin Medical University Cancer Hospital, a multilateral regional cancer-control alliance was founded (China News Service, 19 Oct). Participants include Sri Lanka's National Cancer Institute, Kazakhstan's national oncology research centre, Belarus's N.N. Alexandrov National Cancer Centre, Tashkent Medical University, Bir Hospital of Nepal's National Academy of Medical Sciences, Azerbaijan Medical University, the Indonesian Society of Hematology and Medical Oncology and Kyrgyzstan's national oncology and haematology centre. It will cooperate on screening and early diagnosis, training, research, international referrals and governance. Tianjin approved an international oncology training centre at the hospital, which has opened its first course for oncologists from SCO and Belt and Road countries and signed agreements with Belarus's national cancer centre and Indonesian partners.据中新网10月19日报道，由天津市抗癌协会、天津医科大学肿瘤医院主办的“共建上合健康共同体——癌症防控创新与多边合作学术研讨会”于2026年10月17日至18日在天津举行，并成立肿瘤防治多边区域联盟。斯里兰卡国家癌症中心、哈萨克斯坦国家肿瘤研究中心、白俄罗斯尼·尼·亚历山德罗夫共和国肿瘤学与医学放射学科学实践中心、乌兹别克斯坦塔什干医科大学、尼泊尔国家医学科学院比尔医院、阿塞拜疆医科大学、印度尼西亚血液学与肿瘤内科学会、吉尔吉斯斯坦国家肿瘤与血液病中心共同参与。联盟将围绕共建多边平台、共促早筛诊疗、共育人才队伍、共推科研交流、共拓国际诊疗、共商治理保障六大方向开展协作。天津市卫健委批准在该院成立“天津市国际肿瘤医学人员培训中心”，首届国际肿瘤专科医师培训班已面向上合组织及共建“一带一路”国家招生；该院还与白俄罗斯国家癌症中心、印尼相关学会分会等签署合作协议。

Why it matters: 为何重要：Many of these countries have limited cancer screening and specialist capacity; Chinese cancer centres are increasingly training doctors and setting up referral links across Asia.这些国家中不少癌症筛查和专科能力有限；中国的肿瘤中心正越来越多地为亚洲各国培训医生并建立转诊渠道。

China News Service (Tianjin Medical University Cancer Hospital) ↗ · r-2026-10-tianjin-cancer-hospital-sco-multilateral-regional-cancer-alliance-8-countries-international-oncologist-training

Hefei scientists design a dual-action small molecule against pancreatic cancer: IHMT-140 blocks the collagen receptor DDR1 and also makes cancer cells swell with vacuoles and die, while helping them take up the chemotherapy drug gemcitabine (mouse study)合肥科学家设计出双功能抗胰腺癌小分子：IHMT-140既抑制胶原受体DDR1，又诱导癌细胞空泡化死亡，同时促进癌细胞摄取化疗药吉西他滨（小鼠研究）

Liu Qingsong's pharmacology team at the Institute of Health and Medical Technology, Hefei Institutes of Physical Science (CAS), reported in the Journal of Advanced Research (announced 19 Oct 2026) a new pyrazole-derived DDR1 inhibitor, IHMT-140, that was highly potent and selective in kinase assays. Inhibiting DDR1, a collagen-activated receptor tyrosine kinase linked to pancreatic cancer survival, metastasis and collagen remodelling, reduced collagen secretion and suppressed invasion and metastasis. Separately, the weakly basic compound over-activated macropinocytosis, causing vacuoles to accumulate and triggering methuosis (vacuolar cell death); the increased uptake also boosted cancer cells' intake of gemcitabine, giving a combined effect confirmed in mouse xenograft models. The authors say the approach could help overcome drug delivery barriers in pancreatic cancer's dense stroma; it has not been tested in people.中国科学院合肥物质科学研究院健康所刘青松药学团队在《Journal of Advanced Research》发表研究（2026年10月19日公布），报道了一种新型吡唑衍生物DDR1抑制剂IHMT-140，激酶实验显示其具有高活性与高选择性。DDR1是由胶原激活的受体酪氨酸激酶，与胰腺癌细胞存活、转移及胶原纤维重排密切相关；抑制DDR1可调控胶原分泌，进而抑制胰腺癌侵袭与转移。另一方面，这种弱碱性化合物可诱导巨胞饮过度激活，促进空泡形成和累积，引发空泡化死亡（methuosis）；巨胞饮增强还能促进癌细胞摄取吉西他滨，实现联合增效，并已在小鼠移植瘤模型中得到验证。作者认为该思路有望突破胰腺癌致密基质导致药物难以到位的困局；目前尚未进行人体试验。

Why it matters: 为何重要：Pancreatic cancer has a five-year survival under 12% and is rising in China; ways to get chemotherapy past its dense stroma are a key need — but this is early preclinical work.胰腺癌五年生存率不足12%，在中国发病率持续上升；让化疗药物穿透其致密基质是关键需求——但这仍是早期临床前研究。

Hefei Institutes of Physical Science, CAS ↗ · r-2026-10-hefei-cas-ihmt-140-ddr1-inhibitor-methuosis-macropinocytosis-gemcitabine-pancreatic-cancer-j-adv-res

Pakistan reports its seventh wild polio case of 2026 — a malnourished six-month-old boy in Karachi, the city's first case since December 2024; a campaign targeting 24 million children follows on 2–8 November巴基斯坦报告2026年第7例野生脊髓灰质炎病例——卡拉奇一名营养不良的6个月大男婴，为该市自2024年12月以来首例；11月2日至8日将开展针对2400万儿童的疫苗接种

Pakistan's National Emergency Operation Centre said on 19 Oct 2026 (Dawn) that a six-month-old boy from Union Council Jamali Colony in Karachi East tested positive for wild poliovirus, confirmed by the national polio reference laboratory at NIH Islamabad. The child was malnourished; it is Karachi's first reported case since December 2024, although only one Karachi environmental sample tested positive in September. Of seven cases this year, five are from Khyber Pakhtunkhwa (four from Bannu division) and two from Sindh, compared with 31 in 2025. A sub-national campaign on 2–8 November will target nearly 24 million children in 97 districts, including all of Karachi, synchronised with Afghanistan — the only other country where polio remains endemic.据《黎明报》报道，巴基斯坦国家紧急行动中心2026年10月19日表示，卡拉奇东区贾马里社区一名6个月大男婴的野生脊髓灰质炎病毒检测呈阳性，已由伊斯兰堡国家卫生研究院脊灰参比实验室确认。该患儿营养不良；这是卡拉奇自2024年12月以来首例报告病例，尽管9月该市仅有一个环境监测点呈阳性。今年7例病例中，5例来自开伯尔-普赫图赫瓦省（其中4例在班努专区），2例来自信德省；2025年全年为31例。11月2日至8日将开展次国家级免疫活动，覆盖97个县近2400万名儿童，包括卡拉奇全部地区，并与阿富汗同步——阿富汗是另一个脊灰仍在流行的国家。

Why it matters: 为何重要：As long as wild polio circulates anywhere, imported cases remain possible; China borders both endemic countries and maintains high polio vaccine coverage for this reason.只要野生脊灰病毒仍在任何地方传播，输入病例就仍有可能；中国与这两个流行国家接壤，因此始终保持较高的脊灰疫苗接种率。

Dawn (National Emergency Operation Centre) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-pakistan-7th-wild-polio-case-2026-karachi-east-jamali-colony-6-month-old-first-karachi-since-dec-2024

US National Academy of Medicine elects 100 new members, including Sun Yat-sen University Cancer Center's Ma Jun for nasopharyngeal cancer, Osaka's Nobel laureate Shimon Sakaguchi for regulatory T cells and Singapore's Marcus Ong for cardiac-arrest survival美国国家医学院新增100名院士，其中包括中山大学肿瘤防治中心马骏（鼻咽癌）、大阪大学诺贝尔奖得主坂口志文（调节性T细胞）和新加坡中央医院王永福（Marcus Ong，心脏骤停救治）

The National Academy of Medicine announced on 19 Oct 2026 the election of 90 regular and 10 international members, bringing membership to more than 2,600. International members include Jun Ma of Sun Yat-sen University Cancer Center, Guangzhou, cited for establishing the current standard of care for nasopharyngeal carcinoma with immuno-chemo-radiotherapy and low-toxicity radiotherapy, helping raise five-year survival in China from about 44% to 56%; Shimon Sakaguchi of the University of Osaka, for discovering Foxp3-dependent regulatory T cells and Treg-based therapies; and Marcus Eng Hock Ong of Singapore General Hospital and Duke-NUS, for improving out-of-hospital cardiac arrest survival in Singapore and Asia-Pacific. Regular members include Fred Ramsdell (Foxp3/IPEX), Swee Lay Thein (BCL11A and fetal haemoglobin, the basis of gene-editing cures for sickle cell disease and β-thalassaemia), Kiran Musunuru (first bespoke base-editing therapy), Donald Kohn (stem-cell gene therapy for SCID and sickle cell) and Bing Ren (enhancer maps and 3D genome domains).美国国家医学院于2026年10月19日宣布新选出90名正式院士和10名外籍院士，院士总数逾2,600人。外籍院士包括：广州中山大学肿瘤防治中心马骏，表彰其以免疫化放疗方案和低毒放疗策略确立鼻咽癌现行标准治疗，帮助中国鼻咽癌五年生存率由约44%提高到56%；大阪大学坂口志文，表彰其发现依赖Foxp3的调节性T细胞并开发基于Treg的疗法；新加坡中央医院及杜克-国大医学院Marcus Eng Hock Ong（王永福），表彰其提高新加坡及亚太地区院外心脏骤停生存率。正式院士包括Fred Ramsdell（Foxp3/IPEX综合征）、Swee Lay Thein（发现BCL11A调控胎儿血红蛋白，为镰状细胞病和β地中海贫血基因编辑疗法奠定基础）、Kiran Musunuru（首个个体化碱基编辑疗法）、Donald Kohn（重症联合免疫缺陷和镰状细胞病的造血干细胞基因治疗）和任兵（增强子图谱及染色质拓扑结构域）。

Why it matters: 为何重要：International recognition for work done in China, Japan and Singapore — Ma Jun's NPC regimens matter most in southern China, where the cancer is far more common than elsewhere.这是对在中国、日本和新加坡完成的研究的国际认可——马骏的鼻咽癌治疗方案对鼻咽癌高发的华南地区意义尤为重大。

US National Academy of Medicine ↗ · r-2026-10-nam-elects-100-members-2026-international-jun-ma-sysucc-npc-shimon-sakaguchi-treg-marcus-ong-sgh-swee-lay-thein

West China Hospital team finds a shared weak spot in squamous cell cancers of the oesophagus, head and neck and lung: 'droplets' of the SOX2 protein that switch on cancer genes — and an approved myeloma drug, ixazomib, dissolves them华西医院团队发现食管、头颈部和肺鳞状细胞癌的共同弱点：SOX2蛋白形成的“凝聚体”开启致癌基因——已获批的骨髓瘤药物伊沙佐米可将其溶解

Yuan Yong, Ding Junjun, Guo Anyuan and colleagues at Sichuan University's West China Hospital reported in Cell Reports Medicine (19 Oct 2026) that SOX2 condensates — protein droplets formed by phase separation — are a common hallmark of oesophageal, head-and-neck and lung squamous cell carcinoma. The AD1 domain of SOX2 drives condensate formation through aromatic and hydrophobic residues; the condensates increase SOX2 binding to chromatin, H3K27ac marks and chromatin contacts at oncogenes such as FGFR2, promoting tumour growth. Screening FDA-approved drugs, the team found that the proteasome inhibitor ixazomib (approved for multiple myeloma in 2015) selectively dissolves SOX2 condensates in an HSP70-dependent way, with HSP70 blocking the AD1 domain; it lowered oncogene expression and suppressed xenograft tumours derived from condensate-positive patients.四川大学华西医院袁勇、丁俊军、郭安源等在《细胞报告·医学》（2026年10月19日）发表研究，发现SOX2凝聚体——通过相分离形成的蛋白“液滴”——是食管、头颈部和肺鳞状细胞癌的共同标志。SOX2的AD1结构域通过芳香族和疏水性氨基酸残基驱动凝聚体形成；凝聚体增强SOX2在染色质上的占据、H3K27ac富集以及在FGFR2等致癌基因位点的染色质相互作用，从而促进肿瘤进展。团队筛选FDA已批准药物后发现，蛋白酶体抑制剂伊沙佐米（2015年获批用于多发性骨髓瘤）可通过HSP70依赖的方式选择性溶解SOX2凝聚体，即HSP70阻断AD1结构域；该药可下调致癌基因表达，并抑制来自凝聚体阳性患者的异种移植瘤生长。

Why it matters: 为何重要：Squamous cancers have few targetable mutations, make up about 85% of oesophageal cancers and are common in China; repurposing an approved drug against a biomarker-defined group could reach trials faster — though evidence is so far preclinical.鳞状细胞癌可靶向的基因突变很少，约占食管癌的85%，在中国十分常见；针对生物标志物界定人群重新利用已获批药物，有望更快进入临床试验——但目前证据仍属临床前阶段。

Institutions: 机构：West China华西

Cell Reports Medicine; BioWorld (NetEase) ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-west-china-sox2-condensates-squamous-cell-carcinoma-ixazomib-hsp70-dissolves-cell-rep-med

Why some carriers of the main Alzheimer's risk gene stay sharp: Columbia researchers show APOE4 drives a build-up of fibronectin around brain blood vessels that makes the blood–brain barrier leaky — the damage a rare protective FN1 variant appears to block为何部分阿尔茨海默病主要风险基因携带者仍能保持头脑清晰：哥伦比亚大学研究显示，APOE4导致脑血管周围纤连蛋白堆积、使血脑屏障渗漏——而一种罕见的保护性FN1变异似乎能阻断这一损伤

Caghan Kizil and colleagues at Columbia University Irving Medical Center reported in Nature Aging (ScienceDaily, 19 Oct 2026) the mechanism behind their earlier finding that a rare variant in the fibronectin gene FN1 protects some APOE ε4 carriers. Using human brain tissue and cerebrospinal fluid, single-cell and spatial analyses, stem-cell and 3D vessel models, zebrafish and mice, they found APOE ε4 increases fibronectin around brain blood vessels; APOE ε4 mice had nearly twice as much brain fibronectin as APOE ε3 mice, with a leaky barrier. Raising fibronectin in astrocytes was enough to make the barrier permeable and lowering it improved function. Excess fibronectin acts through integrins and focal adhesion kinase to disrupt VEGF, HBEGF and IGF1 signalling between astrocytes and vessel cells. Possible strategies include limiting fibronectin build-up, blocking its signalling or restoring growth-factor signalling; all remain experimental.哥伦比亚大学欧文医学中心Caghan Kizil团队在《自然·衰老》发表研究（ScienceDaily 2026年10月19日报道），阐明了他们此前发现的纤连蛋白基因FN1罕见变异为何能保护部分APOE ε4携带者。团队利用人脑组织和脑脊液、单细胞与空间分析、干细胞和三维血管模型以及斑马鱼和小鼠，发现APOE ε4会增加脑血管周围的纤连蛋白；APOE ε4小鼠脑内纤连蛋白几乎是APOE ε3小鼠的两倍，且血脑屏障渗漏。仅在星形胶质细胞中增加纤连蛋白即可使屏障通透性增加，减少则改善屏障功能。过量纤连蛋白通过整合素和黏着斑激酶，干扰星形胶质细胞与血管细胞之间的VEGF、HBEGF和IGF1信号。可能的干预策略包括限制纤连蛋白堆积、阻断其信号或恢复生长因子信号；目前均处于实验阶段。

Why it matters: 为何重要：About one in five people carry APOE ε4; copying a natural genetic protection is a different route from removing amyloid or tau.约五分之一的人携带APOE ε4；模仿天然的遗传保护机制，是不同于清除β淀粉样蛋白或tau蛋白的新途径。

Columbia University Irving Medical Center via ScienceDaily; Nature Aging ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-columbia-fibronectin-apoe4-blood-brain-barrier-astrocytes-integrin-fak-fn1-protective-variant-nat-aging

China's NMPA holds an 'AI + drug regulation' meeting: a special plan will back priority AI-in-medicine tracks, move review support earlier to the innovation stage and use AI to make review, inspection and risk monitoring smarter国家药监局召开“人工智能+药品监管”工作推进会：将制定专项计划支持重点赛道率先突破，把审评服务前移到创新源头，并用人工智能让审评审批、检查执法和风险防控更智能

On 19 Oct 2026 the National Medical Products Administration held a working meeting on 'AI + drug regulation' (reported 20 Oct). It said the regulator should set rules, stabilise expectations, strengthen services and cultivate the ecosystem to promote AI-enabled innovation in the pharmaceutical industry; draw up a special plan supporting breakthroughs in key tracks; move review services forward to the source of innovation with an innovation-friendly, 'inclusive and prudent' environment; use AI to make review and approval smarter, inspections more precise and risk prevention more sensitive; and build a whole-lifecycle, continuously updated management mechanism for AI applications while holding the AI safety bottom line.2026年10月19日，国家药监局召开“人工智能+药品监管”工作推进会（10月20日报道）。会议强调要立规则、稳预期、强服务、育生态，积极促进人工智能赋能医药产业创新发展；制定专项计划，支持重点赛道率先突破，把审评服务前移到创新源头，营造鼓励创新、包容审慎的监管环境；运用人工智能推动审评审批更智能、检查执法更精准、风险防控更灵敏、协同监管更高效；建立覆盖全周期、持续迭代的人工智能应用管理机制，守牢人工智能安全底线。

Why it matters: 为何重要：Signals that China intends to speed up AI-discovered drugs and AI medical tools while also using AI inside its own review process.表明中国既要加快人工智能发现药物和医疗AI工具的上市进程，也要在自身审评中运用人工智能。

Yicai (NMPA meeting brief) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nmpa-ai-plus-drug-regulation-meeting-oct19-special-plan-priority-tracks-smarter-review

Indonesia's South Kalimantan adds about 10,000 haze-related respiratory infections a week for five weeks running, mostly in Banjarmasin, Banjar and Banjarbaru; the province opens 'oxygen houses' as national daily new cases begin to slow印尼南加里曼丹连续5周每周新增约1万例与烟霾相关的急性呼吸道感染，主要在马辰、班查尔和班查尔巴鲁；该省开设“氧气屋”，全国每日新增病例开始放缓

South Kalimantan's provincial health office head Dr Diauddin said on 19 Oct 2026 that acute respiratory infection (ARI) cases have risen by about 10,000 a week on average over the past five weeks, with the most cases in Banjarmasin city, Banjar regency and Banjarbaru. The province has set up 'oxygen houses' for residents and put hospitals and puskesmas on alert since July. Nationally, the Health Ministry counted 306,309 ARI cases in fire-affected areas as of 18 Oct (up from 277,075 on 14 Oct), but daily additions eased slightly (2,808 on 16 Oct, 2,778 on 17 Oct) and the ministry says the trend is falling in West, Central, South and East Kalimantan.南加里曼丹省卫生厅厅长Diauddin医生2026年10月19日表示，过去5周该省急性呼吸道感染（ISPA）平均每周新增约1万例，病例最多的是马辰市、班查尔县和班查尔巴鲁市。该省为居民设立“氧气屋”，并自7月起要求医院和社区卫生中心戒备。全国层面，卫生部统计截至10月18日林火受影响地区ISPA累计306,309例（10月14日为277,075例），但每日新增略有放缓（10月16日2,808例，10月17日2,778例），卫生部称西、中、南、东加里曼丹的上升趋势已在下降。

Why it matters: 为何重要：Even as the national curve flattens, provincial clinics are still absorbing a steady weekly surge — children and older people remain most exposed.即便全国曲线趋平，省级医疗机构每周仍在承受稳定的就诊高峰——儿童和老人仍是风险最高人群。

detikKalimantan; Kemenkes data via detikHealth ↗ · r-2026-10-south-kalimantan-ari-rising-10000-a-week-five-weeks-oxygen-houses-banjarmasin

Singapore launches SPADE, a S$6 million spatial-profiling platform: SingHealth Duke-NUS will map exactly where disease cells and their neighbours sit inside patient tissue, starting with cancer, to sharpen diagnosis and treatment choices新加坡启动600万新元的SPADE空间分析平台：新保集团—杜克-新加坡国立大学学术医学中心将精确绘制患者组织中病变细胞及其“邻居”的位置，先从癌症入手，以提升诊断和治疗选择的精准度

SingHealth Duke-NUS Academic Medical Centre (19 Oct 2026) launched the Spatial Profiling and Disease Exploration (SPADE) initiative, a S$6 million platform led by the National Cancer Centre Singapore (NCCS) with Singapore General Hospital and Duke-NUS Medical School as co-leads. Spatial profiling reads gene and protein activity while keeping each cell's position in the tissue, showing how tumour cells, immune cells and surrounding tissue interact. The principal investigator is Asst Prof Jason Chan (NCCS), with Prof Enrico Petretto (Duke-NUS) and Dr Timothy Tay (SGH) as co-PIs. The launch included a research collaboration agreement between NCCS and 10x Genomics. Goals include building a spatial tissue atlas, developing biomarkers to predict treatment response and training local scientists in the technology.新保集团—杜克-新加坡国立大学学术医学中心（2026年10月19日）启动“空间分析与疾病探索”（SPADE）计划，这一600万新元的平台由新加坡国立癌症中心（NCCS）牵头，新加坡中央医院和杜克-新加坡国立大学医学院共同领导。空间分析能在保留每个细胞组织位置的同时读取基因和蛋白活性，揭示肿瘤细胞、免疫细胞与周围组织如何相互作用。项目主要研究者为国立癌症中心助理教授Jason Chan，共同主要研究者为杜克-新加坡国立大学Enrico Petretto教授和新加坡中央医院Timothy Tay医生。启动仪式上，国立癌症中心与10x Genomics签署了研究合作协议。目标包括建立空间组织图谱、开发预测治疗反应的生物标志物，以及培养本地相关技术人才。

Why it matters: 为何重要：Knowing where cells are, not just which genes are active, is becoming key to predicting who responds to immunotherapy and targeted drugs — and Asian tissue data are scarce.不仅知道哪些基因活跃、还知道细胞在哪里，正成为预测免疫治疗和靶向药物疗效的关键——而亚洲人群的组织数据十分稀缺。

Institutions: 机构：Duke-NUS杜克—国大

SingHealth Duke-NUS AMC via Labmate Online ↗ · r-2026-10-singhealth-duke-nus-spade-s6m-spatial-profiling-platform-nccs-10x-genomics

Nature Cell Biology (Fudan / Huashan Hospital): small RNAs sitting on the outside of monocytes grab histones released from damaged cells and amplify inflammation. Patients with inflammatory bowel disease carry more of these cells, and erasing the surface RNAs eased colitis in mice《自然-细胞生物学》（复旦大学/华山医院）：单核细胞表面的小RNA（Y RNA）能捕获受损细胞释放的组蛋白并放大炎症。炎症性肠病患者体内此类细胞更多，清除表面RNA可缓解小鼠结肠炎

A team led by 胡璐璐, 杨恩卓 and 黄鑫欣 (Fudan University) with 刘杰 and 罗忠光 (Huashan Hospital) reported on 19 Oct 2026 that Y RNAs — small non-coding RNAs — are displayed on the surface of human monocytes. These surface Y RNAs capture extracellular histones, which are released when cells die, and strengthen TLR2/TLR4 signalling through NF-κB and AP-1, boosting IL-6 production. The proportion of Y RNA-positive blood mononuclear cells was higher in people with inflammatory bowel disease than in healthy people or those with irritable bowel syndrome. Using a surface-RNA erasure technique the authors call HASTE, they reduced colitis severity in mice. The work adds cell-surface RNA as a new layer of innate immune regulation.复旦大学胡璐璐、杨恩卓、黄鑫欣与华山医院刘杰、罗忠光等团队于2026年10月19日报道：人类单核细胞表面展示着Y RNA这类非编码小RNA。表面Y RNA可捕获细胞死亡时释放的胞外组蛋白，经NF-κB和AP-1增强TLR2/TLR4信号，促进IL-6产生。炎症性肠病患者外周血中Y RNA阳性单个核细胞的比例高于健康人和肠易激综合征患者。研究者利用名为HASTE的表面RNA清除技术，减轻了小鼠结肠炎的严重程度。这项工作把细胞表面RNA列为先天免疫调控的新层面。

Why it matters: 为何重要：If surface RNAs act as inflammation amplifiers, they could become new drug targets or biomarkers for IBD and other inflammatory diseases.如果表面RNA是炎症“放大器”，它们有望成为炎症性肠病等炎症疾病的新药靶点或生物标志物。

Institutions: 机构：Zhongshan (Fudan)复旦中山

Nature Cell Biology; 网易 (BioArt) ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-fudan-huashan-monocyte-surface-y-rna-histone-tlr2-tlr4-il6-ibd-haste-ncb

China's first big look at transthyretin amyloidosis: of 218 patients at a Beijing referral centre, 96% had the inherited form, most had both nerve and heart damage, and diagnosis took 3.4 years on average中国首个大规模转甲状腺素蛋白淀粉样变性研究：北京一家转诊中心的218名患者中，96%为遗传型，多数同时有神经和心脏损害，平均确诊耗时3.4年

Amyloidosis News Today (19 Oct 2026) reported the OverTTuRe China study in the Orphanet Journal of Rare Diseases, led by researchers at the Chinese Academy of Medical Sciences / Peking Union Medical College. It reviewed 218 people diagnosed with ATTR amyloidosis between 2013 and 2024: 96% had hereditary ATTR caused by TTR gene variants and only one (0.5%) had the wild-type form. 72% had a mixed phenotype of polyneuropathy plus cardiomyopathy, about 45% reported a family history and over 70% were men. Mean age at onset was 53.7 years (42.8 for hereditary polyneuropathy), and the average delay to diagnosis was 3.4 years (3.8 years for mixed hereditary disease). About 60% were treated, a median 45 days after diagnosis, mostly with tafamidis (83%) or diflunisal (8%). During more than 1.5 years of follow-up, just over half developed new manifestations, 39% were hospitalised and about 8% died.Amyloidosis News Today（2026年10月19日）报道，中国医学科学院/北京协和医学院研究者在《孤儿罕见病杂志》发表OverTTuRe中国研究，回顾2013–2024年确诊的218名转甲状腺素蛋白淀粉样变性（ATTR）患者：96%为TTR基因变异导致的遗传型，仅1例（0.5%）为野生型。72%为多发性神经病合并心肌病的混合表型，约45%有家族史，男性超过70%。平均发病年龄53.7岁（遗传性多发性神经病型为42.8岁），平均确诊延误3.4年（混合型遗传病例为3.8年）。约60%接受了治疗，确诊后中位45天开始，主要使用氯苯唑酸（83%）或二氟尼柳（8%）。在超过1.5年的随访中，略多于一半出现新症状，39%住院，约8%死亡。

Why it matters: 为何重要：Unlike in Western countries, where wild-type heart disease dominates, ATTR in China is overwhelmingly inherited — family screening and earlier diagnosis could change outcomes.与以野生型心脏病为主的西方国家不同，中国ATTR绝大多数为遗传型——家系筛查和更早诊断有望改善结局。

Institutions: 机构：CAMS / PUMC医科院/协和医学院

Amyloidosis News Today (Orphanet J Rare Dis) ↗ · r-2026-10-china-overtture-attr-amyloidosis-218-patients-96pct-hereditary-mixed-phenotype-3-4y-delay-ojrd

ESMO 2026: China's TROP2 antibody-drug conjugate sac-TMT extends survival in heavily pretreated triple-negative breast cancer — median overall survival 14.7 vs 9.9 months with chemotherapy, a 40% lower risk of death, in final OptiTROP-Breast01 resultsESMO 2026：中国TROP2抗体偶联药物芦康沙妥珠单抗（sac-TMT）延长经治三阴性乳腺癌患者生存——OptiTROP-Breast01最终结果显示中位总生存14.7个月对化疗9.9个月，死亡风险降低40%

Abstract 4639RO (online 19 Oct 2026; rapid oral presentation 26 Oct): the phase 3 OptiTROP-Breast01 trial randomised 263 patients with previously treated metastatic triple-negative breast cancer to Kelun-Biotech's sacituzumab tirumotecan (n=130) or physician's-choice chemotherapy (n=133). At the 17 Sep 2025 data cut-off and median follow-up of 29.4 months, median overall survival was 14.7 vs 9.9 months (HR 0.60, 95% CI 0.45–0.80). OS rates were 33.8% vs 21.4% at 24 months and 26.8% vs 13.2% at 30 months. 27.8% of the chemotherapy group later received an ADC; after adjusting for this crossover, OS was 14.7 vs 9.4 months (HR 0.55). No new safety signals were seen.摘要4639RO（2026年10月19日在线公布，10月26日快速口头报告）：III期OptiTROP-Breast01试验将263名经治转移性三阴性乳腺癌患者随机分配至科伦博泰芦康沙妥珠单抗组（130例）或医生选择化疗组（133例）。截至2025年9月17日数据截止、中位随访29.4个月，中位总生存期分别为14.7个月和9.9个月（HR 0.60，95% CI 0.45–0.80）。24个月总生存率33.8%对21.4%，30个月26.8%对13.2%。化疗组27.8%后续接受了ADC治疗；校正交叉后总生存为14.7个月对9.4个月（HR 0.55）。未发现新的安全性信号。

Why it matters: 为何重要：Mature survival data confirm a real benefit for a Chinese-developed ADC in one of the hardest-to-treat breast cancers.成熟的生存数据证实，这款中国研发的ADC在最难治的乳腺癌之一中带来了真实获益。

ESMO 2026 abstract 4639RO via Oncoletter congress report ↗ · r-2026-10-esmo26-kelun-sac-tmt-optitrop-breast01-final-os-14-7-vs-9-9m-hr-0-60-pretreated-tnbc

ESMO 2026: early trial of SYS6043, a B7-H3-targeted antibody-drug conjugate, shows tumours shrank in 71% of HER2-positive, 71% of triple-negative and 46% of HR+/HER2− advanced breast cancer patientsESMO 2026：靶向B7-H3的抗体偶联药物SYS6043早期试验显示，晚期乳腺癌患者中HER2阳性组71%、三阴性组71%、HR+/HER2−组46%肿瘤缩小

Per the Oncoletter ESMO 2026 report, a phase I/II study of SYS6043 in advanced breast cancer (data cut-off 31 Mar 2026, n=137) found objective response rates of 45.7% in HR+/HER2− disease (n=82), 70.6% in triple-negative breast cancer (n=34) and 71.4% in HER2-positive disease (n=21). Grade ≥3 treatment-related adverse events occurred in 24.1%, including neutropenia in 9.5%. B7-H3 (CD276) is an immune-checkpoint-family protein widely expressed on solid tumours, making it an attractive ADC target across breast-cancer subtypes.据Oncoletter的ESMO 2026报道，SYS6043治疗晚期乳腺癌的I/II期研究（数据截至2026年3月31日，137例）显示：HR+/HER2−组（82例）客观缓解率45.7%，三阴性乳腺癌组（34例）70.6%，HER2阳性组（21例）71.4%。3级及以上治疗相关不良事件发生率24.1%，其中中性粒细胞减少9.5%。B7-H3（CD276）属免疫检查点家族蛋白，在实体瘤中广泛表达，是跨乳腺癌亚型的有吸引力的ADC靶点。

Why it matters: 为何重要：High response rates across all three breast-cancer subtypes, if confirmed in larger trials, would make B7-H3 a broad new target.若在更大规模试验中得到证实，三种乳腺癌亚型均有较高缓解率将使B7-H3成为一个覆盖面广的新靶点。

ESMO 2026 abstract via Oncoletter congress report ↗ · r-2026-10-esmo26-sys6043-b7h3-adc-advanced-breast-cancer-ph1-2-orr-tnbc-70-6pct-her2-71-4pct

ESMO 2026: a Chinese platform trial tests what happens when breast cancer stops responding to one antibody-drug conjugate — switching to another ADC with the same type of drug payload rarely worked (0–8% responses); switching payload type didESMO 2026：一项中国平台试验探索乳腺癌对一种抗体偶联药物耐药后怎么办——换用同类载荷（拓扑异构酶I抑制剂）的另一种ADC几乎无效（缓解率0–8%），而更换载荷类型才见效

Per the Oncoletter ESMO 2026 report, the randomised phase 2 SWITCH platform trial used Hengrui's ADCs SHR-A1811, SHR-A1921, SHR-A2009 and SHR-A2102 in 54 patients whose breast cancer had progressed on a prior ADC. Changing only the antibody target while keeping a topoisomerase-I-inhibitor payload produced confirmed objective response rates of 0–8.3%. Responses were seen only in patients switching from disitamab vedotin, which carries a microtubule-inhibitor payload, to a topoisomerase-I ADC. The authors say this points to payload cross-resistance as the main obstacle to sequencing ADCs.据Oncoletter的ESMO 2026报道，随机II期SWITCH平台试验在54名既往ADC治疗后进展的乳腺癌患者中使用恒瑞的SHR-A1811、SHR-A1921、SHR-A2009和SHR-A2102。仅更换抗体靶点而保留拓扑异构酶I抑制剂载荷时，确认的客观缓解率为0–8.3%。只有从携带微管抑制剂载荷的维迪西妥单抗换用拓扑异构酶I类ADC的患者出现缓解。作者认为，载荷交叉耐药是ADC序贯治疗的主要障碍。

Why it matters: 为何重要：As more patients receive several ADCs in a row, this suggests doctors should change the payload, not just the target.随着越来越多患者先后接受多种ADC，这提示医生应更换载荷，而不仅是更换靶点。

ESMO 2026 abstract via Oncoletter congress report ↗ · r-2026-10-esmo26-hengrui-switch-ph2-adc-sequencing-topi-to-topi-orr-0-8pct-payload-cross-resistance

University of Osaka (JEM): mapping kidney biopsies cell by cell, researchers find injured kidney-tubule cells call in neutrophils that drive ANCA vasculitis damage — and a re-engineered 'one-armed' antibody reduced the kidney injury in mice大阪大学（《实验医学杂志》）：研究者对肾活检进行逐细胞空间图谱分析，发现受损肾小管细胞会招募中性粒细胞，推动ANCA相关血管炎的肾损伤——一种改造的“单臂”抗体在小鼠中减轻了肾损伤

A team including Masayuki Nishide, Atsushi Kumanogoh and Masashi Narazaki, with Chugai Pharmaceutical as a joint research partner, published in the Journal of Experimental Medicine (19 Oct 2026; DOI 10.1084/jem.20260506). Spatial transcriptomics of untreated MPO-ANCA microscopic polyangiitis kidneys (8 patients and 4 healthy donors, about 410,000 cells) revealed a 'neutrophil–epithelial niche': injured tubular cells release CXCL6 and CXCL16 and attract neutrophils, even around glomeruli that look normal. Anti-MPO antibodies recognising diverse epitopes reproduced severe nephritis in mice, while a one-armed anti-MPO antibody engineered not to strongly trigger Fcγ receptors reduced kidney injury.Masayuki Nishide、Atsushi Kumanogoh、Masashi Narazaki等组成的团队（中外制药为共同研究伙伴）在《实验医学杂志》发表成果（2026年10月19日；DOI 10.1084/jem.20260506）。对未经治疗的MPO-ANCA显微镜下多血管炎肾脏（8名患者、4名健康供者，约41万个细胞）进行空间转录组分析，发现“中性粒细胞—上皮生态位”：受损肾小管细胞释放CXCL6和CXCL16，招募中性粒细胞，甚至在外观正常的肾小球周围也是如此。识别多种表位的抗MPO抗体可在小鼠中重现严重肾炎，而经改造、不强烈激活Fcγ受体的单臂抗MPO抗体减轻了肾损伤。

Why it matters: 为何重要：ANCA vasculitis is an autoimmune disease that can destroy the kidneys; pinpointing the tubule–neutrophil circuit suggests treatments more targeted than broad immunosuppression.ANCA相关血管炎是可毁损肾脏的自身免疫病；锁定肾小管—中性粒细胞回路，提示比广泛免疫抑制更精准的治疗方向。

Institutions: 机构：Osaka U阪大

University of Osaka Graduate School of Medicine; Journal of Experimental Medicine ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-osaka-u-mpo-anca-vasculitis-spatial-transcriptomics-neutrophil-epithelial-niche-cxcl6-cxcl16-one-armed-antibody-jem

Singapore widens its haze crackdown to Kalimantan: NEA is issuing preventive-measure notices to three more Indonesian companies under the Transboundary Haze Pollution Act, bringing the total to 10. Senior Minister K Shanmugam says Singapore will use every legal, regulatory and economic lever 'for as long as it takes'新加坡把烟霾执法扩大至加里曼丹：国家环境局依据《跨境烟霾污染法》再向三家印尼公司发出预防措施通知，累计达10家。国务资政K Shanmugam表示，新加坡将动用一切法律、监管和经济手段，追究到底

CNA (19 Oct 2026): NEA said there were indications that smoke from fires on concession land held by PT Buana Megatama Jaya, PT Mananjung Hayak and PT Baratama Putra Perkasa — all in Kalimantan — could have reached Singapore. The notices require the firms to deploy firefighters to put out or contain fires on land they own or occupy, stop and not start any burning, and submit action plans to NEA. This follows notices three days earlier to seven companies over fires in Sumatra; Minister Grace Fu said the government had not heard from those seven and is monitoring them, and that evidence will be shared with other agencies. Mr Shanmugam said Singapore is also ready to strengthen laws 'on an urgent basis'. Under the THPA (in force since 2014), companies that cause or contribute to haze can be fined up to S$100,000 a day, capped at S$2 million, with penalties for ignoring preventive notices; after the 2015 crisis NEA served notices on six firms, and investigations into four are still ongoing.亚洲新闻台（2026年10月19日）：环境局表示，有迹象显示PT Buana Megatama Jaya、PT Mananjung Hayak和PT Baratama Putra Perkasa三家公司（均在加里曼丹）特许经营地上的火灾烟雾可能已飘至新加坡。通知要求这些公司派员扑灭或控制其拥有或占用土地上的火情，停止并不得开始任何焚烧，并向环境局提交行动计划。此前三天，环境局已因苏门答腊火灾向七家公司发出通知；部长傅海燕说政府尚未收到这七家公司的回应，正密切监测，并将把收集的证据提供给其他机构。Shanmugam还表示新加坡准备“紧急”加强相关法律。根据2014年生效的《跨境烟霾污染法》，造成或助长烟霾的公司每天最高可被罚10万新元、上限200万新元，不遵守预防通知也会受罚；2015年危机后环境局曾向六家公司发出通知，其中四家的调查仍在进行。

Why it matters: 为何重要：With the haze episode now longer than 2015's, Singapore is testing how far its law can reach companies operating outside its borders.随着本轮烟霾持续时间超过2015年，新加坡正在检验其法律对境外企业的追责力度。

CNA; National Environment Agency ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-nea-thpa-preventive-notices-3-kalimantan-firms-total-10-shanmugam-every-lever

Why do women get less chronic liver disease? A Cell study of 9,254 people traces part of the answer to a gut-made bile acid, isoUDCA, produced by a six-species bacterial team that estrogen helps to thrive. Giving the bacteria or isoUDCA protected male mice from fatty liver and fibrosis女性为何较少患慢性肝病？一项纳入9,254人的《细胞》研究把部分答案追溯到肠道产生的胆汁酸isoUDCA——它由一个在雌激素帮助下得以繁盛的六种细菌组合生成。给雄性小鼠补充这些细菌或isoUDCA，可减轻脂肪肝和纤维化

Published online in Cell on 19 Oct 2026 (doi 10.1016/j.cell.2026.09.048; authors include Xiaojiao Zheng, Weiping Jia and Wei Jia): using the ATLAS metabolomics database (6,604 health-screening participants and 2,650 patients with chronic liver disease) plus ADNI and TwinsUK for validation, the team found the bile acid isoursodeoxycholic acid (isoUDCA) is higher in women, lower in liver disease, and statistically explains about 19.6% of the female protective effect, consistently across MASLD and hepatitis B fibrosis, cirrhosis and liver cancer. Women's stool bacteria converted CDCA to isoUDCA more efficiently; six species (including Ruminococcus gnavus, Blautia obeum and Eggerthella lenta) carried the full enzyme set. Removing the ovaries in mice cut these bacteria and isoUDCA, and estradiol restored them by reshaping the gut mucus niche (MUC2). In male mouse models (GAN and CDAHFD diets, CCl4 injury), the bacterial consortium or isoUDCA reduced steatohepatitis and collagen; isoUDCA works via SREBP2–STARD4 and CYP7B1 to speed cholesterol handling. The authors call isoUDCA a preclinical candidate; human treatment benefit is unproven.2026年10月19日在线发表于《细胞》（doi 10.1016/j.cell.2026.09.048；作者包括Xiaojiao Zheng、Weiping Jia和Wei Jia）：研究利用ATLAS代谢组学数据库（6,604名健康体检者和2,650名慢性肝病患者），并以ADNI和TwinsUK队列验证，发现胆汁酸异熊去氧胆酸（isoUDCA）在女性中较高、在肝病中降低，统计上可解释约19.6%的女性保护效应，在MASLD以及乙肝相关纤维化、肝硬化和肝癌中结果一致。女性粪便菌群将鹅脱氧胆酸（CDCA）转化为isoUDCA的能力更强；六种细菌（包括Ruminococcus gnavus、Blautia obeum和Eggerthella lenta）具备完整酶系。小鼠去卵巢后这些细菌和isoUDCA减少，雌二醇通过重塑肠道黏液微环境（MUC2）使其恢复。在雄性小鼠模型（GAN和CDAHFD饮食、四氯化碳损伤）中，该菌群或isoUDCA可减轻脂肪性肝炎和胶原沉积；isoUDCA经SREBP2–STARD4及CYP7B1通路加速胆固醇代谢。作者称isoUDCA为临床前候选物，对人体的治疗获益尚未证实。

Why it matters: 为何重要：It offers a non-hormonal explanation — and a possible drug lead — for the long-observed sex gap in liver disease.它为长期观察到的肝病性别差异提供了一个非激素的解释，也可能成为新药线索。

Cell (Elsevier); 生物通 summary ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-cell-isoudca-microbiome-bile-acid-axis-female-protection-chronic-liver-disease-stard4-cyp7b1

ESMO 2026 abstract: Qilu Pharmaceutical's PD-1/CTLA-4 bispecific QL1706 plus chemotherapy (with or without bevacizumab) reaches a median overall survival of 30.95 months as first-line treatment for persistent, recurrent or metastatic cervical cancer in a double-blind phase 3 trialESMO 2026摘要：齐鲁制药PD-1/CTLA-4双功能抗体QL1706联合化疗（±贝伐珠单抗）一线治疗持续性、复发性或转移性宫颈癌的双盲III期试验中，中位总生存期达30.95个月

According to ByDrug (Pharmcube) and a CBA summary of the ESMO 2026 abstract (19 Oct 2026), the multicentre, double-blind, placebo-controlled phase 3 trial randomised previously untreated patients 1:1 to QL1706 5 mg/kg or placebo, each with paclitaxel plus cisplatin/carboplatin, with or without bevacizumab 15 mg/kg, every 3 weeks for six cycles, then maintenance every 3 weeks for up to two years. The reported median OS with QL1706 was 30.95 months. QL1706 is already approved by the NMPA for recurrent/metastatic cervical cancer after platinum chemotherapy, and Qilu has previously said the first-line trial met its PFS and OS endpoints. The placebo-arm median OS and hazard ratio were not available in the sources reviewed.据医药魔方ByDrug及CBA对ESMO 2026摘要的报道（2026年10月19日），这项多中心、双盲、安慰剂对照III期试验将既往未接受全身治疗的患者按1:1随机分配，接受QL1706 5 mg/kg或安慰剂，均联合紫杉醇加顺铂/卡铂±贝伐珠单抗15 mg/kg，每3周一次共6个周期，之后每3周维持治疗最长2年。报道的QL1706组中位总生存期为30.95个月。QL1706已获国家药监局批准用于既往铂类化疗失败的复发/转移性宫颈癌，齐鲁此前表示该一线试验已达到PFS和OS终点。所查阅资料中未给出安慰剂组中位OS和风险比。

Why it matters: 为何重要：If the full data hold up, a single bispecific could bring dual checkpoint blockade into first-line cervical cancer care in China.如果完整数据经得起检验，一种双抗药物就可能把双重免疫检查点阻断带入中国宫颈癌一线治疗。

ByDrug / Pharmcube (ESMO 2026 abstract); CBA Frontier Insights ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-esmo26-qilu-ql1706-pd1-ctla4-bispecific-first-line-cervical-cancer-ph3-median-os-30-95m

Japan: a University of Tokyo study of 4,455 people aged 1–79, each keeping eight days of detailed food records across four seasons, finds diet quality is worst from adolescence to young adulthood (lowest around 16 for girls and 23–24 for young men) and best in middle and older age日本：东京大学一项研究纳入1至79岁的4,455人，每人在四个季节共记录8天的详细饮食，发现饮食质量在青春期至青年期最差（女性约16岁、男性约23至24岁最低），中老年期最好

University of Tokyo press release (19 Oct 2026) on a paper in the British Journal of Nutrition (doi 10.1017/S0007114526108642) by Hitomi Okubo, Kentaro Murakami and colleagues: participants from 32 prefectures recorded everything they ate for two days in each season. Using two indices — HEI-2020 and NRF9.3 — diet quality was lowest in adolescence and young adulthood and relatively high in middle-aged and older people; HEI-2020 bottomed out at 16.1 years in females and 23.4 in males, and NRF9.3 at 24 years in both. In children, higher household income and parental education went with better diets and skipping breakfast with worse ones; in adults, higher income and education were linked to better diets and smoking or skipping breakfast to worse, with patterns differing by age and sex. The authors caution the study is cross-sectional and participants may be more health-conscious than average.东京大学新闻稿（2026年10月19日）介绍发表于《英国营养学杂志》（doi 10.1017/S0007114526108642）的论文，作者包括Hitomi Okubo、Kentaro Murakami等：来自32个都道府县的参与者在每个季节记录两天所吃的全部食物。采用HEI-2020和NRF9.3两项指标评估，饮食质量在青春期和青年期最低，中老年人相对较高；HEI-2020在女性16.1岁、男性23.4岁时最低，NRF9.3则在男女24岁时最低。儿童中，家庭收入和父母学历越高饮食越好，不吃早餐则较差；成人中，收入和学历越高饮食越好，吸烟或不吃早餐则较差，且这些关联因年龄和性别而异。作者提醒这是横断面研究，参与者可能比一般人更关注健康。

Why it matters: 为何重要：It pinpoints the teenage-to-mid-20s window as the life stage where nutrition support in Japan is most needed.研究指出，青少年至二十多岁是日本最需要营养支持的人生阶段。

Institutions: 机构：UTokyo东大

University of Tokyo Graduate School of Medicine; British Journal of Nutrition ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-u-tokyo-diet-quality-lowest-adolescence-young-adulthood-4455-japanese-8-day-records-bjn

Korea: after curative endoscopic removal of early stomach cancer, the chance of a new stomach tumour keeps climbing — from 10.8% at five years to 26.7% at ten — in 876 Ajou University Hospital patients, so check-ups should not stop at five years韩国：早期胃癌经内镜根治性切除后，再发新胃肿瘤的风险持续上升——亚洲大学医院876名患者中，5年累计发生率为10.8%，10年达26.7%，因此复查不应在5年后停止

Korea Biomedical Review (19 Oct 2026): Professor Park Jong-sun's team at Ajou University Hospital, with collaborators at UTHealth Houston, followed 876 patients who had curative endoscopic submucosal dissection (ESD) for early gastric cancer between 2005 and 2020. Because ESD preserves the stomach lining, new (metachronous) tumours can arise elsewhere. Cumulative incidence rose from 10.8% at five years to 26.7% at ten — nearly 2.5 times. Extensive intestinal metaplasia carried 6.5 times the risk, and a family history of gastric cancer 2.1 times. Patients whose final pathology was more advanced than the initial biopsy ('histological upgrading') had no extra risk in the first five years, but significantly higher risk afterwards — which the authors say is the first evidence that this association changes over time. Published in Endoscopy (October 2026).韩国生物医学评论（2026年10月19日）：亚洲大学医院Park Jong-sun教授团队与美国德州大学休斯顿健康科学中心合作者，随访了2005–2020年间因早期胃癌接受内镜黏膜下剥离术（ESD）根治的876名患者。由于ESD保留了胃黏膜，其他部位仍可能出现新的（异时性）肿瘤。累计发生率从5年时的10.8%升至10年时的26.7%，接近2.5倍。广泛肠上皮化生者风险为6.5倍，有胃癌家族史者为2.1倍。最终病理比初次活检更严重（“组织学升级”）的患者在前5年无额外风险，但5年后风险显著升高——作者称这是首次证明该关联会随时间变化。论文发表于《Endoscopy》（2026年10月刊）。

Why it matters: 为何重要：ESD is common across East Asia; this argues for lifelong-style surveillance, especially for people with intestinal metaplasia or a family history.ESD在东亚十分普遍；研究支持长期持续随访，尤其是有肠上皮化生或家族史的人。

Korea Biomedical Review; Endoscopy (Thieme) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-ajou-esd-early-gastric-cancer-metachronous-neoplasm-10-8pct-5y-26-7pct-10y-876-endoscopy

Bangladesh: measles-linked child deaths pass 1,200 (1,201, of which 104 confirmed measles deaths), with five more in 24 hours and more than 214,000 suspected cases since mid-March. The Red Crescent hands over 50,000 dengue test kits and 85,000 bags of saline as dengue deaths stand at 352孟加拉国：与麻疹相关的儿童死亡突破1,200例（1,201例，其中104例为确诊麻疹死亡），24小时内新增5例，3月中旬以来疑似病例超过21.4万。红新月会移交5万份登革热检测试剂和8.5万袋生理盐水，登革热死亡累计352例

The Financial Express (20 Oct 2026), citing Monday's DGHS bulletin: 1,307 suspected and 35 confirmed measles infections were recorded in 24 hours; since mid-March, suspected cases total 214,551 and confirmed cases 23,157. Of 190,663 children admitted to hospital since mid-March, 183,042 have been discharged. Measles-linked child deaths rose to 1,201 (five in the past day), including 104 confirmed measles deaths. On dengue, four more deaths took 2026's toll to 352, with 1,851 new hospitalisations and 114,251 so far this year (107,865 discharged). On Monday the Bangladesh Red Crescent Society gave the DGHS 50,000 dengue NS1 test kits, 70,000 bags of normal saline and 15,000 bags of baby saline with saline sets, plus 5,000 bags of saline to Holy Family Red Crescent Medical College Hospital, under its Dengue Response Operation 2026.《金融快报》（2026年10月20日）援引卫生服务总局周一通报：24小时内录得疑似麻疹1,307例、确诊35例；3月中旬以来疑似病例累计214,551例，确诊23,157例。3月中旬以来住院儿童190,663人，其中183,042人已出院。与麻疹相关的儿童死亡升至1,201例（过去一天5例），其中104例为确诊麻疹死亡。登革热方面，新增4例死亡使2026年累计达352例，新增住院1,851例，今年累计114,251例（107,865人已出院）。孟加拉国红新月会周一根据“2026登革热应对行动”向卫生服务总局移交5万份登革热NS1检测试剂、7万袋生理盐水和1.5万袋婴儿用盐水及输液器，另向圣家红新月医学院医院提供5,000袋生理盐水。

Why it matters: 为何重要：Two large outbreaks — measles in children and record-season dengue — are running at the same time and straining the same hospitals and supply chains.儿童麻疹和登革热两场大规模疫情同时流行，挤压着同一批医院和物资供应链。

The Financial Express (DGHS bulletin) ↗ · r-2026-10-bangladesh-measles-child-deaths-1201-104-confirmed-214551-suspected-bdrcs-dengue-ns1-kits

Lancet Global Health trial in Tanzania: when AI read retinal photos on the spot, twice as many people needing eye care actually got to an eye clinic within eight weeks (35.9% vs 18.2%), and they arrived after about 11 days instead of 37《柳叶刀-全球健康》坦桑尼亚试验：AI现场判读视网膜照片后，需要眼科诊疗者在8周内真正到眼科就诊的比例翻倍（35.9%对18.2%），从筛查到就诊平均约11天，而非37天

Xinhua (19 Oct 2026), reporting a London School of Hygiene & Tropical Medicine release: the randomised trial at 24 hospitals in Tanzania enrolled 2,378 people attending diabetic retinopathy screening and assigned them to AI-assisted or routine screening. Among those confirmed to meet referral criteria, 35.9% in the AI arm attended an eye clinic within eight weeks versus 18.2% with routine screening; among referred patients who attended, the average interval was 10.9 days versus 36.9 days. The researchers think the difference partly reflects that AI gives an immediate result so staff can advise patients face to face, whereas routine grading meant patients learned results by phone weeks later. Lead author Charles Cleland (LSHTM International Centre for Eye Health) said AI screening could widen access where health workers are scarce, but specialist services must expand too. An estimated 44–82 million people may face sight loss from diabetic retinopathy by 2045.新华社（2026年10月19日）报道伦敦卫生与热带医学院公报：这项随机试验在坦桑尼亚24家医院纳入2,378名接受糖尿病视网膜病变筛查者，分配至AI辅助筛查组或常规筛查组。在经评估确认达到转诊标准者中，AI组35.9%在8周内到眼科就诊，常规组为18.2%；在达到转诊标准且随后就诊的患者中，从筛查到就诊的平均间隔分别为10.9天和36.9天。研究者认为差异部分源于AI能立即给出结果，医护人员可当面给出就诊建议，而常规判读往往要数周后才电话告知。论文主要作者、伦敦卫生与热带医学院国际眼科健康中心的Charles Cleland表示，在医护人手紧张的地区，AI筛查有望提升可及性，但还需同步扩大专科服务。据估算，到2045年全球可能有4,400万至8,200万人面临糖尿病视网膜病变导致的视力丧失风险。

Why it matters: 为何重要：It shows AI's value in screening is not just accuracy but speed — turning a result into an immediate conversation that gets patients to treatment.研究表明AI筛查的价值不只在于准确，更在于速度——即时出结果、当面沟通，让患者真正去就诊。

Xinhua (LSHTM release); The Lancet Global Health ↗ · r-2026-10-lancet-glob-health-tanzania-ai-diabetic-retinopathy-screening-rct-24-hospitals-2378-referral-35-9-vs-18-2

Kunming Institute of Zoology (CAS): complement protein C3 working inside ageing cells decides whether senolytic drugs can kill them — in 22-month-old mice lacking C3, the senolytic ABT263 largely lost its ability to lower senescence markers and organ fibrosis中国科学院昆明动物研究所：衰老细胞内的补体C3决定“清除衰老细胞药物”（Senolytic）能否奏效——在22月龄的C3敲除小鼠中，Senolytic药物ABT263降低衰老标志物和脏器纤维化的效果大幅减弱甚至消失

He Yonghan's group (KIZ) with Liu Jing (Kunming University of Science and Technology), Cell Death & Disease (institute release 19 Oct 2026): pooled RNA-seq across cell-senescence models showed C3 is consistently up-regulated, confirmed in ageing mouse and human tissues, making it a conserved ageing marker. Knocking down intracellular C3 (intC3) did not change core senescence features, and C3-knockout mice looked normal after whole-body irradiation — but intC3 knock-down markedly blunted ABT263-induced apoptosis of senescent cells. Wild-type and C3KO mice raised to 22 months were given ABT263: it lowered senescence markers and improved organ fibrosis in wild-type animals, while the effect was much weaker or absent in C3KO mice. Mechanistically, ABT263 inhibits BCL-2-family proteins and also suppresses AKT/S6K pro-survival signalling; without C3, that AKT/S6K suppression is weakened, producing resistance. The authors propose intC3 as a biomarker of senolytic responsiveness.昆明动物研究所何永捍团队与昆明理工大学刘静合作，发表于《细胞死亡与疾病》（研究所2026年10月19日发布）：整合多种细胞衰老模型的RNA测序数据发现C3稳定显著上调，并在衰老小鼠和人体组织中得到验证，是跨物种、跨组织保守的衰老标志物。敲低胞内C3（intC3）并不改变细胞衰老核心表型，C3敲除小鼠经全身辐照后也无明显异常——但intC3敲低会明显削弱ABT263诱导衰老细胞凋亡的作用。团队将野生型与C3敲除小鼠饲养至22月龄后给予ABT263：野生型小鼠衰老标志物下降、脏器纤维化改善，而C3敲除小鼠的这些疗效大幅减弱甚至消失。机制上，ABT263在抑制BCL-2家族抗凋亡蛋白的同时也抑制AKT/S6K促存活通路；C3缺失时这一抑制减弱，导致耐药。作者提出intC3可作为评估Senolytic疗效的生物标志物。

Why it matters: 为何重要：Senolytics work unevenly across tissues; a marker of who will respond could make anti-ageing trials more precise.Senolytic药物在不同组织中效果不一；能预判疗效的标志物有望让抗衰老试验更精准。

Kunming Institute of Zoology, CAS (Cell Death & Disease) ↗ · r-2026-10-kiz-he-yonghan-intracellular-c3-senolytic-abt263-akt-s6k-c3ko-aged-mice-cell-death-dis

China's NMPA accepts five new combination-trial applications aimed at RAS-driven cancers: Betta Pharmaceuticals' pan-RAS 'molecular glue' BPI-572270 with chemotherapy, PD-1/VEGF bispecifics, FAK inhibitors or EGFR antibodies (three INDs), and OncoC4's PD-1/VEGF bispecific cesalatamig with ADCs or pan-RAS inhibitors (two INDs)国家药监局受理5项瞄准RAS驱动肿瘤的联合用药临床申请：贝达药业泛RAS“非降解型分子胶”抑制剂BPI-572270联合化疗、PD-1/VEGF双抗、FAK抑制剂或EGFR抗体（3项），以及OncoC4的PD-1/VEGF双抗cesalatamig联合ADC或泛RAS抑制剂（2项）

Betta Pharmaceuticals (19 Oct 2026) received NMPA acceptance notices CXHL2601291–2601293 for BPI-572270, an in-house pan-RAS non-degrading molecular-glue inhibitor, in combination regimens for advanced solid tumours with or without RAS mutations. The planned single-arm, open-label phase Ib/II dose-escalation/expansion study will test it with chemotherapy, a PD-1/VEGF bispecific, PD-1 antibody plus platinum chemotherapy, a FAK inhibitor and an EGFR antibody; the company says KRAS/NRAS/HRAS mutations occur in about 30% of human cancers and that monotherapy trials are under way. Separately, Rockville-based OncoC4 said on 19 Oct that NMPA accepted INDs CXSL2601129 and CXSL2601130 to test cesalatamig (AI-081), its PD-1/VEGF bispecific, with antibody-drug conjugates in selected solid tumours and with pan-RAS inhibitors in molecularly selected patients; cesalatamig received FDA Fast Track in September 2026 for NSCLC progressing after PD-(L)1 therapy and platinum chemotherapy. Acceptance is the start of review, not approval.贝达药业（2026年10月19日）收到国家药监局受理通知书（受理号CXHL2601291–2601293），其自主研发的泛RAS“非降解型分子胶”抑制剂BPI-572270联合其他药物治疗伴或不伴RAS突变的晚期实体瘤的临床申请获受理。计划开展的单臂、开放标签Ib/II期剂量递增/扩展研究将分别联合化疗、PD-1/VEGF双抗、PD-1单抗+含铂化疗、FAK抑制剂和EGFR抗体；公司称KRAS/NRAS/HRAS突变见于约30%的人类恶性肿瘤，单药临床研究正在推进。另外，总部位于美国罗克维尔的OncoC4于10月19日宣布，国家药监局受理其两项IND（CXSL2601129、CXSL2601130），评估PD-1/VEGF双抗cesalatamig（AI-081）联合ADC治疗特定实体瘤、以及联合泛RAS抑制剂治疗特定分子特征人群；cesalatamig于2026年9月获美国FDA快速通道认定，用于PD-(L)1治疗和含铂化疗后进展的非小细胞肺癌。受理意味着进入审评，并非获批。

Why it matters: 为何重要：RAS mutations drive many hard-to-treat pancreatic, colorectal and lung cancers; China is becoming a main testing ground for RAS-inhibitor combinations.RAS突变驱动许多难治的胰腺癌、结直肠癌和肺癌；中国正成为RAS抑制剂联合疗法的重要试验场。

Betta Pharmaceuticals; OncoC4 (PR Newswire) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nmpa-accepts-pan-ras-combo-inds-betta-bpi-572270-three-oncoc4-cesalatamig-pd1-vegf-two

Japan: Wakayama Medical University builds a mouse model that — unlike earlier models — reproduces both the immunodeficiency and the severe colitis of LIG4 syndrome — a DNA-repair disorder — using a new LIG4 mutation found in a patient; the gut inflammation was driven by the few T cells that survive日本：和歌山县立医科大学利用在患者身上发现的新LIG4基因突变，构建出与以往模型不同、可同时重现“LIG4综合征”（一种DNA损伤修复障碍）免疫缺陷和重症肠炎的小鼠模型；肠道炎症由残存的少量T细胞驱动

Wakayama Shimpo (19 Oct 2026): a group led by Assistant Professor Yamashita (Department of Haematology) and Specially Appointed Professor Tsuneyasu Kaisho, with Kurume University and Osaka Metropolitan University, reported in JCI Insight (published 1 Sep). DNA ligase IV (LIG4) is essential for repairing DNA breaks; in LIG4 syndrome, mutations reduce its function, causing growth failure, microcephaly and lymphocyte-poor immunodeficiency together with inflammatory diseases such as colitis — but existing model mice showed no obvious inflammation. The team identified a new LIG4 mutation in a patient and created mice carrying it: DNA-repair capacity was severely reduced and the mice developed immunodeficiency and severe enteritis. The inflammation was traced to the small number of T cells remaining despite lymphopenia. The researchers say the model is useful not only for this single-gene disease but for refractory colitis and ageing-related diseases linked to accumulated DNA damage.《和歌山新报》（2026年10月19日）：由和歌山县立医科大学血液内科山下友佑助教和学长特命教授改正恒康等牵头、联合久留米大学和大阪公立大学的研究，于9月1日发表在《JCI Insight》。DNA连接酶IV（LIG4）是修复DNA损伤不可或缺的酶；LIG4综合征患者因基因突变导致其功能下降，会出现生长障碍、小头畸形和淋巴细胞减少型免疫缺陷，并合并肠炎等炎症性疾病——但以往的模型小鼠没有明显炎症。团队在一名患者身上发现新的LIG4突变并培育出携带相同突变的小鼠：其DNA修复能力显著下降，并出现免疫缺陷和重症肠炎。炎症源于免疫缺陷后仅少量残存的T细胞。研究者认为该模型不仅有助研究这一单基因病，也可用于难治性肠炎以及与DNA损伤积累密切相关的衰老相关疾病。

Why it matters: 为何重要：It explains how a body can be immunodeficient and inflamed at the same time — a puzzle shared by several inborn errors of immunity.它解释了身体为何能同时处于免疫缺陷和炎症状态——这是多种先天性免疫缺陷病共同的谜题。

Wakayama Shimpo (JCI Insight) ↗ · r-2026-10-wakayama-med-lig4-syndrome-new-mutation-mouse-immunodeficiency-severe-colitis-t-cells-jci-insight

Japan: Shizuoka Children's Hospital says it has performed the world's lowest-weight successful catheter treatment — placing a stent in the narrowed aorta of a baby girl weighing 356 g, born at 25 weeks with coarctation of the aorta; she has since grown to 4.9 kg日本：静冈县立儿童医院宣布完成世界上体重最小的成功导管治疗——为一名体重356克、孕25周出生、患主动脉缩窄的女婴在狭窄的主动脉内置入支架；她如今已长到4.9公斤

Chunichi Shimbun and NHK (19 Oct 2026): the girl was born last October at 25 weeks of gestation weighing 357 g and was diagnosed with coarctation of the aorta — narrowing of part of the main artery carrying blood from the heart to the body — plus a patent ductus arteriosus, the vessel that normally closes within days of birth. Because the vessels and skin of extremely low-birth-weight infants are fragile and even ultrasound examinations are a burden, treatment is difficult; the team passed a catheter into her blood vessels and expanded the narrowed segment from inside with a mesh metal stent when she weighed 356 g. The hospital says this is the smallest successful case of such treatment worldwide. This month she reached 4.9 kg and remains under follow-up.《中日新闻》和NHK（2026年10月19日）：这名女婴去年10月孕25周出生，体重357克，被诊断患有主动脉缩窄（把血液从心脏输送到全身的主动脉部分变窄）以及动脉导管未闭（通常出生后几天内就会闭合的血管未关闭）。超低出生体重儿血管和皮肤脆弱，连超声检查都是负担，治疗难度大；医疗团队在她体重356克时经血管送入导管，用网状金属支架从内部撑开狭窄段。医院称这是此类治疗在全球体重最小的成功病例。本月她体重已达4.9公斤，医院持续随访。

Why it matters: 为何重要：Shows that catheter techniques can now reach babies under 400 g, for whom open surgery is extremely risky.表明导管技术已能用于不足400克的婴儿，而开胸手术对他们风险极高。

Chunichi Shimbun; NHK ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-shizuoka-childrens-hospital-356g-infant-coarctation-aorta-catheter-stent-world-smallest-now-4-9kg

Japan: Keiju Medical Center in Nanao, Noto, starts routine use of 300 consumer smartwatches that automatically measure inpatients' blood pressure and heart rate and write them into the electronic record — which the hospital calls a world first — aiming to ease nurses' workload and catch sudden deterioration sooner日本：石川县能登地区七尾市的惠寿综合医院正式启用300块市售智能手表，自动测量住院患者的血压和心率并写入电子病历——医院称这是全球首例——以减轻护士负担、更早发现病情突变

Ishikawa TV and NHK (19 Oct 2026): Keiju Medical Center began full operation on 19 Oct after a demonstration trial with Huawei and others since June 2025, during which trial data were collected and the system refined. Patients wear commercially available smartwatches; blood pressure, heart rate and other readings are entered automatically into the electronic medical record. The hospital expects a major reduction in nurses' workload and earlier recognition of sudden changes in patients' condition, and plans to extend the system to all wards during January 2027. Chairman Masahiro Kanno said Noto — a microcosm of Japan's shrinking working-age population — should still offer world-class services.石川电视台和NHK（2026年10月19日）：惠寿综合医院自2025年6月起与华为等合作开展实证试验，收集试验数据并改进系统后，于10月19日正式运行。住院患者佩戴市售智能手表，血压、心率等数据自动录入电子病历。医院预计可大幅减轻护士工作量，并更早察觉患者病情突变，计划在2027年1月内推广到全部病房。理事长神野正博表示，能登是日本劳动年龄人口不断减少的缩影，但在这里也要提供世界级的服务。

Why it matters: 为何重要：With nurse shortages worsening in rural Japan, automated bedside monitoring could free staff time for care.日本农村护士短缺日益严重，床旁监测自动化可为护理腾出人手。

Ishikawa TV; NHK ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-keiju-hospital-nanao-300-smartwatches-inpatient-vitals-auto-ehr-huawei-world-first-all-wards-jan-2027

Philippines: DOH aims to give a single HPV vaccine dose to about 2.007 million Grade 4 and 5 girls in public and private schools under its Bakuna Eskwela programme, with out-of-school girls (about 9%) vaccinated at health centres菲律宾：卫生部计划通过“校园接种”（Bakuna Eskwela）项目，为公立和私立学校约200.7万名四、五年级女生接种单剂HPV疫苗，失学女孩（约9%）可在卫生中心接种

Inquirer.net (19 Oct 2026): Dr Alethea De Guzman, director of the DOH Epidemiology Bureau, said the department recommends a single dose for girls aged 9–14, the most effective period before possible exposure, and is targeting 2.007 million learners in Grades 4 and 5; around 9% of the roughly 2 million are out-of-school youth who can be vaccinated at the nearest health centre. Cervical cancer is not a disease under monthly surveillance, so the Philippine Cancer Institute has begun a hospital-based cancer registry; citing IARC, she said there were 7,829 cervical cancer patients in the Philippines as of 2024, and called cervical cancer the second-leading cause of cancer in the country. 'We want to actually prevent females from having the disease,' she said.Inquirer.net（2026年10月19日）：卫生部流行病学局局长Alethea De Guzman说，卫生部建议9–14岁女孩接种单剂HPV疫苗，这是可能接触病毒前最有效的时期，目标是为200.7万名四、五年级学生接种；约200万人中约9%为失学青少年，可到就近卫生中心接种。宫颈癌不属于按月监测的疾病，菲律宾癌症研究所已启动医院癌症登记；她引用国际癌症研究机构数据称，截至2024年菲律宾有7,829名宫颈癌患者，宫颈癌是该国第二大癌症。她说：“我们希望真正预防女性得这种病。”

Why it matters: 为何重要：Single-dose HPV schedules make school-based mass vaccination far cheaper and easier — key to WHO's cervical-cancer elimination goal.单剂HPV接种让校园大规模接种更便宜、更易实施——这是实现世卫组织消除宫颈癌目标的关键。

Inquirer.net ↗ · r-2026-10-philippines-doh-single-dose-hpv-bakuna-eskwela-2-007-million-grade-4-5-girls

Bangladesh dengue: four more deaths and 1,851 new hospital admissions in 24 hours take 2026 totals to 352 deaths and 114,251 hospitalisations; 6,033 patients remain in hospital孟加拉国登革热：24小时内新增4例死亡、1,851人住院，2026年累计352人死亡、114,251人住院；仍有6,033名患者在院治疗

Dhaka Tribune (19 Oct 2026), citing the DGHS daily update for 8am Sunday to 8am Monday: of the 1,851 new admissions, 742 were in Dhaka division, 220 Chittagong, 253 Khulna, 233 Rajshahi, 192 Barisal, 93 Rangpur, 92 Mymensingh and 26 Sylhet. Since January, 114,251 people have been hospitalised with dengue; 107,866 have been discharged and 6,033 remain under treatment. The death toll for the year rose to 352.《达卡论坛报》（2026年10月19日）援引卫生服务总局周日早8时至周一早8时的每日通报：1,851名新住院患者中，达卡专区742人、吉大港220人、库尔纳253人、拉杰沙希233人、巴里萨尔192人、朗布尔93人、迈门辛92人、锡尔赫特26人。今年以来共114,251人因登革热住院，107,866人已出院，6,033人仍在治疗。全年死亡人数升至352人。

Why it matters: 为何重要：Admissions are still running near 2,000 a day in late October, keeping pressure on Dhaka's hospitals.10月下旬每日住院仍接近2,000人，达卡医院压力持续。

Dhaka Tribune (DGHS) ↗ · r-2026-10-bangladesh-dengue-352-deaths-114251-hospitalised-1851-new-6033-in-hospital-oct19

India: an Indian Journal of Medical Research study estimates smokeless tobacco accounts for 57.3% of mouth cancers in men, and tobacco in any form for 73.4% of mouth cancers in women — far above global estimates — with men's shares reaching about 70% in Jharkhand and Odisha印度：《印度医学研究杂志》一项研究估算，男性口腔癌中57.3%可归因于无烟烟草，女性口腔癌中73.4%可归因于各种形式的烟草——远高于全球估计；男性这一比例在贾坎德邦和奥里萨邦约达70%

Guruprasad Vinod and colleagues, 'Head and neck cancer burden attributable to tobacco use in India: national and region-wise estimates' (IJMR; reported by The South First, 19 Oct 2026): 11,285 head and neck cancer patients and 7,154 non-cancer controls seen at the Regional Cancer Centre, Thiruvananthapuram, in 2019–2024 gave risk estimates that were combined with state tobacco-use prevalence to calculate population attributable fractions. In men, smokeless tobacco accounted for an estimated 61.8% of lip, 30.7% of tongue and 57.3% of mouth cancers, and smoking for 40.2% of oropharyngeal, 45.7% of hypopharyngeal and 38.4% of laryngeal cancers; in women smokeless tobacco accounted for 68.8% of lip and 68% of mouth cancers. Odds of mouth cancer with smokeless tobacco were 17.6 times higher in women and 5.5 times in men, though some female estimates have very wide confidence intervals. Global estimates put tobacco's share of oral cancers at 34.4% (men) and 22.8% (women). Limitations: Kerala hospital-based risks were assumed to apply nationwide, and PAFs show preventable share, not individual causation.Guruprasad Vinod等，《印度烟草所致头颈癌负担：全国及分地区估计》（《印度医学研究杂志》；The South First 2026年10月19日报道）：研究以特里凡得琅地区癌症中心2019–2024年11,285名头颈癌患者和7,154名非癌症对照计算风险，再结合各邦烟草使用率估算人群归因分数。男性中，无烟烟草估计导致61.8%的唇癌、30.7%的舌癌和57.3%的口腔癌，吸烟导致40.2%的口咽癌、45.7%的下咽癌和38.4%的喉癌；女性中无烟烟草导致68.8%的唇癌和68%的口腔癌。使用无烟烟草者患口腔癌的比值比女性为17.6、男性为5.5，但部分女性估计的置信区间极宽。全球估计烟草在口腔癌中的占比男性为34.4%、女性为22.8%。局限：以喀拉拉邦医院数据得出的风险被假定适用于全国；归因分数反映可预防比例，而非个体因果。

Why it matters: 为何重要：Smoking-focused tobacco control would miss most of India's mouth-cancer burden, which comes from chewed products like gutkha.只盯着吸烟的控烟政策会漏掉印度口腔癌负担的大部分——它主要来自古特卡等咀嚼类烟草。

The South First; Indian Journal of Medical Research ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-ijmr-tobacco-attributable-head-neck-cancer-india-smokeless-57-3pct-mouth-men-73-4pct-women-rcc

UK: re-mining 2,176 discarded 'non-human' sequencing datasets from prostate cancer patients, University of East Anglia researchers assembled 249 near-complete bacterial genomes from 194 men and found 18 species new to science — mostly oral bacteria such as Porphyromonas and Treponema英国：东英吉利大学研究人员重新挖掘前列腺癌患者2,176份测序数据中通常被丢弃的“非人源”片段，从194名男性中组装出249个近乎完整的细菌基因组，发现18个科学界未知的新物种——大多为卟啉单胞菌、密螺旋体等口腔细菌

University of East Anglia via Medical Xpress (19 Oct 2026), npj Biofilms and Microbiomes, within the Pan Prostate Cancer Group (PPCG; >2,000 prostate cancers from nine countries, co-led with The Institute of Cancer Research): reads from saliva, tumour and blood whole-genome sequencing that did not match human DNA were kept and rebuilt by metagenomic assembly. Of the 249 genomes, 24 matched no known species; 18 new species were identified and 16 given provisional names, including Candidatus Porphyromonas leptis and Candidatus Treponema oralis. Porphyromonas — the genus of the main gum-disease bacterium — was recovered most often; the team predicted growth conditions and validated a DNA test for one species. The authors stress they are not claiming these bacteria cause prostate cancer; in 2022 they reported men carrying certain anaerobic bacteria were more than twice as likely to see their cancer progress, and the next step is isolating strains to test links with aggressive disease.东英吉利大学经Medical Xpress发布（2026年10月19日），论文发表于《npj生物膜与微生物组》，属泛前列腺癌研究组（PPCG，与英国癌症研究所共同主导，汇集9国2,000多例前列腺癌）成果：团队保留唾液、肿瘤和血液全基因组测序中不匹配人类DNA的片段，用宏基因组组装重建细菌基因组。249个基因组中有24个与已知物种不符，最终鉴定出18个新物种，并为其中16个给出暂定名，如Candidatus Porphyromonas leptis和Candidatus Treponema oralis。最常见的是卟啉单胞菌属（牙周病主要致病菌所在属）；团队还预测了培养条件，并为其中一个物种验证了DNA检测方法。作者强调并未声称这些细菌导致前列腺癌；他们2022年曾报告携带某些厌氧菌的男性癌症进展风险高一倍以上，下一步将分离菌株，检验其与侵袭性疾病的关系。

Why it matters: 为何重要：Existing cancer sequencing archives can reveal unseen microbes at no extra cost — a cheap route to new biomarkers.现有癌症测序档案无需额外成本就能揭示未知微生物——这是寻找新生物标志物的低成本途径。

University of East Anglia via Medical Xpress (npj Biofilms and Microbiomes) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-uea-ppcg-18-new-bacterial-species-prostate-cancer-249-genomes-porphyromonas-npj-biofilms

WHO publishes the Global Breast Cancer Initiative Training Manual for programme managers — step-by-step modules from prevention and early detection to diagnosis, treatment, health products, team-based care and patient navigation — aiming for at least 60% of breast cancers to be diagnosed at an early stage世卫组织发布《全球乳腺癌倡议培训手册》（面向项目管理者）——从预防、早期发现到诊断、治疗、卫生产品、多学科团队诊疗和患者导航的分步模块——目标是至少60%的乳腺癌在早期被诊断

WHO departmental update (19 Oct 2026): the GBCI Training Manual is a technical derivative of the Global Breast Cancer Initiative implementation framework and guides countries establishing or strengthening breast cancer programmes. It translates global recommendations into practical, context-specific steps to build capacity at national, subnational and facility levels, with technical modules covering the whole continuum — prevention, early detection, diagnosis and management, health products and technologies, multidisciplinary team-based care and patient navigation. The manual stresses that all countries should prioritise early detection so that at least 60% of new breast cancers are diagnosed at early stages, when curative treatment is most effective, best tolerated and least costly.世卫组织部门动态（2026年10月19日）：《全球乳腺癌倡议培训手册》是该倡议实施框架的技术配套产品，为正在建立或加强乳腺癌防治项目的国家提供指导。手册把全球建议转化为切合当地情况的实操步骤，帮助在国家、地方和医疗机构层面建设能力，技术模块覆盖全流程——预防、早期发现、诊断与治疗、卫生产品和技术、多学科团队诊疗以及患者导航。手册强调各国都应优先抓早期发现，使至少60%的新发乳腺癌在早期确诊，此时根治性治疗最有效、最易耐受、成本也最低。

Why it matters: 为何重要：Stage at diagnosis is the biggest driver of breast cancer survival gaps between countries; this gives managers a practical playbook.确诊时的分期是各国乳腺癌生存差距的最大因素；这本手册为管理者提供了可操作的方案。

World Health Organization ↗ · r-2026-10-who-gbci-training-manual-programme-managers-early-breast-cancer-60pct-early-stage

Singapore: NUH launches what is likely South-east Asia's first personalised transcranial magnetic stimulation (pTMS) service, using fMRI brain maps and AI to aim magnetic pulses at each patient's own mood circuits; in an OCD trial one patient's symptoms fell 35% and another's by 78% within a week新加坡：国立大学医院推出可能是东南亚首个“个体化经颅磁刺激”（pTMS）服务，用功能磁共振脑图和AI为每位患者定位其情绪环路后再施加磁脉冲；强迫症试验中一名患者症状减轻35%，另一名在一周内减轻78%

The Straits Times (19 Oct 2026): standard TMS stimulates the same approximate spot in everyone; pTMS first maps each patient's brain networks with functional MRI and an algorithm developed by Thomas Yeo and Ruby Kong (NUS), then targets them non-surgically. It is approved in Singapore for treatment-resistant depression and anxiety and is offered at NUH and the private Alvernia Psychological Health Centre with NUS spin-off B1Neuro; NUH started in early 2026 and the course currently costs S$15,000, unsubsidised. In Dr Tor Phern Chern's trial for severe treatment-resistant OCD, a 49-year-old woman with 20 years of OCD had a 35% symptom reduction a month after 40 sessions over five days; another participant's score fell 78% by the end of the week and 100% six weeks later. An earlier IMH study found 70% of 21 patients with treatment-resistant depression responded within a month. A National Healthcare Innovation Centre grant will extend pTMS to IMH, Sengkang General and Khoo Teck Puat Hospital, and a 30-patient study in depression with anxiety is planned.《海峡时报》（2026-10-19）：传统经颅磁刺激对所有人刺激大致相同的位置；pTMS则先用功能磁共振和新加坡国立大学Thomas Yeo和Ruby Kong开发的算法绘制每位患者的大脑网络，再以无创方式精准刺激。该疗法在新加坡获批用于难治性抑郁和焦虑，目前由国大医院和私立Alvernia心理健康中心与国大衍生公司B1Neuro合作提供；国大医院2026年初开展，疗程费用1.5万新元，暂无津贴。Tor Phern Chern医生针对重度难治性强迫症的试验中，一名患强迫症20年的49岁女性在5天内接受40次治疗，一个月后症状减轻35%；另一名参与者症状评分在当周结束时下降78%，六周后下降100%。此前心理卫生学院一项研究显示，21名难治性抑郁患者中70%在一个月内有反应。国家医疗创新中心拨款将把pTMS推广至心理卫生学院、盛港综合医院和邱德拔医院，另计划开展一项30人的抑郁伴焦虑研究。

Why it matters: 为何重要：For people whom drugs and talk therapy have not helped, a one-week, surgery-free brain treatment tailored to their own wiring offers new hope.对药物和心理治疗都无效的患者，一种按个人大脑“线路”定制、一周完成且无需手术的治疗带来新希望。

Institutions: 机构：NUH国大医院 · NUS Medicine国大医学

The Straits Times ↗ · r-2026-10-nuh-sg-first-personalised-tms-ptms-fmri-ai-depression-anxiety-ocd-trial-b1neuro-15000

Indonesia: acute respiratory infections in fire-hit regions pass 306,000 — children aged 6–9 (77,022) and under-fives (69,015) are the hardest hit, followed by people over 60 (49,680), the Health Ministry says印尼：林火影响地区急性呼吸道感染病例超过30.6万——卫生部称6至9岁儿童（77,022例）和5岁以下幼儿（69,015例）受影响最重，其次是60岁以上老人（49,680例）

Tirto (19 Oct 2026): Health Ministry spokesman Aji Muhawarman confirmed a cumulative 306,309 acute respiratory infection (ISPA) cases in areas affected by forest and land fires, according to the ministry's PHEOC. New cases were 2,778 on 17 Oct, slightly down from 2,808 on 16 Oct. By vulnerable group: children 6–9 years 77,022, toddlers 0–5 years 69,015, older people over 60 49,680, and people with asthma/COPD 22; data for pregnant women and outdoor workers are still being sorted. Health Minister Budi Gunadi Sadikin ordered 500,000 additional masks per affected province plus oxygen concentrators and medicines, and said every community health centre (puskesmas) in affected areas must open an 'oxygen house' service and stock drugs for respiratory infections and diarrhoea.Tirto（2026-10-19）：卫生部发言人Aji Muhawarman确认，据卫生部公共卫生应急指挥中心（PHEOC）数据，林火影响地区累计急性呼吸道感染（ISPA）病例达306,309例。10月17日新增2,778例，略低于16日的2,808例。按易感人群划分：6至9岁儿童77,022例，0至5岁幼儿69,015例，60岁以上老人49,680例，哮喘/慢阻肺患者22例；孕妇和户外工作者数据仍在整理。卫生部长Budi Gunadi Sadikin下令向每个受影响省份追加50万只口罩及制氧机和药品，并要求受影响地区所有社区卫生中心开设“氧气屋”服务，确保呼吸道感染和腹泻用药供应。

Why it matters: 为何重要：Smoke is hitting children hardest — schools and families in haze areas need masks and clean-air rooms.烟霾对儿童伤害最大——受影响地区的学校和家庭需要口罩和洁净空气房间。

Tirto.id (Kemenkes PHEOC) ↗ · r-2026-10-indonesia-kemenkes-ispa-306309-karhutla-children-6-9-77022-under5-69015-elderly-49680

Tsinghua and PLA General Hospital build 'Airscope', a 1-gram wireless microscope that records more than 8,500 individual neurons across a 6 mm patch of mouse cortex while the animals roam and socialise freely — about 25 times more than comparable devices (Nature)清华大学与解放军总医院研制出仅重1克的无线介观显微镜Airscope，可在小鼠自由活动和社交时，以单细胞分辨率记录6毫米范围大脑皮层中8,500多个神经元，约为同类设备的25倍（《自然》）

Xinhua (19–20 Oct 2026): the team of Academician Dai Qionghai (Tsinghua) with Dai Pu's team (Chinese PLA General Hospital) used an integrated design with only four aspheric lenses to reach single-cell resolution (4–6 µm) over a 6 mm field of view. Existing head-mounted miniscopes usually weigh over 3 g and see less than 1 mm of brain, while wide-field instruments require the head to be fixed or tethered by cables. Airscope compresses images on the device from a 2-megapixel sensor so megapixel frames can be sent wirelessly. The team recorded cortical activity in several mice exploring a 5 m² naturalistic habitat together and tracked long self-directed exploration in a 32-arm maze, finding that cortical activity changed systematically with the terrain. Associate Prof. Wu Jiamin said the tool gives more behavioural freedom for brain and brain-disease research; Dai said it could advance optical brain–computer interfaces and might later be used to follow immune and tumour processes. Published online in Nature on 19 Oct.新华社（2026年10月19–20日）：中国工程院院士、清华大学戴琼海团队与解放军总医院戴朴团队通过集成化设计和系统优化，仅用4片非球面镜片，就在6毫米视场内实现单细胞分辨率（4–6微米）。现有头戴式微型显微镜通常重3克以上、视场不足1毫米，而大视场设备需固定动物头部或用线缆“拴”住。Airscope借助200万像素图像传感器实现端侧压缩，使百万像素级图像得以无线传输。团队在5平方米自然栖息地中同时记录多只小鼠探索时的皮层活动，并在32个末端的大型迷宫中追踪小鼠长时间自主探索，发现皮层活动随所处地貌区域系统性变化。吴嘉敏副教授表示，该工具为脑认知和脑疾病研究提供更高的行为自由度；戴琼海认为它将推动光学脑机接口发展，未来还可能用于追踪免疫和肿瘤过程。成果10月19日在线发表于《自然》。

Why it matters: 为何重要：Watching thousands of brain cells while an animal behaves naturally brings researchers closer to understanding real-world brain function and disease.在动物自然行为时观察成千上万个脑细胞，让科学家更接近理解真实情境下的大脑功能和疾病。

Institutions: 机构：Tsinghua Med/Life清华医学/生科

Xinhua (新华社); Nature ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-tsinghua-pla-airscope-1-gram-wireless-mesoscope-6mm-fov-8500-neurons-freely-moving-mice-nature

Anhui's first PHASE procedure: doctors at USTC First Affiliated Hospital use a screw-in radiofrequency electrode passed through a vein to shrink a thickened heart wall in a 40-year-old with obstructive hypertrophic cardiomyopathy — no chest opening, chest pain gone by the next day安徽首例PHASE手术：中国科大附一院（安徽省立医院）医生经静脉送入螺旋射频电极，为一名40岁梗阻性肥厚型心肌病患者消融肥厚的室间隔，无需开胸，术后次日胸闷胸痛消失

People's Daily Online Anhui (19 Oct 2026): the patient had years of chest tightness and pain on exertion despite several drugs; imaging showed a markedly thickened septum with severe outflow obstruction and a risk of sudden death. He was reluctant to have open surgery and his coronary anatomy ruled out alcohol septal ablation. Dr Su Hao's cardiology team, after a multidisciplinary review, performed percutaneous helical-electrode septal ablation (PHASE) via the left subclavian vein: an open-irrigated helical radiofrequency electrode was screwed into the hypertrophied septum under X-ray and intracardiac echo with 3D navigation, keeping clear of the conduction system and coronary arteries. The outflow-tract gradient fell markedly, there were no arrhythmias or pericardial effusion, and he walked the next day. The access route is the same as for a pacemaker and does not depend on coronary anatomy. Obstructive HCM is an autosomal-dominant inherited heart disease and a common cause of sudden cardiac death in young people.人民网安徽频道（2026-10-19）：患者多年服用多种药物仍劳累后胸闷胸痛；检查显示室间隔明显肥厚、左室流出道重度梗阻，有猝死风险。他对开胸手术有顾虑，冠脉解剖也不适合酒精室间隔消融。苏浩主任医师团队经多学科讨论后，经左锁骨下静脉实施经皮螺旋电极室间隔消融术（PHASE）：在X线和心腔内超声及三维导航引导下，将开放式灌注螺旋射频电极旋入肥厚室间隔，避开传导系统和冠状动脉。术后流出道压差显著下降，无心律失常和心包积液，次日即下床活动。手术入路与常规起搏器手术相同，不依赖冠脉解剖条件。梗阻性肥厚型心肌病是常染色体显性遗传性心脏病，也是青少年和青壮年心源性猝死的常见原因之一。

Why it matters: 为何重要：An inherited heart condition that once meant open-heart surgery can now, for some patients, be treated through a vein like a pacemaker implant.这种过去往往需要开胸的遗传性心脏病，如今部分患者可像装起搏器一样经静脉治疗。

People's Daily Online, Anhui (人民网安徽频道) ↗ · r-2026-10-anhui-provincial-hospital-first-phase-percutaneous-helical-electrode-septal-ablation-ohcm

Xijing Hospital study of 1,009 Chinese breast cancer patients: women with inherited BRCA1 variants were more likely to have all cancer cleared by pre-surgery chemotherapy (50% vs 35.5%), but those left with residual tumour did worse; BRCA2 carriers responded like non-carriers (BMC Cancer)西京医院1,009例中国乳腺癌患者研究：携带遗传性BRCA1致病变异的女性术前化疗后病理完全缓解率更高（50%对35.5%），但仍有残留肿瘤者预后更差；BRCA2携带者反应与非携带者相近（《BMC Cancer》）

Qu et al., BMC Cancer (online Oct 2026; summarised by Scienmag/Bioengineer, 19 Oct): a retrospective cohort at three hospitals in Northwest China led by Xijing Hospital (Fourth Military Medical University, Xi'an) included 1,009 patients with stage I–III breast cancer who had germline BRCA1/2 testing and at least four cycles of neoadjuvant chemotherapy between January 2017 and August 2025. 62 (6.1%) carried BRCA1 and 55 (5.5%) BRCA2 pathogenic/likely pathogenic variants. Pathological complete response (pCR) was 50.0% in BRCA1 carriers versus 35.5% in non-carriers (adjusted OR 1.88, 95% CI 1.07–3.33, P=0.030); BRCA2 carriers had 27.3%, similar to non-carriers. Event-free survival did not differ overall (P=0.148), but among patients without pCR, BRCA1 carriers had significantly worse event-free survival (P=0.007). The authors suggest that this subgroup may warrant intensified strategies such as platinum or PARP inhibitors, though a retrospective design cannot prove which helps.Qu等，《BMC Cancer》（2026年10月在线；Scienmag/Bioengineer 10月19日摘要）：西京医院（第四军医大学，西安）牵头的西北地区三家医院回顾性队列，纳入2017年1月至2025年8月间接受胚系BRCA1/2检测并完成至少4周期新辅助化疗的1,009例I–III期乳腺癌患者。62例（6.1%）携带BRCA1、55例（5.5%）携带BRCA2致病/可能致病变异。BRCA1携带者病理完全缓解（pCR）率50.0%，非携带者35.5%（校正OR 1.88，95%CI 1.07–3.33，P=0.030）；BRCA2携带者为27.3%，与非携带者相近。总体无事件生存期无差异（P=0.148），但在未达pCR的患者中，BRCA1携带者无事件生存期显著更差（P=0.007）。作者认为该亚组可能需要铂类或PARP抑制剂等强化策略，但回顾性设计无法证明何种方案有效。

Why it matters: 为何重要：Knowing BRCA status before chemotherapy helps predict response and flags patients who need closer follow-up if cancer remains after treatment.化疗前了解BRCA状态有助预测疗效，并提示治疗后仍有残留肿瘤的患者需要更密切随访。

BMC Cancer (via Scienmag/Bioengineer summary) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-xijing-bmc-cancer-brca1-carriers-pcr-50-vs-35-neoadjuvant-chemo-1009-pts-worse-efs-if-residual

Hansoh Pharma signs a second antibody-drug conjugate (ADC) deal with Roche: US$400 million upfront, US$110 million on the first anniversary and potentially more than US$15 billion in milestones for a portfolio of new cancer ADCs, with Hansoh keeping Greater China rights翰森制药与罗氏签署第二项抗体偶联药物（ADC）合作：首付款4亿美元、一周年付款1.1亿美元，潜在里程碑付款超过150亿美元，覆盖一系列新型抗癌ADC，翰森保留大中华区权益

Hansoh Pharma press release (Shanghai, 19 Oct 2026; HKEX 03692): the collaboration covers two preclinical Hansoh ADC programmes plus multiple programmes against Roche-proposed targets built on Hansoh's ADC platform. Hansoh will lead development through global phase Ia trials; Roche will develop the programmes worldwide outside mainland China, Hong Kong, Macau and Taiwan, where Hansoh keeps all rights. Besides the upfront and anniversary payments and milestones, Hansoh is eligible for tiered royalties and may opt to co-develop up to two programmes outside Greater China for extra US commercial upside. It is the companies' second ADC partnership, following one announced last year. Hansoh says it has launched seven innovative medicines in China.翰森制药新闻稿（上海，2026-10-19；港交所03692）：合作涵盖翰森两个临床前ADC项目，以及基于翰森ADC技术平台、针对罗氏提出靶点的多个项目。翰森负责早期开发直至完成全球Ia期临床；罗氏负责在中国内地、香港、澳门和台湾以外的全球开发，翰森保留上述地区全部权益。除首付款、周年付款和里程碑付款外，翰森还可获得分级销售提成，并可选择最多两个项目参与大中华区以外的开发，以换取在美国商业化的额外收益。这是双方继去年之后的第二次ADC合作。翰森称已在中国上市7款创新药。

Why it matters: 为何重要：A deal potentially worth more than US$15 billion shows how much global drugmakers now rely on China-developed ADC technology.潜在价值逾150亿美元的交易，表明全球药企对中国自主研发ADC技术的倚重。

Hansoh Pharma press release; HKEX announcement ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hansoh-roche-second-adc-collaboration-400m-upfront-110m-anniversary-15bn-milestones

Chinese AI drug-delivery company METiS (剂泰科技) partners with Eli Lilly to design lipid nanoparticles that deliver medicines to specific tissues beyond the liver — more than US$10 million upfront and up to about US$1.1 billion in total中国AI药物递送企业剂泰科技与礼来达成战略合作，共同开发可将药物递送至肝外特定组织的脂质纳米颗粒（LNP）——首付款逾1,000万美元，总额最高约11亿美元

Securities Times / People's Finance (19 Oct 2026) and the company's HKEX filing (07666.HK): METiS will use its generative-AI ionizable-lipid platform (AiLNP) to optimise targeting and biodistribution of new LNP delivery systems supporting several therapeutic modalities, while Lilly provides drug discovery, development and commercialisation support. METiS receives an upfront payment of more than US$10 million, milestones of up to about US$1.1 billion, and single-digit percentage royalties on sales. The company describes it as China's first strategic collaboration centred on a generative-AI LNP platform and the largest AI-driven extrahepatic LNP delivery deal globally (company claim).证券时报/人民财讯（2026-10-19）及公司港交所公告（07666.HK）：剂泰科技将利用其生成式AI可电离脂质平台AiLNP，优化支持多种治疗模式的新型LNP递送系统的靶向性和生物分布；礼来提供药物发现、开发和商业化支持。剂泰可获逾1,000万美元首付款、最高约11亿美元里程碑付款，以及个位数百分比的销售分成。公司称这是国内首个以生成式AI平台为核心、围绕LNP递送展开的战略合作，也是全球规模最大的AI驱动肝外LNP递送平台合作（公司说法）。

Why it matters: 为何重要：Most mRNA and gene medicines today mainly reach the liver; getting them to other organs could open treatments for many more diseases.目前大多数mRNA和基因药物主要到达肝脏；若能递送到其他器官，将为更多疾病带来治疗可能。

Securities Times (证券时报); HKEX filing (07666.HK) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-metis-lilly-ai-designed-tissue-specific-lnp-delivery-partnership-up-to-1-1bn

China's NMPA approves a label update letting Novo Nordisk's Wegovy (semaglutide for weight management) be kept at 2–30°C for up to 48 hours before first use during delivery to patients — the first GLP-1 weight-loss drug in China with this flexibility国家药监局批准诺和诺德诺和盈®（司美格鲁肽注射液，体重管理）更新产品信息：在配送给患者的过程中、首次开启前，可在2℃～30℃储存最长48小时——中国首个具备这一配送灵活性的GLP-1减重药物

Novo Nordisk announcement reported by NBD and 21st Century Business Herald (19 Oct 2026): until now Wegovy depended on an unbroken cold chain all the way to the patient. The new condition applies only to last-mile distribution — after receipt, unopened pens should be returned to 2–8°C refrigeration away from light as soon as possible and are not for long-term room-temperature storage; once first opened, a pen can be kept below 30°C for up to six weeks. Commentators said it widens the feasibility of online consultation and e-commerce delivery for long-term weight-management treatment.每日经济新闻和21世纪经济报道（2026-10-19）报道诺和诺德公告：此前该产品分销和配送全程依赖冷链。新条件仅适用于末端配送环节——收到后未开启的注射笔应尽快放回2℃～8℃避光冷藏，不可长期常温保存；首次开启后可在30℃以下保存最长6周。评论认为，这将拓宽长期体重管理治疗中线上问诊和电商配送的可行性。

Why it matters: 为何重要：Easier home delivery may help people stay on long-term weight treatment — but pens still belong in the fridge once they arrive.送药上门更方便，或有助患者坚持长期减重治疗——但收到后仍需放回冰箱。

NBD (每日经济新闻); 21st Century Business Herald (21经济网) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nmpa-wegovy-china-label-update-48h-2-30c-before-first-use-distribution-first-glp1

ESMO 2026: Mabwell's Nectin-4 antibody-drug conjugate 9MW2821 (bulumtatug fuvedotin) achieves a 30% response rate in triple-negative breast cancer that had already progressed after topoisomerase-I ADCs, with responses lasting a median 8.7 monthsESMO 2026：迈威生物靶向Nectin-4的ADC 9MW2821（bulumtatug fuvedotin）在既往拓扑异构酶I抑制剂类ADC治疗后进展的三阴性乳腺癌中客观缓解率30%，中位缓解持续时间8.7个月

Mabwell press release (19 Oct 2026), on a phase II oral presentation at ESMO 2026 (CTR20242376): among 60 evaluable patients with locally advanced or metastatic TNBC previously treated with topo-I-payload ADCs, objective response rate was 30.0%, disease control rate 80.0%, median PFS 3.7 months and median duration of response 8.7 months, with overall survival not yet mature and no new safety signals (data cut-off 10 Apr 2026). All ADCs currently approved for TNBC carry topo-I payloads, and patients who progress mostly receive chemotherapy. 9MW2821 has four phase III registration trials under way in urothelial, cervical and triple-negative breast cancer; the company says the TNBC (post-topo-I ADC) indication is the first of its kind globally to reach phase III and has entered phase Ib in the US.迈威生物新闻稿（2026-10-19），介绍将在ESMO 2026口头报告的II期数据（CTR20242376）：60例可评估的既往接受拓扑异构酶I载荷ADC治疗的局部晚期或转移性三阴性乳腺癌患者中，客观缓解率30.0%，疾病控制率80.0%，中位无进展生存期3.7个月，中位缓解持续时间8.7个月，总生存期尚未成熟，未见新的安全性信号（数据截至2026年4月10日）。目前获批用于三阴性乳腺癌的ADC均以拓扑异构酶I抑制剂为载荷，进展后患者多以化疗为主。9MW2821已有4项III期注册临床在尿路上皮癌、宫颈癌和三阴性乳腺癌中进行；公司称其三阴性乳腺癌（Topo I ADC经治）适应症为全球同适应症首款进入III期的品种，并已在美国进入Ib期。

Why it matters: 为何重要：Women whose triple-negative breast cancer stops responding to current ADCs badly need options beyond chemotherapy.对现有ADC失效的三阴性乳腺癌患者，迫切需要化疗以外的新选择。

Mabwell (迈威生物) press release ↗ · r-2026-10-esmo26-mabwell-9mw2821-nectin4-adc-tnbc-after-topo1-adc-orr-30-mdor-8-7

ESMO 2026: in Henlius's US bridging trial ASTRIDE (201 patients), its PD-1 antibody serplulimab plus chemotherapy gave numerically longer survival than atezolizumab plus chemotherapy in extensive-stage small cell lung cancer — median 12.4 vs 10.2 months, 2-year survival 32.2% vs 17.6%ESMO 2026：复宏汉霖在美国开展的桥接试验ASTRIDE（201例）显示，其PD-1单抗斯鲁利单抗联合化疗治疗广泛期小细胞肺癌的总生存期数值上优于阿替利珠单抗联合化疗——中位12.4对10.2个月，24个月生存率32.2%对17.6%

Henlius press release (19 Oct 2026), on abstracts published by ESMO that day: ASTRIDE, led by Prof. David Gandara (UC Davis), randomised 201 US patients at 63 centres (July 2022–October 2025) to serplulimab or atezolizumab with carboplatin–etoposide, followed by maintenance; it is a head-to-head study with descriptive statistics only. At a median follow-up of 14.1 months (cut-off 18 Feb 2026), median OS was 12.4 vs 10.2 months and 24-month OS 32.2% vs 17.6%, with comparable adverse events, although more serplulimab patients had liver metastases at baseline (49.5% vs 40.0%). It will be an oral presentation on 26 Oct. Henlius says the results support extrapolating its global phase III ASTRUM-005 findings to US patients. Ten serplulimab studies were accepted, including Chinese investigator-led trials in neuroendocrine carcinoma (ORR 69.8%, n=43) and non-clear-cell kidney cancer with fruquintinib (ORR 59.0%, n=39).复宏汉霖新闻稿（2026-10-19），介绍ESMO当天公布的摘要：ASTRIDE由加州大学戴维斯分校David Gandara教授牵头，2022年7月至2025年10月在美国63家中心将201例患者随机分配接受斯鲁利单抗或阿替利珠单抗联合卡铂–依托泊苷，再行维持治疗；为头对头、仅作描述性统计的桥接研究。中位随访14.1个月（截至2026年2月18日），中位OS 12.4对10.2个月，24个月OS率32.2%对17.6%，不良事件相当，但斯鲁利单抗组基线肝转移比例更高（49.5%对40.0%）。将于10月26日口头报告。公司称结果支持将全球III期ASTRUM-005结论外推至美国患者。共有10项斯鲁利单抗研究入选，包括中国研究者发起的肺外神经内分泌癌研究（ORR 69.8%，43例）和联合呋喹替尼治疗非透明细胞肾癌研究（ORR 59.0%，39例）。

Why it matters: 为何重要：A Chinese-developed immunotherapy is being tested directly against a US standard in American patients — a key step towards US approval.中国研发的免疫疗法在美国患者中直接对比美国标准方案——是迈向美国获批的关键一步。

Henlius (复宏汉霖) press release ↗ · r-2026-10-esmo26-henlius-serplulimab-astride-us-bridging-es-sclc-os-12-4-vs-10-2-atezolizumab

HKUST-led study finds a repeating 'CCG' stretch of DNA in the control region of the FAM193B gene linked to Alzheimer's: Chinese people whose longer copy has 18+ repeats had about twice the odds of the disease (Nature Neuroscience)香港科技大学牵头研究发现，FAM193B基因调控区一段重复的“CCG”DNA序列与阿尔茨海默病相关：较长拷贝重复18次以上的中国人患病几率约为重复不超过11次者的两倍（《自然·神经科学》）

Medical Xpress (19 Oct 2026) on Cao et al., Nature Neuroscience: using long-read sequencing from 11 Chinese individuals to build a structural-variant reference, the team found a variable CCG repeat (from 4 to more than 30 copies) in the FAM193B promoter. Longer repeats were associated with Alzheimer's in a Hong Kong cohort and an independent mainland Chinese cohort (1,516 patients, 1,674 cognitively normal people combined): those whose longer allele had at least 18 repeats had roughly double the odds compared with 11 or fewer — a group-level association, not a doubling of an individual's lifetime risk. A smaller association, with a different threshold, was seen in UK Biobank participants of European ancestry (2,674 cases, 22,996 controls). Longer repeats were linked to higher FAM193B expression in blood and brain tissue, bound more strongly to the regulator MAZ, and raised FAM193B activity in cells, which increased DNA-damage markers; the gene's normal function remains unclear.Medical Xpress（2026-10-19）报道Cao等人发表于《自然·神经科学》的研究：团队利用11名中国人的长读长测序建立结构变异参考集，在FAM193B启动子中发现一段可变的CCG重复（从4次到30次以上）。在香港队列和独立的内地队列（合计1,516名患者和1,674名认知正常者）中，较长重复与阿尔茨海默病相关：较长等位基因重复至少18次者的患病几率约为11次及以下者的两倍——这是群体层面的关联，并不意味着个人终生风险翻倍。在英国生物样本库欧洲血统人群（2,674例病例、22,996名对照）中也观察到较弱的关联，且阈值不同。较长重复与血液和脑组织中FAM193B表达升高相关，与调控蛋白MAZ结合更强，并在细胞中提高FAM193B活性、增加DNA损伤标志物；该基因的正常功能仍不清楚。

Why it matters: 为何重要：Many Alzheimer's risk genes were found in European populations; this one stands out most in Chinese people and may point to new biology.许多阿尔茨海默病风险基因是在欧洲人群中发现的；这一个在中国人中最为突出，或揭示新的发病机制。

Institutions: 机构：HKUST港科大

Medical Xpress (Nature Neuroscience) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hkust-nature-neuroscience-fam193b-ccg-repeat-alzheimers-risk-chinese-cohorts-2x-odds

Taiwanese entertainer A-Ken says shingles pain once left him collapsed on the floor at night; as an ambassador for the Taiwan Association of Diabetes Educators he urges people with diabetes, who face about 1.8 times the shingles risk, to ask their doctors about prevention台湾艺人阿Ken分享曾因带状疱疹（皮蛇）半夜痛倒在地；他以糖尿病卫教学会卫教大使身份呼吁糖友——其带状疱疹风险约为常人1.8倍——主动向医师询问预防方法

CNA (19 Oct 2026): at a Taiwan Association of Diabetes Educators press event, A-Ken described 'hellish' shingles pain and said he then sought advice on preventing a recurrence; he filmed a public-health ad as a baseball pitcher. Association president Ou Horng-yih said diabetes may affect immune function: a large US database study found people with type 2 diabetes had about 1.8 times the shingles incidence of those without, and Taiwan's National Health Insurance data show one in seven patients with eye shingles has diabetes. Shingles is reactivation of latent varicella-zoster virus; in people with diabetes it can disturb glucose control, and eye involvement can cause keratitis or uveitis. Dr Kuo Chin-sung (Taipei Veterans General Hospital) advised patients to ask at check-ups about shingles complications such as post-herpetic neuralgia and about risk-reduction options, including vaccination.中央社（2026-10-19）：在糖尿病卫教学会记者会上，阿Ken形容带状疱疹疼痛如“地狱般”，此后主动咨询医师预防再次发作，并化身棒球投手拍摄卫教广告。学会理事长欧弘毅表示，糖尿病患者免疫功能可能受影响：美国大型资料库研究显示第2型糖尿病患者带状疱疹发生率约为非糖尿病者的1.8倍；台湾健保大数据显示，每7名眼部带状疱疹患者中就有1人是糖友。带状疱疹是潜伏的水痘带状疱疹病毒再次活化所致；糖友发作可能扰乱血糖控制，侵犯眼部可引发角膜炎、葡萄膜炎。台北荣总郭锦松医师建议糖友回诊时主动询问疱疹后神经痛等并发症以及包括疫苗在内的风险管理方案。

Why it matters: 为何重要：Diabetes weakens defences against a dormant virus — a celebrity's painful experience is a reminder to ask about shingles prevention.糖尿病会削弱身体对潜伏病毒的防御——名人的痛苦经历提醒糖友主动询问带状疱疹预防。

CNA (中央社) ↗ · r-2026-10-taiwan-entertainer-a-ken-shingles-pain-diabetes-educators-zoster-risk-1-8x-1-in-7-ocular

Tohoku University: glioblastoma, the deadliest brain cancer, recycles scarce selenium by secreting its own selenium-carrier protein SeP and taking it back through the receptor LRP8 — a loop controlled by the RNA CCDC152 that powers the antioxidant enzymes GPX1 and GPX4 (Redox Biology)东北大学：最致命的脑癌胶质母细胞瘤会自行分泌硒转运蛋白SeP，再经受体LRP8回收，实现稀缺硒的“循环利用”；这一由RNA CCDC152调控的循环维持抗氧化酶GPX1和GPX4（《Redox Biology》）

Tohoku University press release (19 Oct 2026): Prof. Yoshiro Saito's team at the Graduate School of Pharmaceutical Sciences found that glioblastoma (IDH-wildtype) cells form a 'tumour-associated SeP cycle', producing and secreting selenoprotein P and re-absorbing it via LRP8 (ApoER2). The long non-coding RNA CCDC152 (L-IST), previously known to suppress SeP translation in liver cells, positively regulates both SeP and LRP8 in glioblastoma, sustaining the selenium-dependent antioxidant enzymes GPX1 and GPX4, tumour growth and resistance to cell death. Blocking the CCDC152–SeP–LRP8 axis could weaken the tumour's antioxidant defence and induce cell death. Published in Redox Biology on 12 Oct 2026 (DOI 10.1016/j.redox.2026.104438).东北大学新闻稿（2026-10-19）：药学研究科斋藤芳郎教授团队发现，胶质母细胞瘤（IDH野生型）细胞形成“肿瘤相关SeP循环”——自行产生并分泌硒蛋白P，再通过LRP8（ApoER2）重新摄取。长链非编码RNA CCDC152（L-IST）此前在肝细胞中被认为抑制SeP翻译，而在胶质母细胞瘤中则正向调控SeP和LRP8，维持依赖硒的抗氧化酶GPX1和GPX4、肿瘤增殖及对细胞死亡的抵抗。阻断CCDC152–SeP–LRP8轴有望削弱肿瘤的抗氧化防御并诱导细胞死亡。论文于2026年10月12日发表于《Redox Biology》（DOI 10.1016/j.redox.2026.104438）。

Why it matters: 为何重要：Cutting off a tumour's selenium supply could leave it exposed to oxidative cell death, a new angle against a cancer with few options.切断肿瘤的硒供应可能使其更易因氧化损伤而死亡，为这种治疗选择很少的癌症提供新思路。

Tohoku University press release ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-tohoku-glioblastoma-selenium-recycling-ccdc152-sep-lrp8-axis-gpx4-redox-biology

India: the National Medical Commission withdraws its 2023 Maintenance of Standards of Medical Education Regulations with immediate effect, while keeping the requirement for medical colleges to file annual disclosure reports印度：国家医学委员会即时废止2023年《医学教育标准维持条例》，但保留医学院提交年度信息披露报告的要求

PTI via ETHealthworld (19 Oct 2026): a Gazette notification dated 14 Oct, issued under sections 10, 24, 25 and 57 of the NMC Act 2019, de-notified the regulations notified on 19 Sept 2023. The Annual Disclosure Report requirement continues under sections 24(i) and 25(h) of the Act. Transitional provisions keep actions, approvals, renewals and decisions taken under the 2023 rules valid, and pending applications, appeals and inquiries will still be handled under them; matters arising after de-notification fall under the Act and rules in force at the time.印度报业托拉斯经ETHealthworld（2026-10-19）：依据《2019年国家医学委员会法》第10、24、25和57条发布、日期为10月14日的公报通知，废止了2023年9月19日公布的该条例。年度信息披露报告要求依据该法第24(i)和25(h)条继续有效。过渡条款规定，依2023年条例已采取的行动、批准、续期和决定仍然有效，待处理的申请、上诉和调查仍按该条例处理；废止后出现的事项适用当时有效的法律和规定。

Why it matters: 为何重要：Rules governing how India's medical colleges are inspected are being reset — relevant to the quality of doctors trained there.印度医学院的监管规则正在重置——关系到当地培养医生的质量。

ETHealthworld (PTI) ↗ · r-2026-10-india-nmc-withdraws-maintenance-of-standards-medical-education-regulations-2023-adr-retained

FDA grants accelerated approval to GSK's Jemperli (dostarlimab) alone for untreated stage II–III rectal cancer with mismatch-repair deficiency (dMMR/MSI-H), which may let patients skip chemotherapy, radiation and surgery; in the AZUR-1 trial almost three-quarters needed none of them after two years美国FDA加速批准GSK的Jemperli（多塔利单抗）单药用于初治II–III期错配修复缺陷（dMMR/MSI-H）局部晚期直肠癌，患者有望免于化疗、放疗和手术；AZUR-1试验中近四分之三患者两年后仍无需这些治疗

FDA press announcement (19 Oct 2026): eligible tumours must be dMMR or MSI-H by an FDA-authorised test — about 3% of locally advanced rectal cancers; the DNA-repair defect produces abnormal proteins the immune system can recognise. The decision rests on interim results of the phase 2 AZUR-1 study (NCT05723562) in 154 patients given up to nine doses every three weeks over six months: after a median follow-up of more than two years, almost three-quarters had not needed surgery, radiotherapy or chemotherapy. In an earlier Memorial Sloan Kettering study of 50 patients, none had detectable cancer after treatment, 93% stayed cancer-free for at least 12 months, and of 27 followed at least three years only one recurred. Common side effects included fatigue, rash, diarrhoea and itching; immune-mediated reactions can be severe. Review was completed nearly four months early under the Commissioner's National Priority Voucher pilot (11th approval); continued approval depends on confirmatory follow-up.FDA新闻公告（2026-10-19）：适用肿瘤须经FDA认可的检测确认为dMMR或MSI-H，约占局部晚期直肠癌的3%；DNA修复缺陷会产生可被免疫系统识别的异常蛋白。批准依据II期AZUR-1研究（NCT05723562）中期结果：154例患者每3周给药一次、6个月内最多9剂，中位随访两年多后，近四分之三患者无需手术、放疗或化疗。此前纪念斯隆-凯特琳癌症中心一项50例研究中，所有患者治疗后均无可检测到的癌症，93%维持无癌至少12个月，27例随访至少3年者中仅1例复发。常见副作用包括疲劳、皮疹、腹泻和瘙痒；免疫相关反应可能很严重。该审评在局长国家优先审评券试点下提前近4个月完成（第11个获批项目）；后续须以确证性随访维持批准。

Why it matters: 为何重要：For a small, genetically defined group, immunotherapy alone may preserve normal bowel, bladder, sexual function and fertility.对这一小部分按基因特征界定的患者，仅用免疫治疗就可能保住正常的肠道、膀胱、性功能和生育力。

Institutions: 机构：MSKMSK

U.S. FDA press announcement ↗ · r-2026-10-fda-jemperli-dostarlimab-accelerated-approval-dmmr-msih-locally-advanced-rectal-cancer-azur1

DR Congo's Bundibugyo Ebola outbreak reaches 9,455 confirmed cases and 4,561 deaths (fatality 48.2%); MSF says children make up 24% of new patients and are being left out of vaccine trials and new treatments, while North Kivu bans entry from Ituri for a week刚果（金）本迪布焦型埃博拉疫情确诊病例达9,455例、死亡4,561例（病死率48.2%）；无国界医生称儿童占新增患者的24%，却被排除在疫苗试验和新疗法之外；北基伍省禁止伊图里省人员入境一周

CIDRAP (19 Oct 2026): DRC officials reported 9,455 confirmed cases including 4,561 deaths over the weekend, with eight provinces affected and Ituri still the epicentre; North Kivu is imposing a one-week ban on people entering from Ituri. MSF data show 24% of new Ebola patients are children; children under five make up 24% of confirmed cases in North Kivu and 13% in Ituri, and infants 13% and 6% respectively, with disproportionately high death rates. MSF says general health facilities lack paediatric expertise, equipment and infection control, and urged that children be included in upcoming Bundibugyo vaccine trials and given access to new therapies 'from the outset'. In Kenya, all eight cases remain linked to the imported index patient, with 128 of 130 contacts quarantined and no sign of community spread.CIDRAP（2026-10-19）：刚果（金）官员周末通报确诊9,455例，其中死亡4,561例，8个省受影响，伊图里省仍是疫情中心；北基伍省对来自伊图里省的人员实施为期一周的入境禁令。无国界医生数据显示，新增埃博拉患者中24%为儿童；5岁以下儿童在北基伍和伊图里确诊病例中分别占24%和13%，婴儿分别占13%和6%，且病死率格外高。无国界医生称普通医疗机构缺乏儿科专长、设备和感染控制条件，呼吁将儿童纳入即将开展的本迪布焦疫苗试验，并“从一开始”就让他们获得新疗法。肯尼亚8例病例仍全部与输入性首例患者相关，130名接触者中128人已隔离，未见社区传播。

Why it matters: 为何重要：With no approved vaccine or drug for this Ebola strain, children — a quarter of new cases — risk being left behind by research.这一埃博拉毒株尚无获批疫苗或药物，占新增病例四分之一的儿童有被研究遗漏的风险。

CIDRAP (University of Minnesota) ↗ · r-2026-10-drc-ebola-9455-cases-4561-deaths-cfr-48-msf-children-24pct-north-kivu-ituri-entry-ban

WHO grants Emergency Use Listing to bioMérieux's BioFire Global Fever Special Pathogens Panel, which tests one blood sample for 16 pathogens — including the Bundibugyo Ebola virus behind the current outbreak, Marburg, Lassa and malaria — in about an hour世卫组织将生物梅里埃的BioFire全球发热特殊病原体检测板列入紧急使用清单：用一份全血样本约一小时内检测16种病原体，包括引发当前疫情的本迪布焦埃博拉病毒、马尔堡病毒、拉沙病毒和疟原虫

bioMérieux press release (Marcy-l'Étoile, 19 Oct 2026) and WHO Prequalification news: the multiplex PCR panel, made by BioFire Defense, helps tell Ebola apart from other causes of acute fever with similar symptoms, guiding patient management and contact tracing. WHO's assessment covered its Ebolavirus/Bundibugyo detection claims. The panel is FDA-cleared and recommended by the US CDC for the current response. No specific treatment or licensed vaccine exists for Bundibugyo virus. bioMérieux says it delivered instruments and reagents to the Rwanda Biomedical Centre in June and to Uganda's national laboratories, and is working with DRC's INRB to supply more.生物梅里埃新闻稿（法国马西莱托勒，2026-10-19）及世卫组织预认证新闻：该多重PCR检测板由BioFire Defense生产，可帮助将埃博拉与其他症状相似的急性发热病因区分开来，指导患者管理和接触者追踪。世卫组织评估针对其埃博拉/本迪布焦病毒检测声明。该检测板已获FDA许可，并获美国CDC推荐用于当前疫情应对。本迪布焦病毒目前尚无特效药或获批疫苗。生物梅里埃称已于6月向卢旺达生物医学中心和乌干达国家卫生实验室交付仪器和试剂，并正与刚果（金）国家生物医学研究所合作扩大供应。

Why it matters: 为何重要：Fast, accurate testing is the first line of defence when no vaccine exists — it lets health workers isolate true cases quickly.在没有疫苗的情况下，快速准确的检测是第一道防线——能让医护人员尽快隔离真正的病例。

bioMérieux press release; WHO Prequalification ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-who-eul-biofire-global-fever-special-pathogens-panel-16-pathogens-bundibugyo-ebola

CREST-H (JAMA): opening severe but symptom-free carotid artery blockages with stenting or surgery did not improve thinking skills after one year compared with medication alone in 291 patients with reduced brain blood flowCREST-H研究（《美国医学会杂志》）：291例颈动脉重度狭窄但无症状、脑血流减少的患者中，支架或手术开通血管一年后，认知功能并不比单纯药物治疗更好

Columbia University Irving Medical Center via Medical Xpress (19 Oct 2026): CREST-H, part of the CREST-2 trial, enrolled 291 patients with asymptomatic carotid stenosis of 70% or more and haemodynamic impairment, measuring cerebral blood flow and cognition at enrolment and one year later. Cognitive scores improved slightly in both groups, with no difference between revascularisation and medical therapy. Study leader Dr Randolph Marshall said the hypothesis, supported by animal studies and case series, had never been tested in a randomised trial, and that revascularisation 'cannot be expected' to reverse cognitive decline, underlining the importance of preventing carotid stenosis. CREST-2 itself found that stenting plus medication, but not endarterectomy, halved strokes compared with medication alone. DOI 10.1001/jama.2026.13384.哥伦比亚大学欧文医学中心经Medical Xpress（2026-10-19）：CREST-H是CREST-2试验的一部分，纳入291例颈动脉狭窄≥70%、无症状但有血流动力学受损的患者，在入组时和一年后测量脑血流和认知。两组认知评分均略有提高，血运重建组与药物治疗组无差异。研究负责人Randolph Marshall医生表示，这一得到动物研究和病例系列支持的假说此前从未经随机试验检验；不能指望血运重建逆转认知下降，这凸显预防颈动脉狭窄的重要性。CREST-2本身发现，支架加药物（而非内膜剥脱术）使卒中较单纯药物减半。DOI 10.1001/jama.2026.13384。

Why it matters: 为何重要：A carotid procedure may still prevent strokes, but patients should not expect it to sharpen memory or thinking.颈动脉手术或许仍能预防卒中，但患者不应期待它改善记忆或思维。

Medical Xpress (Columbia University / JAMA) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-crest-h-jama-carotid-revascularization-no-cognitive-benefit-291-asymptomatic-stenosis

Lancet Digital Health: an AI model reading a single face photo sorted cancer patients into higher- and lower-risk groups for death within 90 days; trained on over 40 million faces and 30,000+ cancer patients, it focused on the nose bridge and under-eye area — experts say it is not ready for clinical use《柳叶刀·数字健康》：一个仅凭一张面部照片的AI模型可把癌症患者分为90天内死亡风险较高和较低的组别；它用4,000多万张人脸和3万多名癌症患者照片训练，主要关注鼻梁和眼下区域——专家称尚不能用于临床

Bloomberg via The Straits Times (20 Oct 2026): the model, developed by Raymond Mak's team at Mass General Brigham Cancer Institute, estimated age within about five years and allocated patients to risk groups with different subsequent mortality, working across ages, races, genders and cancer types; the study was published in The Lancet Digital Health on 19 Oct. Mak said doctors are 'in general not very good' at estimating life expectancy and sees the tool as 'one more piece of information', not a way to deny treatment; he noted Hippocrates described sunken eyes and a sharp nose as signs of impending death. Prof. Miroslaw Bober (University of Surrey), not involved, said predicting is not explaining: the study did not show added value beyond doctors' assessment of general health and fitness, which was not measured, and the tool needs testing against clinicians' judgement and across hospitals and patient groups.彭博社经《海峡时报》（2026-10-20）：该模型由麻省总医院布莱根癌症研究所Raymond Mak团队开发，估计年龄误差约5年，并可把患者分入其后死亡率不同的风险组，适用于不同年龄、种族、性别和癌种；研究10月19日发表于《柳叶刀·数字健康》。Mak表示医生“总体上不太擅长”估计预期寿命，他把该工具视为“多一条信息”，而非拒绝治疗的理由；他还指出希波克拉底曾把眼窝凹陷、鼻子尖削描述为临终征兆。未参与研究的萨里大学Miroslaw Bober教授说，预测不等于解释：研究没有证明它比医生对整体健康和体能的评估（研究未测量）更有附加价值，仍需与临床判断比较，并在不同医院和患者群体中验证。

Why it matters: 为何重要：AI may one day help doctors discuss end-of-life care more honestly, but it raises accuracy and ethics questions first.AI未来或许能帮助医生更坦诚地讨论临终照护，但首先要回答准确性和伦理问题。

The Straits Times (Bloomberg; The Lancet Digital Health) ↗ · r-2026-10-lancet-digital-health-face-photo-ai-predicts-cancer-survival-90-day-mortality-mass-general-brigham

Emory study (Nature Communications): a 10-protein blood test distinguished ALS patients from healthy people with 98.3% balanced accuracy in an independent group, using more than 750 ALS cases — and did not rely on neurofilament light alone埃默里大学研究（《自然·通讯》）：一项10种蛋白的血液检测在独立验证组中以98.3%的平衡准确率区分ALS患者与健康人，研究纳入750多例ALS——且并不只依赖神经丝轻链

Kim, Thomas, Glass et al., Nature Communications (published 19 Oct 2026, open access): plasma from 632 ALS patients and 160 healthy controls was profiled with NULISA CNS and inflammation panels and analysed by XGBoost machine learning with SHAP interpretation. A 12-protein candidate panel was refined to 10 proteins — NEFL, FOLR1, pTau-181, TREM1, VEGFA, NEFH, CALCA, NRGN, LAMP3 and PTX3 — and tested in an independent cohort of 144 ALS patients and 37 controls, achieving balanced accuracy of 98.3% and AUC 0.992. Performance was driven by plasma protein signatures rather than clinical variables. The authors say the work supports development of a clinically deployable blood-based ALS screening tool; comparison was with healthy people, not with ALS mimics.Kim、Thomas、Glass等，《自然·通讯》（2026年10月19日开放获取发表）：研究用NULISA中枢神经和炎症检测板分析632例ALS患者和160名健康对照的血浆，并以XGBoost机器学习和SHAP解释方法筛选。12种候选蛋白精简为10种——NEFL、FOLR1、pTau-181、TREM1、VEGFA、NEFH、CALCA、NRGN、LAMP3和PTX3——在144例ALS患者和37名对照的独立队列中验证，平衡准确率98.3%，AUC 0.992。表现由血浆蛋白特征而非临床变量驱动。作者认为可支持开发可用于临床的血液ALS筛查工具；对照为健康人，而非类似ALS的其他疾病。

Why it matters: 为何重要：A simple blood test could speed referral and trial enrolment for ALS — once it is proven against diseases that mimic it.简单的血液检测有望加快ALS转诊和临床试验入组——前提是在与类似疾病的比较中得到验证。

Nature Communications ↗Access limited in certain regions部分地区可能无法访问 · r-2026-10-emory-nature-comms-10-protein-plasma-panel-als-diagnosis-auc-0-992-nulisa-xgboost

Singapore haze, 8pm Monday: 24-h PSI unchanged at Unhealthy in the West (114) and Central (106); hourly PM2.5 in Central eases from 94 to 74 µg/m³ but West (75) and South (59) stay Elevated, while the North drops to 22新加坡烟霾（周一晚8时）：24小时PSI西部（114）和中部（106）仍为“不健康”；中部每小时PM2.5从94回落至74微克/立方米，但西部（75）和南部（59）仍处“偏高”，北部降至22

NEA real-time data (data.gov.sg, 19 Oct 2026, 8pm): 24-h PSI North 87, South 88, East 91 (Moderate), West 114 and Central 106 (Unhealthy). 1-h PM2.5 was 75 µg/m³ in the West, 74 in Central and 59 in the South (Band II Elevated, 56–150), and 51 in the East and 22 in the North (Band I Normal). Central PM2.5 had peaked at 94 at 7pm. NEA's forecast for 20 Oct remains 24-h PSI 90–160 (Moderate to Unhealthy); people should use the hourly PM2.5 reading to decide on immediate outdoor activity, and those with chronic heart or lung disease, older people, pregnant women and children should minimise prolonged or strenuous outdoor exertion.国家环境局实时数据（data.gov.sg，2026-10-19晚8时）：24小时PSI北部87、南部88、东部91（中等），西部114、中部106（不健康）。1小时PM2.5西部75、中部74、南部59微克/立方米（二级“偏高”，56–150），东部51、北部22（一级正常）。中部PM2.5晚7时曾达94的峰值。环境局对10月20日的预测仍为24小时PSI 90–160（中等至不健康）；公众应以每小时PM2.5决定即时户外活动，慢性心肺病患者、老人、孕妇和儿童应尽量减少长时间或剧烈户外活动。

Why it matters: 为何重要：The evening spike in Central has eased, but the West and South are still hazy — check the hourly reading before an evening run.中部傍晚的高峰已回落，但西部和南部仍有烟霾——夜跑前请先看每小时读数。

NEA real-time PSI/PM2.5 (data.gov.sg); NEA health advisory (via Haze.SG) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-8pm-psi-west-114-central-106-pm25-central-eases-74-west-75-elevated

Malaysia haze, 7pm Monday: 25 areas still Unhealthy, with Batu Muda, Kuala Lumpur (166) overtaking Johan Setia (164) as the worst; cloud seeding began in Johor and is scheduled for Melaka, Negeri Sembilan, Selangor, KL and Putrajaya on 21–23 Oct马来西亚烟霾（周一晚7时）：仍有25个地区“不健康”，吉隆坡峇都慕达（166）超过Johan Setia（164）成为最高；柔佛已开始人工降雨，马六甲、森美兰、雪兰莪、吉隆坡和布城定于10月21日至23日进行

Astro Awani (19 Oct 2026, 7:20pm), citing DOE's APIMS: 25 areas were Unhealthy at 7pm, down from 26 an hour earlier, as Port Dickson and Seri Manjung returned to Moderate at 100; Balok Baru, Kuantan rose from 99 to 106. Readings included Bukit Rambai 163, Nilai and Seremban 162, Alor Gajah 160, Bandaraya Melaka 159, Tangkak 158, Tasek Ipoh 152, Pegoh Ipoh 151 (from 137), Larkin 151, Sri Aman 135, Kota Tinggi 120 and Serian 120; Kuching (94) and Samarahan (91) were Moderate. Only Langkawi (49), ILP Miri (44), Kimanis (43) and Limbang (34) were Good. Bernama (via Newswav) reported that cloud-seeding operations by MetMalaysia, NADMA, the air force and CAAM began in Johor on 19 Oct and are planned for Melaka, Negeri Sembilan, Selangor, Kuala Lumpur and Putrajaya from 21 to 23 Oct.Astro Awani（2026-10-19晚7:20）引述环境局APIMS：晚7时有25个地区“不健康”，比前一小时的26个少一个——波德申和实兆远回落至100（中等），关丹Balok Baru则从99升至106。读数包括武吉南眉163、汝来和芙蓉162、亚罗牙也160、马六甲市159、东甲158、怡保打昔152、怡保北固151（原137）、拉庆151、斯里阿曼135、哥打丁宜120和西连120；古晋（94）和三马拉汉（91）为“中等”。仅浜威（49）、美里ILP（44）、金马利（43）和林梦（34）“良好”。马新社（经Newswav）报道，气象局、国家灾难管理机构、空军和民航局联合的人工降雨作业10月19日已在柔佛展开，并计划10月21日至23日在马六甲、森美兰、雪兰莪、吉隆坡和布城进行。

Why it matters: 为何重要：Air in the Klang Valley is now among the worst in the country — rain, natural or seeded, is the main hope for relief this week.巴生谷空气已属全国最差之列——本周能否缓解主要看降雨，无论天然还是人工。

Astro Awani (DOE APIMS); Bernama via Newswav ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-apims-oct19-7pm-25-areas-unhealthy-batu-muda-166-cloud-seeding-oct21-23

Indonesia: Home Affairs Minister Tito Karnavian says burning peat keeps smouldering underground and needs large volumes of water; cloud seeding has brought rain to Palangka Raya, and chemical agents are cooling peat in South Sumatra — while satellites log 20,392 hotspots nationwide in 24 hours印尼：内政部长蒂托称泥炭地着火后会在地下持续闷烧，需要大量水才能扑灭；人工降雨已为帕朗卡拉亚带来降水，南苏门答腊正用化学制剂为泥炭降温——卫星24小时内在全国监测到20,392个热点

CNN Indonesia (19 Oct 2026): after a joint fire meeting at the Coordinating Ministry for Political and Security Affairs, Tito said peat fires persist inside the soil, unlike fires on mineral soil, so water must come either from rain (natural or cloud seeding, which needs cloud seeds) or from rivers, reservoirs and lakes, which may be far away or dry; chemical substances are being used at some fire sites, and in South Sumatra they cool peat with less water. Cloud seeding succeeded in bringing rain to Palangka Raya, Central Kalimantan. BNPB figures for six provinces (Riau, Jambi, South Sumatra, West, Central and South Kalimantan): 1,308.03 ha burned in 24 h, 650.19 ha still to be extinguished, 5,499 hotspots and 247 fire spots, 53,848 personnel deployed. The forestry ministry's SiPongi system (via Databoks, accessed 11:16 WIB) counted 20,392 hotspots nationwide in 24 h (+2,686; 1,379 high-confidence), led by Central Kalimantan 8,239, South Papua 2,426 and West Kalimantan 1,797.CNN印尼（2026-10-19）：蒂托在政治、法律与安全统筹部召开林火联席会议后表示，泥炭地火灾与矿质土壤不同，火会在土壤中持续存在，因此必须注水——要么靠降雨（天然或人工降雨，后者需要有云层可播撒），要么从河流、水库和湖泊取水，但水源可能很远或已干涸；部分火点已使用化学制剂，在南苏门答腊可用较少的水为泥炭降温灭火。人工降雨已成功为中加里曼丹帕朗卡拉亚带来降雨。国家抗灾署六省（廖内、占碑、南苏门答腊、西、中、南加里曼丹）数据：24小时过火1,308.03公顷，尚待扑灭650.19公顷，热点5,499个、火点247个，出动53,848人。林业部SiPongi系统（经Databoks，印尼西部时间11:16读取）24小时在全国监测到20,392个热点（增加2,686个，高可信度1,379个），以中加里曼丹8,239个、南巴布亚2,426个、西加里曼丹1,797个居前。

Why it matters: 为何重要：Smouldering peat is why the haze over Indonesia, Malaysia and Singapore keeps coming back — it will not end until heavy rain soaks the ground.泥炭闷烧正是印尼、马来西亚和新加坡烟霾反复的原因——要等大雨浸透地面才会真正结束。

CNN Indonesia; Databoks (KLHK/Kemenhut SiPongi) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-indonesia-tito-peat-fires-hard-to-extinguish-cloud-seeding-palangka-raya-sipongi-20392-hotspots

Hong Kong: previously healthy 6-year-old girl critically ill in Tuen Mun Hospital's paediatric ICU with influenza A(H1) and shock — unvaccinated this season; 24 severe child flu cases since late June (1 death), and about 440 school flu-like outbreaks since September香港：一名原本健康的六岁女童感染甲型（H1）流感并发休克，在屯门医院儿童深切治疗部情况危殆——本季未接种疫苗；自6月底以来共录得24宗儿童流感严重个案（1宗死亡），9月开学后近440宗学校流感样疾病爆发

Department of Health / CHP (19 Oct 2026): the girl was taken to Tuen Mun Hospital's A&E on 15 Oct with fever, runny nose, vomiting and poor appetite and admitted; she deteriorated on 17 Oct and was moved to the paediatric ICU. Her respiratory sample was positive for influenza A(H1), with a clinical diagnosis of influenza A complicated by shock; she remains critical. She had no travel history during the incubation period and had not received the 2026/27 seasonal flu vaccine; household contacts are asymptomatic. CHP Controller Dr Edwin Tsui said Hong Kong has been in the flu season since late June with activity still high and A(H1) predominant; of 24 severe paediatric cases, 20 have recovered, three are critical and one died. Nearly 440 influenza-like-illness outbreaks in schools have affected about 2,700 people since September. About 840 schools have held vaccination outreach so far, and the school outreach is expected to finish by mid-December, about two weeks earlier than last year. Parents should seek emergency care if a sick child has fast breathing, wheezing, blue lips, chest pain, confusion, persistent fever or convulsions.卫生署卫生防护中心（2026-10-19）：女童10月15日因发烧、流鼻水、呕吐及食欲不振到屯门医院急症室求诊并留院；10月17日情况转坏，转往儿童深切治疗部。呼吸道样本对甲型（H1）流感病毒呈阳性，临床诊断为甲型流感并发休克，目前情况危殆。她在潜伏期内没有外游，未接种2026/27年度季节性流感疫苗；家居接触者暂无病征。中心总监徐乐坚医生表示，香港自6月下旬进入流感季节，目前活跃程度仍高，以甲型（H1）为主；24宗儿童严重个案中20宗已康复出院、3宗危殆、1宗死亡。9月开学以来学校已录得近440宗流感样疾病爆发，影响约2,700人。至今约840间学校已举行疫苗外展活动，预计12月中前完成，比去年提早约两星期。若病童出现呼吸急促、喘鸣、嘴唇发紫、胸痛、神志模糊、持续发烧或抽搐，家长须立即带往急症室。

Why it matters: 为何重要：Flu can turn dangerous quickly even in healthy children — the vaccine is the simplest protection, and warning signs mean going to A&E at once.即使健康的儿童，流感也可能迅速恶化——接种疫苗是最简单的保护，出现危险征兆要立即去急症室。

HKSAR Government press release (DH/CHP) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hk-chp-severe-paediatric-flu-6yo-girl-tuen-mun-picu-h1-shock-24-severe-since-june

Southern Vietnam: Pasteur Institute HCMC says dengue has plateaued at a high level above the epidemic baseline, and serotype DENV-3 has re-emerged in four southern provinces and cities after many years' absence; Dong Nai alone has nearly 18,000 cases and 8 deaths this year越南南部：胡志明市巴斯德研究所称登革热持平但仍处高位、超过流行基线，DENV-3型在多年未见后于南部4个省市重新出现；仅同奈今年已近1.8万例、8人死亡

Dong Nai newspaper (19 Oct 2026), on an online meeting chaired by Assoc. Prof. Nguyen Vu Thuong, deputy director of the Pasteur Institute in Ho Chi Minh City: as of week 41, southern dengue cases were flat but above the standard curve, and hotspots were not yet stable. Virus isolation/PCR positivity in the first nine months rose to 60%, versus 39% in 2024 and 53% in 2025. DENV-2 still dominates, but DENV-3's return raises the risk of severe complications and wider outbreaks. Inspections from August to October found larval indices as high as 320 at some sites in Dong Nai and HCMC versus a safe threshold below 30, and only 17–41% of outbreak foci fully sprayed in some areas; El Niño heat and household water storage add to mosquito breeding. The institute asked provincial CDCs to spray 100% of identified foci, cut larval indices below 20 and step up PCR to track DENV-3.同奈报（2026-10-19）报道胡志明市巴斯德研究所副所长阮武尚副教授主持的南部线上会议：截至第41周，南部登革热病例走势持平但高于标准曲线，多个热点尚未稳定。今年前9个月病毒分离/PCR阳性率升至60%，2024年为39%、2025年为53%。DENV-2型仍占主导，但DENV-3型重现会增加重症并发症和大范围暴发风险。8月至10月检查发现，同奈和胡志明市部分地点幼虫指数高达320，安全阈值应低于30；部分地区疫点彻底喷药率仅17%–41%；厄尔尼诺高温和居民储水也助长蚊虫繁殖。研究所要求各省疾控中心对已确定疫点100%喷药、把幼虫指数降至20以下，并加强PCR检测追踪DENV-3。

Why it matters: 为何重要：A returning serotype means many people have no protection against it, and second infections with a different type are more likely to be severe.重新出现的血清型意味着很多人对它没有保护，而感染不同型别的第二次登革热更容易发展成重症。

Báo Đồng Nai (Pasteur Institute HCMC) ↗ · r-2026-10-pasteur-hcmc-southern-dengue-w41-denv3-reemerges-4-provinces-pcr-60pct-dong-nai-18000

Japan: health ministry plans from FY2027 to train general doctors to recognise menopausal symptoms, list trained doctors on a search website, and develop a smartphone tool so women can record their cycle and symptoms to show their doctor日本：厚生劳动省计划从2027财年起培训一般医生识别更年期症状、在网站上列出受训医生供查询，并开发手机工具让女性记录月经周期和症状给医生看

Yomiuri Shimbun (19 Oct 2026): menopause brings fatigue, hot flushes, finger-joint pain and other complaints as female hormones decline, but the same symptoms can come from other conditions such as thyroid disorders or rheumatoid arthritis, so diagnosis is difficult. A 2007–08 study by Prof. Miyuki Katai (now at the National Graduate Institute for Policy Studies), then at Tokyo Women's Medical University, found that 27% of patients complaining of menopausal symptoms actually had another disease, such as thyroid dysfunction. In FY2027 the ministry will run training for general practitioners on telling these symptoms apart, post institutions with trained doctors on a dedicated website, and work with private firms on a symptom-recording tool, probably a smartphone app. The costs are in the ministry's FY2027 budget request.读卖新闻（2026-10-19）：更年期女性激素分泌下降，会出现倦怠、潮热、手指关节痛等多种不适，但甲状腺功能异常、类风湿关节炎等其他疾病也会引起同样症状，诊断并不容易。片井美雪教授（现任政策研究大学院大学）2007–08年在东京女子医科大学时调查发现，诉说更年期症状的患者中有27%其实是甲状腺功能异常等其他疾病所致。厚劳省将在2027财年为一般医生开设辨别这些症状的研修，在专门网站上公布有受训医生的医疗机构，并与民间企业合作开发记录症状的工具（预计为手机应用）。相关经费已列入2027财年预算概算要求。

Why it matters: 为何重要：About a quarter of 'menopause' complaints turn out to be something else — better-trained doctors and good symptom records help women get the right diagnosis.约四分之一的“更年期”不适其实另有病因——医生受训加上完整的症状记录，能帮女性得到正确诊断。

Yomiuri Shimbun (読売新聞) ↗ · r-2026-10-japan-mhlw-fy2027-menopause-care-doctor-search-site-training-symptom-tracking-app

Japan's National Center Biobank Network passes 250,000 participants and 800,000 specimens across 200+ diseases; review highlights an RNF213 variant linked to pulmonary hypertension, a TLR7 variant raising severe COVID-19 risk 5.3-fold, and 9,850 whole-genome control samples including Ryukyuan people日本国立研究中心生物样本库网络（NCBN）参与者超过25万人、样本超过80万份，涵盖200多种疾病；综述介绍RNF213变异与难治性肺动脉高压有关、TLR7罕见变异使重症新冠风险升高5.3倍，并完成包括琉球人群在内的9,850份全基因组对照样本

Scienmag (19 Oct 2026) on a Frontiers in Genetics review by Yosuke Omae and Katsushi Tokunaga: as of end-March 2026, the six-centre NCBN (National Cancer Center, NCVC, NCNP, NCCHD, NCGG and JIHS) had registered more than 250,000 participants and over 800,000 biospecimens with physician-curated clinical data, and has supplied more than 200,000 specimens to companies and academia. Highlights include a mutational signature of unknown cause in over 70% of Japanese clear-cell kidney cancers versus under 2% elsewhere; an RNF213 variant (known for moyamoya disease in Asians) linked to refractory pulmonary hypertension; elevated BMP4 in Alzheimer's cerebrospinal fluid; a rare TLR7 variant raising severe COVID-19 risk 5.3-fold in an international exome study; and a first genome-wide locus (DAPK2 expression) for argyrophilic grain dementia. Whole-genome sequencing of 9,850 control samples (NCBN Control), capturing Ryukyuan genetic diversity, supports Japan's cancer and rare-disease genomics programme.Scienmag（2026-10-19）报道大前阳介和德永胜士在《遗传学前沿》（Frontiers in Genetics）发表的综述：截至2026年3月底，由国立癌症研究中心、国立循环器病研究中心、国立精神·神经医疗研究中心、国立成育医疗研究中心、国立长寿医疗研究中心和日本健康危机管理研究机构（JIHS）六家组成的NCBN已登记超过25万名参与者、80多万份附有医生整理临床资料的生物样本，并已向企业和学界提供超过20万份样本。成果包括：日本透明细胞肾癌中超过70%带有一种原因不明的突变特征，而其他地区不足2%；RNF213变异（已知与亚洲人烟雾病有关）与难治性肺动脉高压相关；阿尔茨海默病患者脑脊液BMP4升高；国际外显子研究发现TLR7罕见变异使重症新冠风险升高5.3倍；以及首个与嗜银颗粒性痴呆相关的全基因组位点（与DAPK2表达有关）。9,850份对照样本的全基因组测序（NCBN Control）涵盖琉球人群的遗传多样性，用于支持日本癌症和罕见病基因组计划。

Why it matters: 为何重要：Large, well-documented Asian patient biobanks reveal genetic risks that studies of European populations miss.资料完整的大型亚洲患者样本库能发现以欧洲人群为主的研究所遗漏的遗传风险。

Institutions: 机构：NCC Japan日本国立癌症中心

Scienmag (Frontiers in Genetics review, Omae & Tokunaga) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-ncbn-national-center-biobank-network-250000-participants-800000-specimens-frontiers-genetics

Kirin trial: eight weeks of heat-killed Lacticaseibacillus paracasei KW3110 eased eye symptoms of mild-to-moderate hay fever during peak pollen weeks versus placebo in 130 Japanese adults (company study, presented at the Japanese Society of Allergology)麒麟试验：130名日本成人连续8周摄入加热灭活的副干酪乳杆菌KW3110，在花粉高峰期的轻中度花粉症眼部症状较安慰剂改善（企业研究，在日本过敏学会年会上发表）

Kirin Holdings release (19 Oct 2026): in a randomised, double-blind, placebo-controlled trial, 130 adults aged 20–65 with mild-to-moderate allergic rhinitis and eye symptoms who did not regularly use medication took a food containing 50 mg of heat-killed L. paracasei KW3110 or placebo for eight weeks between January and March. Using the Japanese allergic-rhinitis QOL questionnaire (JRQLQ No.1), ocular symptom scores and the 'concern about others' perceptions' score improved significantly versus placebo at weeks 6 and 8, the high-pollen period. Kirin says the strain boosts IL-12 production, which dampens type 2 allergic inflammation. Results were presented at the 75th Annual Meeting of the Japanese Society of Allergology (Kyoto, 15–18 Oct). The study was run and funded by the company and has not yet been published in a peer-reviewed journal.麒麟控股新闻稿（2026-10-19）：一项随机、双盲、安慰剂对照试验纳入130名20至65岁、有轻中度过敏性鼻炎和眼部症状且未常规用药的成人，在1月至3月期间连续8周摄入含50毫克加热灭活副干酪乳杆菌KW3110的食品或安慰剂。以日本过敏性鼻炎生活质量问卷（JRQLQ No.1）评估，第6周和第8周（花粉高峰期）的眼部症状评分和“在意他人眼光”评分较安慰剂显著改善。麒麟称该菌株能促进抑制2型过敏炎症的IL-12生成。结果在第75届日本过敏学会学术大会（京都，10月15日至18日）上发表。该研究由企业主导和资助，尚未在同行评审期刊发表。

Why it matters: 为何重要：A food-based option for mild hay fever is appealing, but this is one company-funded trial — it is not a substitute for proven allergy treatment.以食品缓解轻度花粉症颇具吸引力，但这只是一项企业资助的试验——不能替代已证实有效的抗过敏治疗。

Kirin Holdings (company release) ↗ · r-2026-10-kirin-kw3110-lactic-acid-bacteria-hay-fever-ocular-symptoms-rct-130-jsa-kyoto

University of Tsukuba pilot: 28 schoolchildren doing video-guided eye-movement exercises at home for 24 weeks (4.6 times a week on average) improved eye-hand coordination and tracking of moving digits, but not balance, the main outcome; there was no control group筑波大学试点研究：28名学龄儿童在家跟随视频做眼球运动训练24周（平均每周4.6次），手眼协调和追踪移动数字的能力提高，但主要指标平衡能力未改善；研究没有对照组

University of Tsukuba via Medical Xpress (19 Oct 2026), on a study in BMC Pediatrics (Suzuki et al.): 28 children in Tsukuba City followed a 24-week home programme of saccades, smooth-pursuit exercises and combined head-and-eye movements based on the vestibulo-ocular reflex, with adherence tracked objectively by the SUKUBARA remote system recording video viewing time. Children trained an average of 4.6 times a week. Eye-hand coordination and the ability to identify horizontally moving digits improved, and eye-hand coordination tended to improve more in children who trained more often. Balance, measured by the Index of Postural Stability, did not improve significantly. Because this was a single-group pilot without controls, the training's effectiveness cannot be established.筑波大学经Medical Xpress（2026-10-19）介绍发表于《BMC儿科》的研究（铃木等）：筑波市28名儿童在家进行为期24周的训练，包括扫视、平稳追踪以及基于前庭眼反射的头眼联合运动，并通过SUKUBARA远程系统记录视频观看时间来客观追踪依从性。儿童平均每周训练4.6次。手眼协调和辨认水平移动数字的能力有所提高，训练越频繁者手眼协调改善越明显。以姿势稳定性指数衡量的平衡能力没有显著改善。由于这是没有对照组的单组试点研究，尚不能确定训练的效果。

Why it matters: 为何重要：Simple home exercises children actually stick to could help visual skills — but a controlled trial is needed before recommending them.孩子能坚持的简单居家练习或许有助视觉技能——但在推荐之前还需要有对照的试验。

Medical Xpress (University of Tsukuba; BMC Pediatrics) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-tsukuba-home-eye-movement-training-24-weeks-28-children-eye-hand-coordination-bmc-pediatrics

Korea: GIST team builds InFo-DRP, an AI model that predicts how cancer cells will respond to drugs it has never seen, by combining drug structure with tumour-cell gene data and using 'invariant learning' to avoid over-relying on familiar drugs韩国：光州科学技术院团队开发AI模型InFo-DRP，结合药物结构和肿瘤细胞基因信息，并用“不变学习”避免过度依赖熟悉的药物，可预测癌细胞对从未见过的药物的反应

Dong-A Ilbo (19 Oct 2026): a team led by Prof. Lee Hyun-ju of GIST's AI department, with Prof. Kim Jun-woo of Wonkwang University, addressed a weakness of earlier models, which predicted responses well for drugs seen in training but poorly for new ones. InFo-DRP learns from existing drugs' chemical structures, cancer cells' genetic information and experimental results, analyses drug structure and properties in several ways, and applies invariant learning so that it does not depend too heavily on features of specific drugs. The researchers expect it to help rank candidate compounds and prioritise experiments early in drug development. The study was published in IEEE Journal of Biomedical and Health Informatics on 30 Sept.东亚日报（2026-10-19）：光州科学技术院（GIST）AI学系李贤珠（Lee Hyun-ju）教授团队与圆光大学金俊佑（Kim Jun-woo）教授合作，针对以往模型对训练中见过的药物预测准确、对新药却明显失准的局限，开发了InFo-DRP。该模型学习已有药物的化学结构、癌细胞的基因信息和实验结果，从多个角度分析药物结构与性质，并采用“不变学习”技术，避免过度依赖特定药物的特征。研究人员期望它能在新药开发早期帮助预测候选物反应、确定实验优先次序。研究于9月30日发表在《IEEE生物医学与健康信息学杂志》（IEEE JBHI）。

Why it matters: 为何重要：Better early predictions could cut the number of lab experiments needed to find which new cancer drugs are worth testing.更好的早期预测可减少筛选值得测试的抗癌新药所需的实验数量。

Dong-A Ilbo (GIST; IEEE JBHI) ↗ · r-2026-10-gist-info-drp-ai-predicts-cancer-cell-response-unseen-drugs-invariant-learning-ieee-jbhi

Korea's National Cancer Center develops an AI 'gastric cancer tissue scanner' that reads tissue autofluorescence without stains to tell cancer from normal layers (sensitivity 90.8%, specificity 91.9%), aiming to replace slow frozen-section checks during surgery韩国国立癌症中心开发“AI胃癌组织高速扫描仪”，无需染色、仅凭组织自发荧光即可区分癌组织与正常层次（敏感度90.8%、特异度91.9%），目标是取代手术中耗时的冰冻切片检查

Electronic Times (19 Oct 2026): a team led by Yoon Hong-man, head of NCC Korea's Gastric Cancer Center, combined autofluorescence spectroscopy — analysing faint light emitted by fluorescent substances in tissue — with deep learning. On gastric cancer tissue sections, the model classified four regions (cancer, mucosa, submucosa and muscle) with 88.1% accuracy, finding cancer with 90.8% sensitivity and 91.9% specificity. In gastric surgery, surgeons must confirm no cancer remains at the resection margin, usually by an urgent frozen-section test involving freezing, sectioning, H&E staining and microscopy, which takes time and can introduce spatial errors. Data acquisition currently takes 20–25 minutes; the team is building a high-speed spectroscopy system to cut it below 10 minutes and is pursuing larger clinical validation. It could also apply to colorectal, oesophageal and breast cancer.电子新闻（2026-10-19）：韩国国立癌症中心胃癌中心主任尹洪万（Yoon Hong-man）团队把自发荧光光谱法——分析组织中荧光物质发出的微弱光——与深度学习相结合。在胃癌组织切片验证中，模型以88.1%的准确率区分癌、黏膜、黏膜下层和肌层四类组织，识别癌组织的敏感度为90.8%、特异度为91.9%。胃癌手术中必须确认切缘没有残留癌细胞，通常要做紧急冰冻切片检查，需经冷冻、切片、HE染色和显微镜判读，费时且可能产生空间位置误差。目前数据采集需20至25分钟，团队正开发高速光谱系统以缩短到10分钟内，并推进更大规模的临床验证。该技术也可用于结直肠癌、食管癌和乳腺癌。

Why it matters: 为何重要：Faster margin checks could shorten operations and reduce the chance of leaving cancer behind.更快的切缘检查可缩短手术时间，降低癌组织残留的风险。

Electronic Times (etnews; National Cancer Center Korea) ↗ · r-2026-10-ncc-korea-ai-autofluorescence-gastric-cancer-tissue-scanner-intraoperative-sens-90-8-spec-91-9

Fujian's first prescription of a new orexin-receptor agonist for type 1 narcolepsy goes to a 17-year-old who had been treated for depression and epilepsy for five years before the correct diagnosis福建首张新型食欲素受体激动剂处方开出：一名17岁高三学生被当作抑郁症、癫痫治疗5年后才确诊1型发作性睡病

Fuzhou Evening News via Minnan Net (19 Oct 2026): on 16 Oct the sleep medicine centre of Fujian Provincial Hospital (Fuzhou University affiliated) wrote the province's first prescription for the new oral orexin-receptor agonist, approved by the NMPA in July 2026 for type 1 narcolepsy in people aged 16 and over. The patient, a Fuzhou senior-high student, had five years of poor night sleep, uncontrollable daytime sleepiness and sudden leg weakness when laughing (cataplexy); several hospitals had treated him for depression or epilepsy without benefit. Interviews, polysomnography, multiple sleep latency testing and sleep–mood assessment confirmed type 1 narcolepsy, which is caused by loss of the hypothalamic neurons that make orexin. Earlier drugs only eased symptoms; the new drug activates orexin receptors to address the missing signal. Dr Lin Yiqi urged people with long-term daytime sleepiness or limb weakness during strong emotion to see a sleep specialist.福州晚报经闽南网（2026-10-19）：10月16日，福州大学附属省立医院睡眠医学中心开出福建省首张新型口服食欲素受体激动剂处方，该药于2026年7月获国家药监局批准，用于16岁及以上1型发作性睡病患者。患者是福州一名高三学生，5年来夜间睡眠差、白天随时犯困，开怀大笑时双腿突然发软（猝倒）；先后在多家医院按抑郁症、癫痫治疗均无改善。经访谈、多导睡眠监测、多次睡眠潜伏期试验及睡眠与情绪评估，确诊为1型发作性睡病——病因是下丘脑分泌食欲素的神经细胞受损。以往药物只能缓解症状，新药通过激活食欲素受体弥补缺失的信号。林懿祺副主任医师提醒，长期白天嗜睡或情绪激动时肢体无力者应及时到睡眠专科就诊。

Why it matters: 为何重要：Narcolepsy is often mistaken for laziness, depression or epilepsy — the first drug aimed at its cause makes correct diagnosis even more important.发作性睡病常被误认为懒惰、抑郁或癫痫——首个针对病因的药物让准确诊断更加重要。

Minnan Net (闽南网; Fuzhou Evening News 福州晚报) ↗ · r-2026-10-fujian-first-orexin-receptor-agonist-prescription-narcolepsy-type1-17yo-provincial-hospital

Zhejiang University and Westlake University detect gastric cancer from DNA remnants in red blood cells: using 1–2 mL of blood, a classifier reached 83–90% sensitivity and 89–94% specificity across three validation cohorts, including early-stage disease浙江大学与西湖大学利用红细胞中残留DNA检测胃癌：只需1–2毫升血，分类模型在三个验证队列中敏感度83%–90%、特异度89%–94%，早期胃癌表现相当

iNature via Bioon (19 Oct 2026) on a Med paper (13 Oct; corresponding authors Han Yuehua, Zhejiang University, and Gao Xiaofei, Westlake University): red blood cells have no nucleus but retain DNA remnants (rbcDNA) linked to disease stress. Whole-genome profiling identified reproducible gastric cancer-associated rbcDNA features. A model built on a discovery cohort of 215 gastric cancer patients and 220 endoscopy-confirmed non-cancer controls was tested in an independent test cohort and three validation cohorts (total 321, two from external centres), with 83–90% sensitivity and 89–94% specificity and similar performance in stage I disease; it also worked in patients negative for routine serum tumour markers. China accounts for about 37% of new gastric cancer cases worldwide, and most are diagnosed late; stage I disease has over 90% five-year survival.iNature经生物谷（2026-10-19）介绍发表于《Med》的论文（10月13日；通讯作者浙江大学韩跃华、西湖大学高晓飞）：红细胞虽无细胞核，却保留与病理应激相关的DNA残留（rbcDNA）。全基因组分析找出了可重复的胃癌相关rbcDNA特征。基于215例胃癌患者和220例经内镜证实的非胃癌对照组成的发现队列建立模型，并在独立测试队列和三个验证队列（共321人，其中两个来自外部中心）中检验，敏感度83%–90%、特异度89%–94%，在I期患者中表现相当；在常规血清肿瘤标志物阴性的患者中同样有效。中国约占全球新发胃癌病例的37%，多数确诊时已属晚期；I期胃癌5年生存率超过90%。

Why it matters: 为何重要：A simple blood test could pick out who most needs an endoscopy, catching more stomach cancers early.简单的验血有望筛出最需要做胃镜的人，让更多胃癌被早期发现。

Bioon (生物谷) / iNature (Med) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-zju-westlake-rbcdna-red-blood-cell-dna-gastric-cancer-early-detection-sens-83-90-med

China's CDE cleared 16 Class 1 innovative drugs for first clinical trials in the week of 12–18 Oct, including MTS109, an mRNA-encoded CD19×BCMA×CD3 trispecific T-cell engager made inside the body for lupus, and SNA01, a long-acting RSV antibody for newborns and infants国家药监局药审中心10月12日至18日一周批准16款1类创新药首次开展临床试验，包括在体内生成、mRNA编码的CD19×BCMA×CD3三特异性T细胞衔接器MTS109（用于红斑狼疮），以及用于新生儿和婴幼儿的长效抗RSV单抗SNA01

Vaccine.vip daily digest (19 Oct 2026), citing CDE and industry media, and Medvalley (19 Oct): the 16 Class 1 INDs span small molecules, antibodies, ADCs, siRNA, bi- and trispecifics, cell, gene and mRNA therapies. MTS109 (Jitai Technology) is an mRNA-encoded trispecific TCE delivered by lipid nanoparticles to lymphoid organs to deplete B cells and plasma cells deeply, cleared for systemic lupus erythematosus (lupus nephritis, systemic sclerosis and B-cell cancers are possible future uses). SNA01 (Institute of Biophysics, CAS, with Sinovac) is a long-acting anti-RSV monoclonal antibody to prevent RSV lower-respiratory infection in newborns and infants. Others include AN4035, a CEACAM5-targeted ADC with a pan-RAS(ON) inhibitor payload; HCRB001 for preventing influenza A and B; Qilu's QLS2401 PSMA/STEAP1/CD3 trispecific for advanced prostate cancer; ES502, a RAS G12V-targeted TCR-TCE; and Novartis's DKB903 for rheumatoid arthritis.疫苗网每日要闻（2026-10-19，援引药审中心及行业媒体）和医谷网（10月19日）：这16款1类新药IND涵盖小分子、抗体、ADC、siRNA、双抗/三抗、细胞、基因和mRNA疗法。剂泰科技的MTS109是一款mRNA编码三特异性T细胞衔接器，经脂质纳米颗粒递送至淋巴器官，在体内生成以深度清除B细胞和浆细胞，获批用于系统性红斑狼疮（狼疮性肾炎、系统性硬化症和B细胞肿瘤为潜在后续方向）。中科院生物物理所与科兴的SNA01是长效抗RSV单克隆抗体，用于预防新生儿和婴幼儿RSV下呼吸道感染。其他品种包括：以泛RAS(ON)抑制剂为载荷的CEACAM5靶向ADC AN4035；预防甲型和乙型流感的HCRB001；齐鲁制药用于晚期前列腺癌的PSMA/STEAP1/CD3三抗QLS2401；靶向RAS G12V的TCR-TCE ES502；以及诺华用于类风湿关节炎的DKB903。

Why it matters: 为何重要：Making a T-cell engager inside the body with mRNA could offer a simpler alternative to CAR-T for resetting the immune system in lupus.用mRNA在体内生成T细胞衔接器，或可为狼疮患者提供比CAR-T更简便的免疫系统“重置”方案。

Vaccine.vip (疫苗网) daily digest; Medvalley (医谷网); CDE ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-cde-week-oct12-18-16-class1-ind-mts109-mrna-trispecific-tce-sle-sna01-rsv-mab

Chipscreen Biosciences receives NMPA clearance to trial NW001, an 'epigenetic-immune' antibody conjugate that links a PD-L1 antibody to an HDAC-inhibitor payload, as monotherapy in advanced malignant tumours微芯生物获国家药监局批准开展NW001临床试验：这款“表观免疫偶联药物”将PD-L1抗体与HDAC抑制剂载荷相连，获准单药用于晚期恶性肿瘤

Caijing (19 Oct 2026), citing a Chipscreen Biosciences announcement: the company and Chengdu Chipscreen NewWay Biotech received a clinical trial approval notice for injectable NW001 for advanced malignant tumours. NW001 is an epigenetic immunomodulatory antibody conjugate (EIMAC): a humanised PD-L1 monoclonal antibody coupled to a newly improved histone deacetylase inhibitor (HDACi) payload. After binding PD-L1 on the cell surface it is internalised, cleaved inside the cell and releases the highly active small-molecule HDACi, combining epigenetic and immune anti-tumour effects.财经网（2026-10-19）援引微芯生物公告：公司与成都微芯新域生物技术有限公司合作研发的注射用NW001获得《药物临床试验批准通知书》，同意单药用于晚期恶性肿瘤的临床试验。NW001是一款表观免疫偶联药物（EIMAC）：抗体部分为人源化PD-L1单抗，偶联全新改进的组蛋白去乙酰化酶抑制剂（HDACi）载荷；与细胞表面PD-L1结合后被内吞，在细胞内裂解并释放高活性小分子HDACi，发挥表观调控与免疫的综合抗肿瘤作用。

Why it matters: 为何重要：Delivering an epigenetic drug straight to PD-L1-bearing tumour cells could make immunotherapy work for more patients with fewer side effects.把表观遗传药物直接送到带PD-L1的肿瘤细胞，有望让免疫治疗惠及更多患者、副作用更少。

Caijing (财经网; Chipscreen announcement) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-chipscreen-nw001-eimac-pd-l1-hdaci-conjugate-ind-approved-advanced-tumours

Shanghai East Hospital's UBD spinal endoscopy — one port, two channels, working in air or water — shrinks incisions for complex spine surgery from about 20 cm to under 1 cm; used in 2,000+ operations in China and introduced in about 10 countries, foreign surgeons said at a Shanghai meeting上海东方医院原创UBD脊柱内镜技术——单孔双通道、可在气体或水介质中操作——把复杂脊柱手术切口从约20厘米缩小到不足1厘米；国内已完成2,000多例，并已引入约10个国家，外国专家在上海会议上给予高度评价

China Daily (19 Oct 2026): at an international conference in Shanghai on Friday (16 Oct), co-hosted by the China Rehabilitation Technology Transfer and Development Promotion Association and Shanghai East Hospital (Tongji University), more than 40 experts from 12 countries discussed the uni-port bi-channel dual-media (UBD) technique developed by Prof. He Shisheng about a decade ago. One channel gives a high-definition view and the other allows precise work, letting surgeons remove calcified disc tissue while avoiding nerves and vessels. The technique holds 40 patents, has been used in over 2,000 operations in China, and has been introduced in about 10 countries including Brazil and India, with training centres in Japan and Thailand. Robot-assisted UBD was also showcased. Yasushi Fujiwara, head of spine surgery at Hiroshima City North Medical Center, who observed a procedure, said Japanese surgeons are interested in trialling it.中国日报（2026-10-19）：上周五（10月16日）在上海举行、由中国康复技术转化及发展促进会与同济大学附属东方医院联合主办的国际会议上，来自12个国家的40多位专家讨论了何仕诚教授约十年前提出的单孔双通道双介质（UBD）技术。一个通道提供高清视野，另一个通道进行精准操作，可在避开神经和血管的同时切除钙化椎间盘组织。该技术拥有40项专利，在国内已完成2,000多例手术，并已引入巴西、印度等约10个国家，在日本和泰国设有培训中心。会上还展示了机器人辅助UBD手术。现场观摩手术的广岛市立北部医疗中心脊柱外科主任Yasushi Fujiwara表示，日本医生有意试用这项技术。

Why it matters: 为何重要：Smaller incisions mean less tissue damage and faster recovery for people needing complex spine operations.切口更小意味着组织损伤更少，复杂脊柱手术患者恢复更快。

China Daily ↗ · r-2026-10-shanghai-east-hospital-ubd-uni-port-bi-channel-spinal-endoscopy-2000-ops-10-countries

Taiwan: organoid pioneer Hans Clevers, on his first visit, is named chair professor at Taipei Medical University's College of Medicine to help build disease organoid models for drug development台湾：“类器官之父”汉斯·克利弗斯首度访台，获聘台北医学大学医学院讲座教授，协助建立用于新药研发的疾病类器官模型

CNA (19 Oct 2026): Clevers, a member of the Royal Netherlands Academy of Arts and Sciences regarded as a Nobel Prize contender, lectured at TMU on how organoids model human disease. TMU president Wu Mai-szu said the appointment will deepen cooperation in research methods, training and clinical use, aiming for disease organoid models that better represent patients. Tsai Kun-chih, director of TMU's Graduate Institute of Clinical Medicine, said Clevers first grew near-human mini-organs in vitro in 2009, letting researchers test on human tissue such as mini-intestines, mini-livers and tumour organoids instead of relying only on animals; organoid biobanks now help predict drug effects before clinical trials. TMU set up Taiwan's first organoid technology core lab in 2023 with intestinal and colorectal cancer organoid banks, built what it calls Asia's first high-throughput organoid screening platform, is allied with the Cambridge Stem Cell Institute, and plans to add AI, single-cell sequencing and functional immune organoids.中央社（2026-10-19）：克利弗斯是荷兰皇家艺术与科学院院士，被视为诺贝尔奖热门人选，当天在北医大演讲，分享类器官模拟人类疾病的研究。北医大校长吴麦斯表示，聘任将使双方在研究方法、人才培育到临床应用上深化合作，建立更具临床代表性的疾病类器官模型。北医大临床医学研究所所长蔡坤志说，克利弗斯2009年率先在体外培育出近似人体器官的类器官，使医界能直接用微肠、微肝和类肿瘤等人体组织做体外试验，不再只依赖动物模式；类器官生物库让新药在进入临床前更准确预测药效。北医大2023年成立全台首个“类组织技术核心实验室”，建置肠道与大肠癌类组织库，打造其所称的亚洲第一套类器官高通量筛选平台，并与英国剑桥大学干细胞中心结盟，未来将整合AI、单细胞基因测序，拓展至功能性免疫类器官。

Why it matters: 为何重要：Testing drugs on patients' own mini-organs can predict who will respond, before anyone takes a pill.在患者自身的“迷你器官”上试药，可在服药前预测谁会有效。

Central News Agency (中央社) ↗ · r-2026-10-tmu-hans-clevers-organoid-pioneer-chair-professor-first-taiwan-visit-organoid-drug-screening

Taiwan: NTU psychiatrist Gau Shur-Fen's team cuts the 50-item Autism-Spectrum Quotient to 13 questions ('AQ13') in an AI quick-screening app for children and teens, aimed at lowering the barrier to early checks in under-served areas台湾：台大医学院高淑芬团队把50题自闭症量表精简为13题“AQ13”，开发“儿少心智健康AI快速筛检App”，以降低资源不足地区早期筛检的门槛

China Times (19 Oct 2026): speaking at the 'Big Health New Future' forum at Feng Chia University, Taichung, on 17 Oct, Gau, an NTU College of Medicine distinguished professor who studies autism from genes and brain imaging to neurocognition and gut microbes, presented the app: users answer 13 questions online and the system scores them automatically to flag children who may need further assessment. The tool is patented and won a National Innovation Award. Gau said autistic traits vary widely and some children are only recognised in university or work; early identification and intervention with family and school support improve social adaptation. No drug yet treats autism's core symptoms, and the AI screen does not replace diagnosis by a professional team.中时（2026-10-19）：台大医学院特聘教授高淑芬长期从基因、脑影像、神经认知到肠道微生物研究自闭症，她17日在台中逢甲大学“大健康新未来双轴论坛”上介绍这款App：用户在线回答13道题，系统自动计分，帮助找出可能需要进一步评估的儿童。该工具已取得专利，并获国家新创奖。高淑芬指出，自闭症特质差异很大，有些孩子直到上大学或进入职场才被发现；及早识别并在家庭和学校支持下介入，有助提升社会适应能力。目前尚无药物能有效治疗自闭症核心症状，AI筛检也不能取代专业团队的诊断。

Why it matters: 为何重要：A short free screen can tell parents in remote areas whether a specialist assessment is worth seeking.简短的筛检能让偏远地区的家长知道是否该寻求专科评估。

China Times (中时新闻网) ↗ · r-2026-10-ntu-gau-shur-fen-aq13-ai-autism-trait-screening-app-13-items-from-50

India: National Medical Commission clarifies that doctors may remotely review and digitally sign lab, pathology and radiology reports and discharge summaries, while staying fully accountable; hospital body Nathealth says it will speed up care in smaller towns印度：国家医学委员会明确医生可远程审阅并以数字签名认证检验、病理、影像报告和出院小结，但须承担全部责任；医院行业组织Nathealth表示此举将加快小城镇的医疗服务

ETHealthworld (19 Oct 2026): an NMC advisory issued on 13 Oct says registered medical practitioners can remotely review and authenticate electronic medical records using a digital or electronic signature recognised under the Information Technology Act, 2000. It covers laboratory, pathology and radiology reports, diagnostic interpretations, discharge summaries and other electronic clinical documents. The doctor must review the relevant clinical information and exercise independent professional judgement before signing, and remains fully accountable. Nathealth president Dr Sangita Reddy (Apollo Hospitals) said reports no longer need to wait for a doctor to be physically present; Dr Lal PathLabs CEO Shankha Banerjee said it ends uncertainty about remote sign-off and lets labs extend service hours and reach places without on-site specialists.ETHealthworld（2026-10-19）：国家医学委员会10月13日发布咨询意见，明确注册执业医生可使用《2000年信息技术法》认可的数字或电子签名，远程审阅并认证电子病历，范围包括检验、病理和影像报告、诊断解读、出院小结及其他电子临床文件。医生签署前必须审阅相关临床信息并作出独立专业判断，并对记录承担全部责任。Nathealth主席Sangita Reddy医生（阿波罗医院）表示，报告不再需要等医生亲自到场；Dr Lal PathLabs首席执行官Shankha Banerjee说，这消除了远程签发的不确定性，让检验机构可延长服务时间，并覆盖没有驻点专科医生的地区。

Why it matters: 为何重要：Patients in small towns could get signed test results faster without the doctor having to be on site.小城镇患者无需等医生到场，就能更快拿到已签发的检查结果。

ETHealthworld (Economic Times) ↗ · r-2026-10-india-nmc-advisory-remote-digital-authentication-electronic-medical-records-nathealth-welcomes

Brazilian actress Isabel Teixeira reveals she has Li-Fraumeni syndrome, an inherited TP53 cancer-predisposition condition found in 2019 after her mother and grandmother died of cancer; she had preventive mastectomy, and her daughter tested positive while her son tested negative巴西女演员伊莎贝尔·特谢拉公开自己患有李-佛美尼综合征——一种由TP53基因变异引起、可遗传的癌症易感病，2019年在母亲和外祖母相继死于癌症后确诊；她已做预防性乳房切除，女儿检测阳性、儿子阴性

G1 / TV Globo's Fantástico (19 Oct 2026): Teixeira's grandmother died of cancer in 2005 and her mother in 2006; in 2019 she sought genetic testing and was diagnosed with Li-Fraumeni syndrome, caused by a change in TP53, the 'guardian' gene that helps stop damaged cells multiplying. It raises cancer risk but does not make cancer certain. She quit smoking, cut out alcohol, took up exercise and chose preventive removal of her breasts. Testing her children showed her son negative and her daughter positive; her daughter has since paid more attention to diet and exercise. The report notes that Brazil, especially the South, has a high frequency of a Li-Fraumeni-associated variant, possibly spread by an 18th-century European muleteer's descendants; Brazil's National Cancer Institute (INCA) is analysing more than 100,000 newborn heel-prick samples to map it. Regular screening (annual MRI, ultrasound, blood tests) helps catch tumours early; testing costs about R$300 in some places. 'Prevention is also a cure,' she said.G1/环球电视台《Fantástico》（2026-10-19）：特谢拉的外祖母2005年、母亲2006年相继死于癌症；2019年她接受基因检测，确诊李-佛美尼综合征，病因是TP53基因改变——这一“守护者”基因帮助阻止受损细胞增殖。该综合征提高患癌风险，但并不意味着必然患癌。她戒烟、戒酒、开始运动，并选择预防性切除双乳。为子女检测后，儿子阴性、女儿阳性；女儿此后更注意饮食和运动。报道指出，巴西尤其南部某种与该综合征相关的变异频率较高，可能源自一名18世纪欧洲赶骡商人的后代；巴西国家癌症研究所（INCA）正分析超过10万份新生儿足跟血样本以绘制其分布。定期筛查（每年磁共振、超声和验血）有助及早发现肿瘤；部分地方检测费用约300雷亚尔。她说：“预防也是治疗。”

Why it matters: 为何重要：A family history of many cancers can point to an inherited cause — knowing it allows screening that catches tumours early.家族中多人患癌可能提示遗传原因——知道了就能通过筛查及早发现肿瘤。

G1 (Globo / Fantástico) ↗ · r-2026-10-isabel-teixeira-li-fraumeni-tp53-preventive-mastectomy-daughter-positive-fantastico

TOSYMA trial (Lancet Oncology, ~99,000 German women): 3D tomosynthesis screening cut 24-month invasive interval breast cancers by 24% versus standard digital mammography (14.2 vs 18.6 per 10,000), but the difference was not statistically significant; the 12-month reduction (29%) wasTOSYMA试验（《柳叶刀·肿瘤学》，约9.9万名德国女性）：三维断层合成（DBT）筛查使24个月内浸润性间期乳腺癌较普通数字乳腺X线摄影减少24%（每万人14.2对18.6），但差异无统计学意义；12个月内减少29%则有统计学意义

Medscape (19 Oct 2026) on the TOSYMA trial (Weigel et al., University Hospital Münster; Lancet Oncology online 9 Oct): 99,689 women aged 50–70 at 17 German screening sites were randomised to one round of DBT plus synthesised 2D mammography or digital mammography; 98,755 with negative screens were analysed. Invasive interval cancers within 24 months: 14.2 vs 18.6 per 10,000 (adjusted OR 0.76, P=0.11). Within 12 months: 4.5 vs 6.3 per 10,000 (aOR 0.71, 95% CI 0.52–0.97). In women attending repeat screening the 24-month rate was 13.5 vs 18.8 (aOR 0.72, 95% CI 0.51–1.01). Programme sensitivity was 83.5% vs 72.3% with similar specificity; the difference was mainly in small T1 tumours. COVID-19 disruption left the study with about 70% power, and interval cancer is a surrogate outcome; advanced-stage rates will be assessed in the next screening round.Medscape（2026-10-19）报道TOSYMA试验（明斯特大学医院Weigel等，《柳叶刀·肿瘤学》10月9日在线发表）：德国17个筛查点的99,689名50至70岁女性随机接受一轮DBT加合成二维摄影或数字乳腺X线摄影筛查，分析了98,755名筛查阴性者。24个月内浸润性间期癌每万人14.2对18.6（校正OR 0.76，P=0.11）；12个月内4.5对6.3（校正OR 0.71，95%CI 0.52–0.97）。复筛女性24个月发生率13.5对18.8（校正OR 0.72，95%CI 0.51–1.01）。项目敏感度83.5%对72.3%，特异度相近；差异主要来自较小的T1肿瘤。受新冠影响，研究统计效能仅约70%，且间期癌是替代终点；晚期癌发生率将在下一轮筛查中评估。

Why it matters: 为何重要：3D mammography finds more cancers at screening and may mean fewer are missed in between, but proof of fewer advanced cancers is still pending.三维乳腺摄影在筛查中发现更多癌症，可能减少两次筛查之间的漏诊，但能否减少晚期癌仍有待证实。

Medscape (Lancet Oncology) ↗ · r-2026-10-tosyma-lancet-oncol-dbt-tomosynthesis-interval-cancers-24-month-14-2-vs-18-6-not-significant

Singapore haze, 7pm Monday: 24-h PSI still Unhealthy in the West (114) and Central (106); 1-h PM2.5 climbs to 94 µg/m³ in Central, its highest reading of the day, with South and West also Elevated; NEA forecasts PSI 90–160 for Tuesday新加坡烟霾（周一晚7时）：24小时PSI西部（114）和中部（106）仍属“不健康”；中部1小时PM2.5升至94微克/立方米，为当天最高，南部和西部也处于“偏高”；环境局预测周二PSI为90–160

NEA real-time data (data.gov.sg, 19 Oct 2026, 7pm): 24-h PSI North 89, South 88, East 90, West 114, Central 106. 1-h PM2.5 was 94 µg/m³ in Central, 67 in the West and 57 in the South (Band II Elevated), and 43 in the North and 52 in the East (Normal). Central PM2.5 had fallen to the mid-20s around noon and has risen through the afternoon and evening. NEA's health advisory forecasts 24-h PSI of 90–160 (Moderate to Unhealthy) for 20 Oct: healthy people should cut back on prolonged or strenuous outdoor exertion, and older people, pregnant women, children and people with chronic heart or lung disease should minimise or avoid it, using the hourly PM2.5 to decide on immediate activities.国家环境局实时数据（data.gov.sg，2026-10-19晚7时）：24小时PSI北部89、南部88、东部90、西部114、中部106。1小时PM2.5中部94、西部67、南部57微克/立方米（二级“偏高”），北部43、东部52（正常）。中部PM2.5中午前后曾降至20多，午后至傍晚持续回升。环境局健康建议预测10月20日24小时PSI为90–160（中等至不健康）：健康人士应减少长时间或剧烈户外活动；老人、孕妇、儿童及慢性心肺疾病患者应尽量减少或避免，并以每小时PM2.5决定即时户外活动。

Why it matters: 为何重要：The evening rise means tonight and Tuesday morning may feel worse than midday — check the hourly reading before exercising outdoors.傍晚回升意味着今晚和周二早上可能比中午更差——户外运动前请先查看每小时读数。

NEA real-time PSI/PM2.5 (data.gov.sg); NEA health advisory (via Haze.SG) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-7pm-psi-west-114-central-106-pm25-central-94-elevated-forecast-oct20-90-160

Singapore team designs a 'nanobody' (E8) against peritoneal cancer spread after finding two ascites proteins, PAI-1 and S100A10, that feed tumours; in tissue samples from 10 patients about 70% of tumour cells were eliminated — clinical trials hoped for within five years新加坡团队从腹水中找到助长肿瘤的两种蛋白PAI-1和S100A10，并据此研发纳米抗体E8对抗腹膜转移癌；在10名患者的组织样本中约70%肿瘤细胞被清除，团队希望五年内启动临床试验

Lianhe Zaobao (19 Oct 2026): led by the National Cancer Centre Singapore with A*STAR's Institute of Molecular and Cell Biology, Singapore General Hospital and NUS Yong Loo Lin School of Medicine, the team analysed one of the world's largest ascites (abdominal fluid) databases and identified PAI-1 and S100A10 as key drivers of tumour growth on the abdominal lining. The nanobody E8 suppressed tumour growth with very low toxicity; tested on tissue samples from 10 patients, it eliminated about 70% of tumour cells. The work was published in Molecular Cancer in September. Peritoneal metastasis (from bowel, ovarian or stomach cancer) carries average survival under nine months; more than 1.2 million cases are diagnosed worldwide each year. This is laboratory work — no patient has yet received the drug.联合早报（2026-10-19）：由新加坡国立癌症中心牵头，联合新加坡科技研究局分子与细胞生物学研究院、新加坡中央医院和国大杨潞龄医学院，团队分析全球规模最大的腹水数据库之一，找出PAI-1和S100A10两种蛋白是腹膜表面肿瘤生长的关键驱动力。据此研发的纳米抗体E8可有效抑制肿瘤生长且毒性极低；在10名患者组织样本中测试，约70%肿瘤细胞被清除。成果已于9月发表于《分子癌症》（Molecular Cancer）。腹膜转移癌（源自肠癌、卵巢癌或胃癌）患者平均生存期不足九个月，全球每年诊断超过120万例。目前仍属实验室阶段，尚无患者用药。

Why it matters: 为何重要：A targeted option could one day spare people with abdominal cancer spread some of the harsh side-effects of chemotherapy.靶向疗法未来或能让腹膜转移患者少受化疗的严重副作用。

Lianhe Zaobao (联合早报); NCCS / A*STAR IMCB / SGH (Molecular Cancer) ↗ · r-2026-10-nccs-astar-imcb-sgh-e8-nanobody-pai1-s100a10-peritoneal-metastasis-molecular-cancer

Malaysia haze, 4pm Monday: 27 areas Unhealthy, led by Johan Setia, Selangor (169); Melaka, Negeri Sembilan, KL, Putrajaya, Johor, Pahang, Perak and Sarawak all affected; only three areas Good马来西亚烟霾（周一下午4时）：27个地区空气污染指数“不健康”，雪兰莪州Johan Setia最高（169）；马六甲、森美兰、吉隆坡、布城、柔佛、彭亨、霹雳和砂拉越均受影响，仅3地“良好”

Bernama via Malay Mail (19 Oct 2026), citing DOE's APIMS portal at 4pm: Selangor — Johan Setia 169, Petaling Jaya 158, Klang 156, Banting 154, Shah Alam 153; Melaka — Alor Gajah 165, Bukit Rambai 164, Bandaraya Melaka 161; Negeri Sembilan — Nilai 164, Seremban 164, Port Dickson 120; KL — Batu Muda 164, Cheras 152; Putrajaya 154; Johor — Tangkak 161, Pasir Gudang 157, Batu Pahat 156, Larkin 140, Kota Tinggi 128, Kluang 105; Pahang — Rompin 155, Indera Mahkota Kuantan 152; Sarawak — IPD Serian 139, Sri Aman 113; Perak — Tasek Ipoh 136, Pegoh Ipoh 125, Seri Manjung 114. 38 areas were Moderate and only Labuan (48), Kimanis, Sabah (43) and Limbang, Sarawak (35) were Good. API 101–200 is Unhealthy.马新社经《马来邮报》（2026-10-19）引述环境局APIMS下午4时数据：雪兰莪——Johan Setia 169、八打灵再也158、巴生156、万津154、莎阿南153；马六甲——亚罗牙也165、武吉南眉164、马六甲市161；森美兰——汝来164、芙蓉164、波德申120；吉隆坡——峇都慕达164、蕉赖152；布城154；柔佛——东甲161、巴西古当157、峇株巴辖156、拉庆140、哥打丁宜128、居銮105；彭亨——云冰155、关丹英德拉马哥打152；砂拉越——西连139、斯里阿曼113；霹雳——怡保打昔136、怡保北固125、实兆远114。另有38地“中等”，仅纳闽（48）、沙巴金马利（43）和砂拉越林梦（35）“良好”。指数101–200为“不健康”。

Why it matters: 为何重要：Haze is spread across most of the peninsula's west coast — the Klang Valley and Melaka are now as affected as Johor.烟霾已覆盖半岛西海岸大部——巴生谷和马六甲受影响程度已与柔佛相当。

Malay Mail (Bernama; DOE APIMS) ↗ · r-2026-10-malaysia-apims-oct19-4pm-27-areas-unhealthy-johan-setia-169-sarawak-perak

Malaysia: schools in Melaka, Selangor, Negeri Sembilan and Kuantan, Rompin and Bentong (Pahang) open as usual on Tuesday but all outdoor activities are suspended; masks advised, and the Education Ministry extends assessment-mark deadlines by about a week because of haze disruption马来西亚：马六甲、雪兰莪、森美兰及彭亨关丹、云冰、文冬的学校周二照常开课，但暂停所有户外活动；建议学生戴口罩，教育部因烟霾干扰将评估成绩录入截止日期延后约一周

Bernama via Malay Mail (19 Oct 2026): state education departments said all educational institutions in Melaka, Selangor and Negeri Sembilan, and in Kuantan, Rompin and Bentong in Pahang, will operate on 20 Oct with outdoor activities postponed. Students are encouraged to wear face masks, especially those with respiratory symptoms or in high-risk groups; in Melaka, worried parents may keep children at home if they inform the school, and administrators must keep monitoring DOE API readings. The Education Ministry extended the MOEIS deadline for end-of-session assessment and exam marks (UASA, PAT/PASA) from 21 to 28 Nov, and for the physical, sports and co-curricular assessment (PAJSK) from 30 Nov to 5 Dec. Under the National Haze Action Plan, outdoor activities stop when API exceeds 100 and schools close above 200.马新社经《马来邮报》（2026-10-19）：各州教育局表示，马六甲、雪兰莪、森美兰全州及彭亨关丹、云冰、文冬的教育机构10月20日照常运作，户外活动延期。鼓励学生戴口罩，尤其有呼吸道症状或属高风险者；马六甲允许担忧的家长在通知学校后让孩子留家，校方须持续监测环境局空气污染指数。教育部将MOEIS学年末评估及考试（UASA、PAT/PASA）成绩录入截止日期从11月21日延至28日，体育、运动与课外活动评估（PAJSK）从11月30日延至12月5日。按国家烟霾行动计划，指数超过100停止户外活动，超过200才关闭学校。

Why it matters: 为何重要：Children keep learning, but outdoor sport stops — parents of children with asthma may still choose to keep them home.孩子照常上课但停止户外运动——哮喘儿童的家长仍可选择让孩子留家。

Malay Mail (Bernama); Sinar Daily ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-melaka-selangor-ns-pahang-schools-open-oct20-outdoor-halt-moe-marks-deadline-extended

Hong Kong: three new community-acquired Legionnaires' disease cases in the week to 17 Oct (men aged 44–67 in Tai Po and Kwai Tsing), bringing 2026's total to 160 — near 2025's full-year 167香港：10月11日至17日新增3宗社区感染退伍军人病（大埔及葵青44至67岁男性），今年累计160宗，接近2025年全年167宗

Department of Health / CHP (19 Oct 2026): the cases were a 44-year-old male smoker and a 67-year-old man with underlying illnesses, both living in Tai Po, and a 59-year-old man with underlying illnesses in Kwai Tsing. Initial investigation found them sporadic with no links to other cases. As of 17 Oct, 160 cases had been recorded this year (167 in 2025, 135 in 2024). Men, people over 50, smokers, heavy drinkers and people with weakened immunity are more susceptible. Immunocompromised people should use sterile or boiled water for drinking and tooth-brushing, avoid humidifiers and other mist-generating devices (or fill them only with sterile or cooled boiled water), and building water tanks should be drained and cleaned at least quarterly.卫生署卫生防护中心（2026-10-19）：3名患者分别为居于大埔、有吸烟史的44岁男子，居于葵青、有基础病的59岁男子，以及居于大埔、有基础病的67岁男子。初步调查显示为散发个案，与其他个案无流行病学关联。截至10月17日今年共录得160宗（2025年167宗，2024年135宗）。男性、50岁以上、吸烟者、酗酒者及免疫力较弱者较易感染。免疫力低下者应以无菌水或煮沸的水饮用及刷牙，避免使用加湿器等产生水雾的装置（如使用只注入无菌水或冷却的开水），大厦水箱应至少每季排空清洗一次。

Why it matters: 为何重要：Legionella grows in warm building water systems — people with weak immunity are most at risk, and simple water hygiene helps.军团菌在温暖的楼宇供水系统中滋生——免疫力弱者风险最高，简单的用水卫生就能降低风险。

HKSAR Government press release (DH/CHP); RTHK ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hk-chp-legionnaires-3-cases-oct11-17-160-ytd

WHO Western Pacific Regional Committee opens its 77th session in Manila (19–22 Oct), with AI, hypertension control, immunisation, tobacco and pooled emergency stockpiles on the agenda; Hong Kong's Director of Health Ronald Lam reports on ageing, NCDs and workforce pressures世卫西太平洋区域委员会第77届会议在马尼拉开幕（10月19–22日），议程涵盖人工智能、高血压防控、免疫接种、控烟及应急物资储备与联合采购；香港卫生署署长林文健介绍慢性病、医护人力等挑战

WHO WPRO lists RC77 in Manila from 19 to 22 Oct 2026, bringing together representatives of 38 countries and areas; agenda items include artificial intelligence in health, hypertension control, immunisation, tobacco control, a ministerial roundtable on essential-health stockpiles and pooled procurement, and programme budgets for 2028–2029. In a HKSAR government release (19 Oct), Director of Health Dr Ronald Lam said WHO's latest progress report shows the region's universal health coverage index has risen significantly, and that Hong Kong faces a growing non-communicable disease burden, healthcare workforce strain, communicable diseases and climate-related health risks, and is using digital tools and AI in primary care.世卫西太区网站显示，第77届区域委员会会议于2026年10月19日至22日在马尼拉举行，38个国家和地区代表出席；议程包括卫生领域人工智能、高血压防控、免疫接种、控烟、关于基本卫生物资储备与联合采购机制的部长级圆桌会议，以及2028–2029年规划预算。香港特区政府新闻稿（10月19日）称，卫生署署长林文健医生表示世卫最新进展报告显示本区域全民健康覆盖指数显著上升；香港面临非传染病负担加重、医护人力、传染病及气候相关健康风险等挑战，正运用数字工具和人工智能优化基层医疗。

Why it matters: 为何重要：Regional health ministers set shared priorities this week — pooled stockpiles matter for the next outbreak.本周区域卫生部长将确定共同优先事项——联合储备对应对下一场疫情很重要。

WHO Western Pacific (RC77); HKSAR Government press release ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-who-wpro-rc77-manila-oct19-22-hk-dh-ronald-lam-ai-hypertension-stockpiles

Taiwan's 2026 Global Health and Welfare Forum opens in Taipei on trust-centred digital health; Health Minister Shih Chung-liang sets out 'Taiwan's Digital Health 2030' — moving from smart healthcare to 'proactive healthcare' using NHI data, AI and FHIR interoperability“2026台湾全球健康福祉论坛”在台北开幕，主题为可信赖的数字健康；卫福部长石崇良发表“Taiwan's Digital Health 2030”，要从“智慧医疗”迈向“主动健康”，善用健保数据、AI及FHIR信息互通

Ministry of Health and Welfare (19 Oct 2026): co-hosted with the Ministry of Foreign Affairs at TICC on 19–20 Oct, the forum's theme is 'The Future of Global Care: Achieving Trust-Centric Digital Health'. It brought 21 health ministers, deputy ministers and senior officials from 11 countries and 13 experts from five countries. Shih said digital health must rest on data security, privacy, interoperability and transparent governance. Facing ageing, more chronic disease and staff shortages, Taiwan is pushing smart healthcare, standardised electronic records and FHIR data exchange, and by 2030 aims to use NHI data, AI and digital tools for personalised risk assessment and early intervention. Keynotes chaired by Academia Sinica president Chen Chien-jen included Karen DeSalvo, Allen Hsiao and Martin McKee.卫福部（2026-10-19）：论坛由卫福部与外交部于10月19–20日在台北国际会议中心合办，主题为“打造值得信赖的全球数字健康”，邀请11国21位卫生部部次长及高级官员和5国13位国际专家。石崇良表示数字健康须建立在资料安全、隐私保护、资讯互通和透明治理之上。面对高龄化、慢性病增加和医护人力短缺，台湾持续推动智慧医疗、电子病历标准化及FHIR互通，展望2030年善用健保数据、AI和数字工具，推动个人化风险评估与早期介入。由中研院院长陈建仁主持的大会演讲邀请了Karen DeSalvo、Allen Hsiao及Martin McKee等专家。

Why it matters: 为何重要：Taiwan's single-payer data could power earlier, personalised prevention — if privacy and trust are built in from the start.台湾单一支付健保数据可助力更早、更个人化的预防——前提是从一开始就把隐私和信任放在首位。

Ministry of Health and Welfare, Taiwan (衛福部) ↗ · r-2026-10-taiwan-global-health-welfare-forum-digital-health-2030-proactive-healthcare-fhir

Taiwan: anti-smoking and parent groups urge legislators to pass the Tobacco Hazards Prevention Act amendment this session — possessing or using e-cigarettes would carry fines up to NT$100,000; Health Minister Shih backs fast passage; 633 kg of e-cigarettes handed in at 432 amnesty bins in the first month台湾：反烟及家长团体呼吁立法院本会期三读《烟害防制法》修正案——持有或使用电子烟最高罚10万元新台币；卫福部长石崇良表态支持尽速通过；全台432处电子烟回收桶首月回收633公斤

CNEWS via PChome (19 Oct 2026): the Executive Yuan's draft would add possession of e-cigarettes and similar products to administrative penalties, with fines up to NT$100,000 for use or possession, plus rules on illegal supply, online platform responsibility and 85% graphic pack warnings. Current law already bans making, importing, selling and using e-cigarettes, but not possessing them. Since 8 Sept, 432 'surrender without penalty' bins collected 633 kg of e-cigarettes in a month (about 12,660 devices at 50 g each, per HPA data to 15 Oct) — groups stressed this does not measure the real market. NTUH family physician Kuo Feng-jan cited WHO warnings on nicotine, toxic and carcinogenic aerosol content and risks to adolescent brain development. Shih said the bill has cleared committee and caucus negotiation.匯流新聞網经PChome（2026-10-19）：行政院草案将持有电子烟等类烟品纳入行政罚，使用或持有最高罚10万元，并规范非法供应、网络平台责任及85%烟盒警示图文。现行法已禁止电子烟制造、输入、贩卖和使用，但“持有”尚无罚则。自9月8日起全台设置432处“自首免罚”回收桶，据国健署10月15日统计首月回收633公斤（以每支50克计约12660支）；团体强调回收量不代表实际流通规模。台大医院家医部郭斐然医师引述世卫提醒：电子烟气溶胶含尼古丁及其他有毒、部分致癌物质，并可能影响青少年脑部发育。石崇良表示草案已完成委员会审查并经党团协商。

Why it matters: 为何重要：Closing the 'possession' loophole is aimed at protecting teenagers from nicotine and spiked vape pods.堵住“持有”漏洞旨在保护青少年免受尼古丁和掺药烟弹危害。

CNEWS (匯流新聞網) via PChome News ↗ · r-2026-10-taiwan-tobacco-act-ecig-possession-fine-100k-ngos-urge-third-reading-633kg-recycled

Korea Brain Research Institute (Science Advances): reducing NMDA-receptor function in adolescent mice weakens the thalamus-to-prefrontal-cortex connection and causes lasting short-term memory loss; re-activating that circuit restores memory — a clue for schizophrenia's thinking problems韩国脑研究院（《科学进展》）：青春期小鼠NMDA受体功能降低会削弱丘脑—前额叶连接，造成持久短期记忆障碍；重新激活该回路可恢复记忆——为精神分裂症认知障碍提供线索

Asia Economy (19 Oct 2026): Ra Jong-cheol's team gave adolescent mice the NMDA blocker ketamine for two weeks. Their performance on a Y-maze short-term memory test fell and had not recovered 28 days after stopping the drug; adult mice did not show this lasting deficit. Neurotransmitter release efficiency fell selectively at thalamus-to-prefrontal synapses, not at synapses within the cortex, and prefrontal neurons processed direction information less well. Strengthening the circuit with chemogenetics restored both direction coding and memory. The researchers say this moves from correlation (seen in patient brain scans) to causation in an animal model; whether the same applies in people with schizophrenia needs further study.亚洲经济（2026-10-19）：Ra Jong-cheol团队给青春期小鼠连续两周注射NMDA受体阻断剂氯胺酮，小鼠在Y迷宫短期记忆测试中表现下降，停药28天后仍未恢复；成年小鼠则未出现这种持久障碍。丘脑至前额叶突触的神经递质释放效率选择性下降，皮层内部突触无明显变化，前额叶神经元处理方向信息的能力也下降。用化学遗传学方法增强该回路后，方向信息处理和记忆均恢复正常。研究者称这在动物模型中从相关性（患者脑影像所见）走向了因果关系；是否适用于精神分裂症患者仍需进一步研究。

Why it matters: 为何重要：Memory and thinking problems are among the hardest parts of schizophrenia to treat; a specific circuit gives drug developers a target.记忆和思维障碍是精神分裂症最难治疗的部分之一，明确的回路为药物研发提供了靶点。

Asia Economy (아시아경제); Korea Brain Research Institute (Science Advances) ↗ · r-2026-10-kbri-ketamine-adolescent-nmda-thalamus-prefrontal-synapse-short-term-memory-schizophrenia-sciadv

Korean nationwide study: people with seropositive rheumatoid arthritis had 33% higher cardiovascular risk and 93% higher risk of death than matched controls — whether their LDL cholesterol was high or low韩国全国数据研究：血清阳性类风湿关节炎患者心血管病风险比对照组高33%、死亡风险高93%——无论LDL胆固醇高低

Newspim (19 Oct 2026): Prof Kang Byung-joo's team at Uijeongbu Eulji University Hospital analysed National Health Insurance Service data on 15,385 people newly diagnosed with seropositive RA in 2010–2017 and 76,727 controls matched for age, sex and check-up year, followed to the end of 2019. RA patients had 33% higher risk of cardiovascular disease, 16% higher stroke risk, 49% higher coronary artery disease risk and 93% higher all-cause mortality. The excess risk did not differ meaningfully by LDL level. Published online 1 Oct 2026 in the Scandinavian Journal of Rheumatology. The authors urge treating RA itself as an independent cardiovascular risk factor and controlling inflammation, smoking, blood pressure, glucose and weight.Newspim（2026-10-19）：议政府乙支大学医院风湿科Kang Byung-joo教授团队分析国民健康保险公团数据，纳入2010–2017年新确诊血清阳性类风湿关节炎患者15385人及按年龄、性别、体检年份匹配的对照76727人，随访至2019年底。患者心血管病风险高33%、卒中高16%、冠心病高49%、全因死亡高93%，且超额风险不随LDL水平明显变化。论文于2026年10月1日在线发表于《斯堪的纳维亚风湿病学杂志》。作者建议将类风湿关节炎本身视为独立心血管危险因素，并控制炎症、戒烟及管理血压、血糖和体重。

Why it matters: 为何重要：A 'normal' cholesterol result does not mean low heart risk for people with this autoimmune disease — controlling joint inflammation also protects the heart.对这种自身免疫病患者而言，胆固醇“正常”不代表心脏风险低——控制关节炎症也是在保护心脏。

Newspim (뉴스핌); Uijeongbu Eulji University Hospital (Scand J Rheumatol) ↗ · r-2026-10-eulji-ra-cvd-33pct-death-93pct-higher-regardless-ldl-nhis-15385-sjr

Korea's MFDS approves the country's third and fourth digital therapeutics — VIVID Brain, a 12-week VR visual-perception training app for visual-field loss after brain disease, and EasyBreath, an 8-week pulmonary rehabilitation app for COPD, asthma and lung cancer patients韩国食药处批准第3、4号数字疗法——VIVID Brain（针对脑疾病后视野缺损、为期12周的VR视知觉训练App）和EasyBreath（针对慢阻肺、哮喘和肺癌患者、为期8周的呼吸康复App）

Medigate News (19 Oct 2026): more than a year after Korea's first two digital therapeutics (both for insomnia), MFDS approved Nunaps' cognitive-therapy software VIVID Brain and Share & Service's respiratory-rehabilitation software EasyBreath, both mobile apps. VIVID Brain gives patients whose visual field has narrowed because of brain disease 12 weeks of repeated VR-based perceptual-learning tasks to activate the visual cortex and promote plasticity. EasyBreath provides an assessment, a personalised exercise prescription, guided breathing-rehab exercise with logs and progress checks over 8 weeks to ease breathlessness and improve aerobic capacity. Both were designated innovative medical devices and fast-tracked via the integrated review-and-evaluation route. Minister Oh Yu-kyoung said they show DTx can reduce disability, not only treat disease.Medigate News（2026-10-19）：在韩国首两款数字疗法（均为失眠）获批一年多后，食药处批准Nunaps的认知治疗软件VIVID Brain和Share & Service的呼吸康复软件EasyBreath，均为手机App。VIVID Brain为因脑疾病视野变窄的患者提供12周基于VR的视知觉学习训练，激活视觉皮层、促进脑可塑性。EasyBreath在8周内提供康复前评估、个性化运动处方、呼吸康复运动与记录及进度检查，以减轻呼吸困难、提高有氧能力。两者均被指定为创新医疗器械，并通过“整合审查评价制度”加快进入临床。处长Oh Yu-kyoung表示，这表明数字疗法不仅能治疗疾病，还能减轻残障。

Why it matters: 为何重要：Rehab by smartphone could reach patients who cannot travel to hospital programmes several times a week.手机康复训练可惠及无法每周多次往返医院的患者。

Medigate News (메디게이트뉴스); MFDS ↗ · r-2026-10-mfds-digital-therapeutics-3-4-vivid-brain-visual-field-easybreath-pulmonary-rehab

China's National Healthcare Security Administration launches 'medical insurance wallet 2.0': from 16 Oct every province lets employees share personal-account funds with close relatives across provinces, usable for care, medicines and resident insurance or long-term-care premiums国家医保局推出医保钱包2.0版：自10月16日起各省份全部上线，职工医保个人账户可跨省共济给近亲属，用于就医购药及缴纳城乡居民医保和长护险

CCTV News via China News Service (19 Oct 2026): the upgraded wallet, live in all provinces, autonomous regions, municipalities and the Xinjiang Production and Construction Corps since 16 Oct, completes nationwide roll-out of cross-province family sharing of employee medical-insurance personal accounts. It can be used via the National Medical Insurance Service Platform app, an Alipay mini-program or offline counters (helpful for older people). Shared funds can now be used outside the recipient's province and for paying urban-rural resident insurance and long-term-care insurance contributions. Safeguards include identity checks, binding limited to close relatives, quota controls (shared funds cannot be passed on again) and abnormal-use monitoring. Over five years, in-province sharing exceeded 780 million transactions and more than 100 billion yuan.央视新闻经中新网（2026-10-19）：升级后的医保钱包自10月16日起已在各省、自治区、直辖市及新疆生产建设兵团全部上线，职工医保个人账户跨省共济给近亲属在全国全面落地。可通过国家医保服务平台App、支付宝小程序及线下窗口办理，方便老年人。共济资金使用由省内扩展至跨省，并从就医购药扩展到缴纳城乡居民医保和长期护理保险费。安全措施包括身份核验、共济对象限定近亲属、额度管控（不可再次共济）及异常监测。5年来省内共济累计超7.8亿人次、金额超1000亿元。

Why it matters: 为何重要：Families split between provinces can now use a working member's insurance savings to pay a parent's or child's medical bills.分居不同省份的家庭，现在可以用在职成员的医保个账为父母或子女支付医疗费用。

China News Service (中新网) / CCTV News; NHSA ↗ · r-2026-10-nhsa-medical-insurance-wallet-2-cross-province-family-sharing-nationwide

Zhejiang serosurvey (Fudan, HKU, Taizhou CDC): toddlers aged 16–36 months have the weakest immunity to human metapneumovirus — only 67.8% had neutralising antibodies, versus near-100% from age six浙江台州血清学调查（复旦、港大、台州疾控）：16–36月龄幼儿对人偏肺病毒免疫力最弱——仅67.8%有中和抗体，6岁起接近100%

Scienmag summary (19 Oct 2026) of a BMC Infectious Diseases paper (Chang Liu, Qiang Wang, Fudan Shanghai Institute of Infectious Disease and Biosecurity; David Hodgson, Charité; Taizhou CDC; University of Hong Kong; doi 10.1186/s12879-026-14417-w): sera from 1,303 people aged 16 months to 93 years were collected in Taizhou in June 2024. Children 16–<36 months had the lowest neutralising titres (GMT 217) and 67.8% (137/202) seropositivity; GMT rose to 331 at 3–4 years and above 1,000 from 5–11 years, and was 1,829 in adults 65+. Under-five titres rose about 75% per year of age. hMPV titres correlated modestly with RSV pre-F IgG (rho 0.302). No hMPV vaccine is licensed. Medium confidence: details are from a research-news aggregator summary; the journal page was not checked directly.Scienmag（2026-10-19）对《BMC传染病》论文的摘要（复旦大学上海市传染病与生物安全应急响应重点实验室刘畅、王强，柏林夏里特医院David Hodgson，台州市疾控中心，香港大学；doi 10.1186/s12879-026-14417-w）：2024年6月在台州采集16月龄至93岁共1303人血清。16至不足36月龄幼儿中和抗体滴度最低（几何平均滴度217），阳性率67.8%（137/202）；3–4岁升至331，5–11岁超过1000，65岁以上成人为1829。5岁以下儿童每长一岁滴度约升高75%。人偏肺病毒滴度与RSV融合前F蛋白IgG呈弱正相关（rho 0.302）。目前尚无获批的人偏肺病毒疫苗。可信度“中”：细节来自科研资讯聚合网站的摘要，未直接核对期刊页面。

Why it matters: 为何重要：Pinpoints the age window where a future hMPV vaccine or antibody would help most — children in their second and third years.明确了未来人偏肺病毒疫苗或抗体最能发挥作用的年龄窗口——1至3岁幼儿。

Scienmag (BMC Infectious Diseases) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-fudan-hku-taizhou-hmpv-neutralizing-antibody-toddlers-67-8pct-seropositive-bmc-id

Beijing Children's Hospital study of 289,026 paediatric stays under China's DRG payment system (Chengdu, Hangzhou): costs rise with hospital tier within the same groups, and Kawasaki disease and complex anorectal malformations cost significantly more than their assigned groups — authors urge child-specific grouping北京儿童医院研究成都、杭州按DRG付费的289026例儿科住院：同一分组内医院级别越高费用越高，川崎病和复杂肛门直肠畸形费用显著高于所在分组——作者呼吁建立适合儿童的分组

Scienmag summary (19 Oct 2026) of a BMC Pediatrics paper (Song F, Na C, Lv Y, Zang Z, Zhao C; Beijing Children's Hospital, Capital Medical University; doi 10.1186/s12887-026-07693-7) using National Healthcare Security Administration data for January–June 2025. In adjacent DRG groups ES3, DT1 and EX2, average costs rose with hospital level, yet DRG payments are the same across tiers. Average costs for Kawasaki disease and for anorectal malformation with rectal malformation were significantly higher than for the adjacent groups they were assigned to. The authors call for paediatric-specific refinement of high-heterogeneity groups. Medium confidence: details are from a research-news aggregator summary; the journal page was not checked directly.Scienmag（2026-10-19）对《BMC儿科》论文的摘要（宋F、那C、吕Y、臧Z、赵C；首都医科大学附属北京儿童医院；doi 10.1186/s12887-026-07693-7），使用国家医保局2025年1–6月数据。在相邻DRG组ES3、DT1和EX2中，医院级别越高平均费用越高，但DRG支付标准在各级医院相同。川崎病及合并直肠畸形的肛门直肠畸形平均住院费用显著高于其所在的相邻分组。作者呼吁针对费用异质性高的病组进行儿科专属细化。可信度“中”：细节来自科研资讯聚合网站的摘要，未直接核对期刊页面。

Why it matters: 为何重要：If payments do not fit sick children's real costs, top children's hospitals may be squeezed on exactly the hardest cases.若支付标准不符合患儿实际费用，顶级儿童医院可能恰恰在最复杂病例上承受压力。

Scienmag (BMC Pediatrics) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-bch-drg-paediatric-cost-homogeneity-289026-chengdu-hangzhou-kawasaki-bmc-pediatrics

AIIMS Delhi surgeons map two 'warning zones' for complex cancer surgery in women — a 'Red Alert Zone' below the uterine vessels and a hepatocaval triangle near the liver — after reviewing 255 radical hysterectomies印度全印医学科学研究所（德里）外科医生为女性复杂癌症手术划定两个“警示区”——子宫血管下方的“红色警戒区”和肝脏附近的肝腔静脉三角——基于255例根治性子宫切除术分析

Times Now, citing PTI (19 Oct 2026): Dr M D Ray, professor of surgical oncology at Dr BRA-IRCH, AIIMS Delhi, and team studied 255 radical or modified radical hysterectomies for cervical, endometrial and ovarian cancers, analysed causes of bleeding and injury, and modified their approach for the later 105 cases. 'Ray's Zone' below the uterine vessels lies close to the ureter, bladder, pelvic nerves and major vessels; the technique stresses careful visualisation, magnification when needed, ligation of individual vessels and avoiding excessive cautery near the pelvic ureter. A second area, 'Ray's Hepatocaval Triangle', is described for liver mobilisation near the inferior vena cava and hepatic veins. The report does not give comparative complication figures.Times Now援引印度报业托拉斯（2026-10-19）：德里全印医学科学研究所Dr BRA-IRCH肿瘤外科教授M D Ray团队分析了255例因宫颈癌、子宫内膜癌和卵巢癌实施的根治性或改良根治性子宫切除术中出血和损伤的原因，并在后105例中改进术式。子宫血管下方的“Ray区”紧邻输尿管、膀胱、盆腔神经及大血管；改良技术强调仔细辨认解剖、必要时放大、逐一结扎血管、避免在盆腔输尿管附近过度电凝。另描述了“Ray肝腔静脉三角”，用于在下腔静脉和肝静脉附近游离肝脏时参考。报道未提供对比并发症数据。

Why it matters: 为何重要：Clear anatomical landmarks can help surgeons avoid bleeding and damage to the bladder and nerves, protecting quality of life after cancer surgery.清晰的解剖标志有助于外科医生减少出血、避免损伤膀胱和神经，保护癌症术后生活质量。

Times Now (PTI) ↗ · r-2026-10-aiims-ray-zone-hepatocaval-triangle-255-hysterectomies-bleeding-ureter

Thailand: in Ratchaburi's Photharam district, where some homes have been flooded for nearly two weeks, the provincial health chief urges anyone with fever or unusual calf pain after wading in floodwater to see a doctor quickly because of leptospirosis risk泰国叻丕府班蓬县部分房屋被淹近两周，府卫生长官提醒：涉水后出现发烧或小腿异常疼痛者应尽快就医，警惕钩端螺旋体病

Khaosod English (19 Oct 2026): Dr Pajaree Areerob, Ratchaburi's provincial public health doctor, visited flood-affected patients and older residents in Photharam, where stagnant floodwater has turned black and foul-smelling, and handed out relief bags and medicines. She warned of skin problems and immersion foot damage as well as leptospirosis, especially for people standing in floodwater for long periods or with cuts on their feet. People who cannot avoid floodwater should wash their feet with clean water and soap afterwards and check for wounds; anyone who develops high fever or calf pain after exposure should seek care immediately and tell the doctor about the exposure, as blood tests may be needed so treatment can start promptly.Khaosod English（2026-10-19）：叻丕府卫生医师Pajaree Areerob探望班蓬县受洪灾影响的患者和老人，当地积水已发黑发臭，她并分发救济包和药品。她警告长期涉水会引发皮肤问题和浸泡足损伤，并有钩端螺旋体病风险，尤其是长时间站在积水中或脚上有伤口者。无法避免接触洪水者事后应用清水和肥皂洗脚并检查伤口；接触后出现高烧或小腿疼痛应立即就医并告知接触史，可能需验血以便及早治疗。

Why it matters: 为何重要：Leptospirosis is treatable with early antibiotics but can turn severe — telling the doctor about floodwater exposure matters.钩端螺旋体病及早用抗生素可治，但可能转重——告诉医生曾接触洪水很重要。

Khaosod English ↗ · r-2026-10-thailand-ratchaburi-photharam-flood-two-weeks-leptospirosis-fever-calf-pain-warning

TRICYCLE trial (Critical Care): starting angiotensin II, vasopressin and norepinephrine together in septic shock lowered renin and lactate faster and improved organ scores versus stepwise escalation, with far fewer fast heart rhythms (15.6% vs 68.6%); mortality did not differTRICYCLE试验（《重症监护》）：脓毒性休克中同时启用血管紧张素II、血管加压素和去甲肾上腺素，与逐步升级相比肾素和乳酸下降更快、器官评分改善更多，快速性心律失常大幅减少（15.6%对68.6%）；死亡率无差异

ReachMD (19 Oct 2026) on the phase II, single-blind randomised trial in 79 adults with septic shock at ICUs in Slovenia and Croatia (norepinephrine ≥0.15 µg/kg/min, lactate >2 mmol/L after fluids). Concurrent therapy (n=38) vs stepwise (n=41): plasma renin fell 2.61% vs 1.67% per hour (P=0.015, primary endpoint); lactate 1.53% vs 1.01% per hour (P=0.006); SOFA fell 3 vs 0 points by 72 h (P=0.018). Tachyarrhythmias occurred in 5/32 vs 24/35 patients with data. The trial was not powered for mortality; baseline renin and lactate were higher in the concurrent group, and it cannot separate the effects of angiotensin II and vasopressin.ReachMD（2026-10-19）报道这项在斯洛文尼亚和克罗地亚ICU开展的II期单盲随机试验，纳入79名脓毒性休克成人（补液后去甲肾上腺素≥0.15 µg/kg/min、乳酸>2 mmol/L）。同时用药组（38人）对逐步升级组（41人）：血浆肾素每小时下降2.61%对1.67%（P=0.015，主要终点）；乳酸1.53%对1.01%（P=0.006）；72小时SOFA评分下降3分对0分（P=0.018）。有数据者中快速性心律失常5/32对24/35。试验未针对死亡率设计统计效能；同时用药组基线肾素和乳酸更高，且无法区分血管紧张素II与血管加压素各自的作用。

Why it matters: 为何重要：Suggests an earlier multi-drug approach may stabilise septic shock with fewer heart-rhythm side effects — a larger trial is needed to show lives saved.提示更早的多药联合可能以更少心律副作用稳定脓毒性休克——需要更大规模试验证明能挽救生命。

ReachMD (Critical Care) ↗ · r-2026-10-tricycle-concurrent-angiotensin-ii-vasopressin-norepinephrine-septic-shock-renin-critcare

Singapore haze, 5pm Monday: 24-h PSI still Unhealthy in the West (114) and Central (105) and Moderate elsewhere (87–91); 1-h PM2.5 back in the Elevated band in North (59), West (66) and Central (73)新加坡烟霾（周一下午5时）：24小时PSI西部（114）和中部（105）仍属“不健康”，其余地区“中等”（87–91）；1小时PM2.5在北部（59）、西部（66）和中部（73）重回“偏高”

NEA real-time data (data.gov.sg, 19 Oct 2026, 5pm): 24-h PSI North 87, South 89, East 91, West 114, Central 105, little changed from 3–4pm. 1-h PM2.5 was 59 µg/m³ in the North, 66 in the West and 73 in Central (Band II Elevated) and 52 in the South and 47 in the East (Normal), after an island-wide Normal reading at noon. CNA reported that NEA still sees a continued risk of severe transboundary haze, with hotspots in Kalimantan and southern Sumatra and dry conditions persisting in parts of the southern ASEAN region.国家环境局实时数据（data.gov.sg，2026-10-19下午5时）：24小时PSI北部87、南部89、东部91、西部114、中部105，与下午3–4时相差不大。1小时PM2.5北部59、西部66、中部73微克/立方米（二级“偏高”），南部52、东部47（正常）；中午时全岛曾一度全部正常。亚洲新闻台报道，环境局认为严重跨境烟霾风险仍在：加里曼丹和苏门答腊南部有热点，东盟南部部分地区持续干燥。

Why it matters: 为何重要：Evening air is worse again than at midday — people with heart or lung conditions should check the hourly reading before going out.傍晚空气又比中午差——心肺疾病患者外出前应先查看每小时读数。

NEA real-time PM2.5/PSI (data.gov.sg); CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-5pm-psi-west-114-central-105-pm25-elevated-north-west-central

Indonesia haze: four areas in the 'hazardous' (black) PM2.5 band on Monday morning — Pangkalan Bun 1,048.8 µg/m³, Palangka Raya 471.8, Muaro Jambi 329.2 and Jambi city 307; BNPB still counts 5,499 hotspots in six priority provinces印尼烟霾：周一上午4地PM2.5处于“危险”（黑色）级——邦卡兰布翁1048.8微克/立方米、帕朗卡拉亚471.8、穆阿罗占碑329.2、占碑市307；国家抗灾署仍统计到六个重点省份5499个热点

CNN Indonesia (19 Oct 2026), citing BMKG at 08:00 WIB: smoke from forest and land fires covered much of Sumatra (North and West Sumatra, Riau, Jambi, Riau Islands, Bengkulu, Bangka Belitung, South Sumatra, Lampung) and West, Central, South and East Kalimantan, and was also seen over Maluku and Papua. Transboundary haze from Sumatra and Kalimantan was detected over Peninsular Malaysia and Singapore, and from Kalimantan over Sarawak. PM2.5 above 250.5 µg/m³ (hazardous) was recorded at Pangkalan Bun, Central Kalimantan (1,048.8), Palangka Raya (471.8), Muaro Jambi (329.2) and Jambi city (307). BNPB's dashboard (as of Sunday) listed 5,499 hotspots and 247 fire spots in six priority provinces.CNN印尼（2026-10-19）引述气象局（BMKG）当地时间08:00数据：林地火灾烟雾覆盖苏门答腊大部（北苏、西苏、廖内、占碑、廖内群岛、明古鲁、邦加勿里洞、南苏、楠榜）及西、中、南、东加里曼丹，马鲁古和巴布亚上空亦见烟雾。来自苏门答腊和加里曼丹的跨境烟霾飘至马来西亚半岛和新加坡，加里曼丹烟霾还影响砂拉越。PM2.5超过250.5微克/立方米（危险级）的地区有中加里曼丹邦卡兰布翁（1048.8）、帕朗卡拉亚（471.8）、穆阿罗占碑（329.2）和占碑市（307）。国家抗灾署（BNPB）看板（截至周日）显示六个重点省份有5499个热点和247个火点。

Why it matters: 为何重要：PM2.5 above 1,000 µg/m³ is roughly 70 times WHO's 24-hour guideline (15 µg/m³) — a serious threat to children, older people and anyone with lung disease.PM2.5超过1000微克/立方米约为世卫24小时指导值（15微克/立方米）的70倍——对儿童、老人和肺病患者构成严重威胁。

CNN Indonesia (BMKG; BNPB) ↗ · r-2026-10-indonesia-bmkg-oct19-pangkalan-bun-pm25-1048-palangka-raya-jambi-hazardous-bnpb-5499-hotspots

Taiwan's National Health Research Institutes opens a Dementia Research Office to build a national dementia database; about 398,000 people aged 65+ (7.99%) live with dementia, expected to reach 680,000 by 2041台湾国家卫生研究院成立“失智症研究办公室”，将建构全国失智症数据库；65岁以上失智人口约39.8万（盛行率7.99%），预计2041年倍增至68万

CNA (19 Oct 2026, Yunlin): NHRI launched the office at its National Center for Geriatrics and Welfare Research, led by centre director Hsu Chih-cheng. It will focus on data, evidence and technology: a national dementia database, evidence-based practice, international collaboration and care-technology innovation, working with government, industry, academia and care providers. NHRI estimates dementia prevalence of 7.99% among people aged 65+, about 398,000 people, doubling to 680,000 by 2041. The Ministry of Health and Welfare said its Dementia Policy 3.0 targets a 'Dementia-Friendly Taiwan 888' by 2035, after reaching the earlier '777' goal in 2025.中央社（2026-10-19，云林）：国卫院在国家高龄医学暨健康福祉研究中心成立失智症研究办公室，由中心主任许志成主持。办公室将聚焦数据、实证与科技：建构国家级失智症数据库、落实实证医学应用、扩展国际合作、推广医疗与照护科技创新，并与产官学研及照护机构合作。国卫院估计65岁以上失智症盛行率7.99%，约39.8万人，2041年将倍增至68万人。卫福部表示，“失智症防治照护政策纲领暨行动方案3.0”目标是2035年达成“失智友善台湾888”，此前已于2025年达成“777”目标。

Why it matters: 为何重要：A fast-ageing society needs national data to plan dementia care; a dedicated research office is a step toward that.快速老龄化的社会需要全国数据来规划失智照护，专门的研究办公室是迈向这一目标的一步。

CNA Taiwan (中央社) ↗ · r-2026-10-taiwan-nhri-dementia-research-office-yunlin-398k-patients-680k-by-2041

Taiwan study: the plasticiser DEHP may raise the uraemic toxin indoxyl sulfate by boosting its production in the liver and cutting its removal by the kidneys; in 395 dialysis patients, higher DEHP went with higher toxin levels台湾研究：塑化剂DEHP可能增加肝脏生成、减少肾脏排除尿毒素“硫酸吲哚酚”，导致其累积；395名透析患者中DEHP越高、尿毒素越高

Liberty Times health (19 Oct 2026): a team led by Kuo Ko-Lin, head of the haemodialysis centre at Taipei Tzu Chi Hospital, with National Taiwan University College of Medicine, published in Journal of Hazardous Materials Advances. In cells and chronic kidney disease mouse models, DEHP increased liver enzymes that make indoxyl sulfate (IS) and lowered kidney transporters that excrete it; DEHP-exposed CKD mice had higher blood IS, creatinine and urea nitrogen and worse kidney fibrosis. Among 395 stable dialysis patients, groups with higher DEHP levels tended to have higher IS. The data are associative in humans. Advice: avoid putting hot, oily food or long-stored food in unsuitable plastic; prefer food-grade glass or stainless steel.自由健康网（2026-10-19）：台北慈济医院血液透析中心主任郭克林与台大医学院团队在《Journal of Hazardous Materials Advances》发表研究。细胞和慢性肾病小鼠模型显示，DEHP会增加肝脏中生成硫酸吲哚酚（IS）相关酶的表现，并降低肾脏排出IS的转运蛋白；接触DEHP的慢性肾病小鼠血中IS、肌酸酐和尿素氮明显升高，肾纤维化更重。在395名稳定透析患者中，DEHP浓度越高的组别IS浓度也有较高趋势；人体部分为相关性数据。建议牢记“热、油、久”：盛装高温、高油或久放食物时注意容器材质，优先选择适合食品接触的玻璃或不锈钢容器。

Why it matters: 为何重要：Suggests everyday plastic exposure could add to the toxin burden of people with kidney disease — a practical reason to choose containers with care.提示日常塑化剂暴露可能加重肾病患者的尿毒素负担——这是谨慎选择容器的实际理由。

Liberty Times Health (自由健康网); Taipei Tzu Chi Hospital ↗ · r-2026-10-taipei-tzuchi-ntu-dehp-plasticizer-indoxyl-sulfate-uremic-toxin-ckd-395-dialysis

Taiwan: amended Senior Citizens Welfare Act will have the government pay full NHI premiums for people 65+ below a 20% income-tax rate (income up to NT$1.33m); Health Minister Shih Chung-liang says about 83% of seniors qualify and warns the insurance system could be destabilised台湾：《老人福利法》修正案通过，综所税率未达20%（年所得上限133万新台币）的65岁以上长者由政府全额补助健保费；卫福部长石崇良称约83%长者符合资格，警告健保制度恐面临崩溃

CNA (19 Oct 2026): the Legislative Yuan passed, on third reading, an amendment to Article 22 of the Senior Citizens Welfare Act pushed by the opposition KMT and TPP. People aged 65+ whose income was below the filing threshold or taxed at under 20%, capped at NT$1.33 million a year, will have their full National Health Insurance premium paid by the central authority. Minister Shih Chung-liang said about 83% of seniors fall under the threshold, calling the tax-rate cut-off 'too crude' and saying it departs from NHI's ability-to-pay principle. He confirmed the amendment removed earlier provisions allowing subsidies of co-payments and non-NHI medical costs for low-income seniors, leaving only the premium subsidy.中央社（2026-10-19）：蓝白推动的《老人福利法》第22条修正案在立法院三读通过：近1年综合所得未达申报标准或综所税率未达20%、年所得上限133万元的65岁以上民众，由中央主管机关补助全额健保费。卫福部长石崇良表示，约83%长者落在门槛内，以所得税率“一刀切”过于粗糙，偏离健保量能负担原则，健保制度恐面临崩溃。他证实修法后原条文中对中低收入老人健保部分负担及非健保医疗费用的补助被删除，只剩健保费补助。

Why it matters: 为何重要：A major change to who pays for Taiwan's single-payer insurance — its long-term funding is now a live political fight.谁来负担台湾单一支付健保的重大变化——健保长期财务已成政治焦点。

CNA Taiwan (中央社) ↗ · r-2026-10-taiwan-senior-welfare-act-art22-nhi-premium-waiver-83pct-elderly-minister-shih-warns-collapse

Chiba University: psychological stress re-ignites settled arthritis in mice through a nerve → brown fat → IL-6 → joint-fibroblast pathway; in patients, stress tracked disease activity only in those with the normal-function β3-adrenergic receptor gene variant (Science Advances)千叶大学：心理压力经“交感神经→褐色脂肪→IL-6→关节滑膜成纤维细胞”通路使小鼠已缓解的关节炎复发；患者中，仅携带正常功能型β3肾上腺素受体基因者的压力与病情活动度相关（《科学进展》）

Chiba University press release (19 Oct 2026; Science Advances, 17 Oct; Shigeru Tanaka, Hiroshi Nakajima et al.): in mice whose arthritis had gone into remission, stress caused relapse. Sympathetic activation made brown adipose tissue release IL-6; IL-6 acted via gp130 on FAP-positive synovial fibroblasts, which produced the neutrophil-attracting chemokine CXCL1. Blocking sympathetic nerves, removing brown fat, inhibiting IL-6, deleting fibroblast gp130 or blocking the β3-adrenergic receptor all reduced flare-ups, and IL-6 alone could trigger relapse. In rheumatoid arthritis patients, psychological stress correlated with disease activity in carriers of the usual β3-receptor gene type but not in carriers of a low-response variant.千叶大学新闻稿（2026-10-19；《科学进展》10月17日在线，田中繁、中岛裕史等）：关节炎已缓解的小鼠受到压力后再次发病。交感神经激活使褐色脂肪组织分泌IL-6，IL-6经gp130作用于FAP阳性滑膜成纤维细胞，使其产生招募中性粒细胞的趋化因子CXCL1。抑制交感神经、切除褐色脂肪、阻断IL-6、敲除成纤维细胞gp130或阻断β3肾上腺素受体，都能减少复发；单独给予IL-6即可诱发复发。在类风湿关节炎患者中，携带常见型β3受体基因者的心理压力与病情活动度相关，而低反应型携带者没有这种相关。

Why it matters: 为何重要：Explains a common patient experience — flares after stress — and points to drug targets on the stress pathway itself.解释了患者常见的“压力后复发”体验，并把药物靶点指向压力通路本身。

Chiba University (PR Times); Science Advances ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-chiba-stress-arthritis-relapse-sympathetic-brown-fat-il6-synovial-fibroblast-cxcl1-adrb3-sciadv

Japan: health ministry proposes building home-helpers' travel costs into home-visit long-term-care fees in the FY2027 revision, as rural agencies struggle with long trips to clients' homes日本：厚生劳动省提出在2027年度介护报酬改定中，把上门照护人员前往利用者家中的交通成本纳入访问介护报酬，以缓解地方事业所长途奔波的经营压力

NHK and Nihonkai Shimbun (19 Oct 2026): at a Social Security Council subcommittee on Monday, MHLW set out a plan to fundamentally review the current fee framework for home-visit care (houmon kaigo), an essential service for older people living at home, including appropriately reflecting the cost and time of travelling to each client's home. Agencies, mainly in rural areas, face long distances to clients, and travel costs and time have been squeezing their finances. Details are to be worked out in the FY2027 long-term-care fee revision.NHK与《日本海新闻》（2026-10-19）：厚劳省周一在社会保障审议会分科会上提出，将从根本上调整访问介护（上门照护）现行报酬框架——这是高龄者在家生活不可或缺的服务——包括把前往各利用者家中的交通成本和时间适当反映到报酬中。地方事业所因利用者住所分散、路途遥远，交通成本和时间挤压经营。具体内容将在2027年度介护报酬改定中敲定。

Why it matters: 为何重要：Keeping home care viable outside cities matters for millions of older Japanese who want to stay at home.维持城市以外地区上门照护的可持续性，关系到数以百万计希望居家养老的日本老人。

NHK; Nihonkai Shimbun ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-mhlw-fy2027-home-visit-care-fees-reflect-staff-travel-costs-rural-providers

Korea: adults 65+ now make up about half of RSV hospitalisations — 3,299 of 6,706 this year as of 3 Oct, 1.7 times all of last year's elderly admissions and, for the first time, more than children aged 0–6韩国：65岁以上老人已占RSV住院病例约一半——截至10月3日今年6706例中有3299例，是去年全年老年住院数的1.7倍，并首次超过0–6岁儿童

Health Chosun (19 Oct 2026): lawmaker Baek Jong-heon's analysis of KDCA sentinel surveillance found 3,299 RSV inpatients aged 65+ by 3 Oct, versus 1,906 in all of 2025. Older adults were 49.2% of 6,706 RSV hospitalisations, while children 0–6 were 2,455 (36.6%); the children's share has fallen from 89.9% in 2022, and the elderly share has risen from 5.2%. This year's figures include early-2026 cases from last winter's wave, and RSV usually climbs from autumn. Baek said KDCA prevention messaging still targets daycare and postpartum centres and urged guidance for nursing hospitals and long-term care facilities.韩国《健康朝鲜》（2026-10-19）：国会议员白钟宪分析疾病管理厅哨点监测数据发现，截至10月3日，65岁以上RSV住院患者3299人，而2025年全年为1906人。老人占6706例RSV住院的49.2%，0–6岁儿童2455例（36.6%）；儿童占比已从2022年的89.9%下降，老人占比则从5.2%上升。今年数据包含上一个冬季流行延续到年初的病例，RSV通常从秋季开始上升。白钟宪指出，疾管厅的预防宣传仍主要面向托育机构和产后护理中心，呼吁为疗养医院和长期照护机构制定指引。

Why it matters: 为何重要：RSV is not just a baby virus — older adults with heart or lung disease face real risk, and vaccines exist for them.RSV不只是婴儿病毒——患心肺疾病的老人风险真实存在，而且已有针对老人的疫苗。

Health Chosun (KDCA sentinel data via Rep. Baek Jong-heon) ↗ · r-2026-10-korea-rsv-hospitalisations-65plus-3299-49pct-first-exceed-young-children-kdca-sentinel

Korean study of 9.76 million lab results (JAMA Internal Medicine): most routine blood tests barely change with fasting time — glucose, triglycerides and lipase are the main exceptions, and fasting beyond 12 hours adds nothing over 8–12 hours韩国976万项检验结果研究（《JAMA内科学》）：多数常规血检几乎不受空腹时长影响——主要例外是血糖、甘油三酯和脂肪酶；空腹超过12小时与8–12小时相比无额外差异

Digital Today (19 Oct 2026) and JAMA Internal Medicine: a team including Ulsan University College of Medicine analysed 9,755,547 results from 101,148 adults at one 670-bed university hospital near Seoul (Feb 2021–Dec 2023), grouped by fasting under 8 hours, 8–12 hours and over 12 hours. Of 121 tests, 27 differed beyond allowable error, and only 10 when the same patient was compared. With under 8 hours' fasting, glucose was 10.8% higher, triglycerides 20.1% and lipase 36.4%; blood counts, kidney markers, electrolytes and most liver enzymes barely changed, and no test differed meaningfully between 8–12 and >12 hours. The authors suggest test-specific fasting rules; it is a single-centre observational study, and patients should follow their clinicians' instructions.Digital Today（2026-10-19）及《JAMA内科学》：包括蔚山大学医学院在内的团队分析首尔都市圈一家670床大学医院2021年2月至2023年12月101148名成人的9755547项检验结果，按空腹<8小时、8–12小时、>12小时分组。121个项目中27个差异超出允许误差，同一患者比较时仅10个。空腹不足8小时时血糖高10.8%、甘油三酯高20.1%、脂肪酶高36.4%；血细胞、肾功能、电解质和多数肝酶几乎不变，8–12小时与>12小时之间无项目出现有意义差异。作者建议按检验项目设定空腹要求；这是单中心观察性研究，患者仍应遵从医护指示。

Why it matters: 为何重要：Could spare many patients long, uncomfortable fasts — especially older people and people with diabetes — when only some tests need it.既然只有部分项目需要空腹，许多患者——尤其老人和糖尿病患者——或可免受长时间空腹之苦。

JAMA Internal Medicine; Digital Today ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-jama-im-korea-fasting-duration-9-76m-tests-101148-adults-only-glucose-tg-lipase-differ

Manila: dengue cases this year pass 4,000 (4,048 from 1 Jan to 19 Oct, 31 new on Monday); the city has also logged 1,648 leptospirosis, 2,508 influenza-like illness and 525 SARI cases马尼拉：今年登革热病例突破4000例（1月1日至10月19日共4048例，周一新增31例）；全市另记录钩端螺旋体病1648例、流感样病例2508例、严重急性呼吸道感染525例

Inquirer (19 Oct 2026), citing the Manila Health Department's daily disease report (EDCS-IS, 6am 19 Oct): 4,048 dengue cases from 1 Jan to 19 Oct, including 31 new on 19 Oct, plus 28 new influenza-like illness cases, two SARI cases and one leptospirosis case that day. Year-to-date: 2,508 ILI, 1,648 leptospirosis, 525 SARI, 106 confirmed COVID-19, 85 typhoid and four cholera cases. Mayor Isko Moreno urged residents to seek care early rather than wait for symptoms to worsen.《菲律宾每日问询者报》（2026-10-19）引述马尼拉市卫生局每日疫情报告（EDCS-IS，10月19日早6时）：1月1日至10月19日登革热4048例，其中10月19日新增31例；当天另新增流感样病例28例、严重急性呼吸道感染2例、钩体病1例。年内累计：流感样病例2508例、钩体病1648例、SARI 525例、新冠确诊106例、伤寒85例、霍乱4例。市长伊斯科·莫雷诺呼吁居民身体不适尽早就医，不要等症状加重。

Why it matters: 为何重要：Dengue and leptospirosis both peak after the rains — early care saves lives.登革热和钩体病都在雨季后高发——及早就医可以挽救生命。

Philippine Daily Inquirer (Manila Health Department) ↗ · r-2026-10-manila-dengue-4048-cases-jan1-oct19-31-new-leptospirosis-1648-ili-2508-sari-525

Shanghai Geriatric Medical Center launches an AI 'comprehensive geriatric assessment' agent that turns a 2–3-hour specialist assessment into a chat-style Q&A usable in hospital, community clinics and at home上海老年医学中心上线“银龄智护·老年综合评估智能体”，把耗时两三个小时的专科老年综合评估变成聊天式问答，可在医院、社区和居家使用

Jiefang Daily via the Shanghai government portal (19 Oct 2026): the agent, released recently and covering all of the centre's departments, has been opened almost 5,000 times through its mini-program. Combining voice interaction, video capture and AI, it lets older people answer questions and perform set movements on a smart screen while data are collected automatically, replacing paper scales that need trained staff and two to three hours. Comprehensive geriatric assessment (CGA) covers physical function, cognition and mood, nutrition and social support to spot 'geriatric syndromes'. Community health centres can run standardised assessments and send results to family doctors; multi-centre roll-out is planned.解放日报经上海市政府网（2026-10-19）：该智能体不久前发布，覆盖中心所有科室，小程序点击使用近5000次。它融合语音交互、视频采集与人工智能，老人通过智慧屏回答问题、完成指定动作，信息自动采集，取代需专门培训人员、耗时两三个小时的纸质量表评估。老年综合评估（CGA）涵盖躯体功能、认知与心理、营养和社会支持等维度，用于发现“老年综合征”风险。社区卫生服务中心可为辖区老人开展标准化评估，结果同步至家庭医生；下一步将多中心推广。

Why it matters: 为何重要：Makes a time-consuming but valuable check-up for frail older people far easier to reach.让耗时却很有价值的老年体检对体弱老人更易获得。

Jiefang Daily (Shanghai Municipal Government portal) ↗ · r-2026-10-shanghai-geriatric-medical-center-ai-comprehensive-geriatric-assessment-agent-hospital-community-home

Kenya Ebola: doctors' union KMPDU demands an immediate seat in outbreak decision-making, saying frontline doctors are most exposed; Africa CDC backs Kenya's response as cases stand at eight with one death肯尼亚埃博拉：医生工会KMPDU要求立即参与疫情应对决策，称一线医生暴露风险最高；非洲疾控中心表态支持肯尼亚应对，病例累计8例、1人死亡

The Star (19 Oct 2026): at a union retreat in Naivasha, KMPDU national chair Dr Abidan Mwachi said doctors were being treated as 'consumers' of Ministry of Health plans rather than contributors, and demanded their inclusion 'right now' in preparedness, prevention and treatment decisions. The demand comes as Kenya responds to the Bundibugyo-strain outbreak with eight confirmed cases including one death, amid concern about protecting frontline health workers (three infected staff treated the first patient). Africa CDC said the early detection of the latest cases showed the value of contact tracing, surveillance and timely isolation and that it is supporting surveillance, coordination and risk communication.《星报》（2026-10-19）：肯尼亚医师、药剂师和牙医工会（KMPDU）全国主席阿比丹·姆瓦奇在奈瓦沙工会会议上表示，医生被当作卫生部计划的“执行者”而非参与制定者，要求“立即”让医生参与埃博拉防备、预防和救治决策。目前肯尼亚本迪布焦型埃博拉确诊8例、1人死亡，一线医护防护问题备受关注（3名感染医护曾救治首例患者）。非洲疾控中心表示，最新病例被及早发现说明接触者追踪、监测和及时隔离的重要性，并在监测、技术协调和风险沟通方面支持肯尼亚。

Why it matters: 为何重要：Health-worker infections are often how Ebola outbreaks grow; listening to frontline staff is part of stopping it.医护感染往往是埃博拉疫情扩大的途径，倾听一线人员是遏制疫情的一部分。

The Star (Kenya) ↗ · r-2026-10-kenya-kmpdu-demands-doctors-in-ebola-response-decisions-naivasha-africa-cdc-support

Science: David Baker's team unveils RFdiffusion3, an AI that designs proteins and nucleic acids atom by atom — beat its predecessor on 37 of 41 enzyme active sites, runs about 10× faster, and produced working enzymes including one that cuts a peptide tied to transthyretin amyloidosis《科学》：戴维·贝克团队发布RFdiffusion3，可在原子层面设计蛋白质和核酸——41个酶活性位点中37个优于前代、速度约快10倍，并设计出有活性的酶，包括一种切割与转甲状腺素蛋白淀粉样变性相关肽段的蛋白酶

Science and Technology Daily via CAS (19 Oct 2026) on the Science paper 'Atomic functional site scaffolding in biopolymers with RFdiffusion3' (University of Washington; Baker, 2024 Nobel laureate): instead of starting from amino-acid 'building blocks', RFD3 lets designers specify which atoms take part in a reaction, where they sit and which must form hydrogen bonds. In computational tests on 41 known enzyme active sites, it outperformed RFdiffusion2 in 37 and generated structures about 10 times faster. Lab tests confirmed a designed enzyme that breaks down the toxic organophosphate paraoxon and a protease that cuts a specific peptide linked to transthyretin amyloidosis. It can also design RNA.科技日报经中国科学院网站（2026-10-19）报道《科学》论文《Atomic functional site scaffolding in biopolymers with RFdiffusion3》（华盛顿大学；2024年诺贝尔化学奖得主贝克）：RFD3不再从氨基酸“积木”入手，而让设计者直接指定参与反应的原子及其位置，并要求特定原子间形成氢键。在41个已知酶活性位点的计算测试中，37个优于RFdiffusion2，生成结构速度约为其10倍。实验验证了一种能分解有毒有机磷化合物对氧磷的酶，以及一种切割与转甲状腺素蛋白淀粉样变性相关特定肽段的蛋白酶。RFD3还可设计RNA等核酸分子。

Why it matters: 为何重要：Atom-precise design brings custom enzymes — for detoxification or for breaking down disease proteins — closer to reality.原子级精准设计让定制酶——用于解毒或分解致病蛋白——更接近现实。

Science; Chinese Academy of Sciences (S&T Daily) ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-science-baker-rfdiffusion3-atomic-level-enzyme-rna-design-37-of-41-sites-10x-faster

Singapore haze: at noon Monday 1-h PM2.5 was Normal in all five regions (27–44 µg/m³) for the first time since 4 Oct; by 3pm Central (76) and West (62) were back in the Elevated band while 24-h PSI stayed Unhealthy in West 115 and Central 104新加坡烟霾：周一中午全岛五区1小时PM2.5（27–44微克/立方米）10月4日以来首次全部“正常”；但至下午3时中部（76）与西部（62）再回“偏高”，24小时PSI西部115、中部104仍属不健康

Lianhe Zaobao citing NEA (19 Oct 2026, 12:20): by noon all five regions had 1-h PM2.5 in Band I Normal — West 44, East 34, North and South 33, Central 27 µg/m³ — the first island-wide Normal reading since 4 Oct. 24-h PSI kept falling, with only West (122) and Central (103) still Unhealthy. NEA real-time data at 3pm showed 24-h PSI North 86, South 89, East 94, Central 104, West 115, while 1-h PM2.5 had risen again to 76 in Central and 62 in the West (Elevated) and 40–51 elsewhere. NEA's forecast for Monday remains 101–190 Unhealthy; south-southeasterly winds should limit Kalimantan smoke, but some Sumatran smoke may still drift in.《联合早报》引述国家环境局（2026-10-19 12:20）：截至中午，五区1小时PM2.5均处一级“正常”——西部44、东部34、北部和南部33、中部27微克/立方米，是10月4日以来首次全岛正常。24小时PSI继续回落，仅西部（122）和中部（103）仍属不健康。环境局实时数据显示，下午3时24小时PSI北部86、南部89、东部94、中部104、西部115；1小时PM2.5则在中部回升至76、西部62（偏高），其余地区40–51。环境局对周一的预测仍为101–190不健康；东南偏南风有助减少加里曼丹烟霾，但苏门答腊部分烟霾仍可能飘来。

Why it matters: 为何重要：A real but brief clean-air window — the hourly reading can swing back within hours, so check it before going outdoors.确有但短暂的清洁空气窗口——每小时读数数小时内即可反弹，外出前应先查看。

Lianhe Zaobao (NEA); NEA real-time PSI/PM2.5 (data.gov.sg) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-noon-pm25-all-normal-first-since-oct4-3pm-central-76-elevated-again

Singapore makes Crimean-Congo haemorrhagic fever, Lassa fever and Marburg virus disease legally notifiable from 31 Oct — doctors and labs must report suspected and confirmed cases; 'dangerous infectious diseases' list grows to eight新加坡自10月31日起将克里米亚-刚果出血热、拉沙热和马尔堡病毒病列为法定须通报传染病——医生和化验所须通报疑似及确诊病例；“危险传染病”名单增至8种

The Straits Times (19 Oct 2026): following September amendments to the Infectious Diseases Act by MOH, the Communicable Diseases Agency (CDA) said all medical practitioners and clinical laboratories must notify suspected and confirmed CCHF, Lassa and Marburg cases from 31 Oct. All three are viral haemorrhagic fevers with person-to-person potential and no approved vaccine or specific antiviral; WHO puts fatality as high as about 40% (CCHF) and about 50% on average (Marburg). CDA said the local risk remains low and the move strengthens early detection, isolation and contact tracing. They join Ebola, MERS, plague, SARS and yellow fever on the Second Schedule, making eight 'dangerous infectious diseases'; CDA's weekly bulletin will include them from November.《海峡时报》（2026-10-19）：卫生部9月修订《传染病法》后，传染病机构（CDA）表示，自10月31日起所有医生和临床化验所须通报克里米亚-刚果出血热、拉沙热和马尔堡病毒病的疑似与确诊病例。三者均为可能人传人的病毒性出血热，尚无获批疫苗或特效抗病毒药；世卫数据显示病死率最高可达约40%（克里米亚-刚果出血热），马尔堡平均约50%。CDA称本地风险仍低，此举旨在加强早期发现、隔离和接触者追踪。三种疾病将与埃博拉、中东呼吸综合征、鼠疫、SARS和黄热病一同列入第二附表，“危险传染病”增至8种；CDA周报将自11月起纳入。

Why it matters: 为何重要：Preparedness move as Ebola spreads in East Africa — Singapore widens its legal net for high-fatality viral fevers.在东非埃博拉扩散之际的备战举措——新加坡扩大对高致死病毒性出血热的法律监测网。

The Straits Times (Communicable Diseases Agency) ↗ · r-2026-10-sg-cda-cchf-lassa-marburg-added-ida-mandatory-notification-oct31

North Sumatra: fire smoke reaching Toba regency linked to about 500 ISPA visits in a week across 18 puskesmas (most at Pintu Pohan Meranti, 51); some patients needed hospital care for breathlessness北苏门答腊：林火烟霾飘至多巴县，一周内18家社区卫生中心合计约500例急性呼吸道感染就诊（Pintu Pohan Meranti最多，51例）；部分气促患者需住院

Mistar.id (19 Oct 2026): Toba Health Office head Freddy Sibarani (also acting director of RSUD Porsea) said smoke from forest fires elsewhere has been carried into the regency and ISPA cases are found daily, mostly mild cough but some with shortness of breath requiring hospital care; the rise is 'not very significant'. Last-week counts across 18 puskesmas add up to 497 (e.g., Pintu Pohan Meranti 51, Soposurung 45, Tandang Buhit 45, Laguboti 41; Tampahan and Nassau 7 each). Residents are urged to wear masks outdoors, limit outdoor activity when smoke is thick, eat well, rest and seek care for breathing complaints.Mistar.id（2026-10-19）：多巴县卫生局长Freddy Sibarani（兼波尔赛县医院代理院长）表示，外地林火烟霾随风进入该县，每天都有急性呼吸道感染病例，多为轻咳，也有气促需住院者；增幅“不算显著”。上周18家社区卫生中心病例合计497例（如Pintu Pohan Meranti 51、Soposurung 45、Tandang Buhit 45、Laguboti 41；Tampahan和Nassau各7）。呼吁居民外出戴口罩、浓烟时减少户外活动、注意营养休息，有呼吸道不适及时就医。

Why it matters: 为何重要：Shows haze health effects reaching districts far from the fire hotspots, around Lake Toba.显示烟霾健康影响已波及远离火点的多巴湖周边地区。

Mistar.id (Dinkes Kabupaten Toba) ↗ · r-2026-10-north-sumatra-toba-haze-ispa-497-cases-18-puskesmas-week-pintu-pohan-51

Japan MHLW issues a revised workplace health-promotion guideline (effective 19 Oct): employers should now encourage screening and follow-up for cancer, women's health problems, dental disease, osteoporosis and eye disease, and support treatment-work balance日本厚生劳动省公示修订版《事业场劳动者健康保持增进指针》（10月19日起适用）：雇主应鼓励员工接受癌症、女性特有健康问题、牙科疾病、骨质疏松和眼科疾病的筛查与精查，并支持治疗与工作兼顾

MHLW public notice No. 13 under Article 70-2 of the Industrial Safety and Health Act (19 Oct 2026, Minister Kenichiro Ueno): beyond primary prevention of lifestyle disease, the revision explicitly places secondary prevention — encouraging screening and detailed follow-up tests for cancer, women-specific issues (irregular or heavy periods, dysmenorrhoea, PMS, menopause), dental disease, osteoporosis and eye disease — among workplace health-promotion measures. It also spells out cooperation with health insurers and support for employees to keep working while being treated. Applies from 19 Oct 2026.厚生劳动省依据《劳动安全卫生法》第70条之2发布第13号公示（2026-10-19，大臣上野贤一郎）：在生活习惯病一级预防之外，修订版明确将二级预防——鼓励接受癌症、女性特有健康问题（月经不调、痛经、经量过多、经前综合征、更年期障碍等）、牙科疾病、骨质疏松和眼科疾病的筛查与精密检查——列为职场健康保持增进措施，并写明与医疗保险者合作及治疗与就业兼顾支援。自2026年10月19日起适用。

Why it matters: 为何重要：Pushes Japan's employers from lifestyle advice toward catching disease early, including women's health for the first time in this guideline.推动日本雇主从生活方式建议转向早期发现疾病，并首次在该指针中纳入女性健康。

Ministry of Health, Labour and Welfare (Japan) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-mhlw-revised-workplace-health-guideline-cancer-womens-health-dental-osteoporosis-eye-screening

Japan's NIBN and the Cancer Institute (JFCR) build a T-cell-engaging bispecific antibody against the shared KRAS G12V neoantigen that works across two HLA types (A*11:01 and A*03:01); shrinks tumours in mice — could fit about 5% of pancreatic and 2% of colorectal cancers日本医药基盘·健康·营养研究所与癌研会开发靶向共享KRAS G12V新抗原的T细胞衔接双特异性抗体，可跨两种HLA型（A*11:01与A*03:01）起效；小鼠中抑制肿瘤——或适用于约5%胰腺癌和2%结直肠癌患者

NIBN press release (19 Oct 2026; J Immunother Cancer, doi 10.1136/jitc-2026-016411): Kazuma Kiyotani's team engineered a bispecific that binds the KRAS G12V peptide presented on HLA-A*11:01 and CD3 on T cells, redirecting T cells to kill cancer cells and suppressing tumour growth in mouse xenografts. The same antibody also recognised the G12V neoantigen on HLA-A*03:01, so one drug may serve two HLA types. Based on KRAS G12V and HLA frequencies, about 5% of pancreatic and 2% of colorectal cancer patients could be eligible; more HLA-specific antibodies could widen reach. Preclinical only.医药基盘研究所新闻稿（2026-10-19；《癌症免疫治疗杂志》，doi 10.1136/jitc-2026-016411）：清谷一马团队构建了同时结合HLA-A*11:01所呈递KRAS G12V肽段与T细胞CD3的双特异性抗体，引导T细胞杀伤癌细胞，在小鼠移植瘤模型中抑制肿瘤生长。该抗体也能识别HLA-A*03:01呈递的G12V新抗原，一种药或可覆盖两种HLA型。按KRAS G12V与HLA频率估算，约5%胰腺癌和2%结直肠癌患者可能适用；开发更多HLA型抗体可扩大覆盖。目前仅为临床前研究。

Why it matters: 为何重要：An 'off-the-shelf' route to hit a common cancer mutation — and HLA-A*11:01 is especially common in East Asians.针对常见癌症突变的“现货型”路径——且HLA-A*11:01在东亚人群中尤为常见。

NIBN / JFCR press release (Kyodo PR Wire); Journal for ImmunoTherapy of Cancer ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nibn-jfcr-kras-g12v-neoantigen-tcr-mimic-bispecific-hla-a1101-a0301-jitc

Korea KDCA: plans to switch older adults to high-dose/adjuvanted flu vaccines — 75+ from 2027, 70+ in 2028, 65+ in 2029, if funded — but says extra conjugate pneumococcal (PCV) shots for people who already had PPSV23 need longer-term review韩国疾病管理厅：计划为老年人改用高剂量／佐剂流感疫苗——若获拨款，2027年起75岁以上、2028年70岁以上、2029年65岁以上；但已接种23价多糖肺炎疫苗者是否追加结合疫苗（PCV）需中长期研究

Medical Today/Ilgan Bosa (19 Oct 2026), citing KDCA written answers to National Assembly audit questions: KDCA agrees PCV gives strong, 10+-year protection, but notes PPSV still shows 34.0–73.1% effectiveness against invasive pneumococcal disease in people 65+ (PCV 36.0–75.0%) and that the UK and Japan did not re-vaccinate prior PPSV recipients, so funding PCV for them will be reviewed on clinical evidence, cost-effectiveness and budget. For influenza, KDCA aims to move all 65+ to high-immunogenic vaccines (high-dose and adjuvanted), starting with 75+ in the October 2027 season, then expanding by five years of age annually — though the 2027 government budget bill does not yet include the money.《医学新闻·日刊保社》（2026-10-19）援引疾病管理厅对国会国政监查书面质询的答复：疾管厅认同PCV保护力强且可维持10年以上，但指出65岁以上人群中PPSV对侵袭性肺炎球菌病仍有34.0–73.1%的保护效果（PCV为36.0–75.0%），且英日两国未给既往PPSV接种者补种，因此是否资助补种PCV将视临床证据、成本效益和财政情况中长期研究。流感方面，疾管厅目标是将65岁以上全部转为高免疫原性疫苗（高剂量与佐剂型），自2027年10月流感季先覆盖75岁以上，此后每年下调5岁——但2027年政府预算案尚未纳入相关经费。

Why it matters: 为何重要：Sets out how Korea plans to upgrade vaccines for its fast-ageing population — and where the money is still missing.勾勒韩国为快速老龄化人群升级疫苗的路线图——以及仍缺的经费。

Medical Today / Ilgan Bosa (KDCA audit answers) ↗ · r-2026-10-kdca-pcv-for-ppsv-recipients-long-term-review-high-immunogenic-flu-vaccine-75plus-2027

Korean team turns urine-derived stem cells into NGF-boosted neural crest cells on a 3D-printed scaffold, restoring erectile function in rats with cavernous-nerve injury — aimed at impotence after prostate-cancer surgery (Bioactive Materials)韩国团队将尿液来源干细胞分化为高表达神经生长因子的神经嵴细胞并负载于3D打印支架，使海绵体神经损伤大鼠的勃起功能恢复——针对前列腺癌术后勃起功能障碍（《Bioactive Materials》）

Financial News (19 Oct 2026): Konkuk University's Cho Ssang-goo with Seoul National University and Wonkwang University teams differentiated urine-derived stem cells into neural crest cells and added the nerve growth factor (NGF) gene, so they secrete over 1,000 times more NGF. The cells were loaded on a 3D-printed biodegradable polymer scaffold coated with chitosan/hyaluronic-acid hydrogel so they stay at the injury site. In rats with cavernous-nerve injury, the ICP/MAP erectile ratio returned to normal, myelinated fibre ratio doubled, and penile apoptosis and fibrosis were reduced. About 60–70% of prostate-cancer surgery patients develop erectile dysfunction from nerve injury. Animal data only.《韩国金融新闻》（2026-10-19）：建国大学赵双求团队联合首尔大学、圆光大学团队，将尿液来源干细胞分化为神经嵴细胞并导入神经生长因子（NGF）基因，使其NGF分泌量提高1,000倍以上；再将细胞负载于涂有壳聚糖／透明质酸水凝胶的3D打印可降解高分子支架上，以便留驻损伤部位。在海绵体神经损伤大鼠中，海绵体内压与平均动脉压之比恢复至正常，有髓神经比例提高一倍，阴茎组织凋亡与纤维化减轻。约60–70%前列腺癌手术患者会因神经损伤出现勃起功能障碍。目前仅为动物数据。

Why it matters: 为何重要：A low-burden cell source (urine) plus gene-boosted cells targets a common, quality-of-life-wrecking side effect of cancer surgery.以低负担的细胞来源（尿液）加基因增强细胞，针对癌症手术常见且严重影响生活质量的副作用。

Financial News (Konkuk University) ↗ · r-2026-10-konkuk-snu-wonkwang-urine-stem-cell-ngf-neural-crest-3d-scaffold-cavernous-nerve-ed-bioact-mater

Catholic Medical Center (Seoul) coats stem-cell-derived heart muscle cells with a collagen-hybridizing peptide in under an hour — no gene editing — so they stick to damaged collagen after heart attack; better engraftment and heart function in animals韩国天主教中央医疗院在1小时内、无需基因改造，为干细胞来源心肌细胞表面接上胶原杂交肽，使其靶向心梗后变性胶原；动物实验中细胞存活和心功能改善

Kuki News (19 Oct 2026): Koo Hee-beom and Uijeongbu St. Mary's cardiologist Park Hun-jun used lipid insertion and click chemistry to attach collagen-hybridizing peptide (CHP) evenly to human pluripotent-stem-cell-derived cardiomyocytes. Modified cells bound selectively to denatured collagen (abundant in infarcted tissue) while keeping their structure and electrophysiological and metabolic function. Injected into the border zone of ischaemia-reperfusion infarcts in animals, they kept ejection fraction and fractional shortening higher than controls from week 1 and reduced adverse remodelling over 6 weeks. Published online in Bioactive Materials.《国民日报·Kuki新闻》（2026-10-19）：具熙范教授与议政府圣母医院循环内科朴勋俊教授团队利用脂质插入和点击化学，将胶原杂交肽（CHP）均匀连接到人多能干细胞来源心肌细胞表面。改造后的细胞选择性结合心梗组织中大量存在的变性胶原，且结构及电生理、代谢功能不受影响。注入动物缺血再灌注心梗边缘区后，自第1周起射血分数和缩短分数均高于对照，6周内不良心脏重构减轻。成果在线发表于《Bioactive Materials》。

Why it matters: 为何重要：Tackles the main reason cardiac cell therapy fails — transplanted cells wash away — with a quick, gene-free fix.以快速、无基因改造的方法解决心脏细胞治疗失败的主因——移植细胞被冲走。

Kuki News (Catholic Medical Center) ↗ · r-2026-10-cmc-catholic-collagen-hybridizing-peptide-surface-cardiomyocytes-engraftment-mi-bioact-mater

Taiwan: Nantou reports 17 flu/COVID severe-complication deaths this year, with case-fatality above the national rate; nationally 1,747 severe flu cases and 378 deaths, 794 severe COVID cases and 176 deaths; none of Nantou's dead were vaccinated台湾：南投县今年流感及新冠并发重症死亡累计17例，死亡比例高于全台；全台流感并发重症1,747例、死亡378例，新冠并发重症794例、死亡176例；南投死者均未接种疫苗

China Times (19 Oct 2026): Nantou County Health Bureau said that as of 19 Oct the county had 39 severe flu cases with 10 deaths (25.6%) and 30 severe COVID cases with 7 deaths (23.3%), both above national ratios. Taiwan CDC national figures: 1,747 severe flu cases, 378 deaths (21.6%); 794 severe COVID cases, 176 deaths (22.2%). Apart from one 49-year-old with chronic illness (flu) and one 56-year-old (COVID), all who died were 70+, and none had been vaccinated. Phase 2 of publicly funded vaccination opens on 1 Nov to everyone 50+.《中时新闻网》（2026-10-19）：南投县卫生局称，截至10月19日县内流感并发重症39例、死亡10例（25.6%），新冠并发重症30例、死亡7例（23.3%），均高于全台比例。疾管署全台数据：流感并发重症1,747例、死亡378例（21.6%）；新冠并发重症794例、死亡176例（22.2%）。除一名49岁慢性病患者（流感）和一名56岁患者（新冠）外，死者均为70岁以上，且全部未接种疫苗。第二阶段公费疫苗11月1日起开放50岁以上民众接种。

Why it matters: 为何重要：Concrete local evidence that unvaccinated older adults bear most deaths in Taiwan's early flu–COVID season.具体的地方证据：台湾提早到来的流感与新冠季中，未接种疫苗的长者承担了大部分死亡。

China Times (Nantou County Health Bureau; Taiwan CDC) ↗ · r-2026-10-taiwan-nantou-17-flu-covid-severe-deaths-fatality-above-national-1747-378-flu-794-176-covid

Taiwan CDC: 3,240,421 flu and 1,016,881 COVID doses given 1–17 Oct (up 9.5% and 37.2% on last year); spokesperson expects flu and COVID to stay fairly stable to year-end barring viral change, with the next wave around Lunar New Year台湾疾管署：10月1–17日流感疫苗接种324万421剂、新冠疫苗101万6881剂（较去年同期增9.5%和37.2%）；发言人预估除非病毒变异，年底前疫情相对稳定，下一波或在明年农历春节

Hit FM news (19 Oct 2026): Taiwan CDC figures show 3,240,421 flu doses from 1–17 Oct vs 2,958,755 a year earlier, and 1,016,881 COVID doses vs 741,194. Spokesperson Lin Ming-cheng credited health-coin incentives, rising COVID activity and fewer side effects with this year's vaccine. Weighing hosts, pathogen and environment, he said flu and COVID should be relatively stable through year-end unless the viruses mutate, but crowds at election rallies call for vaccination, hand-washing and masks; another wave is expected around Lunar New Year 2027.Hit FM新闻（2026-10-19）：疾管署统计10月1–17日流感疫苗接种3,240,421剂（去年同期2,958,755剂），新冠疫苗1,016,881剂（去年同期741,194剂）。发言人林明诚将增长归因于健康币诱因、新冠疫情上升及今年新冠疫苗副作用较少。综合人群、病原和环境因素，他表示除非病毒变异，年底前流感和新冠应相对稳定，但选举造势人潮聚集仍须接种疫苗、勤洗手、戴口罩；预计明年农历春节前后会再有一波。

Why it matters: 为何重要：Shows incentives can lift uptake — and gives Taiwan's official read on when the next surge may come.显示激励措施可提升接种率——并给出台湾官方对下一波高峰时间的判断。

Hit FM news (Taiwan CDC) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-taiwan-cdc-flu-vax-3240421-up-9-5pct-covid-1016881-up-37-2pct-next-wave-lunar-new-year

India: FSSAI proposes banning added sucrose and fructose in foods for infants up to six months, in a draft amendment to the 2020 Infant Nutrition Regulations open for 60 days of comment印度：食品安全标准局拟禁止在6个月以下婴儿食品中添加蔗糖和果糖，《婴儿营养条例（2020）》修订草案公开征求意见60天

PTI via ETHealthworld (19 Oct 2026), citing the Health Ministry: the draft Food Safety and Standards (Foods for Infant Nutrition) Amendment Regulations, 2026 state that 'sucrose and fructose shall not be added in the products intended for infants up to the age of 6 months'. Current rules prefer lactose and glucose polymers as carbohydrate sources but allow sucrose/fructose within limits. The ministry links the change to cutting early exposure to added sugar and childhood-obesity risk, and says it complements advice for exclusive breastfeeding in the first six months. Stakeholders have 60 days to object or suggest changes.PTI经ETHealthworld（2026-10-19）援引卫生部：《食品安全与标准（婴儿营养食品）修订条例草案（2026）》规定“6个月以下婴儿产品中不得添加蔗糖和果糖”。现行规定以乳糖和葡萄糖聚合物为首选碳水来源，但允许在限量内添加蔗糖／果糖。卫生部称此举旨在减少早期添加糖暴露及儿童肥胖风险，并与前6个月纯母乳喂养建议相辅相成。相关方可在60天内提出异议或建议。

Why it matters: 为何重要：Targets added sugar at the very start of life in the world's most populous country.在全球人口最多的国家，从生命最初阶段限制添加糖。

ETHealthworld / PTI (Ministry of Health and Family Welfare; FSSAI) ↗ · r-2026-10-india-fssai-draft-ban-added-sucrose-fructose-infant-foods-under-6-months-60-day-consultation

Hebei: Handan First Hospital treats a 63-year-old man with complete situs inversus ('mirror-image organs', about 1 in 10,000) and life-threatening gallstone cholangitis with staged ERCP then laparoscopic gallbladder removal; no complications河北：邯郸市第一医院为一名63岁完全性内脏反位（“镜面人”，约万分之一）合并危重胆管炎患者分期完成ERCP取石与腹腔镜胆囊切除，无并发症

Handan Evening News via Sina (19 Oct 2026): the man arrived with four days of upper-abdominal pain, jaundice, gallbladder and common-bile-duct stones, obstructive jaundice and cholestatic hepatitis, and briefly went into shock from severe cholangitis. Because his liver, gallbladder and bile duct sit on the left, the team chose a staged plan: Peng Xinghua's team first cleared the duct stones by ERCP with reversed anatomy, then Wang Lin's team removed the gallbladder laparoscopically once liver function recovered. There was no bleeding, infection, bile-duct injury or pancreatitis, and he has been discharged.《邯郸晚报》经新浪（2026-10-19）：患者因上腹痛4天入院，伴黄疸，诊断为胆囊结石、胆总管结石、梗阻性黄疸、胆汁淤积性肝炎，因重症胆管炎一度休克。由于其肝脏、胆囊、胆总管均位于左侧，团队采取分期方案：彭星华团队先在反向解剖下经ERCP清除胆总管结石，待肝功能恢复后由王琳主任团队完成腹腔镜胆囊切除。术中术后无出血、感染、胆管损伤或胰腺炎，患者已康复出院。

Why it matters: 为何重要：Shows how surgeons adapt routine procedures for a rare congenital mirror-image anatomy.展示外科医生如何针对罕见先天镜像解剖调整常规手术。

Handan Evening News (via Sina Finance) ↗ · r-2026-10-handan-first-hospital-situs-inversus-totalis-63m-ercp-then-laparoscopic-cholecystectomy

Kenya Ebola (Bundibugyo): health chief warns more cases are possible among quarantined contacts; 128 of 130 contacts traced and two still missing; pathologist questions why exposed health workers entered quarantine only on 9 Oct肯尼亚埃博拉（本迪布焦型）：卫生总干事警告隔离接触者中仍可能出现新病例；130名接触者中已追踪128人，仍有2人下落不明；病理学家质疑暴露医护为何10月9日才隔离

The Star, Kenya (19 Oct 2026): Director General for Health Patrick Amoth said nearly everyone exposed to the index case is quarantined and new cases are possible until their 21-day monitoring ends, but risk to the public is low; 128 of 130 identified contacts are traced (above the 85% benchmark), with efforts to find two more. The article lists patients as the index case (40-year-old who lived in DR Congo, died in Nairobi 5 Oct), three relatives and three health workers who treated him on 3–4 Oct; later reports put the total at eight. Pathologist Ahmed Kalebi asked the ministry to reconcile changing contact numbers and explain the gap before health workers' quarantine. No approved vaccine or specific treatment exists for Bundibugyo virus.肯尼亚《星报》（2026-10-19）：卫生总干事Patrick Amoth表示，几乎所有与首例接触者均已隔离，在21天观察期结束前仍可能出现新病例，但公众风险低；已识别的130名接触者中追踪到128人（高于85%基准），仍在寻找2人。文中列出的病例包括首例（曾居住刚果（金）的40岁男子，10月5日在内罗毕死亡）、三名亲属及10月3–4日为其诊治的三名医护；此后报道总数为8例。病理学家Ahmed Kalebi要求卫生部解释接触者数字变动，以及医护隔离前的时间空档。本迪布焦病毒目前无获批疫苗或特效疗法。

Why it matters: 为何重要：Contact-tracing gaps decide whether Kenya's Ebola cluster stays contained — and Asian airports are already screening (see Korea).接触者追踪漏洞决定肯尼亚埃博拉聚集能否得到控制——亚洲机场已在加强检疫（见韩国）。

The Star (Kenya Ministry of Health) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-kenya-ebola-128-of-130-contacts-traced-2-missing-amoth-more-cases-possible-hcw-quarantine-questions

ANESTHESIOLOGY 2026 (Moffitt): cancer-surgery patients who walked or exercised at least seven times a week before surgery had about half the risk of post-operative delirium (258 patients; retrospective)美国麻醉医师学会年会（ANESTHESIOLOGY 2026，莫菲特癌症中心）：术前每周步行或运动至少7次的癌症手术患者，术后谵妄风险约降低一半（258例；回顾性研究）

Yonhap (19 Oct 2026) on Jeffrey Huang's team presenting at the ASA annual meeting in San Diego: among 258 patients who had tumour surgery in 2024–2025, 64 developed delirium (CAM-positive). Those reporting walking plus moderate-to-vigorous activity (≥10 minutes per bout) seven or more times a week had about 50% lower delirium risk than less active patients; delirium patients also sat more each day. Post-operative delirium affects about one in five surgical patients and slows recovery. The authors stress it is a retrospective case-control study using self-reported activity, so causation is not proven, but it supports prehabilitation.韩联社（2026-10-19）报道Jeffrey Huang团队在圣地亚哥美国麻醉医师学会年会上的发布：2024–2025年接受肿瘤手术的258名患者中有64人出现谵妄（CAM阳性）。自报每周步行加中高强度活动（每次≥10分钟）7次及以上者，谵妄风险比活动少者低约50%；谵妄患者每天久坐时间也更长。约五分之一手术患者会出现术后谵妄并拖慢恢复。作者强调这是基于自报活动的回顾性病例对照研究，不能证明因果，但支持术前康复（prehabilitation）。

Why it matters: 为何重要：A simple, low-cost step — staying active before surgery — may also protect the brain.简单低成本的一步——术前保持活动——或许也能保护大脑。

Yonhap News (ANESTHESIOLOGY 2026) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-asa-anesthesiology-2026-moffitt-prehab-activity-7x-week-postop-delirium-50pct-lower-258-cancer

Singapore Monday afternoon haze: 24-h PSI mostly Unhealthy again — about 92 Moderate in the North to 139 Unhealthy in the West — with 1-h PM2.5 Elevated in four regions after the morning Moderate break新加坡周一午后烟霾：24小时PSI大多再度“不健康”——北部约92“中等”至西部约139“不健康”——四区1小时PM2.5偏高，上午的“中等”喘息后反弹

Red Hot Singapore reprinting CNA/NEA (19 Oct 2026): afternoon framing put the 24-h PSI from about 92 Moderate in the North to 139 Unhealthy in the West, with hourly PM2.5 Elevated in west, central, south and east. Morning readings had briefly put North, South and East into Moderate for the first time since 9 Oct while the West stayed Unhealthy (~129 at 10am). NEA still forecasts Monday 101–190 Unhealthy; showers and south-southeasterly winds may limit Kalimantan smoke Monday–Tuesday, with possible return from Tuesday night. Use 1-h PM2.5 for immediate outdoor decisions.Red Hot Singapore转载CNA/NEA（2026-10-19）：午后表述24小时PSI介于北部约92“中等”至西部约139“不健康”，西部、中部、南部和东部1小时PM2.5偏高。上午北部、南部、东部曾短暂出现10月9日以来首次“中等”，西部10时仍约129不健康。NEA仍预报周一101–190不健康；阵雨与南南东风或可限制周一至周二加里曼丹烟霾，周二晚起或再来。即时户外活动请看1小时PM2.5。

Why it matters: 为何重要：Documents how quickly Monday's Moderate relief faded in most regions.记录周一多数区域“中等”缓解消退之快。

Red Hot Singapore (CNA/NEA) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-afternoon-west-139-north-92-moderate-pm25-elevated-four-regions

Jakarta: provincial government says Kalimantan/Sumatra fire smoke is drifting away from Jabodetabek, but keeps 367 health facilities on standby (31 hospitals, 44 puskesmas, 292 pustu) and water-mist spraying at 145 buildings for respiratory surge risk雅加达：省政府称加里曼丹／苏门答腊林火烟霾正离开大雅加达，但仍备勤367家医疗机构（31家医院、44家社区卫生中心、292家辅助卫生站），并在145栋建筑喷水雾，以防呼吸道病例上升

Kompas (19 Oct 2026): Governor's special staff Chico Hakim said BMKG satellite monitoring shows smoke that briefly reached Jakarta's atmosphere beginning to move away from western Java including Jabodetabek as winds shift. Local ISPU readings can still be moderate to unhealthy from traffic and industry. Pemprov DKI has put 31 hospitals, 44 puskesmas and 292 pustu on standby for ISPA and other respiratory complaints (367 facilities total), runs water-mist devices at 145 buildings (179 units), and keeps cloud-seeding ready. If air worsens again, options include remote learning, outdoor limits for vulnerable groups and mask advisories.《罗盘报》（2026-10-19）：省长特别助理Chico Hakim称，据BMKG卫星监测，一度进入雅加达大气的烟霾正随风向变化离开包括大雅加达在内的西爪哇西部。本地ISPU仍可能因交通和工业处于中等至不健康。雅加达省政府已备勤31家医院、44家社区卫生中心和292家辅助卫生站共367家机构应对ISPA等呼吸道问题，在145栋建筑部署179套水雾设备，并保持气象催化准备。若空气再度恶化，可能采取远程教学、限制脆弱人群户外活动和口罩提示等措施。

Why it matters: 为何重要：A capital-city readiness posture after smoke briefly reached Jakarta — haze health risk is not only for fire provinces.烟霾短暂抵达雅加达后首都的备勤姿态——烟霾健康风险不限于起火省份。

Kompas (Pemprov DKI Jakarta) ↗ · r-2026-10-jakarta-dki-karhutla-smoke-easing-367-health-facilities-standby-water-mist

West Java Health Office issues an ISPA prevention circular as haze smoke spreads, urging masks and hygiene even though it has not yet received a formal Kemenkes karhutla-impact alert西爪哇省卫生厅在烟霾扩散背景下发布ISPA防控通知，即使尚未收到印尼卫生部林火健康影响正式预警，仍敦促戴口罩并做好卫生防护

Kompas Bandung (19 Oct 2026): West Java Dinkes head Raden Vini Adiani Dewi said the province is monitoring ISPA cases amid reports of fire smoke spreading to more areas. She said Dinkes has not received a Ministry of Health warning specifically on karhutla smoke impacts but has already issued a circular and asks residents to wear masks outdoors or in crowds, wash hands, rest and stay healthy. She noted influenza A is not new and vaccines exist, but vulnerable people with comorbidities can become severely ill; hospital visits she has made do not show an influenza A surge so far.《罗盘报》万隆（2026-10-19）：西爪哇省卫生厅长Raden Vini Adiani Dewi表示，在林火烟霾据报扩散至更多地区之际，省厅正监测ISPA病例。她称尚未收到卫生部专门针对林火烟霾健康影响的预警，但已发出通知，并建议民众户外或人群中戴口罩、洗手、休息并保持健康。她指出甲型流感并非新病且有疫苗，但有基础病的脆弱人群可能重症；她走访医院所见目前未见甲流病例明显激增。

Why it matters: 为何重要：Shows provincial health systems acting ahead of a formal national haze-health alert.显示省级卫生系统在全国正式烟霾健康预警之前已主动行动。

Kompas Bandung (Dinkes Jawa Barat) ↗ · r-2026-10-west-java-dinkes-ispa-circular-haze-smoke-spread-no-kemenkes-alert-yet

South Korea: with flu still circulating, only about half of priority groups are vaccinated — 45.8% of people 65+ and 43.7% of children as of 16 Oct; W41 ILI 21.6 per 1,000 (above last year's 14.4) — KDCA urges faster uptake韩国：流感仍在流行，重点人群接种仅约一半——截至10月16日65岁及以上45.8%、儿童43.7%；第41周ILI每千人21.6（高于去年同期14.4）——疾管厅敦促加快接种

Yonhap citing KDCA (19 Oct 2026): as of 16 Oct, flu vaccine coverage was 45.8% in adults ≥65 and 43.7% in children (vs 27.7% children a year earlier); COVID vaccine coverage in ≥65 was 22.1%. National free flu vaccination covers ages 6 months–14 years, pregnant people and adults ≥65. Outpatient ILI rate in week 41 (4–10 Oct) was 21.6 per 1,000 clinic patients, still above 14.4 a year earlier though down from recent weeks (W38 32.3, W39 33.0, W40 23.6). KDCA says autumn temperature swings favour respiratory viruses and urges eligible people to vaccinate promptly and follow cough etiquette.韩联社援引韩国疾病管理厅（2026-10-19）：截至10月16日，65岁及以上流感疫苗接种率45.8%，儿童43.7%（去年同期儿童27.7%）；65岁及以上新冠疫苗接种率22.1%。国家免费流感接种覆盖6个月至14岁、孕妇及65岁及以上。第41周（10月4–10日）门诊ILI为每千名就诊者21.6人，仍高于去年同期14.4，但低于近几周（第38周32.3、第39周33.0、第40周23.6）。疾管厅称秋日温差利于呼吸道病毒流行，敦促符合条件者尽快接种并做好咳嗽礼仪。

Why it matters: 为何重要：Coverage gaps in the highest-risk groups while ILI stays above last year's level.最高风险人群接种仍有缺口，而ILI仍高于去年同期。

Yonhap (KDCA) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-kdca-flu-vax-coverage-65plus-45-8pct-children-43-7pct-w41-ili-21-6

China: after a CCTV Weekly Quality Report on myopia-control lenses, Danyang (Jiangsu) market regulators open cases against four local firms for labelling and false-ad issues — microstructure lenses wholesale ~¥30 vs retail reference ¥1,980中国：央视《每周质量报告》曝光近视防控镜后，江苏丹阳市场监管对4家当地企业就标识与虚假广告立案——微结构镜片批发价约30元、零售参考价1980元

China Economic Net / Danyang AMR (19 Oct 2026): on the evening of 18 Oct, after CCTV's Weekly Quality Report on myopia-control glasses, Danyang Market Supervision Bureau said Yaocheng Optics, Boda Optics, Duo Aimei Glasses and Jicai Lenses had irregular lens labelling and false advertising; on-site checks largely confirmed the report and cases were opened. Danyang produces nearly 400 million lenses a year. Investigators found some multi-point defocus (microstructure) lenses for ≤300-degree myopia (1.56 index) wholesaled at about ¥30 — close to ordinary lenses — while product manuals listed a retail reference of ¥1,980; buyers could choose their own brand and price.中国经济网／丹阳市场监管（2026-10-19）：10月18日晚，央视《每周质量报告》报道近视防控镜问题后，丹阳市市场监督管理局通报耀程光学、博大光学、多爱美眼镜、极采镜片等4家主体存在镜片标识标签不规范、虚假广告等问题，现场核查基本属实并已立案。丹阳年产镜片近4亿副。调查发现，部分宣称高科技的多点离焦（微结构）镜片（折射率1.56、适配300度以内近视）批发价仅约30元，与普通近视镜片相近，而产品手册零售参考价为1980元；采购商可自行贴牌定价。

Why it matters: 为何重要：A major China optics hub under scrutiny over youth myopia products that parents pay premium prices for.中国重要眼镜产业基地因家长高价购买的青少年近视产品问题受到监管审查。

China Economic Net (Danyang AMR / CCTV) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-danyang-myopia-control-lenses-cctv-expose-four-firms-investigated-30-vs-1980

Lancet Gastroenterology & Hepatology: Haisco's oral THR-β agonist simedeutirom (HSK31679) in a 52-week China phase 2b MASH trial — MASH improvement without fibrosis worsening 37.3% (80 mg) and 30.0% (160 mg) vs 10.0% placebo in F2–F3 patients《柳叶刀·胃肠病与肝病学》：海思科口服THR-β激动剂simedeutirom（HSK31679）中国MASH II期b试验52周——F2–F3患者中，改善MASH且纤维化不恶化比例为80 mg组37.3%、160 mg组30.0%，安慰剂10.0%

Lancet Gastroenterol Hepatol abstract and EASL late-breaker materials (2026): multicentre, randomised, double-blind, placebo-controlled phase 2b in Chinese adults with biopsy-confirmed metabolic dysfunction-associated steatohepatitis and F2–F3 fibrosis (about 186 participants). At week 52, the primary histologic endpoint of MASH improvement without fibrosis worsening was 37.3% with HSK31679 80 mg and 30.0% with 160 mg versus 10.0% with placebo. Safety was described as generally acceptable. Haisco has also listed a larger phase 3 programme (NCT07581951). Figures are from the published abstract/conference summary; full peer-reviewed details should be checked in the paper.《柳叶刀·胃肠病与肝病学》摘要及欧洲肝病学会最新摘要（2026）：在中国成人活检确诊代谢相关脂肪性肝炎（MASH）且纤维化F2–F3患者中开展多中心、随机、双盲、安慰剂对照II期b试验（约186人）。第52周，主要组织学终点“改善MASH且纤维化不恶化”在HSK31679 80 mg组为37.3%、160 mg组30.0%，安慰剂组10.0%。安全性总体可接受。海思科另已启动更大规模III期（NCT07581951）。数据来自已发表摘要／会议综述，完整细节应以论文为准。

Why it matters: 为何重要：A China-led oral THR-β candidate posts clear histologic gains in MASH — a huge unmet need in Asia.中国牵头的口服THR-β候选药在MASH组织学终点上取得明确获益——亚洲巨大未满足需求。

The Lancet Gastroenterology & Hepatology; EASL late-breaker ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-haisco-hsk31679-simedeutirom-mash-ph2b-lancet-gastro-china-37pct-80mg

Singapore haze eases on Monday 19 Oct: 24-h PSI falls into the Moderate band in the North, South and East — the first Moderate readings anywhere in Singapore since 9 Oct — while the West (129) stays Unhealthy; NEA warns Kalimantan smoke may return from Tuesday night新加坡烟霾10月19日（周一）缓解：北部、南部和东部24小时PSI降至“中等”——为10月9日以来全岛首次出现“中等”读数；西部（129）仍属“不健康”；NEA提醒周二晚起加里曼丹烟霾或再度飘来

CNA (19 Oct 2026, NEA data): at 10am the 24-h PSI ranged from 86 in the North (Moderate) to 129 in the West (Unhealthy). The North dropped into the Moderate band at 1am — the first time any region recorded Moderate air since 9 Oct — followed by the South at 8am and the East at 10am. 1-h PM2.5 remained Elevated in the West and Central regions; the South returned to Normal at 7am. The improvement follows Sunday's 2026 peak of 230 in the West (Very Unhealthy from 8pm Saturday to 5pm Sunday). NEA still forecasts 101–190 (Unhealthy) for Monday; south-southeasterly winds and showers may limit Kalimantan smoke on Monday and Tuesday, but winds are likely to turn east-southeasterly from Tuesday night and could bring smoke back overnight. MOH reiterates: use 1-h PM2.5 for immediate decisions; N95 is generally not needed for commuting or indoors; KN95, FFP2 and KF94 masks are also effective.CNA（2026-10-19，NEA数据）：上午10时24小时PSI介于北部86（中等）至西部129（不健康）。北部于凌晨1时率先降至“中等”——为10月9日以来全岛首个“中等”读数——南部于上午8时、东部于上午10时相继跟进。西部和中部1小时PM2.5仍为“偏高”；南部于上午7时回到“正常”。此前周日西部创下2026年峰值230（自周六晚8时至周日下午5时处“很不健康”）。NEA仍预报周一为101–190（不健康）；周一、周二吹南南东风并伴阵雨，可能限制加里曼丹烟霾输入，但周二晚起风向可能转东南偏东，夜间或将烟霾带回。卫生部重申：即时活动看1小时PM2.5；通勤或室内一般无需N95；KN95、FFP2和KF94口罩同样有效。

Why it matters: 为何重要：The first real break in a record-equalling unhealthy streak — but forecasters expect it to be brief.这是追平纪录的不健康连续期中首次明显缓解——但预报显示可能只是短暂喘息。

CNA (NEA readings and advisory) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct19-morning-three-regions-moderate-first-since-oct9-west-129

South Korea adds Kenya to its Ebola 'priority quarantine management areas' from 20 Oct: arrivals who stayed in or transited Kenya in the past 21 days must file a health declaration via Q-CODE or paper form; overall domestic risk stays 'low'韩国自10月20日起将肯尼亚列入埃博拉“重点检疫管理地区”：过去21天内曾在肯尼亚停留或中转的入境者须通过Q-CODE或健康状况问卷申报；国内综合风险维持“低”

Electronic Times / KDCA (19 Oct 2026): after Kenya's first imported case on 5 Oct, further infections among family members and health workers took Kenya's total to 8 confirmed (1 death) as of 18 Oct; 128 of 130 contacts are quarantined and 2 are being traced, with no evidence yet of wide community spread. From 20 Oct KDCA will require health-status reporting for all entrants who stayed in or passed through Kenya within 21 days, send infection-prevention texts to travellers to and residents in Kenya, and link the drug utilisation review (DUR) and overseas-travel-history systems so clinics can see a patient's travel history for up to the 21-day incubation period. Anyone with fever or abdominal pain after arrival should call 1339 or a public health centre. KDCA commissioner Lim Seung-kwan said community surveillance during the 21 days after entry is as important as airport screening.《电子新闻》／韩国疾病管理厅（2026-10-19）：肯尼亚10月5日出现首例输入病例后，家属及医护人员相继感染，截至10月18日累计确诊8例（1例死亡）；130名接触者中128人已隔离、2人追踪中，尚无广泛社区传播证据。自10月20日起，疾管厅要求过去21天内在肯尼亚停留或中转的所有入境者申报健康状况，向前往及身在肯尼亚的人士发送防感染短信，并联通药品安全使用服务（DUR）与海外旅行史信息系统，使医疗机构在最长21天潜伏期内可查询患者旅行史。入境后出现发热或腹痛者应拨打1339或联系保健所。疾管厅长林承宽表示，入境后21天的社区监测与机场检疫同样重要。

Why it matters: 为何重要：A formal Asian quarantine escalation in response to Kenya's cluster, showing how the Bundibugyo outbreak is reshaping travel health rules.韩国就肯尼亚聚集性疫情正式升级检疫，显示本迪布焦埃博拉疫情正在改变旅行卫生规则。

Electronic Times (etnews) citing KDCA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-kdca-kenya-ebola-priority-quarantine-area-oct20-qcode-mandatory-21-days

Vietnam: Hanoi records 509 dengue cases in 91 wards/communes in the week of 9–16 Oct with 17 new outbreaks and 30 still active; 4,860 cases so far in 2026, no deaths — plus 230 hand-foot-mouth cases, 3 measles and 1 pertussis case in the week越南：河内10月9日至16日一周在91个坊/社录得509例登革热，新增17个疫点、仍有30个活跃疫点；2026年累计4,860例，无死亡——同周另有手足口病230例、麻疹3例、百日咳1例

VTV (19 Oct 2026) citing Hanoi CDC: weekly dengue cases rose to 509 (vs about 400 in the previous reporting period), with 17 new clusters; 30 outbreaks remain active. Year-to-date dengue totals 4,860 cases with no deaths, 3,876 below the 2021–2025 average for the same period. Hand-foot-mouth disease fell to 230 cases (−56), 6,244 YTD, with 2 active clusters. The city also logged 3 measles, 1 pertussis and 7 COVID-19 cases in the week (YTD 409 measles, 113 pertussis, 1,674 COVID-19; no deaths). Health stations are ordered to step up environmental clean-up, larval control and spraying during the September–November dengue peak, and to watch kindergartens for HFMD.越南国家电视台（2026-10-19）援引河内疾控中心：每周登革热病例升至509例（前一报告期约400例），新增17个疫点，30个仍活跃。全年累计4,860例，无死亡，比2021–2025年同期平均水平低3,876例。手足口病降至230例（减少56例），全年6,244例，2个活跃疫点。同周另录得麻疹3例、百日咳1例、新冠7例（全年麻疹409例、百日咳113例、新冠1,674例，均无死亡）。各卫生站须在9–11月登革热高峰期加强环境清理、灭蚊幼虫和喷药，并加强幼儿园手足口病监测。

Why it matters: 为何重要：Hanoi's dengue curve is still climbing into the peak months even though the year overall remains milder than average.尽管全年整体低于平均水平，河内登革热曲线仍在进入高峰月份时攀升。

VTV (Hanoi CDC) ↗ · r-2026-10-hanoi-cdc-dengue-509-cases-week-oct9-16-30-active-foci-4860-ytd-hfmd-230

South Korea: 548 patient suicide and self-harm incidents reported at medical facilities from 2022 to May 2026 — one in four (139) fatal; nursing hospitals and patient rooms most common settings韩国：2022年至2026年5月医疗机构共报告548起患者自杀及自伤事件——四分之一（139起）致死；疗养医院和病房最为常见

The Korea Herald (19 Oct 2026), citing Korea Institute for Healthcare Accreditation data obtained by Rep. Han Zee-a: annual totals were 110 (2022), 153 (2023), 120 (2024), 112 (2025) and 53 in Jan–May 2026. Of the 548, 139 (25.4%) resulted in death, 29 were severe and 97 moderate. Patients aged 80+ were involved most often (107), followed by under-19s (79). Nursing hospitals reported 151, tertiary hospitals 133, general hospitals 127 and psychiatric hospitals 110; 66.1% occurred in patient rooms. The institute said its reporting form does not record whether patients had been flagged as high-risk; the lawmaker urged better risk identification and staffing. (Korea suicide prevention hotline: 109.)《韩国先驱报》（2026-10-19）援引国会议员韩智雅获得的韩国医疗机构评价认证院数据：各年分别为110起（2022）、153起（2023）、120起（2024）、112起（2025），2026年1–5月53起。548起中139起（25.4%）致死，29起重度、97起中度。80岁以上患者最多（107起），其次为19岁以下（79起）。疗养医院报告151起，上级综合医院133起，综合医院127起，精神专科医院110起；66.1%发生在病房。认证院表示其报告表未记录患者事先是否被识别为高风险；议员呼吁改进风险识别并增加人手。（韩国自杀预防热线：109）

Why it matters: 为何重要：Highlights a patient-safety blind spot in Asia's fastest-ageing society, especially in long-term care hospitals.揭示亚洲老龄化最快社会中的患者安全盲区，尤其是长期疗养医院。

The Korea Herald ↗ · r-2026-10-korea-hospital-patient-suicide-self-harm-548-incidents-139-deaths-koiha

Korea: Bundang CHA Hospital's 'CAPTAIN' AI uses six routine blood tests to predict which liver-cancer patients will respond to atezolizumab + bevacizumab immunotherapy, beating CRAFITY and ALBI scores in IMbrave150 and real-world validation (Cancer Communications)韩国：盆唐CHA医院“CAPTAIN”AI模型利用6项常规血液指标预测肝癌患者对阿替利珠单抗+贝伐珠单抗免疫治疗的反应，在IMbrave150及真实世界验证中优于CRAFITY和ALBI评分（《癌症通讯》）

The Asia Business Daily (19 Oct 2026): Prof Jeon Hongjae (medical oncology), Prof Hwang Sohyun (pathology) and CHA University's Jo Gyehun built the machine-learning model on CRP, AFP, platelet count, total bilirubin, lymphocyte and neutrophil counts. It was trained on 354 patients from Bundang CHA and the Medical University of Vienna, then externally validated on 99 IMbrave150 Phase 3 participants and 184 Severance Hospital real-world patients, with 100 sorafenib/lenvatinib patients as comparators (737 analysed of 949 reviewed). AUC was 0.70 in IMbrave150, and CAPTAIN-defined groups differed significantly in overall and progression-free survival. Because all inputs are routine labs, it could guide first-line treatment choice without extra testing; further clinical validation is planned.《亚洲经济》（2026-10-19）：肿瘤内科全弘在教授、病理科黄素贤教授与CHA大学博士生赵桂勋基于CRP、AFP、血小板计数、总胆红素、淋巴细胞和中性粒细胞计数构建机器学习模型。模型以盆唐CHA医院和维也纳医科大学354名患者训练，并在99名IMbrave150三期试验受试者和184名延世Severance医院真实世界患者中外部验证，另以100名索拉非尼/仑伐替尼治疗患者作对照（共审阅949例，分析737例）。在IMbrave150中AUC为0.70，按CAPTAIN分组的患者总生存期和无进展生存期差异显著。由于所用指标均为常规检验，有望在不增加检测的情况下指导一线治疗选择；后续将开展进一步临床验证。

Why it matters: 为何重要：A cheap, routine-lab tool to personalise first-line immunotherapy for liver cancer, a leading cancer killer in East Asia.用廉价常规化验为肝癌一线免疫治疗提供个体化工具，而肝癌是东亚主要致死癌症之一。

The Asia Business Daily (Bundang CHA Hospital); Financial News ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-bundang-cha-captain-ai-six-blood-tests-predict-atezo-bev-hcc-response-cancer-commun

Guangdong study of 1,091 adults finds a high pre-treatment neutrophil-to-platelet ratio (NPR) from a routine blood count independently predicts severe influenza A and B and tracks IL-6 (BMC Infectious Diseases; medium — single-centre retrospective, via science-news write-up)广东一项纳入1,091名成人的研究发现，常规血常规中治疗前中性粒细胞/血小板比值（NPR）升高可独立预测甲、乙型重症流感并与IL-6相关（《BMC感染性疾病》；中等可信度——单中心回顾性研究，经科学新闻转述）

Scienmag (19 Oct 2026) summarising Zou S. et al., BMC Infectious Diseases (doi:10.1186/s12879-026-14465-2): researchers at Guangdong Second Provincial General Hospital, with Universiti Selangor (Malaysia) and Southern Medical University, analysed lab-confirmed influenza patients treated March 2016–December 2023. Pre-treatment NPR was significantly higher in severe than non-severe cases, fell after treatment (P=0.012 flu A; P=0.028 flu B), correlated with IL-6 (P<0.0001) and remained an independent predictor of severity in logistic regression (P=0.001 flu A; P<0.0001 flu B). Combining NPR with lymphocyte count better distinguished influenza patients from healthy people. Medium confidence: retrospective, single hospital, no validated cut-off reported in the write-up; prospective validation needed. Timely as flu activity rises in southern China.Scienmag（2026-10-19）概述邹某等人发表于《BMC感染性疾病》的论文（doi:10.1186/s12879-026-14465-2）：广东省第二人民医院联合马来西亚雪兰莪大学和南方医科大学，分析2016年3月至2023年12月实验室确诊的流感患者。重症患者治疗前NPR显著高于非重症，治疗后下降（甲流P=0.012；乙流P=0.028），与IL-6正相关（P<0.0001），并在逻辑回归中仍为重症的独立预测因素（甲流P=0.001；乙流P<0.0001）。NPR联合淋巴细胞计数可更好区分流感患者与健康人。中等可信度：回顾性单中心研究，转述中未给出经验证的临界值，需前瞻性验证。正值华南流感活动上升之际。

Why it matters: 为何重要：A zero-cost triage signal for flu wards if it holds up in prospective studies.若在前瞻性研究中得到证实，将成为流感病房零成本的分诊信号。

Scienmag (BMC Infectious Diseases paper) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-guangdong-second-provincial-npr-neutrophil-platelet-ratio-severe-influenza-bmc-id

Nine papers in Cell, Molecular Cell, Current Biology and Cell Press Blue map mitochondrial proteomes across six organisms spanning the eukaryotic tree — 8,619 proteins in 3,199 families, including 33 families found in parasites such as malaria and sleeping-sickness pathogens but absent in humans《细胞》《分子细胞》《当代生物学》等9篇论文绘制覆盖真核生命之树6种生物的线粒体蛋白质图谱——8,619种蛋白、3,199个家族，其中33个家族存在于疟疾、昏睡病等寄生虫中而人类没有

China Science Daily via Sina (19 Oct 2026): the consortium led by HHMI mitochondrial biologist Vamsi Mootha combined new proteomes from five single-celled parasites and one plant with known human and yeast data. About 43% of the 3,199 families are not in the Pfam database. In Giardia (≈280 million infections a year) they identified 59 mitochondrion-like proteins, 27 of them new and 34 of unknown function, hinting at unexplored metabolic pathways. Mootha says the parasite-only families are ideal precision drug targets. AI prediction across 203 eukaryotic genomes found 1,420 previously unrecorded families; phylogenetic mapping supports a late origin of mitochondria in eukaryotic evolution, though Nick Lane cautions long branches can also reflect rapid evolution. Papers include doi:10.1016/j.cell.2026.08.029 and doi:10.1016/j.cub.2026.07.074.《中国科学报》经新浪（2026-10-19）：由霍华德·休斯医学研究所线粒体生物学家Vamsi Mootha领导的团队，将5种单细胞寄生虫和1种植物的新线粒体蛋白质组与已知的人类和酵母数据整合。3,199个家族中约43%未被Pfam数据库收录。在每年感染约2.8亿人的贾第鞭毛虫中鉴定出59种类线粒体细胞器蛋白，其中27种为新发现、34种功能未知，提示存在尚未研究的代谢途径。Mootha表示，仅见于寄生虫的蛋白家族是理想的精准药物靶点。对203种真核生物基因组的AI预测发现1,420个此前未记录的家族；系统发育分析支持线粒体在真核生物进化后期出现的假说，但Nick Lane提醒长分支也可能反映快速进化。论文包括doi:10.1016/j.cell.2026.08.029及doi:10.1016/j.cub.2026.07.074。

Why it matters: 为何重要：A new parts list for the cell's power plants that could yield drugs hitting parasites but sparing human cells.为细胞“能量工厂”提供新的零件清单，或可开发只打击寄生虫而不伤人体细胞的药物。

Institutions: 机构：Broad布罗德

China Science Daily (via Sina Tech); Cell ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-mootha-mitochondrial-proteome-atlas-six-eukaryotes-8619-proteins-parasite-targets-cell

Philippines: Agusan del Sur dengue outbreak worsens to 2,572 cases and 16 deaths this year; children aged 10–14 hit hardest and schools suspend classes for fogging菲律宾：南阿古桑省登革热疫情恶化，今年已达2,572例、16人死亡；10–14岁儿童受影响最重，学校停课灭蚊

Philippine Daily Inquirer (19 Oct 2026): the province declared a dengue outbreak on 1 Oct after sustained rises; from January to 15 Oct it recorded 2,572 cases and 16 deaths (ages 4–52). Children aged 10–14 made up 18.39% of infections and the mean patient age was 16; about 73.7% of cases needed hospital admission or facility treatment. Bayugan City had six deaths and Rosario five; Rosario has the highest attack rate at 12 per 1,000 residents (649 cases). Agusan del Sur National High School suspended classes on 13 Oct for misting and fogging; the Provincial Health Office has deployed vector-control teams and active community screening, and warns against self-medication. Nationally, DOH counted 192,112 dengue cases to 7 Oct (logged earlier).《菲律宾每日询问者报》（2026-10-19）：该省在病例持续上升后于10月1日宣布登革热疫情；1月至10月15日共录得2,572例、16人死亡（4–52岁）。10–14岁儿童占18.39%，患者平均年龄16岁；约73.7%的病例需住院或在医疗机构治疗。巴尤甘市死亡6人、罗萨里奥5人；罗萨里奥发病率最高，每千人12例（649例）。南阿古桑国立高中10月13日停课进行喷雾灭蚊；省卫生办公室已派出病媒控制队并在社区主动筛查，警告勿自行用药。全国方面，卫生部统计截至10月7日登革热192,112例（此前已收录）。

Why it matters: 为何重要：Local dengue flare-ups can be deadly even when national totals fall — and here they strike school-age children.即便全国总数下降，局部登革热暴发仍可致命——而这次主要波及学龄儿童。

Philippine Daily Inquirer (Agusan del Sur Provincial Health Office) ↗ · r-2026-10-philippines-agusan-del-sur-dengue-outbreak-2572-cases-16-deaths

Kerala's official surveillance sheet counts 184 confirmed cases of brain-eating amoeba infection and 45 deaths so far in 2026, alongside 618 confirmed measles cases and 119 leptospirosis deaths印度喀拉拉邦官方监测日报：2026年迄今共确诊184例阿米巴脑膜脑炎（“食脑虫”感染），45人死亡；另有618例麻疹确诊病例和119例钩端螺旋体病死亡

The Kerala Directorate of Health Services' Integrated Disease Surveillance Programme daily report for 18 Oct 2026 lists, as cumulative 2026 figures, 184 confirmed amoebic meningoencephalitis cases and 45 deaths (7 cases and 1 death in October). Measles stands at 618 confirmed cases (1 death) and 1,321 suspected (2 deaths), with 102 confirmed and 485 suspected in October alone. Leptospirosis has 2,318 confirmed cases and 119 deaths; dengue 12,464 confirmed and 44 deaths; hepatitis A 6,243 confirmed and 43 deaths; scrub typhus 578 confirmed and 13 deaths; influenza 11,737 and 123 deaths. Nipah remains at one case this year. The state notes that daily figures are provisional, pending laboratory confirmation and death audits.喀拉拉邦卫生服务局综合疾病监测项目（IDSP）2026年10月18日日报列出的2026年累计数据显示：阿米巴脑膜脑炎确诊184例、死亡45例（10月新增7例、死亡1例）。麻疹确诊618例（死亡1例）、疑似1,321例（死亡2例），仅10月就有102例确诊、485例疑似。钩端螺旋体病确诊2,318例、死亡119例；登革热确诊12,464例、死亡44例；甲型肝炎确诊6,243例、死亡43例；恙虫病确诊578例、死亡13例；流感11,737例、死亡123例。尼帕病毒病今年仍为1例。邦政府说明，日报数据为初步数据，有待实验室确认和死亡审核。

Why it matters: 为何重要：Kerala has stepped up testing for free-living amoebae, which partly explains its high counts; the infection usually follows exposure to warm fresh water, and it is rarely survived.喀拉拉邦加强了对自由生活阿米巴的检测，这在一定程度上解释了其病例数之高；这种感染通常源于接触温暖淡水，存活者极少。

Kerala Directorate of Health Services (IDSP daily report) ↗ · r-2026-10-kerala-idsp-oct18-amoebic-meningoencephalitis-184-cases-45-deaths-measles-618-confirmed-lepto-2318-119-deaths

Fake-paper factories may be gaming citations in cancer research: an analysis of 33,159 cancer-journal articles found about 4,000 with paper-mill hallmarks that drew 50–100% more citations than others despite fewer readers论文工厂或在操纵癌症研究的引用数：一项对33,159篇癌症期刊论文的分析发现，约4,000篇带有论文工厂特征的论文虽读者更少，引用数却比其他论文多50%–100%

An analysis published in the Proceedings of the National Academy of Sciences (reported by The Hindu/PTI, 18–19 Oct 2026) examined 33,159 articles in cancer journals and found tell-tale citation patterns in about 4,000 suspected products of 'research paper mills' — organisations that sell authorship on fabricated papers. Clusters of interconnected suspect papers received 50–100% more citations within one to three years of publication, yet had fewer readers and were accessed less often online. They were concentrated in a subset of journals, including the Journal of Experimental and Clinical Cancer Research and Molecular Cancer, while other journals were only marginally affected. Author Adrian Barnett of Queensland University of Technology said citation counts used to judge researchers may themselves be manipulated, distorting the evidence base.据《印度教徒报》/印度报业托拉斯2026年10月18–19日报道，一项发表于《美国国家科学院院刊》（PNAS）的分析考察了33,159篇癌症期刊论文，发现约4,000篇疑似“论文工厂”（出售虚构论文署名权的机构）产品存在明显的引用异常。这些相互关联的可疑论文在发表后一到三年内获得的引用比其他论文多50%–100%，但读者更少、在线访问量更低。它们集中在部分期刊中，包括《Journal of Experimental and Clinical Cancer Research》和《Molecular Cancer》，其他期刊只受到轻微影响。作者、昆士兰科技大学的Adrian Barnett表示，用于评价科研人员的引用数本身可能遭到操纵，从而扭曲证据基础。

Why it matters: 为何重要：Medium confidence as summarised from a news report of the study; a reminder to read highly cited cancer papers critically, especially when used to justify new treatments.中等可信度：内容依据对该研究的新闻报道整理；提醒读者应批判性地看待高被引癌症论文，尤其是被用来支持新疗法时。

The Hindu (PTI) on PNAS study ↗ · r-2026-10-pnas-qut-barnett-paper-mill-citation-manipulation-4000-of-33159-cancer-articles-50-100pct-more-citations-fewer-readers

Fatty liver disease is really five different conditions, Mayo Clinic finds: combining exome data with health records for over 4,600 patients revealed five subtypes, and the genetic forms were more likely to progress to serious liver damage even without obesity or diabetes梅奥诊所发现脂肪肝实为五种不同疾病：结合4,600多名患者的外显子组数据和病历，识别出五种亚型，其中遗传型即使没有肥胖或糖尿病，也更可能进展为严重肝损伤

Researchers at Mayo Clinic and Virginia Tech (co-senior authors Shulan Tian and Eric Klee) reported in Nature Communications (ScienceDaily, 18 Oct 2026) an analysis of genetic sequencing and detailed clinical data — liver enzymes, BMI, lipids and conditions such as diabetes, depression and sleep apnoea — from more than 4,600 patients with metabolic dysfunction-associated steatotic liver disease (MASLD) in Mayo's Research Data Atlas, drawing on the Tapestry exome study of over 100,000 participants. Computer models identified five biologically distinct subtypes with different risks of liver failure, cancer, heart disease and transplant. Some were tied to obesity and diabetes, others to inherited genetic differences; the genetic subtypes were more likely to progress to advanced liver damage even in people without typical metabolic risk factors. Some subtypes were linked to depression, sleep apnoea and migraine. The team plans validation in larger, more diverse populations and will test whether subtypes respond differently to treatments such as GLP-1 drugs.梅奥诊所与弗吉尼亚理工大学研究人员（共同通讯作者Shulan Tian和Eric Klee）在《自然·通讯》发表研究（ScienceDaily 2026年10月18日报道），分析了梅奥研究数据图谱中4,600多名代谢功能障碍相关脂肪性肝病（MASLD）患者的基因测序及详细临床数据——肝酶、体重指数、血脂以及糖尿病、抑郁和睡眠呼吸暂停等疾病，数据来源包括逾10万名参与者的Tapestry外显子组研究。计算模型识别出五种生物学上不同的亚型，其肝衰竭、癌症、心脏病及肝移植风险各不相同。部分亚型与肥胖和糖尿病相关，另一些则与遗传差异相关；遗传亚型即使在没有典型代谢危险因素的人群中，也更可能进展为晚期肝损伤。部分亚型还与抑郁、睡眠呼吸暂停和偏头痛相关。团队计划在更大、更多样的人群中验证，并检验不同亚型对GLP-1类药物等治疗的反应是否不同。

Why it matters: 为何重要：Many East Asians develop fatty liver without being obese, where genetics (for example PNPLA3 variants) plays a big role; subtyping could flag who needs closer watching — though this cohort was mostly American.许多东亚人在不肥胖的情况下也会患脂肪肝，遗传因素（如PNPLA3变异）作用很大；分型有助于识别需要密切随访的人——但该队列主要为美国人群。

Institutions: 机构：Mayo梅奥

Mayo Clinic via ScienceDaily; Nature Communications ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-mayo-virginia-tech-masld-five-subtypes-4600-patients-tapestry-exome-genetic-forms-progress-natcommun

ESMO 2026: GSK's B7-H3 antibody-drug conjugate risvutatug rezetecan (Ris-Rez, licensed from China's Hansoh) shrinks tumours in 61% of patients with relapsed extensive-stage small cell lung cancer at the 8 mg/kg dose in its first global trial dataESMO 2026：GSK的B7-H3抗体偶联药物risvutatug rezetecan（Ris-Rez，授权自中国翰森制药）首个全球数据显示，8 mg/kg剂量下复发广泛期小细胞肺癌患者客观缓解率达61%

GSK press release (18 Oct 2026) on the phase Ib dose-optimisation part of EMBOLD PanTumour-101, to be presented as a poster at ESMO 2026 in Madrid: confirmed objective response rate was 61% (11/18; 95% CI 35.7–82.7) at 8 mg/kg and 32% (7/22) at 6 mg/kg every three weeks, in 50 patients with a median of two prior therapies, including some after topoisomerase-1 inhibitors or tarlatamab and with brain or liver metastases. Grade ≥3 treatment-related adverse events occurred in 42% vs 15%, mostly haematological; interstitial lung disease occurred in one of 50 patients (grade 2). Median follow-up was only 100.5 days. Together with Hansoh's Chinese phase III ARTEMIS-008 (reported to cut the risk of death by 54% vs topotecan), the data support the 8 mg/kg dose in GSK's global phase III EMBOLD SCLC-301. Investigator Dr Hye Ryun Kim (Yonsei Cancer Center) called the results encouraging.GSK新闻稿（2026-10-18）介绍EMBOLD PanTumour-101研究Ib期剂量优化部分，将在马德里ESMO 2026以壁报发布：每3周给药8 mg/kg组确认客观缓解率61%（11/18；95%CI 35.7–82.7），6 mg/kg组32%（7/22）；共50例患者，中位既往治疗2线，部分曾接受拓扑异构酶I抑制剂或tarlatamab治疗，或有脑、肝转移。≥3级治疗相关不良事件分别为42%和15%，以血液学为主；间质性肺病1/50例（2级）。中位随访仅100.5天。结合翰森在中国开展的III期ARTEMIS-008研究（报告较拓扑替康降低54%死亡风险），数据支持在GSK全球III期EMBOLD SCLC-301中采用8 mg/kg剂量。研究者、延世癌症中心Hye Ryun Kim医生称结果令人鼓舞。

Why it matters: 为何重要：Small cell lung cancer relapses fast and has few options; a China-invented ADC is now being tested worldwide.小细胞肺癌复发快、选择少；一款源自中国的ADC正在全球开展验证。

GSK press release (ESMO 2026) ↗ · r-2026-10-esmo26-gsk-ris-rez-b7h3-adc-hansoh-es-sclc-orr-61pct-8mgkg-embold-pantumour-101

Vietnam: Can Tho reports over 2,000 dengue and 1,400 hand-foot-mouth cases in Q3; year-to-date about 5,000 dengue (up on 2025) and 4,000 HFMD cases with three deaths, plus scattered measles, mpox and Japanese encephalitis越南：芹苴市第三季度登革热逾2000例、手足口病逾1400例；年内累计登革热约5000例（高于2025年同期）、手足口病逾4000例，共3人死亡，另有麻疹、猴痘和日本脑炎散发

Dan Tri (18 Oct 2026), citing the Can Tho Health Department: dengue rose seasonally with more than 2,000 cases in Q3 and 5,000 so far this year, higher than the same period of 2025, with one death. HFMD had over 1,400 Q3 cases and over 4,000 year-to-date (similar to last year), with two deaths. In Q3, 13 suspected measles/rubella cases were found (2 lab-confirmed measles, 10 clinical measles); four mpox cases (9 this year); and one more Japanese encephalitis case (6 this year). The department says the situation is basically under control and is stepping up surveillance, outbreak response and rainy-season prevention.越南《民智报》（2026-10-18）引述芹苴市卫生厅：登革热季节性上升，第三季度逾2000例，年内累计5000例，高于2025年同期，1人死亡；手足口病第三季度逾1400例，年内逾4000例（与去年持平），2人死亡。第三季度发现13例疑似麻疹/风疹（2例实验室确诊麻疹、10例临床麻疹）；猴痘4例（年内9例）；日本脑炎新增1例（年内6例）。卫生厅称疫情基本受控，将加强监测、疫点处置和雨季防控。

Why it matters: 为何重要：The Mekong Delta is facing dengue and HFMD at the same time — parents should watch for warning signs in children.湄公河三角洲正面临登革热与手足口病“叠加流行”——家长应留意儿童的危险征兆。

Dan Tri (Can Tho Department of Health) ↗ · r-2026-10-can-tho-q3-dengue-2000-ytd-5000-hfmd-4000-three-deaths-mpox-9-je-6

Singapore dengue: Lentor Gardens/Tung Po Avenue becomes a third red cluster (≥10 cases) alongside Bishan Street 12 and Ho Ching Road; 79 cases in E-week 40 and 49 in partial E-week 41; 2,643 YTD through week 40新加坡登革热：Lentor Gardens／Tung Po Avenue成为继碧山第12街、Ho Ching路之后第三个红色疫点（≥10例）；第40疫周79例、第41疫周部分49例；前40周累计2,643例

Little Big Red Dot citing NEA (18 Oct 2026): a cluster at Lentor Gardens (10) and Tung Po Avenue (2) reached red alert (≥10 cases), joining Bishan Street 12 (~16) and the large Ho Ching/Kang Ching/Tah Ching/Yuan Ching cluster (~95 cumulative). Seven clusters were active around 16 Oct. NEA logged 79 cases in the week ending 10 Oct (+8 WoW) and 49 from 11 Oct to 11am on 16 Oct; cumulative 2,643 in the first 40 E-weeks. Officers continue spraying and larviciding; residents urged to follow Mozzie Wipeout B-L-O-C-K and S-A-W bite prevention. No Zika or chikungunya clusters.Little Big Red Dot援引NEA（2026-10-18）：Lentor Gardens（10例）与Tung Po Avenue（2例）疫点升至红色警报（≥10例），与碧山第12街（约16例）及Ho Ching／Kang Ching／Tah Ching／Yuan Ching大型疫点（累计约95例）并列。10月16日前后约有7个活跃疫点。截至10月10日当周79例（周环比+8），10月11日至16日上午11时49例；前40个疫周累计2,643例。执法人员继续喷药灭幼虫；居民须落实Mozzie Wipeout的B-L-O-C-K及S-A-W防叮措施。目前无寨卡或基孔肯雅疫点。

Why it matters: 为何重要：A new northern red cluster as Singapore sits at the end of its May–October dengue peak.新加坡处在5–10月登革热高峰尾声，北部再添红色疫点。

Little Big Red Dot (NEA data) ↗ · r-2026-10-sg-dengue-lentor-gardens-tung-po-third-red-cluster-w40-79-w41-49

Indonesia haze: Health Ministry counts 311,363 acute respiratory infection (ISPA) cases in fire-hit areas as of 17 Oct — 70,239 in children under five and 49,634 in older people — across 65 districts in seven provinces; 2,609 new cases on 17 Oct after 3,827 the day before印尼烟霾：卫生部统计截至10月17日林火受灾地区急性呼吸道感染（ISPA）累计311,363例——其中5岁以下儿童70,239例、老年人49,634例——涉及7省65个县市；10月17日新增2,609例，前一日新增3,827例

Aktualitas and Metro TV (18–19 Oct 2026), quoting the Kemenkes official report of Sunday 18 Oct: cumulative ISPA cases in karhutla-affected areas rose to 311,363 (up from 283,270 reported earlier in the week), spanning Riau, South Sumatra, Jambi and West, Central, East and South Kalimantan. Under-fives account for 70,239 cases and older people 49,634. Daily new cases were 3,827 on 16 Oct and 2,609 on 17 Oct. The ministry is separating out data on pregnant women and people with asthma and COPD, and continues to monitor ISPU air-quality readings (101–199 unhealthy, 200–299 very unhealthy, >300 hazardous). The update follows the ministry's order to send 500,000 extra masks to each affected province and open oxygen houses at all affected puskesmas.Aktualitas与Metro TV（2026-10-18至19）援引印尼卫生部10月18日（周日）官方报告：林火受灾地区ISPA累计升至311,363例（本周早些时候为283,270例），覆盖廖内、南苏门答腊、占碑以及西、中、东、南加里曼丹。5岁以下儿童70,239例，老年人49,634例。每日新增病例10月16日为3,827例、10月17日为2,609例。卫生部正单独统计孕妇及哮喘、慢阻肺患者数据，并持续监测ISPU空气质量（101–199不健康、200–299很不健康、300以上危险）。此前卫生部已下令向每个受影响省份追加50万只口罩，并在所有受影响社区卫生中心开设氧气屋。

Why it matters: 为何重要：Nearly one in four haze-linked respiratory cases is a young child — the most vulnerable group is bearing the brunt.近四分之一与烟霾相关的呼吸道病例是幼儿——最脆弱的群体首当其冲。

Aktualitas (Kemenkes report); Metro TV News ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-indonesia-kemenkes-ispa-311363-oct17-70239-under5-49634-elderly-65-districts

BBC Indonesia: families of children who died amid the Kalimantan smoke — a 14-month-old in Samarinda and a 6-year-old in Kayong Utara — urge the government not to downplay the haze; public-health association IAKMI says child respiratory cases already amount to a health emergency (doctors say causation is not yet established)BBC印尼语：加里曼丹烟霾中离世儿童的家属——萨马林达一名14个月大女婴、北加荣一名6岁女童——呼吁政府勿轻视烟霾；印尼公共卫生专家协会（IAKMI）称儿童呼吸道病例已构成“卫生紧急状况”（医生表示因果关系尚未确定）

BBC News Indonesia (published 18/19 Oct 2026): media reports count at least three children who died amid the smoke. Yazlyn Syanindita, 14 months, of Palaran, Samarinda (East Kalimantan), developed breathing difficulty during a month of smoke, was initially sent home, then admitted and died on 15 Oct; her paediatrician said he could not confirm the haze as the cause, noting pneumonia and other factors. In Kayong Utara (West Kalimantan), 6-year-old Anya Shezan Banafsya died on 14 Oct of respiratory failure from ARDS with septic shock after a lung infection, in an area under months of smoke. IAKMI chair Hermawan Saputra said the 62,400 under-five ISPA cases recorded by 12 Oct are an iceberg and the situation is already a health emergency; respiratory paediatrician Fifi Sofiah explained why children (faster breathing, developing immunity) are more vulnerable to peat-fire PM2.5. East Kalimantan local data show 322,067 ISPA cases from January to 12 Oct. The article also carries practical advice: clean-air rooms, closed windows, purifiers, avoiding indoor smoke sources and keeping children under two indoors.BBC印尼语（2026年10月18/19日发布）：据媒体报道，至少三名儿童在烟霾笼罩下离世。东加里曼丹萨马林达帕拉兰区14个月大的Yazlyn Syanindita在一个月的烟霾期间出现呼吸困难，起初被建议回家，后入院并于10月15日去世；主治儿科医生表示无法确认烟霾为死因，并指出肺炎等其他因素。西加里曼丹北加荣县6岁的Anya Shezan Banafsya在肺部感染后，于10月14日因急性呼吸窘迫综合征（ARDS）合并感染性休克导致呼吸衰竭去世，当地已被烟霾笼罩数月。IAKMI主席Hermawan Saputra称，截至10月12日记录的62,400例5岁以下ISPA病例只是冰山一角，形势已属卫生紧急状况；呼吸科儿科医生Fifi Sofiah解释儿童（呼吸更快、免疫尚在发育）更易受泥炭火PM2.5伤害。东加里曼丹地方数据显示，1月至10月12日ISPA病例达322,067例。文章还提供实用建议：设置洁净空气房间、关闭门窗、使用空气净化器、避免室内烟源，两岁以下婴幼儿留在室内。

Why it matters: 为何重要：Puts human faces on the haze statistics and raises hard questions about triage and referral delays for sick children.让烟霾统计数字有了具体面孔，也对患病儿童的分诊与转诊延误提出尖锐问题。

BBC News Indonesia ↗ · r-2026-10-bbc-indonesia-haze-child-deaths-samarinda-kayong-utara-iakmi-health-emergency

Bangladesh: six more dengue deaths and 2,088 hospital admissions in 24 hours to 8am Sunday 18 Oct take the 2026 toll to 348 deaths and 112,400 admissions; October deaths pass 100 in 18 days孟加拉国：截至10月18日（周日）上午8时的24小时内新增登革热死亡6例、住院2,088例，2026年累计死亡348例、住院112,400例；10月前18天死亡已超过100例

UNB citing the Directorate General of Health Services (18 Oct 2026): of the six latest deaths, two each were in Dhaka South and Dhaka North city corporations and one each in Dhaka and Sylhet divisions. Since 1 January, 112,400 dengue patients have been admitted, of whom 106,026 have recovered. Ajker Patrika and The Asian Age report October's death toll has crossed 100 (103) within 18 days. The outbreak runs alongside Bangladesh's large measles epidemic reported earlier this month.UNB援引孟加拉国卫生服务总局（2026-10-18）：最新6例死亡中，达卡南市和达卡北市各2例，达卡专区和锡尔赫特专区各1例。自1月1日以来累计112,400名登革热患者住院，其中106,026人已康复。《今日报》（Ajker Patrika）及《亚洲时代报》报道，10月前18天死亡已超过100例（103例）。登革热流行与本月早些时候报道的大规模麻疹疫情同时发生。

Why it matters: 为何重要：Bangladesh's dengue outbreak is accelerating in October, with most deaths in Dhaka.孟加拉国登革热疫情在10月加速，死亡病例多集中在达卡。

UNB (DGHS); Ajker Patrika ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-bangladesh-dengue-348-deaths-112400-admissions-october-over-100-deaths

South Korea details telemedicine rules ahead of the 24 Dec law: repeat video consults only for the same symptom seen face-to-face at that clinic within 6 months; first-visit telemedicine only within the patient's own province (rare-disease, type 1 diabetes and disabled patients exempt); 7-day prescription cap and no narcotics or obesity drugs韩国在12月24日新法施行前细化远程诊疗规则：复诊须为6个月内在同一机构面诊过的相同症状；初诊远程诊疗仅限患者所在市道（罕见病、1型糖尿病、残障等患者例外）；处方原则上不超过7天，禁止开具麻醉药品和减肥药

Ministry of Health and Welfare via Digital Times / Yonhap (18 Oct 2026): draft amendments to the Medical Service Act enforcement rules and administrative-sanction rules are open for comment from 19 Oct to 9 Nov. Telemedicine stays clinic-based in principle, with hospital-level exceptions for rare-disease and post-surgical follow-up patients. First-visit prescriptions are limited to 7 days (one-time 30 days if prior treatment is verified). Narcotics/psychotropics, drugs prone to misuse and obesity medicines are banned except for rare-disease needs. Telemedicine is capped at 30% of a clinic's half-year visits and 500 per doctor per month on average (130 for dentists and Korean-medicine doctors), excluding night/holiday care. Video is the default, voice allowed in some cases. Platforms must register; those with 100,000+ users need certification; delivery rebates and free-drug inducements are banned, with corrective orders or business suspension for violations.韩国保健福祉部（经《数字时报》／韩联社，2026-10-18）：《医疗法实施规则》及《医疗相关行政处分规则》修订草案自10月19日至11月9日公开征求意见。远程诊疗原则上由诊所级机构提供，罕见病、术后随访等可例外由医院级机构实施。初诊处方原则上不超过7天（核实既往诊疗后可一次性开至30天）。禁止开具麻醉／精神药品、易滥用药物和减肥药，罕见病治疗需要除外。远程诊疗量不得超过机构半年总诊疗量的30%，医生月均不超过500例（牙医、韩医130例），夜间和节假日除外。原则上采用视频，部分情况允许语音。中介平台须申报，用户超10万须认证；禁止配送回扣和免费赠药等诱导行为，违者可被责令改正、停业。

Why it matters: 为何重要：Sets out how one of Asia's most wired health systems will make telemedicine permanent — and where it draws the safety lines.勾勒出亚洲数字化程度最高的医疗体系之一如何让远程诊疗常态化，以及安全红线划在哪里。

Digital Times (Yonhap / Ministry of Health and Welfare); korea.kr press release ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-korea-mohw-telemedicine-rules-notice-6-month-same-symptom-7-day-rx-no-obesity-drugs

Japan's health ministry issues guidelines for policy ads tied to films and TV dramas after a cancer-support poster linked to a film about a dying woman drew criticism — campaigns must first check acceptance by patients and families日本厚生劳动省为与电影、电视剧合作的政策宣传制定指南——此前一张与讲述女性因癌离世电影联动的癌症患者支援海报遭批评；今后须事先确认患者和家属能否接受

Jiji via The Japan Times (18 Oct 2026): the ministry had partnered with a film about a woman diagnosed with cancer to promote its support system for cancer patients and sent the poster to hospitals, but repeated social-media criticism over how patients would feel led it to ask institutions to take it down. The new guidelines ask whether such ads 'would be accepted by the people concerned' and whether they risk fostering misunderstanding or prejudice; staff must preview the work, consult cancer survivors, families and medical professionals (e.g., for screening campaigns), and the bureau director gives final approval. Other ministries have asked about the guidelines.时事通信社／《日本时报》（2026-10-18）：厚生劳动省曾与一部讲述女性确诊癌症的电影合作宣传癌症患者支援制度，并向医院等机构寄送海报，但社交媒体上就患者感受的批评不断，最终要求各机构撤下。新指南要求确认此类广告“是否能被当事人接受”及是否可能引发误解或偏见；相关部门须先观看样片，就筛查宣传等征求癌症幸存者、家属和医疗专业人员意见，最终由局长批准。其他部委已就该指南进行咨询。

Why it matters: 为何重要：A small but telling shift toward patient-centred health communication in Japan.这是日本健康传播向以患者为中心转变的一个虽小却有代表性的信号。

The Japan Times (Jiji) ↗ · r-2026-10-japan-mhlw-guidelines-tie-up-ads-films-dramas-after-cancer-poster-criticism

Tsinghua and Wuhan Tongji teams' AI-powered RUSH3D-HR intravital microscope films electroacupuncture calming immune cells in mouse spleens in real time — inflammatory neutrophil 'swarms' fall more than five-fold (Nature Biotechnology; shown at the World Conference on Traditional Medicine)清华大学与武汉同济医院团队的AI赋能活体介观三维显微成像系统RUSH3D-HR，实时拍下电针调控小鼠脾脏免疫细胞——炎症中性粒细胞“群聚”事件减少5倍以上（《自然·生物技术》；亮相世界传统医药大会）

China News Service (18 Oct 2026): the system, developed by Academician Dai Qionghai's team at Tsinghua with Prof Wang Wei's team at Tongji Hospital (Huazhong University of Science and Technology), was showcased at the 2026 World Conference on Traditional Medicine in Beijing (17–18 Oct). In a mouse acute-inflammation model, splenic neutrophils rose about 30% and formed swarms of hundreds of cells roughly 10 times more often than normal; 0.5 mA electroacupuncture at the Zusanli (ST36) point cut swarm events more than five-fold, while needling without current had a weaker effect. A custom 'Kunlun' wide-field, high-NA objective gives millimetre-scale fields at subcellular resolution, and AI-based motion correction, denoising and 3D reconstruction speed processing more than 1,000-fold; co-first author Lu Zhi said one experiment equals the throughput of about 100 earlier ones. China Daily notes the work was cited in a conference report on AI in traditional medicine. Animal study; human relevance not shown.中新网（2026-10-18）：该系统由清华大学戴琼海院士团队与华中科技大学同济医学院附属同济医院王伟教授团队联合研发，在10月17–18日于北京举行的2026世界传统医药大会上亮相。在小鼠急性炎症模型中，脾脏中性粒细胞数量增加约30%，并以约正常10倍的频率形成数百个细胞规模的“群聚”；在足三里穴施加0.5毫安电针后，群聚事件减少5倍以上，而不通电的针刺效果较弱。自主研发的“昆仑”大视场高数值孔径物镜在保持亚细胞分辨率的同时将视野扩展到毫米级，AI运动伪影校正、降噪和三维重建使数据处理速度提升千倍以上；共同第一作者卢志表示单次实验通量约相当于过去100次实验总和。《中国日报》指出该成果被收录于大会发布的人工智能赋能传统医学报告。动物研究，尚未证明对人体的意义。

Why it matters: 为何重要：Brings cell-level, visual evidence to long-debated claims about acupuncture's anti-inflammatory effects.为长期存在争议的针灸抗炎效应提供细胞层面的可视化证据。

Institutions: 机构：Tsinghua Med/Life清华医学/生科

China News Service (chinanews.com.cn); China Daily ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-tsinghua-dai-tongji-rush3d-hr-ai-intravital-imaging-electroacupuncture-spleen-neutrophil-swarms

World Conference on Traditional Medicine (Beijing): report finds 3,030 AI-related traditional-medicine patents since 2000 — 80.4% from China — with AI tongue diagnosis 85–92% accurate for some syndromes and 'digital twin' master-practitioner models piloted in county hospitals世界传统医药大会（北京）：报告显示2000年以来全球人工智能相关传统医学专利3,030件——中国占80.4%；部分证型AI舌诊准确率达85–92%，名老中医“数字孪生”模型已在县级中医院试点

China Daily and Xinhua (18–19 Oct 2026): the report, led by the CACMS Institute of Information on TCM and initiated by the Global Alliance for Traditional and Integrative Medicine, was released on Sunday at the 2026 World Conference on Traditional Medicine. It counts 6,882 high-quality academic papers since 1990 (China 47%). AI is used for tongue, pulse and facial examination, herb identification and supply-chain traceability, active-ingredient screening and digitising ancient texts; it also covers traditional Korean medicine and Ayurveda devices. Premier Li Qiang, opening the conference on Saturday, called for digital and intelligent transformation of TCM. Experts flagged gaps: high-quality datasets, language barriers, explainability and unified regulation of AI-assisted traditional medicine. Accuracy figures come from the report and have not been independently validated here.《中国日报》及新华社（2026-10-18至19）：该报告由中国中医科学院中医药信息研究所牵头、世界传统医药与整合医学联盟发起，于周日在2026世界传统医药大会期间发布。报告统计1990年以来高质量学术论文6,882篇（中国占47%）。AI已用于舌诊、脉诊、面诊，药材鉴定与供应链溯源，有效成分筛选及古籍数字化；报告还涵盖韩医传承和阿育吠陀智能诊断设备。国务院总理李强周六在开幕式上强调推动中医药数字化、智能化转型。专家指出仍需解决高质量数据集、语言障碍、可解释性及AI辅助传统医学统一监管等问题。准确率数据来自报告本身，此处未经独立验证。

Why it matters: 为何重要：Maps how fast AI is being folded into traditional medicine — and how dominant China is in the field.勾勒出AI融入传统医学的速度，以及中国在该领域的主导地位。

China Daily; Xinhua ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-wctm-beijing-ai-traditional-medicine-report-3030-patents-china-80pct-tongue-diagnosis

Indian TV actress Aishwarya Sakhuja (Saas Bina Sasural) marks 10 years of living with autoimmune type 1 diabetes, recalling she was first misdiagnosed and urging fellow patients to be gentler with themselves印度电视剧女演员艾什瓦娅·萨库加（《没有婆婆的婆家》）纪念与自身免疫性1型糖尿病共处10年，回忆最初曾被误诊，并鼓励病友善待自己

IANS (18 Oct 2026): in an Instagram post Sakhuja wrote that she was misdiagnosed 10 years ago before learning she had type 1 diabetes, describing 'ten years of insulin… highs, lows, lessons, frustration'. She said she won't romanticise the condition — 'it can be exhausting, unfair and incredibly demanding' — but it is part of her life, not all of it, and told others with T1D they don't have to manage it perfectly to be doing their best. Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells; adult-onset cases are often initially mistaken for type 2.IANS（2026-10-18）：萨库加在Instagram上写道，10年前她先被误诊，后来才得知患有1型糖尿病，形容这是“十年胰岛素……高低起伏、教训与挫败”。她说不会美化这种疾病——“它可能令人疲惫、不公平且要求极高”——但它只是生活的一部分而非全部，并告诉其他1型糖尿病患者不必做到完美也已在尽力。1型糖尿病是一种自身免疫病，免疫系统会破坏胰腺中产生胰岛素的β细胞；成人起病者常被误认为2型糖尿病。

Why it matters: 为何重要：A well-known Asian face for type 1 diabetes and the common problem of misdiagnosis in adults.为1型糖尿病及成人常见误诊问题提供了一个知名的亚洲面孔。

IANS ↗ · r-2026-10-aishwarya-sakhuja-type-1-diabetes-10-years-misdiagnosed-instagram

Singapore haze weekend: West 24-h PSI hits 230 at 10am Sunday 18 Oct — a new 2026 high — on the 14th straight unhealthy day, equalling the 2015 streak; air eases to 104–171 by 10pm as winds turn southerly; NEA forecasts 101–190 (Unhealthy) for Monday 19 Oct新加坡烟霾周末：10月18日（周日）上午10时西部24小时PSI达230，创2026年新高；当天为连续第14个不健康日，追平2015年纪录；随风向转南，晚10时回落至104–171；NEA预报10月19日（周一）为101–190（不健康）

CNA / NEA (18 Oct 2026): the West had been Very Unhealthy since 8pm Saturday and its 24-h PSI peaked at 230 at 10am Sunday, the highest reading in Singapore this year; 1-h PM2.5 at 10am was West 139, Central 117, South 82, North 72, East 71 µg/m³ (all Elevated). Malay Mail citing The Straits Times: 18 Oct was the 14th consecutive day of unhealthy air since 5 Oct, matching the 14-day run of 23 Sep–7 Oct 2015; this year's highest 1-h PM2.5 remains 288 (West, 3pm 14 Oct). NEA's 6pm update: 24-h PSI 109–192 and PM2.5 36–69 after winds shifted to blow from the south; at 10pm PSI was 104–171. Forecast for 19 Oct: 101–190 with showers, but NEA warns winds may turn east-southeasterly from Tuesday night and bring Kalimantan smoke back overnight. Weekend disruption: the FA Cup final and third-place play-off (17 Oct, Jurong East) were postponed after the West breached the FAS PSI 200 threshold; the Great Eastern Women's Run (1 Nov) was cancelled and The Purple Parade postponed to the first half of 2027. ActiveSG facilities reopened on Saturday. MOH reminds the public to use 1-h PM2.5, not 24-h PSI, for immediate outdoor decisions.CNA／NEA（2026-10-18）：西部自周六晚8时起处“很不健康”，24小时PSI于周日上午10时升至230，为今年新加坡最高读数；上午10时1小时PM2.5为西部139、中部117、南部82、北部72、东部71 µg/m³（均为“偏高”）。《马来邮报》援引《海峡时报》：10月18日是自10月5日以来连续第14个不健康空气日，追平2015年9月23日至10月7日的14天纪录；今年最高1小时PM2.5仍为288（西部，10月14日下午3时）。NEA傍晚6时更新：风向转南后24小时PSI为109–192、PM2.5为36–69；晚10时PSI为104–171。10月19日预报101–190，伴有阵雨；但NEA提醒周二晚起风向可能转东南偏东，夜间或再将加里曼丹烟霾带来。周末影响：西部超过新加坡足总PSI 200门槛，10月17日在裕廊东举行的足总杯决赛及季军赛延期；11月1日大东方女子跑取消，紫色游行（The Purple Parade）延至2027年上半年。ActiveSG设施已于周六重开。卫生部提醒：即时户外决定请看1小时PM2.5而非24小时PSI。

Why it matters: 为何重要：A new annual peak and a record-equalling streak show the haze crisis is not over, even as Monday's forecast offers some relief.年度新峰值与追平纪录的连续天数表明烟霾危机尚未结束，尽管周一预报稍有缓解。

CNA (NEA advisories); Malay Mail (The Straits Times); NEA Haze Situation Update 18 Oct ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-haze-oct18-west-psi-230-year-high-14th-day-oct19-forecast-101-190

Malaysia: Johor extends closure of all schools and educational institutions for five more days from 19 Oct as haze persists; state records 30,648 asthma and upper-respiratory infection cases in October, up 20.7% week on week马来西亚：烟霾持续，柔佛州自10月19日起再延长全州学校及教育机构停课5天；该州10月已录得30,648例哮喘及上呼吸道感染，周增幅20.7%

Malay Mail / Bernama and CNA (18 Oct 2026): State Education and Information Committee chairman Dr Muhammad Naqib Md Ghazali said the Johor Haze Management Coordination Committee decided on Saturday to extend closures for five days from Monday because API readings remain at concerning levels with no significant improvement, taking into account northward wind movement and the 3–4-day forecast; the step follows the directive of the Regent of Johor, Tunku Mahkota Ismail. Home-based teaching and learning (PdPR, MOE Manual 2.0) continues; limited exceptions may be made for exam candidates under strict SOPs, with daily review by the Johor Education Department. Private institutions and childcare centres decide for themselves but must keep activities indoors with masks. Health authorities reported 30,648 asthma and URTI cases in Johor so far in October, a 20.7% weekly increase. Johor schools first closed for two days from 8 Oct, then extended from 12 Oct.《马来邮报》／马新社及CNA（2026-10-18）：柔佛州教育与新闻委员会主席Muhammad Naqib Md Ghazali博士表示，柔佛烟霾管理协调委员会于周六决定自周一起再延长停课5天，原因是空气污染指数仍处令人担忧水平、未见明显改善，并考虑到风向北移及未来3–4天天气预报；此举遵照柔佛摄政王东姑依斯迈的指示。居家教学（PdPR，教育部手册2.0版）继续；考生可在严格标准作业程序下获有限例外，由柔佛教育局每日检讨。私立教育机构及托儿所自行决定是否开放，但须在室内活动并佩戴口罩。卫生当局称，柔佛10月迄今录得30,648例哮喘及上呼吸道感染，周增幅20.7%。柔佛学校最初自10月8日停课两天，10月12日起延长。

Why it matters: 为何重要：Johor, next to Singapore, now faces a third week of school disruption while haze-linked respiratory cases keep rising.紧邻新加坡的柔佛已进入第三周停课，而与烟霾相关的呼吸道病例仍在上升。

Malay Mail (Bernama); CNA ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-johor-schools-closed-5-more-days-oct19-asthma-urti-30648-up-20pct

Malaysia: schools in Selangor, Negeri Sembilan, Melaka, Pahang and Penang reopen on 19 Oct and Kuala Lumpur schools stay open — but all outdoor activities are suspended, masks encouraged, and Negeri Sembilan postpones end-of-session exams马来西亚：雪兰莪、森美兰、马六甲、彭亨及槟城学校10月19日复课，吉隆坡学校照常开放——但全部户外活动暂停、鼓励戴口罩，森美兰推迟学年末考试

The Straits Times and The Star / Bernama (18–19 Oct 2026): Selangor and KL education departments said face-to-face classes continue with outdoor activities suspended; students and staff are encouraged to wear masks, and parents worried about health may keep children home if they inform the school. Negeri Sembilan directed schools to postpone and reschedule end-of-academic-session and internal exams and to halt all outdoor activities whenever API exceeds 100. Melaka told administrators to monitor DOE API readings and watch high-risk students; Pahang's Bentong district operates as usual but outdoor activities are postponed; Penang asked schools to ensure enough drinking water. This follows MOE's return to the National Haze Action Plan (close at API 200, stop outdoor classes above 100). Johor schools remain shut (separate item).《海峡时报》及《星报》／马新社（2026-10-18至19）：雪兰莪及吉隆坡教育局表示面授课程继续，但暂停户外活动；鼓励师生戴口罩，担心健康的家长可在通知学校后让孩子留家。森美兰指示各校推迟并重新安排学年末考试及校内考试，并在API超过100时停止一切户外活动。马六甲要求校方监测环境局API读数并关注高风险学生；彭亨文冬县学校照常运作但户外活动延后；槟城要求学校确保饮用水充足。此前教育部已恢复执行《国家烟霾行动计划》（API达200停课、超过100停止户外课）。柔佛学校仍停课（另条）。

Why it matters: 为何重要：Shows how most of peninsular Malaysia is choosing 'open but indoors' rather than closures, shifting the burden to masks, exam rescheduling and parental choice.显示马来西亚半岛多数州选择“开放但留在室内”而非停课，把应对重点转向口罩、考试改期和家长自主选择。

The Straits Times; The Star (Bernama) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-malaysia-selangor-ns-melaka-pahang-penang-schools-reopen-oct19-outdoor-halt-masks

Indonesia Health Ministry orders 500,000 extra masks for each haze-hit province plus oxygen concentrators and medicines; every community health centre (puskesmas) in affected areas must open an 'oxygen house', and Posyandu services go door to door印尼卫生部下令向每个受烟霾影响省份追加50万只口罩，并配送制氧机和药品；受影响地区所有社区卫生中心（puskesmas）须开设“氧气屋”，社区健康站（Posyandu）上门服务

Kemenkes press release (Jakarta, 18 Oct 2026): at a daily health-sector forest/land-fire coordination meeting on Saturday 17 Oct, Coordinating Minister for Human Development and Culture Sugiono called for an integrated central–regional emergency response. Health Minister Budi Gunadi Sadikin instructed immediate dispatch of 500,000 additional masks to each affected province, with oxygen concentrators and medicines sized to local needs; all puskesmas in affected areas must run oxygen-house services and guarantee drugs, especially for acute respiratory infections and diarrhoea. Posyandu outreach will visit homes so children, pregnant women and older people keep receiving care while residents are told to stay indoors; health workers were asked to support firefighters in the field. The ministry's Health Crisis Centre (Puskris) team has been redeployed. The seven affected provinces are Riau, South Sumatra, Jambi and East, South, West and Central Kalimantan.印尼卫生部新闻稿（雅加达，2026-10-18）：在10月17日（周六）卫生领域林火每日协调会上，人类发展与文化统筹部长Sugiono要求中央与地方开展一体化应急响应。卫生部长布迪·古纳迪·萨迪金指示立即向每个受影响省份追加发送50万只口罩，并按当地需要配送制氧机和药品；受影响地区所有puskesmas须开设氧气屋服务并保障药品供应，特别是急性呼吸道感染和腹泻用药。Posyandu将上门服务，确保居民被建议留在室内期间儿童、孕妇和老人仍能获得照护；并要求医护人员在现场为灭火人员提供救治。卫生部卫生危机中心（Puskris）团队已再次派驻。七个受影响省份为廖内、南苏门答腊、占碑以及东、南、西、中加里曼丹。

Why it matters: 为何重要：Concrete national supply and service orders for millions living under the smoke, beyond the earlier case counts.在此前病例统计之外，为数以百万计生活在烟霾下的民众下达了具体的全国物资与服务指令。

Kementerian Kesehatan RI (Kemenkes) press release ↗ · r-2026-10-indonesia-kemenkes-500k-masks-per-province-oxygen-houses-all-puskesmas-posyandu-home

Indonesia, Central Kalimantan: five air stations in the 'hazardous' band on the morning of 18 Oct, led by Palangka Raya's Jekan Raya at an index of 4,099 (PM10, an extreme reading — medium confidence); forestry minister announces a dry-ice trial to clear smoke near the city's airport印尼中加里曼丹：10月18日早晨五个空气监测站处“危险”级，帕朗卡拉亚Jekan Raya站指数达4,099（PM10，极端读数——中等可信度）；林业部长宣布在该市机场附近试用干冰驱散烟霾

Kaltenginfo (citing official KLH/BPLH ISPU data at 06:38 WIB, 18 Oct 2026): Jekan Raya (Palangka Raya) 4,099 (PM10); Gunung Mas 537 (PM10); Sanggu, Barito Selatan 530 (PM10); Murung Raya 392 (PM2.5); Kotawaringin Timur 333 (PM2.5) — all above the hazardous threshold of 301, and among the 10 highest in Indonesia that morning. The outlet itself cautions that a single station does not represent a whole city and that the index is not a concentration. Forestry Minister Raja Juli Antoni, visiting fire operations in Sampit on 17 Oct, said dry ice from a Kalimantan supplier would arrive Sunday for an initial trial over Palangka Raya, mainly to improve visibility around Tjilik Riwut Airport; the method was earlier tested in South Sumatra and remains experimental. Palangka Raya's fire emergency status runs to 9 Nov (Antara). Flag: medium confidence — the 4,099 figure comes via a regional outlet and is far outside normal ranges; treat as indicative of hazardous smoke rather than a precise exposure level.Kaltenginfo（援引KLH/BPLH官方ISPU数据，2026-10-18 西印尼时间06:38）：Jekan Raya（帕朗卡拉亚）4,099（PM10）；Gunung Mas 537（PM10）；南巴里托Sanggu 530（PM10）；Murung Raya 392（PM2.5）；东哥打瓦林因333（PM2.5）——均超过301的危险门槛，并位列当晨全国前十。该媒体自身提醒：单一站点不代表全市，且指数不等于浓度。林业部长拉贾·朱利·安东尼10月17日在桑皮特视察灭火时表示，来自加里曼丹供应商的干冰将于周日运抵，首先在帕朗卡拉亚试用，主要为改善Tjilik Riwut机场周边能见度；该方法此前在南苏门答腊试验过，仍属试验性质。帕朗卡拉亚林火应急状态延至11月9日（安塔拉社）。标记：中等可信度——4,099数据来自地区媒体且远超常规范围，应视为烟霾危险的指示而非精确暴露水平。

Why it matters: 为何重要：Borneo, the source region of the smoke reaching Singapore and Malaysia, is enduring air far worse than its neighbours.向新加坡和马来西亚输送烟霾的源头婆罗洲，正承受远比邻国恶劣的空气。

Kaltenginfo (KLH/BPLH ISPU data); ANTARA Kalteng ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-kalteng-ispu-oct18-5-stations-hazardous-jekan-raya-4099-dry-ice-trial

Hong Kong CHP investigates fatal invasive pneumococcal disease in a previously healthy 9-year-old boy who died of severe pneumonia with empyema, septic shock and kidney failure; urges on-schedule PCV vaccination香港卫生防护中心调查一宗侵入性肺炎球菌病死亡个案：一名素来健康的9岁男童因重症肺炎并发脓胸、败血性休克及急性肾衰竭离世；呼吁按时接种肺炎球菌结合疫苗

HKSAR Government press release (CHP, 18 Oct 2026, 17:20): the boy developed fever, runny nose, cough and chest pain from 10 Oct, saw private doctors on 10 and 13 Oct, attended Tin Shui Wai Hospital A&E on 14 Oct with shortness of breath, was moved to the Tuen Mun Hospital paediatric ICU and died on 15 Oct. Pleural fluid grew Streptococcus pneumoniae; serotyping is pending. No travel history; home contacts are asymptomatic; the case is referred to the Coroner. CHP notes about 3% of paediatric IPD cases in the past decade were fatal; PCV (in the childhood programme since 2009) cuts children's IPD risk by 60–90%, and local incidence fell 85% in children ≤2 and 35% in those aged 2–5 after its introduction. Parents should seek urgent care for breathlessness, chest pain, blue lips, convulsions, drowsiness, stiff neck, refusal to eat, persistent vomiting or less urination.香港特区政府新闻公报（卫生防护中心，2026-10-18 17:20）：男童自10月10日起发热、流鼻水、咳嗽及咳嗽时胸痛，10月10日及13日到私家诊所求诊，14日因气促到天水围医院急症室，转往屯门医院儿童深切治疗部，15日不治。胸腔积液检出肺炎链球菌，血清型分析待完成。潜伏期内无外游；家居接触者暂无病征；个案已转介死因裁判官。中心指过去十年本地儿童侵入性肺炎球菌病约3%致命；肺炎球菌结合疫苗（2009年起纳入儿童免疫接种计划）可将儿童患病风险降低60%–90%，推行后2岁或以下及2至5岁儿童发病率分别下降85%及35%。若出现气促、胸痛、嘴唇发紫、抽搐、昏睡、颈部僵硬、拒食、持续呕吐或小便减少，应立即到急症室求医。

Why it matters: 为何重要：A reminder that pneumococcal disease can kill healthy school-age children within days, at the start of the respiratory season.呼吸道疾病季节伊始，提醒肺炎球菌病可在数日内夺去健康学龄儿童的生命。

HKSAR Government press release (Centre for Health Protection) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hk-chp-fatal-ipd-9yo-boy-tuen-mun-empyema-septic-shock-oct18

Japan: Kyoto and Hyogo prefectures pass the influenza 'advisory' level (Week 41: 10.97 and 10.15 patients per sentinel clinic) as the early-season wave spreads across Kansai; national Week 42 data due 23 Oct日本：京都府与兵库县流感超过“注意报”水平（第41周每定点医疗机构分别为10.97和10.15人），提前到来的流感潮在关西蔓延；全国第42周数据将于10月23日公布

NHK (18 Oct 2026, 6:01am) reported that patient numbers in Kyoto and Hyogo exceeded the advisory level, which signals a large epidemic may follow, and that other Kansai prefectures are also rising. MHLW's Week 41 table (5–11 Oct) lists Kyoto at 10.97 and Hyogo at 10.15 per sentinel (advisory threshold 10), nationally 12.81 with 47,746 reports versus 2.36 a year earlier; JIHS says AH1pdm09 made up 97% of recent detections and weekly flu hospitalisations rose to 1,123. MHLW will publish Week 42 (12–18 Oct) on Friday 23 Oct.NHK（2026-10-18 6:01）报道，京都府和兵库县患者数超过“注意报”水平（意味着今后可能出现大流行），关西其他府县也在增加。厚生劳动省第41周（10月5–11日）数据：京都10.97、兵库10.15（注意报门槛为10），全国12.81、报告47,746例，去年同期为2.36；国立健康危机管理研究机构称近期检出97%为AH1pdm09，每周流感住院升至1,123例。第42周（10月12–18日）数据将于10月23日（周五）公布。

Why it matters: 为何重要：The unusually early H1N1 wave is now reaching Japan's big western population centres.异常提前的H1N1流感潮正蔓延至日本西部人口密集地区。

NHK News; MHLW influenza press release (Week 41); JIHS ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-kyoto-hyogo-flu-advisory-level-oct18-w41-10-97-10-15

India: Kerala's long-running mumps outbreak (74,907 cases in 2024, 26,462 in 2025, 6,606 so far in 2026) renews calls to add MMR to the national immunisation programme; NIV study finds circulating genotype C differs from the vaccine strain印度：喀拉拉邦持续多年的腮腺炎疫情（2024年74,907例、2025年26,462例、2026年迄今6,606例）再度引发将麻腮风（MMR）疫苗纳入国家免疫规划的呼声；国家病毒研究所研究发现流行株为C基因型，与疫苗株不同

The Hindu (18–19 Oct 2026): mumps averaged just over 2,000 cases a year in Kerala until surging from November 2023, forcing weeks-long school and hostel closures in Alappuzha, Thrissur and Kottayam. India's Universal Immunisation Programme gives two doses of measles-rubella (MR) vaccine, which does not cover mumps; the Indian Academy of Paediatrics has long urged MMR instead. An RTI reply to Tamil Nadu said NTAGI does not consider mumps-associated disability a significant public-health concern and that adding mumps would more than double vaccine cost. A study by NIV's Kerala unit (Infection, Genetics and Evolution, Sept 2026) found 2024–25 viruses were genotype C, unlike the genotype N (L-Zagreb) vaccine strain — though the paper notes genetic difference alone does not prove vaccine failure. Paediatricians cite complications including pancreatitis, encephalitis, meningitis and permanent sensorineural hearing loss.《印度教徒报》（2026-10-18至19）：喀拉拉邦腮腺炎原本年均约2,000余例，自2023年11月起激增，阿勒皮、特里苏尔和戈德亚姆的学校和宿舍被迫停课数周。印度全民免疫规划提供两剂麻疹-风疹（MR）疫苗，不含腮腺炎成分；印度儿科学会长期主张改用MMR。一份对泰米尔纳德邦的信息公开答复称，国家免疫技术咨询组不认为腮腺炎相关残疾构成重大公共卫生问题，且加入腮腺炎成分会使疫苗成本增加一倍以上。国家病毒研究所喀拉拉分所的研究（《感染、遗传与进化》，2026年9月）发现2024–25年流行株为C基因型，不同于疫苗所用N基因型（L-Zagreb株）——但论文指出仅凭基因差异不能证明疫苗无效。儿科医生列举的并发症包括胰腺炎、脑炎、脑膜炎及永久性感音神经性耳聋。

Why it matters: 为何重要：A vaccine-policy gap affecting hundreds of millions of children, now backed by local outbreak and virus-sequencing data.影响数亿儿童的疫苗政策缺口，如今有本地疫情和病毒测序数据作为佐证。

The Hindu ↗ · r-2026-10-kerala-mumps-outbreak-mmr-uip-demand-genotype-c-niv-oct18

China NHC holds its 2026 National Food Safety Publicity Week theme day: 1,775 national food-safety standards now in force, digital food labels being promoted, and 11 dietary guides including one for child and adolescent obesity国家卫生健康委举办2026年全国食品安全宣传周主题日活动：累计发布食品安全国家标准1775项，推广食品数字标签，推出儿童青少年肥胖等11项食养指南

Science and Technology Daily (18 Oct 2026): the event, themed 'Uphold integrity and law, share food safety — deepen whole-chain supervision', was held at the China National Children's Center in Beijing. An official of the NHC Food Department said the commission has issued 1,775 national food-safety standards covering farm to table, is promoting digital food labels, strengthening risk monitoring and early warning, and coordinating food safety with nutrition — including dietary guidance for school and elder meals and 11 'food-as-nourishment' guides (such as for child and adolescent obesity), promoting 'less oil, more soy, add milk' and more vegetables, fruit, whole grains and aquatic foods. Expert talks covered nutrition for older people and children, children's food safety and foodborne-disease prevention; NHC, Beijing Health Commission, the China National Center for Food Safety Risk Assessment and China CDC's nutrition institute took part.《科技日报》（2026-10-18）：活动以“尚德守法，共享食安——深化全链条监管”为主题，在北京中国儿童中心举办。国家卫生健康委食品司有关负责人表示，委员会累计发布食品安全国家标准1775项，让从农田到餐桌全过程有标可依，并推广食品数字标签；强化风险监测评估和预警提示；推进食安与营养协同，加强学生餐、老年餐膳食指导，推出儿童青少年肥胖等11项食养指南，普及“减油、增豆、加奶”及多吃蔬果、全谷物和水产品等理念。专家围绕“一老一小”营养膳食、儿童食品安全科普、食源性疾病防控开展讲座；国家卫生健康委食品司、北京市卫生健康委、国家食品安全风险评估中心、中国疾控中心营养所等参加。

Why it matters: 为何重要：Sets out where China's food-safety and nutrition policy stands after recent product-safety scares.在近期产品安全事件之后，梳理中国食品安全与营养政策的现状。

Science and Technology Daily (科技日报) / NHC ↗ · r-2026-10-nhc-food-safety-week-theme-day-1775-national-standards-11-diet-guides

Kenya's Ebola (Bundibugyo) cases rise to eight: four new on Saturday — a relative and three health workers who cared for the first patient — and a 49-year-old hospital patient attendant on Sunday; all in quarantine before symptoms, says MoH肯尼亚埃博拉（本迪布焦型）病例增至8例：周六新增4例——首例患者的一名亲属及三名照护他的医护人员；周日新增一名49岁医院护工；卫生部称均在出现症状前已被隔离

Citizen Digital (18 Oct 2026), quoting Health Director-General Patrick Amoth: 38 people were tested on Sunday and one — a 49-year-old patient attendant (not a clinician) who handled utensils and linen and developed fever, headache and muscle pain — was positive for Bundibugyo virus. Saturday's four new cases were a close male relative of the index patient and three health workers. All confirmed patients are receiving monoclonal-antibody treatment under compassionate use and 'responding very well'. Amoth said contacts developed symptoms around day 9–10 while already quarantined, so community spread risk is minimal, and warned against misinformation. Kenya's first case, a man arriving from DRC on 3 Oct, died at Nairobi Hospital on 5 Oct; Kenya's costed contingency plan is about US$20 million over 3–6 months, supported by WHO, the US government and AMREF.Citizen Digital（2026-10-18）援引卫生部总干事Patrick Amoth：周日检测38人，其中一名49岁医院护工（非临床人员，负责清洗餐具和床单，出现发热、头痛和肌肉痛）本迪布焦病毒阳性。周六新增的4例为首例患者的一名男性近亲及三名医护人员。所有确诊者均在同情用药下接受单克隆抗体治疗，“反应非常好”。Amoth称接触者约在第9–10天、已处隔离状态时才发病，社区传播风险极低，并警告勿信谣传。肯尼亚首例为10月3日自刚果（金）抵达的男子，10月5日在内罗毕医院死亡；肯尼亚应急计划预算约2,000万美元（3–6个月），获世卫组织、美国政府及AMREF支持。

Why it matters: 为何重要：Health-worker infections in a regional hub like Nairobi are a key test of whether Ebola can be contained outside DRC.内罗毕这样的区域枢纽出现医护人员感染，是检验埃博拉能否在刚果（金）以外被遏制的关键。

Citizen Digital (Kenya Ministry of Health); AP ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-kenya-ebola-8-cases-patient-attendant-hcws-monoclonal-oct18

Australia: UTS researchers' transformer AI reads DNA to flag ischaemic-stroke risk, identifying 18 linked variants and the brain-cortex gene EDEM2; the highest genetic-risk group had a 22% higher stroke chance澳大利亚：悉尼科技大学团队用Transformer人工智能读取DNA评估缺血性卒中风险，发现18个相关变异及脑皮层基因EDEM2；遗传风险最高组卒中概率高22%

Xinhua (Sydney, 18 Oct 2026), citing a University of Technology Sydney statement: the model was trained on thousands of genetic variations and tested on UK Biobank and a large US database, outperforming earlier polygenic tools at distinguishing people who had a stroke from those who had not. People in the highest genetic-risk group had a 22% higher chance of ischaemic stroke than the lower-risk group. EDEM2 expression in brain cortex emerged as a key contributor to susceptibility and a research target. The team is now building a multimodal tool combining genetics with health and lifestyle surveys and imaging.新华社（悉尼，2026-10-18）援引悉尼科技大学声明：模型以数千个遗传变异训练，并在英国生物银行及一个大型美国数据库中测试，在区分卒中与非卒中人群方面优于以往多基因风险工具。遗传风险最高组发生缺血性卒中的概率比较低风险组高22%。脑皮层中EDEM2基因被确定为卒中易感性的关键贡献因素和研究靶点。团队正开发结合遗传、健康与生活方式问卷及影像的多模态工具。

Why it matters: 为何重要：Genetic risk scores boosted by AI could help target stroke prevention before the first event.AI增强的遗传风险评分有望在首次卒中前实现精准预防。

Xinhua (University of Technology Sydney statement) ↗ · r-2026-10-uts-transformer-ai-stroke-genetic-risk-18-variants-edem2-xinhua

Singapore: born floppy at 29 weeks and first thought to have muscular dystrophy, 16-year-old Jarren Ng has congenital hypomyelinating neuropathy — a fewer-than-one-in-a-million disorder in which nerves lack their myelin insulation. Ventilator-dependent since age two, he has finished his N Levels and wants a career in cybersecurity新加坡：29周早产、出生时全身松软、起初被疑为肌营养不良的16岁少年Jarren Ng，最终确诊“先天性髓鞘形成不良性神经病”——发病率不到百万分之一，神经缺乏髓鞘“绝缘层”。他两岁起依赖呼吸机，如今已完成N水准考试，希望从事网络安全工作

The Straits Times 'Medical Mysteries' series (17 Oct 2026): Jarren was delivered by emergency caesarean at 29 weeks after his mother had a 42 °C fever, and went straight to the NICU with hypotonia needing breathing and feeding support. Dr Koh Ai Ling (Genomic Medicine, KK Women's and Children's Hospital) said blood tests, brain imaging, muscle biopsy, electromyography and genetic testing were done; it was the nerve conduction study that pointed to congenital hypomyelinating neuropathy (CHN), in which myelin around peripheral nerves fails to develop so signals are slowed or disrupted. CHN occurs in fewer than one in a million live births, there is no routine antenatal screen, and in Jarren's case genetic tests did not identify a cause. He was tube-fed until two, then had a PEG button and a tracheostomy, relies on a ventilator, has an annual sleep study and microlaryngobronchoscopy, and had undergone 14 operations by age six. A KKH multidisciplinary home-care team supports him; some literature says severely affected babies may not live past three. Now 16, he will start at ITE next year.《海峡时报》“医学谜团”系列（2026年10月17日）：母亲孕29周时高烧42°C，紧急剖腹产下Jarren，他一出生即因肌张力低下进入新生儿重症监护室，需要呼吸和喂养支持。竹脚妇幼医院基因组医学科顾问医生Koh Ai Ling说，团队做了血液检查、脑部影像、肌肉活检、肌电图和基因检测，最终是神经传导检查提示“先天性髓鞘形成不良性神经病”（CHN）：外周神经的髓鞘发育不正常，神经信号传导变慢或受阻。CHN在活产儿中发生率不到百万分之一，没有常规产前筛查；Jarren的基因检测未找到致病原因。他两岁前靠鼻胃管喂食，之后装上胃造口（PEG）和气管造口，依赖呼吸机，每年做睡眠监测和显微喉支气管镜检查，6岁时已经历14次手术。竹脚妇幼医院多学科居家护理团队为他提供支持；部分文献称重症患儿可能活不过3岁。如今16岁的Jarren明年将进入工艺教育学院（ITE）。

Why it matters: 为何重要：Even when genetic tests come back empty, a careful nerve study can name a rare disorder — and long-term team care can let a child beat grim odds.即使基因检测找不到原因，细致的神经检查也能确诊罕见病；长期的团队照护能让孩子跨越悲观的预期。

The Straits Times ↗ · r-2026-10-st-jarren-ng-congenital-hypomyelinating-neuropathy-kkh-ventilator-n-levels-cybersecurity

Singapore MOH opens a voluntary TCM Accreditation Programme for clinics and practitioners (run by the Academy of Chinese Medicine) and a second TCM Integrative Sandbox call from 3 Nov for public-hospital trials of evidence-based TCM新加坡卫生部推出自愿性中医认证计划（由新加坡中医学院负责，覆盖中医诊所和中医师），并自11月3日起开放第二轮“中医综合沙盒”征集，供公立医院试验循证中医疗法

MOH press release (17 Oct 2026): from 17 Oct TCM service providers and practitioners can apply for accreditation under two pillars — services (governance, hygiene and infection control, medication preparation and dispensing, incident management) and practitioners (qualifications, clinical experience, standing with the TCM Practitioners Board). The Academy of Chinese Medicine, Singapore (ACMS) is the accrediting body. A second TCM Integrative Sandbox (TCMIS) open call runs 3 Nov 2026 to 2 Nov 2029; seven projects from the 2025 first call are under way, including acupuncture for post-stroke rehabilitation, cancer supportive care, migraine, knee osteoarthritis, female infertility and drug-resistant epilepsy.卫生部新闻稿（2026-10-17）：自10月17日起，中医服务机构和中医师可申请认证，分两大支柱——服务认证（治理、卫生与感染控制、药物调配与配发、事故管理等）和医师认证（学历、临床年资、在中医管理委员会的执业状况等）。新加坡中医学院（ACMS）为认证机构。第二轮“中医综合沙盒”（TCMIS）公开征集期为2026年11月3日至2029年11月2日；2025年首轮选出的7个项目正在进行，包括针灸用于中风后康复、癌症支持治疗、偏头痛、膝骨关节炎、女性不孕和难治性癫痫。

Why it matters: 为何重要：Brings quality benchmarks and hospital-based evidence-building to TCM, widely used by Singapore's ethnic-Chinese majority.为新加坡华人多数群体广泛使用的中医引入质量标准，并在医院内积累证据。

Ministry of Health Singapore ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-moh-tcm-accreditation-programme-acms-second-tcm-integrative-sandbox-call-nov3

India FSSAI prosecutes Priyagold maker Surya Food for using cattle-feed bran as biscuit fibre, Dodla Dairy over detergent/caustic soda in milk, and Ueir Organic over pesticide-laden raisins — plus notices to three other operators印度FSSAI对Priyagold制造商Surya Food用牛饲料麸皮作饼干纤维提起检控，并对Dodla乳业牛奶检出洗涤剂／烧碱、Ueir有机葡萄干农药超标提起检控——另对3家经营者发出通知

Business Standard / FSSAI (17 Oct 2026): the regulator said it opened prosecutions against Surya Food & Agro (Priyagold) after inspectors found bran labelled for cattle feed used as fibre unfit for human consumption, plus hygiene, pest-control and storage failures; against Dodla Dairy after full-cream milk was found substandard for fat and unsafe for detergent/caustic soda on referral-lab appeal; and against Ueir Organic Foods after yellow raisins exceeded Thiamethoxam and Fluopyram metabolite limits. Notices went to Narpadham Foods, Sun Ridges Health Carers and Sha Kantilal Jayantilal for licence, hygiene and documentation gaps.《商业标准报》／印度食品安全标准局（2026-10-17）：监管机构称已对Surya Food & Agro（Priyagold）提起检控，因检查发现将标示供牛用的麸皮用作人体不宜食用的纤维，并存在卫生、虫害与仓储问题；对Dodla乳业提起检控，因全脂牛奶脂肪不达标，复议送检检出洗涤剂／烧碱；对Ueir Organic Foods提起检控，因黄葡萄干噻虫嗪与氟吡菌胺代谢物超标。另对Narpadham Foods、Sun Ridges Health Carers和Sha Kantilal Jayantilal就许可证、卫生与文件问题发出通知。

Why it matters: 为何重要：A nationwide food-safety crackdown that puts hospital and school canteens on notice as well as branded snacks.全国性食品安全整治，涵盖品牌零食以及医院和学校食堂供应链。

Business Standard (FSSAI) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-india-fssai-priyagold-cattle-feed-bran-prosecution-dodla-detergent-milk

Mumbai: Maharashtra FDA suspends Sodexo's food-business licence for Fortis Hospital Mulund kitchen after finding cockroaches in prep areas, clogged drains, fungus-hit meal containers and rusted knives孟买：马哈拉施特拉邦FDA因备餐区蟑螂、下水道堵塞、送餐容器发霉及锈蚀刀具，暂停索迪斯运营的Fortis Hospital Mulund厨房食品经营许可

Hindustan Times (17 Oct 2026): state FDA suspended the on-premise kitchen licence held by Sodexo India Services at Fortis Hospital, Mulund, after an inspection found cockroaches in food-preparation areas, food waste clogging drains, fungus-infested containers used to transport meals and rusted knives. Fortis said patient safety is paramount, directed the third-party provider to fix issues, and is arranging alternative safe meals. The action is part of a wider Mumbai crackdown that also suspended Sophia College for Women canteen's licence the same day.《印度斯坦时报》（2026-10-17）：马哈拉施特拉邦FDA检查后暂停索迪斯印度服务公司在Mulund的Fortis医院院内厨房许可，发现备餐区有蟑螂、食物残渣堵塞下水道、运送餐食的容器发霉以及使用锈蚀刀具。Fortis表示患者安全至上，已责令第三方供应商整改，并安排替代安全供餐。同日行动还暂停了Sophia女子学院食堂许可，属孟买更广食品安全整治的一部分。

Why it matters: 为何重要：Hospital food hygiene failures put already-ill patients at direct infection risk.医院餐饮卫生失效使本已患病的患者直接面临感染风险。

Hindustan Times (Maharashtra FDA) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-mumbai-fortis-mulund-kitchen-fda-suspends-sodexo-licence-cockroaches-fungus

India's first public dengue vaccination drive begins: Tamil Nadu launches a Qdenga (Takeda TAK-003) pilot in high-incidence Kadayanallur, Tenkasi district, with ICMR scientists to study impact before wider rollout印度首个公共登革热疫苗接种行动启动：泰米尔纳德邦在高发地区登卡西县卡达亚纳卢尔试点接种Qdenga（武田TAK-003），印度医学研究理事会科学家将评估效果后再扩大推广

The New Indian Express (19 Oct 2026): Tamil Nadu Health Minister K.G. Arunraj launched the pilot on Saturday 17 Oct. He said two doses three months apart give about 80% protection, that CDSCO has approved the vaccine for ages 4–60, and that no Indian state had used it before. Two ICMR scientists will study the vaccination's impact in Kadayanallur; expansion to other Tamil Nadu districts will be announced after an inspection report, and the minister said the findings would guide the whole country. Tamil Nadu reported 21,655 dengue cases and 10 deaths by 7 Oct (InfectionIndia/ISAMID). Note: the 80% figure is the minister's statement; published Qdenga trial efficacy varies by serotype and serostatus.《新印度快报》（2026-10-19）：泰米尔纳德邦卫生部长K.G. Arunraj于10月17日（周六）启动试点。他表示间隔三个月接种两剂可提供约80%保护，印度中央药品标准控制组织已批准该疫苗用于4–60岁人群，此前尚无印度邦使用。两名ICMR科学家将在卡达亚纳卢尔评估接种效果；待检查报告提交后再宣布扩展至泰米尔纳德邦其他县，部长称研究结果将为全国提供指导。截至10月7日泰米尔纳德邦报告登革热21,655例、死亡10例（InfectionIndia/ISAMID）。注：80%为部长表述；已发表的Qdenga试验效力因血清型和既往感染状态而异。

Why it matters: 为何重要：A first step toward vaccine-based dengue control in the country with one of the world's largest dengue burdens.在全球登革热负担最重的国家之一，迈出以疫苗防控登革热的第一步。

The New Indian Express ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-tamil-nadu-kadayanallur-tenkasi-india-first-dengue-vaccination-drive-qdenga-pilot

India notifies a 30% trade-margin cap on 137 non-scheduled anti-cancer drugs, cutting retail prices by up to 70%; new MRPs take effect 9 November印度正式公告对137种非目录抗癌药实施30%流通加价上限，零售价最多降低70%；新最高零售价11月9日起生效

The Hindu and Indian Express (17–19 Oct 2026): the National Pharmaceutical Pricing Authority's Gazette notification of 17 Oct applies trade margin rationalisation under paragraph 19 of DPCO 2013 to 137 drugs recommended by a DGHS expert committee of oncologists and hospital specialists; the list will be updated periodically. It builds on the 2019 pilot covering 42 cancer drugs, after which MRPs of 526 brands fell by up to 90%. Revised prices are based on March 2026 price-to-stockist data; manufacturers must report revised prices within seven days, and the cap covers combinations, patented formulations and hospital supplies. Access campaigners caution that hospitals may shift costs to consumables, diagnostics and consultations. This formalises the in-principle approval reported on 8 Oct.《印度教徒报》及《印度快报》（2026-10-17至19）：国家药品定价局10月17日发布政府公报，依据《2013年药品价格控制令》第19段，对由卫生服务总局肿瘤及医院专家委员会推荐的137种药品实施流通加价合理化，名单将定期更新。此举延续2019年覆盖42种抗癌药的试点，当时526个品牌的最高零售价降幅最高达90%。新价格以2026年3月的出厂至经销商价格为基础；生产商须在7天内报备调整后价格，上限适用于复方、专利制剂和医院直供。药品可及性倡导者提醒，医院可能把成本转移到耗材、检查和诊疗费上。此举正式落实10月8日报道的原则性批准。

Why it matters: 为何重要：Could make immunotherapies and targeted cancer drugs markedly cheaper for millions of Indian patients.有望令数以百万计的印度患者显著降低免疫治疗和靶向抗癌药的费用。

The Hindu; Indian Express; NPPA Gazette notification ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-india-nppa-gazette-137-anti-cancer-drugs-30pct-trade-margin-prices-nov9

Taiwan CDC: 3.15 million publicly funded flu shots given 1–16 Oct (+15.8% on last year) and 988,000 COVID-19 shots (+39.7%); Pingtung leads with 42.1% of over-65s and 41.3% of preschoolers vaccinated台湾疾管署：10月1日至16日公费流感疫苗已接种315万剂（较去年同期增15.8%），新冠疫苗98.8万剂（增39.7%）；屏东县65岁以上长者及学龄前幼儿接种率分别达42.1%及41.3%居首

TVBS / Taiwan CDC briefing (17 Oct 2026): Deputy Director-General Lin Ming-cheng said 3,151,137 flu doses were given from 1 to 16 Oct versus 2,721,826 a year earlier (+15.8%). Over-65 coverage was highest in Pingtung (42.1%), Changhua and Lienchiang (42%) and Chiayi County (40.7%); preschool coverage highest in Pingtung (41.3%), Penghu and Chiayi County (40.3%); healthcare workers reached 55.5%. COVID-19 doses totalled 988,347 versus 707,347 (+39.7%). CDC had announced on 13 Oct extra procurement of nearly 500,000 flu and COVID doses, including 174,000 Novavax XFG doses expected from mid-November (logged earlier).TVBS／台湾疾管署记者会（2026-10-17）：副署长林明诚表示，10月1日至16日流感疫苗接种3,151,137剂，去年同期为2,721,826剂（增15.8%）。65岁以上接种率以屏东42.1%最高，彰化及连江42%，嘉义县40.7%；学龄前幼儿以屏东41.3%最高，澎湖及嘉义县40.3%；医事人员达55.5%。新冠疫苗接种988,347剂，去年同期707,347剂（增39.7%）。疾管署已于10月13日宣布追加采购近50万剂流感及新冠疫苗，其中Novavax XFG疫苗17.4万剂最快11月中旬提供（此前已收录）。

Why it matters: 为何重要：Strong early uptake matters as Taiwan's flu season runs ahead of normal and severe cases lag the case curve.台湾本季流感提前到来、重症滞后于病例曲线，早期高接种率尤为关键。

TVBS News (Taiwan CDC briefing) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-taiwan-cdc-flu-vax-3151137-up-15-8pct-covid-988347-pingtung-tops-oct17

Vietnam: Ho Chi Minh City school meningococcal B cluster grows to four (one death) as a 12-year-old close contact tests positive; Health Ministry orders 10-day contact monitoring and targeted antibiotics, warns against self-medicating越南：胡志明市学校B群脑膜炎球菌聚集疫情增至4例（1例死亡），一名12岁密切接触者检测阳性；卫生部下令对接触者监测10天并定向预防性服药，警告勿自行用药

VOV (17 Oct 2026, 23:20): the Ministry of Health said three Grade 7 pupils born in 2014 at Hai Ba Trung Secondary School, Hiep Phuoc Commune, fell ill between 14 and 16 Oct; one died and two are isolated at the Hospital for Tropical Diseases. HCMC's Department of Health then reported a fourth case on 17 Oct — a 12-year-old boy in close contact with a confirmed case, with high fever, headache, sore throat, muscle aches and petechiae; blood PCR was positive for serogroup B meningococcus and he also tested positive for influenza B; he is stable. The Department of Preventive Medicine directed the Pasteur Institute HCMC to investigate; close contacts at school and home are monitored for 10 days and given prophylactic antibiotics per medical guidance; the school is being cleaned, disinfected and ventilated. Updates the 3-case report logged on 16 Oct.越南之声（2026-10-17 23:20）：卫生部称，协福社雄王中学（Hai Ba Trung）3名2014年出生的七年级学生于10月14日至16日发病，1人死亡，2人在热带病医院隔离治疗。胡志明市卫生厅随后于10月17日报告第4例——一名12岁男孩，为确诊者密切接触者，出现高热、头痛、咽痛、肌肉酸痛及皮下出血点；血液PCR检出B群脑膜炎球菌，同时乙型流感阳性，目前病情稳定。预防医学局指示胡志明市巴斯德研究所开展调查；学校及家庭密切接触者监测10天，并依医嘱给予预防性抗生素；学校正在清洁消毒并加强通风。本条更新10月16日收录的3例报道。

Why it matters: 为何重要：A fast-moving, often fatal infection among schoolchildren — and a sign of secondary spread to contacts.学童中进展迅速、常可致命的感染——并出现向接触者二代传播的迹象。

VOV (Vietnam Ministry of Health / HCMC Department of Health) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-hcmc-meningococcal-b-4th-case-hai-ba-trung-school-moh-warning-oct17

India: ICMR chief Rajiv Bahl says a home-grown Kyasanur Forest Disease ('monkey fever') vaccine developed with Indian Immunologicals is ready for human trials and an ICMR-partnered dengue vaccine is in Phase 3 (medium — interview claims)印度：印度医学研究理事会（ICMR）总干事拉吉夫·巴尔称，与印度免疫制品公司合作研发的国产基萨那森林病（“猴热”）疫苗已可进入人体试验，ICMR参与研发的登革热疫苗处于III期（中等可信度——采访表态）

ETV Bharat (18 Oct 2026) interview with Dr Rajiv Bahl, ICMR Director General and Secretary of the Department of Health Research, at AIIMS Gorakhpur's annual Research Day on Saturday 17 Oct: the dengue vaccine developed with a pharmaceutical partner is in Phase 3 clinical trials; the KFD vaccine, developed with Indian Immunologicals Ltd for a tick-borne illness that has spread across five states around Karnataka and caused deaths, is ready for human trials. Bahl claimed India is the first country to develop vaccines for both diseases and said ICMR's research budget is about ₹5,000 crore. Flag: medium confidence — statements come from a media interview; no trial registration details or timelines were given.ETV Bharat（2026-10-18）专访印度医学研究理事会总干事兼卫生研究部秘书拉吉夫·巴尔博士（10月17日周六出席全印医学科学研究所戈勒克布尔分院年度科研日）：与制药伙伴合作研发的登革热疫苗正在进行III期临床试验；与印度免疫制品有限公司合作研发的基萨那森林病疫苗——针对一种已蔓延至卡纳塔克周边五个邦并造成死亡的蜱传疾病——已可开展人体试验。巴尔称印度是首个同时研发这两种疾病疫苗的国家，并表示ICMR科研经费约500亿卢比（₹5,000 crore）。标记：中等可信度——表态来自媒体采访，未提供试验注册信息或时间表。

Why it matters: 为何重要：Vaccines for neglected tropical infections that mainly affect South Asia could fill gaps global pharma has left.针对主要影响南亚的被忽视热带感染的疫苗，有望填补全球药企留下的空白。

ETV Bharat (interview with ICMR DG Rajiv Bahl) ↗ · r-2026-10-icmr-bahl-dengue-vaccine-ph3-kfd-monkey-fever-vaccine-human-trials

Nature Communications: Fujian Medical University-led team's EBVScan maps antibodies to Epstein–Barr virus at epitope level across 42 strains; responses to a TK protein segment (139–194) separate nasopharyngeal cancer from controls with AUC 0.97《自然·通讯》：福建医科大学牵头团队开发EBVScan，在42种EB病毒株范围内绘制表位级抗体图谱；针对TK蛋白139–194区段的抗体应答区分鼻咽癌与对照的AUC达0.97

Nature Communications (online 17 Oct 2026; DOI 10.1038/s41467-026-78818-w), with Xiamen University and Shanghai Jiao Tong University: quantitative phage display tested IgA/IgG responses to tiled EBV proteome fragments from 42 isolates. In multicentre validation, antibodies against TK residues 139–194 distinguished nasopharyngeal carcinoma (NPC) from controls with an AUC of 0.97; baseline antibody signatures were linked to chemotherapy response and progression-free survival. Response regions enriched in healthy carriers overlapped viral receptor-binding interfaces, and peptides from them reduced EBV infection in vitro. Caveat: accuracy must be confirmed in large prospective screening, and the anti-infection peptides are lab-stage only.《自然·通讯》（2026-10-17在线；DOI 10.1038/s41467-026-78818-w），合作单位厦门大学、上海交通大学：研究用定量噬菌体展示检测来自42株EB病毒、切分为片段的病毒蛋白组的IgA/IgG应答。多中心验证中，针对TK蛋白139–194位的抗体区分鼻咽癌与对照的AUC为0.97；患者基线抗体签名还与化疗应答及无进展生存相关。在健康携带者中富集的应答区段与病毒受体结合界面重叠，由其筛选的多肽在体外减少EB病毒感染。提示：准确性需在大规模前瞻性筛查中确认，抗感染多肽仍处实验室阶段。

Why it matters: 为何重要：Nasopharyngeal cancer is especially common in southern China; a sharper blood test could improve screening and treatment planning.鼻咽癌在华南尤为高发；更精细的血液检测有望改进筛查和治疗分层。

Nature Communications (Fujian Medical University / Xiamen University / SJTU); Biocloudy summary ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-fjmu-xmu-sjtu-ebvscan-epitope-antibody-map-npc-auc-097-natcommun

Singapore's NUHS pharmacogenomics pilot has now tested more than 4,000 patients: every one carried at least one drug-relevant gene variant, and one in five had a variant predicting an unusual response to a medicine they had been prescribed新加坡国立大学卫生系统药物基因组学试点已检测逾4,000名患者：每人至少携带一个与用药相关的基因变异，五分之一的人携带可预测其所用药物出现异常反应的变异

The Straits Times (16 Oct 2026) reported on the National University Health System's pre-emptive pharmacogenomics (PPGx) clinical implementation pilot, which analyses variants in 16 genes that affect responses to commonly prescribed drugs. Recruitment began in 2023 with a target of 1,000 patients; with funding from PRECISE (Precision Health Research, Singapore) more than 4,000 have now been tested. Every patient carried at least one genetic variant, and one in five had a variant that could predict an atypical response to one of their prescribed medications. Cardiology specialist pharmacist Doreen Tan said more than 60% of locals carry variants affecting the antiplatelet drug clopidogrel, and that people with very poor gene function are about 10 times more likely to have a recurrent cardiac event. One heart-attack patient who became breathless on ticagrelor was switched to clopidogrel after testing showed it would work for him. The team is calling for subsidies so results sit in patients' records before drugs are needed.《海峡时报》（2026年10月16日）报道了新加坡国立大学卫生系统（NUHS）的“预先药物基因组学”（PPGx）临床实施试点，该项目分析16个影响常用药物反应的基因变异。项目于2023年开始招募，原定目标1,000人；在新加坡精准健康研究机构（PRECISE）资助下，目前已有逾4,000人接受检测。每名患者都至少携带一个基因变异，五分之一的人携带可预测其所用某种药物出现非典型反应的变异。心脏专科药剂师Doreen Tan表示，超过60%的本地人携带影响抗血小板药氯吡格雷的变异，基因功能极差者再次发生心脏事件的可能性约高10倍。一名服用替格瑞洛后出现气促的心肌梗死患者，经检测确认氯吡格雷对其有效后改用该药。团队呼吁提供补贴，使检测结果在需要用药前就已存入病历。

Why it matters: 为何重要：CYP2C19 loss-of-function variants that blunt clopidogrel are far more common in East Asians, including Chinese, than in Europeans — so testing before prescribing matters especially in Asia.削弱氯吡格雷疗效的CYP2C19功能缺失变异在包括中国人在内的东亚人群中远比欧洲人常见——因此用药前检测在亚洲尤为重要。

The Straits Times (NUHS) ↗ · r-2026-10-nuhs-pre-emptive-pharmacogenomics-pilot-4000-patients-all-carry-variant-1-in-5-atypical-drug-response-clopidogrel

Diabetes pills called SGLT2 inhibitors linked to better recovery after stroke clot removal: in 429 diabetic patients in Korea, Switzerland and Italy, 65% of those prescribed them were living independently at three months versus 45% of othersSGLT2抑制剂类降糖药与脑卒中取栓后恢复更好相关：韩国、瑞士和意大利429名糖尿病患者中，服用者3个月时65%可独立生活，未服用者为45%

Kim Jeong-min (Seoul National University Hospital) and Yang Wook-jin (Asan Medical Center) led a retrospective study of 429 diabetic patients who underwent endovascular thrombectomy for acute ischaemic stroke between January 2020 and March 2025 at four centres in Korea, Italy (Bologna) and Switzerland (Lausanne), published in Stroke (announced 16 Oct 2026). Mean age was 73.5 and median NIHSS 12 (moderate-to-severe). After adjustment, the 51 patients discharged on SGLT2 inhibitors had less disability at three months (median mRS 2 vs 3; common OR 2.31, 95% CI 1.30–4.10), and 65.1% versus 45.3% were functionally independent (mRS 0–2; OR 2.26, 1.15–4.43). Results held with propensity-score methods and across subgroups. SGLT2 prescribing in the cohort rose from 4.5% in 2020 to 21.1% in 2024–25. The authors call for prospective trials.首尔大学医院金廷敏教授与峨山医院杨旭镇教授团队回顾分析了2020年1月至2025年3月在韩国、意大利（博洛尼亚）和瑞士（洛桑）4家中心因急性缺血性脑卒中接受血管内取栓的429名糖尿病患者，结果发表于《Stroke》（2026年10月16日公布）。患者平均年龄73.5岁，NIHSS中位数12分（中重度）。校正后，出院时服用SGLT2抑制剂的51名患者3个月残疾程度更轻（mRS中位数2分对3分；共同OR 2.31，95% CI 1.30–4.10），功能独立（mRS 0–2）比例为65.1%对45.3%（OR 2.26，1.15–4.43）。倾向评分等方法及各亚组分析结果一致。队列中SGLT2抑制剂处方率从2020年的4.5%升至2024–25年的21.1%。作者呼吁开展前瞻性试验。

Why it matters: 为何重要：There are almost no drugs that help the brain recover after a stroke; if confirmed in trials, a cheap, widely used diabetes drug could change discharge prescribing — but this is observational and only 51 patients took it.目前几乎没有帮助脑卒中后大脑恢复的药物；若经试验证实，一种廉价、常用的降糖药可能改变出院用药——但这是观察性研究，且仅51名患者服用。

Seoul National University Hospital ↗ · r-2026-10-snuh-amc-sglt2-inhibitors-diabetic-stroke-after-thrombectomy-independence-65-1-vs-45-3pct-429-pts-stroke

Actor Colin Farrell launches a foundation for adults with developmental disabilities, inspired by his 20-year-old son James, who has the rare genetic disorder Angelman syndrome; his biggest fear is who will look after James when his parents are gone演员科林·法瑞尔为发育障碍成年人成立基金会，灵感来自其20岁的儿子詹姆斯——詹姆斯患有罕见遗传病天使综合征；他最大的担忧是父母离世后谁来照顾詹姆斯

In an interview with People (reported by Dublin Live, 16 Oct 2026), Colin Farrell, 50, said he is launching the Colin Farrell Foundation in honour of his eldest son James, 20, who has Angelman syndrome, a rare neurogenetic disorder affecting movement, speech and cognitive development. He said James 'works incredibly hard' to reach everyday milestones and is 'a really well-adjusted, really happy young man', but that turning 20 prompted the family to think about the next chapter. His fear is that if something happens to James's mother or to him, James might have to move into residential care with nobody to visit him. The foundation plans advocacy, education and programmes to build independence for adults with intellectual disabilities, including a summer camp.据Dublin Live（2026年10月16日）援引《人物》杂志专访报道，50岁的科林·法瑞尔表示，他将以长子、20岁的詹姆斯之名成立科林·法瑞尔基金会；詹姆斯患有天使综合征，这是一种影响运动、言语和认知发育的罕见神经遗传病。他说詹姆斯“极其努力”才能达到日常发育里程碑，是“一个适应得很好、非常快乐的年轻人”，而年满20岁促使全家思考人生的下一阶段。他担心，若詹姆斯的母亲或他本人遭遇不测，詹姆斯可能不得不住进照护机构，而无人前去探望。基金会将为智力障碍成年人开展倡导、教育和促进独立生活的项目，包括开办夏令营。

Why it matters: 为何重要：Angelman syndrome is usually caused by loss of the maternal copy of the UBE3A gene on chromosome 15 and most cases are not inherited; as children with rare genetic disorders grow up, adult services are a gap in China and Asia too.天使综合征通常由15号染色体上来自母亲的UBE3A基因拷贝缺失或失活引起，多数病例并非遗传自父母；随着罕见遗传病患儿长大成人，成人服务的缺口在中国和亚洲同样存在。

Dublin Live (People interview) ↗ · r-2026-10-colin-farrell-son-james-angelman-syndrome-age-20-foundation-adults-developmental-disabilities

Australian researchers use a transformer AI, the architecture behind ChatGPT, to read DNA for stroke risk: it found 18 variants linked to ischaemic stroke, flagged the gene EDEM2, and beat earlier genetic risk tools in UK and US data澳大利亚研究者用ChatGPT同类的Transformer人工智能读取DNA评估中风风险：发现18个与缺血性中风相关的变异，提示EDEM2基因的作用，并在英美数据中优于既往遗传风险工具

Yue (Eric) Yang, Kairui Guo, Jie Lu and colleagues at the University of Technology Sydney, with Liverpool Hospital neurologist Dennis Cordato, reported a transformer model trained on genetic variants that accounts for their genomic location and interactions ('Predicting risk of ischaemic stroke: A transformer model using genomic data'; UTS release 16 Oct 2026, covered by Euronews 20 Oct). Tested on UK Biobank and the US All of Us database, it distinguished people with and without stroke more accurately than previous genetic risk tools. It identified 18 variants associated with ischaemic stroke; people in the highest genetic-risk group had a 22% higher chance of stroke than the lower-risk group. EDEM2 expression in brain cortex emerged as a key contributor. The team is building a multimodal tool that adds clinical and lifestyle data and has proposed a preventive trial.悉尼科技大学Yue (Eric) Yang、Kairui Guo、Jie Lu等与利物浦医院神经科医生Dennis Cordato合作，构建了一个考虑变异基因组位置及相互作用的Transformer模型（论文《Predicting risk of ischaemic stroke: A transformer model using genomic data》；悉尼科技大学2026年10月16日发布，欧洲新闻台10月20日报道）。在英国生物银行和美国All of Us数据库中，该模型区分中风与非中风人群的准确性优于既往遗传风险工具。研究识别出18个与缺血性中风相关的变异；最高遗传风险组的中风几率比低风险组高22%。脑皮层中EDEM2的表达被认为是关键因素。团队正开发结合临床和生活方式数据的多模态工具，并已提出预防性临床试验方案。

Why it matters: 为何重要：Genetics is rarely part of stroke-risk checks today; tools like this could help families of young stroke patients know their own risk — though the models were trained mainly on non-Asian data.目前中风风险评估很少纳入遗传因素；此类工具可帮助年轻中风患者家属了解自身风险——但模型主要基于非亚洲人群数据训练。

University of Technology Sydney; Euronews ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-uts-transformer-genomic-model-ischaemic-stroke-risk-18-variants-edem2-uk-biobank-all-of-us

First in mainland China: Ruijin Hainan Hospital in the Boao Lecheng pilot zone implants Abbott's second-generation AVEIR AR2 — a leadless pacemaker that paces the right atrium — in a 61-year-old woman with sinus node dysfunction, through a vein in the thigh and without open surgery中国大陆首例：位于博鳌乐城先行区的瑞金海南医院为一名61岁窦房结功能障碍女性患者植入雅培第二代AVEIR AR2心房无导线起搏器，经大腿静脉微创植入，无需开胸

On 16 Oct 2026, a team led by Wu Liqun, head of cardiology at Shanghai Ruijin Hospital, with Ruijin Hainan Hospital (Hainan Boao Research Hospital) staff, implanted the AVEIR AR2 in a patient who had suffered repeated dizziness and near-blackouts for two years and was diagnosed with sinus arrest; post-operative pacing parameters were reported as ideal. It is the first clinical use of this device in mainland China. Most leadless pacemakers already marketed in China pace only the ventricle or offer VDD mode, so they cannot provide true atrial pacing for sinus node dysfunction; the hospitals describe AR2 as the world's first and only implantable leadless pacemaker for right atrial pacing. Compared with the first-generation device introduced at the hospital earlier, AR2 has a larger battery (about 22.4% more capacity and roughly 25% longer expected life, per DrVoice), which should mean fewer replacement procedures. Ruijin Hainan said the Lecheng pilot-zone policy allows international devices to be used before mainland approval.2026年10月16日，上海瑞金医院心内科主任吴立群团队联合瑞金海南医院（海南博鳌研究型医院）团队，为一名两年来反复头晕、偶有黑矇并确诊窦性停搏的患者植入AVEIR AR2，术后各项起搏指标均达理想状态。这是该器械在中国大陆的首次临床应用。国内已上市的无导线起搏器多为单心室起搏或VDD模式，无法为窦房结功能障碍患者提供真正的心房起搏；医院称AR2是全球首个且目前唯一可提供右心房起搏的植入式无导线起搏器。与此前在该院落地的第一代产品相比，AR2电池容量更大（据严道医声网，容量提升约22.4%、预期寿命延长约25%），有望减少更换手术。瑞金海南医院表示，乐城先行区政策让国际创新器械可先行先试。

Why it matters: 为何重要：Leadless devices avoid lead fractures and pocket infections; an atrial option extends that benefit to the large group of patients whose problem is the heart's natural pacemaker.无导线起搏器可避免导线故障和囊袋感染；心房型产品把这一好处扩展到窦房结功能障碍这一大类患者。

Institutions: 机构：Ruijin瑞金

Hainan Health Net (海南健康网); DrVoice (严道医声网) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-ruijin-hainan-first-mainland-aveir-ar2-atrial-leadless-pacemaker-sinus-node-dysfunction

Singapore opens CIPHER, its first centre dedicated to stem-cell research on the Asian heart: blood samples from patients are reprogrammed into iPS cells and beating heart cells to model inherited cardiomyopathies and test drugs, building on more than 40 patient-derived disease models at the National Heart Centre新加坡启用首个专注“亚洲人心脏”干细胞研究的中心CIPHER：把患者血样重编程为iPS细胞并分化成会跳动的心肌细胞，用于模拟遗传性心肌病等疾病和测试药物；中心以国家心脏中心已建立的40多个患者来源疾病模型为基础

The Straits Times (16 Oct 2026): the Centre for Integrative Human Cell Research and Translation (CIPHER) was launched by Senior Minister of State for Health Tan Kiat How at the NHCS Heart to Heart Gala. Deputy director Chrishan Ramachandra said Asian patients develop heart disease earlier, have different symptoms and tend to fare worse than Western patients, yet models have been built largely on animals and Western biology; CIPHER turns a 5 ml blood sample into induced pluripotent stem cells. NHCS's library of more than 40 patient-derived models covers heart failure, arrhythmogenic disorders (rare inherited conditions in which heart-muscle cells fail to stick together) and cardiomyopathy. Director Derek Hausenloy said the platforms can show which patients are likely to respond to a drug without exposing them to it, and Singapore's Chinese, Malay and Indian populations allow ethnic-specific study. With Medera, CIPHER is developing 'Human Heart-in-a-Jar', a fingertip-sized bioengineered ventricle described as a first in Asia. About 23 people a day die of heart disease and stroke in Singapore. SingHealth Duke-NUS also announced a S$2.5 million Tong Ming Chuan Professorship in Cardiothoracic Surgery.《海峡时报》（2026年10月16日）：“人类细胞综合研究与转化中心”（CIPHER）由卫生部高级政务部长陈杰豪在国家心脏中心慈善晚宴上启用。副主任Chrishan Ramachandra说，亚洲患者发病更早、症状不同、预后往往更差，但过去的研究模型大多基于动物和西方人群生物学；CIPHER可把5毫升血样重编程为诱导多能干细胞。国家心脏中心已有40多个患者来源模型，涵盖心衰、致心律失常性疾病（心肌细胞无法正常黏附的罕见遗传病）和心肌病。主任Derek Hausenloy说，这些平台可在不让患者用药的情况下预判谁可能对药物有反应，新加坡华族、马来族和印度族人群也便于开展族群特异性研究。CIPHER与Medera合作开发指尖大小的生物工程心室“人类心脏罐”，被称为亚洲首个。新加坡每天约23人死于心脏病和中风。新保集团杜克—国大学术医学中心同时宣布设立250万新元的“Tong Ming Chuan心胸外科教授席位”。

Why it matters: 为何重要：Drugs and dosing tested on Western biology do not always fit Asian hearts; patient-derived cells let researchers check that before treatment.基于西方人群开发的药物和剂量未必适合亚洲人的心脏；患者来源细胞让研究者能在治疗前先行验证。

Institutions: 机构：Duke-NUS杜克—国大

The Straits Times ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-nhcs-cipher-asian-heart-ipsc-centre-40-patient-disease-models-heart-in-a-jar-medera

Seoul National University of Science and Technology: AI adapted from electronic-stethoscope recordings detects abnormal lung sounds in children from smartphone audio (AUROC 0.911; 0.862 in an independent cohort) — a screening proof of concept首尔科技大学：从电子听诊器录音迁移训练的AI可通过手机录音识别儿童异常肺音（AUROC 0.911；独立队列0.862）——属筛查概念验证

Medical Xpress / SeoulTech release (16 Oct 2026; IEEE Journal of Biomedical and Health Informatics; Seong-Eun Kim, Seunggyu Jeong): electronic-stethoscope lung recordings came from 611 children aged 0–6, 147 of whom also had paired smartphone recordings at the same four chest sites, plus 48 smartphone-only children for external validation. Smartphone audio was low-pass filtered at 1 kHz and downsampled to 4 kHz, and a directional MixStyle module in an Audio Spectrogram Transformer made stethoscope data look 'smartphone-like'. On smartphone recordings the model reached F1 0.802 and AUROC 0.911, beating smartphone-only (0.732) and naive pooling (0.708); on the external cohort it reached F1 0.744 / AUROC 0.862, while a stethoscope-only model collapsed (AUROC 0.388). Larger, real-world, multi-phone validation is needed before clinical use.Medical Xpress/首尔科技大学新闻稿（2026-10-16；《IEEE生物医学与健康信息学杂志》；Seong-Eun Kim、Seunggyu Jeong）：数据包括611名0–6岁儿童的电子听诊器肺音，其中147人在相同4个胸部部位同时有手机录音，另有48名仅手机录音的儿童用于外部验证。手机音频经1 kHz低通滤波并降采样至4 kHz，并在音频频谱Transformer中加入定向MixStyle模块，使听诊器数据更“像手机”。在手机录音上模型F1为0.802、AUROC 0.911，优于仅用手机数据（0.732）和简单合并（0.708）；外部队列F1 0.744、AUROC 0.862，而仅用听诊器训练的模型几乎失效（AUROC 0.388）。临床应用前仍需更大规模、真实场景、多机型验证。

Why it matters: 为何重要：Parents could one day screen a coughing child's chest at home and share it with a doctor — but this is still early.未来家长或可在家用手机给咳嗽的孩子“听肺”并发给医生——但目前仍处早期。

Medical Xpress (SeoulTech; IEEE JBHI) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-seoultech-smartphone-lung-sounds-children-domain-adaptive-auroc-0911-jbhi

Shanghai Renji Hospital completes post-approval CLDN18.2 CAR-T (CT041, satri-cel) treatment in three advanced gastric-cancer patients; all had stable disease at first scan and one came off drainage tubes and resumed eating (hospital report)上海仁济医院完成3例晚期胃癌患者CLDN18.2 CAR-T（CT041，舒瑞基奥仑赛）上市后全程治疗，首次影像评估均为病情稳定，其中一人拔除引流管恢复进食（医院报道）

China News Service Shanghai (16 Oct 2026): Prof Xiao Xiuying's oncology team at Renji Hospital (Shanghai Jiao Tong University) completed cell collection, manufacturing, infusion and first imaging assessment for three advanced gastric-cancer patients treated with commercially approved CT041, an autologous CAR-T targeting CLDN18.2 described as the first CAR-T approved for a solid tumour. All three had stable disease at first evaluation. One patient with widespread peritoneal metastases, heavy ascites and partial bowel obstruction after several lines of therapy had nasointestinal and abdominal drains removed and resumed normal eating; CA19-9 fell from 1,467 to 190 U/mL. Renji says it has the most patients worldwide to complete this treatment and first assessment. Medium confidence: hospital-reported, three patients, early follow-up.中新网上海（2026-10-16）：上海交通大学医学院附属仁济医院肿瘤科肖秀英教授团队为3例晚期胃癌患者完成上市后CT041治疗的细胞采集、制备、回输及首次影像学评价。CT041是靶向CLDN18.2的自体CAR-T产品，报道称为全球首款获批用于实体瘤的CAR-T。三例首次评价均为病情稳定。其中一位广泛腹膜转移、大量腹水和不完全性肠梗阻、经多线治疗仍进展的患者，在CAR-T及支持治疗后先后拔除鼻肠减压管和腹腔引流管，恢复正常进食；CA19-9由1467 U/mL降至190 U/mL。仁济称其为全球完成该治疗及首次疗效评估患者最多的中心。中等可信度：医院自报、仅3例、随访尚短。

Why it matters: 为何重要：Early real-world use of the first solid-tumour CAR-T — small numbers, but a meaningful quality-of-life gain for one very ill patient.首款实体瘤CAR-T的早期真实世界应用——例数虽少，但为一位重症患者带来了实际的生活质量改善。

China News Service Shanghai (中新网上海) ↗ · r-2026-10-renji-ct041-satricabtagene-post-marketing-3-gastric-cancer-pts-stable-disease-ca199-1467-190

Preprint: the monkey brain flips about 15 times a second between representing the image it consciously sees and the one it suppresses — even while perception stays steady (Hesse, Tsao et al., bioRxiv; not yet peer reviewed)预印本：猴脑在知觉保持不变时，仍以每秒约15次的频率在“意识到的图像”与“被压制的图像”之间切换表征（Hesse、曹颖等，bioRxiv；尚未同行评审）

bioRxiv (posted 16 Oct 2026; Janis K. Hesse, Doris Y. Tsao and colleagues): Neuropixels recordings across face patches in inferotemporal and prefrontal cortex during binocular flash suppression, where one of two continuously shown images is consciously seen and the other suppressed. Activity alternated about 15 times per second between 'conscious' and 'suppressed' micro-epochs; in conscious epochs a pure signal allowed the seen face to be reconstructed from neural activity, and in suppressed epochs the hidden face could be reconstructed. Single neurons switched selectivity accordingly, though feature tuning was stronger in conscious epochs. The authors argue conscious access needs selection in time, not just location. Medium confidence: preprint, not yet peer reviewed.bioRxiv（2026-10-16上线；Janis K. Hesse、曹颖等）：研究在双眼闪光抑制范式下（两幅图像持续呈现，一幅被意识到、另一幅被压制）用Neuropixels记录猴下颞叶与前额叶多个面孔区。神经活动以每秒约15次在“意识”与“压制”微时段间交替；意识时段可从神经活动重建被看见的面孔，压制时段则可重建被隐藏的面孔。单个神经元随之切换选择性，但意识时段的特征调谐更强。作者认为意识通达需要时间上的选择，而不仅是脑区定位。中等可信度：预印本，尚未同行评审。

Why it matters: 为何重要：A fresh clue on how awareness arises — timing, not just which brain area is active.为“意识如何产生”提供新线索——关键或在时间，而不仅是哪个脑区活跃。

bioRxiv ↗ · r-2026-10-biorxiv-hesse-tsao-conscious-suppressed-alternation-15hz-neuropixels-face-patches-preprint

JAMA Network Open (eSTEPS): letting primary-care clinics prescribe a 10-minute home strength-and-balance routine from the health record cut recorded falls by about 9% among 11,945 at-risk adults aged 65+《JAMA网络开放》（eSTEPS试验）：让基层诊所通过电子病历开具每次约10分钟的居家力量与平衡训练，11945名有跌倒风险的65岁以上成人记录在案的跌倒减少约9%

Medical Daily (17 Oct 2026) on the trial published 16 Oct (Brigham and Women's Hospital, Harvard, UTMB, Mass General Brigham; NCT04993781): 22 primary-care practices; when patients screened positive for fall risk, clinicians saw a non-interruptive alert and order set for tailored exercises simplified from the Otago programme (four levels, seated by default, no equipment). Falls were 19.3 vs 21.2 per 100 patient-years and fall injuries 15.7 vs 16.7; about 29 patients needed to be covered for two years to prevent one fall, with no serious adverse events. Limits: only about 22% actually received a prescription, adherence wasn't tracked, falls came from diagnosis codes, and it was one health system.Medical Daily（2026-10-17）报道10月16日发表的试验（布莱根妇女医院、哈佛、得州大学医学分部、麻省总医院布莱根；NCT04993781）：22家基层诊所中，患者跌倒风险筛查阳性时，医生会看到非打断式提醒和医嘱模板，可开具源自Otago方案的简化居家训练（四个难度，默认坐姿，无需器械）。跌倒为每100人年19.3次对21.2次，跌倒相关损伤15.7对16.7；约29人覆盖两年可预防一次跌倒，未见严重不良事件。局限：仅约22%患者实际获得处方、未追踪是否锻炼、跌倒依据诊断编码、仅在一个医疗系统开展。

Why it matters: 为何重要：A low-cost nudge in the medical record helps keep older people on their feet — modest, but easy to scale.病历中的低成本提醒帮助老人少摔跤——效果温和，但容易推广。

Medical Daily (JAMA Network Open) ↗ · r-2026-10-jama-netw-open-esteps-ehr-home-otago-exercise-falls-19-3-vs-21-2-per-100py-11945-older-adults

Japan flu: 1,703 nurseries and schools closed classes, grades or whole schools in the week of 5–11 Oct — about five times the 328 a year earlier; 4,793 facilities so far this season日本流感：10月5–11日一周内全国1,703所托儿所和学校实施停课（班级/年级/全校）——约为去年同期328所的5倍；本季累计4,793所

MHLW influenza-like illness school report No. 6 (published 16 Oct 2026, week 41): 1,703 facilities took action that week — 31 whole-school closures, 333 grade closures and 1,339 class closures — covering 82,483 enrolled pupils with 24,490 patients. Season totals since 31 Aug: 4,793 facilities, 236,369 enrolled, 67,537 patients. Same week last year: 328 facilities. The largest weekly counts were in Chiba (146), Saitama (134), Tokyo (99) and Osaka (93); Yokohama city alone reported 76.厚生劳动省流感样疾病学校报告第6报（2026-10-16发布，第41周）：当周1,703所设施采取措施——全校停课31所、年级停课333所、班级停课1,339所，涉及在籍学生82,483人、患者24,490人。自8月31日起本季累计4,793所、在籍236,369人、患者67,537人。去年同期为328所。当周最多的是千叶（146）、埼玉（134）、东京（99）和大阪（93）；仅横滨市就有76所。

Why it matters: 为何重要：School closures are an early, hard signal that Japan's unusually early flu season is spreading fast among children.停课是硬指标，表明日本异常提早的流感季正在儿童中快速扩散。

MHLW / JIHS influenza-like illness school report (No. 6) ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-japan-mhlw-flu-school-closures-w41-1703-facilities-vs-328-last-year-4793-season

FOP: UMass Chan team designs an allele-selective siRNA that silences only the mutant ACVR1 R206H gene, and a single two-in-one molecule also hitting IL-1β; both cut bone forming in muscle in FOP mice (Nat Commun)进行性骨化性纤维发育不良（FOP）：美国马萨诸塞大学陈医学院设计只沉默突变ACVR1 R206H基因的等位基因选择性siRNA，以及同时靶向IL-1β的“二合一”单分子；两者均减少FOP小鼠肌肉内异位成骨（《自然·通讯》）

Nature Communications (published 16 Oct 2026; Yang, Gross, Cooper et al.; corresponding Julia Alterman and Jae-Hyuck Shim): FOP is mainly caused by the dominant ACVR1 R206H mutation, which triggers heterotopic ossification after inflammatory flare-ups. A docosanoic-acid-conjugated siRNA targeting R206H while sparing wild-type ACVR1, alone or with an IL-1β siRNA, reduced heterotopic bone in mice in both post-trauma and preventive dosing, and the combination worked better. A lipophilic divalent molecule carrying both sequences matched the combined monovalent forms after local and systemic dosing. Treatment dampened inflammatory, WNT, Notch, Hedgehog and TGF-β signalling in fibro-adipogenic progenitors. Mouse data only; patents filed.《自然·通讯》（2026-10-16发表；Yang、Gross、Cooper等，通讯作者Julia Alterman与Jae-Hyuck Shim）：FOP主要由显性ACVR1 R206H突变引起，炎症发作后诱发异位骨化。偶联二十二烷酸的siRNA特异靶向R206H而保留野生型ACVR1，单用或联合IL-1β siRNA，在损伤后给药和预防给药两种策略下均减少小鼠异位骨，联合更优。携带两条序列的亲脂双价分子在局部和全身给药后与两种单价药联用效果相当。治疗抑制了纤维脂肪生成祖细胞中的炎症、WNT、Notch、Hedgehog和TGF-β信号。目前仅为小鼠数据，已申请专利。

Why it matters: 为何重要：A precise 'silence only the broken copy' approach for a dominant genetic disease that turns muscle into bone.针对把肌肉变成骨头的显性遗传病，提出“只沉默坏拷贝”的精准思路。

Nature Communications; Biocloudy ↗Access limited in certain regions部分地区可能无法访问 · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-umass-allele-selective-sirna-acvr1-r206h-il1b-divalent-fop-mice-natcommun

Singapore NEA to send Transboundary Haze Pollution Act preventive notices to seven Indonesian firms linked to fires — deploy firefighters, stop burning, submit action plans (Grace Fu; catch-up)新加坡国家环境局将依据《跨境烟霾污染法》向7家与火点相关的印尼公司发出预防性通知——要求派员灭火、停止燃烧并提交行动计划（傅海燕；补录）

CNA / Business Times (16 Oct 2026): Sustainability Minister Grace Fu said NEA will issue notices under the Transboundary Haze Pollution Act to PT Bumi Andalas Permai, PT Bumi Mekar Hijau, PT Paramitra Mulia Langgeng, PT Sumatera Alam Anugerah, PT SBA Wood Industries, PT Hutan Lestari Raya and PT Bangkanesia. Notices require firefighting deployment, no burning on owned/occupied land, and action plans to extinguish fires and prevent recurrence. Several are linked to South Sumatra / Bangka Belitung timber plantations; three APP-linked firms also faced 2015 notices. Fu offered civilian firefighting and cloud-seeding help to Indonesia and said fines or charges remain options if warranted.CNA／《商业时报》（2026-10-16）：可持续发展与环境部长傅海燕表示，国家环境局将依据《跨境烟霾污染法》向PT Bumi Andalas Permai、PT Bumi Mekar Hijau、PT Paramitra Mulia Langgeng、PT Sumatera Alam Anugerah、PT SBA Wood Industries、PT Hutan Lestari Raya和PT Bangkanesia发出通知，要求派员灭火、不得在自有或占用土地上燃烧，并提交灭火与防再发行动计划。多家与南苏门答腊／邦加-勿里洞林业种植园相关；其中三家与APP有关的公司在2015年烟霾危机中也曾收通知。傅海燕向印尼提出民用灭火与人工增雨协助，并表示必要时罚款或起诉仍是选项。

Why it matters: 为何重要：Singapore's strongest named-company haze enforcement step this season, aimed at fire sources beyond its borders.新加坡本季最明确的点名企业烟霾执法步骤，指向境外火源。

CNA (Grace Fu / NEA); The Business Times ↗ · China-reachable alternative国内可访问替代链接 ↗ · r-2026-10-sg-nea-transboundary-haze-act-notices-seven-indonesian-firms-grace-fu